"","X.2","X.1","...1","X","PG.ProteinGroups","PG.Genes","short.name","GO","sub.cell","description","GO.ID","ConditionNorm_P_0_1","ConditionNorm_P_0_2","ConditionNorm_P_0_3","ConditionNorm_P_150_1","ConditionNorm_P_150_2","ConditionNorm_P_150_3","logFC","AveExpr","t","P.Value","adj.P.Val","B","mass","neglog.adj.P.Val.","TotalPeptidesOverallInGene","P0_Undetected","P150_Undetected","medians_.ConditionNorm_P_0_1_ConditionNorm_P_0_2_ConditionNorm_P_0_3","medians_.ConditionNorm_P_150_1_ConditionNorm_P_150_2_ConditionNorm_P_150_3","Ratio","Ratio_log2"
"1",1,2,2,2,"P61247","RPS3A","RS3A_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03122, ECO:0000269|PubMed:17289661}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03122}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.","40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)","GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0022627; GO:0030154; GO:0043066; GO:0048027; GO:0070062; GO:1990904",3.47272381175392e-06,1e-07,1e-07,0.0137835069422885,0.014004195854657,0.0139780506143327,0.0139206935624888,0.00696157102251499,191.596544910111,1.2475184370221e-09,5.3393789104546e-06,12.5301032430566,29945,5.27250925822423,8,2,0,1e-07,0.0139780506143327,139780.506143327,17.0928036502336
"2",2,3,3,3,"O43312","MTSS1","MTSS1_HUMAN","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","Metastasis suppressor protein 1 (Metastasis suppressor YGL-1) (Missing in metastasis protein)","GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013",1e-07,1e-07,1e-07,0.0524461678380948,0.0519641695429614,0.0531548212412645,0.0525216195407736,0.0262609097703868,157.057279322128,2.93618599659115e-09,6.76076803332627e-06,11.4834449378016,82251,5.17000396475529,5,3,0,1e-07,0.0524461678380948,524461.678380948,19.0004778355529
"3",3,5,5,5,"P62380","TBPL1","TBPL1_HUMAN","cytoplasm [GO:0005737]; transcription factor TFIIA complex [GO:0005672]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.","TATA box-binding protein-like protein 1 (TBP-like protein 1) (21 kDa TBP-like protein) (Second TBP of unique DNA protein) (STUD) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein)","GO:0000978; GO:0000981; GO:0001077; GO:0001675; GO:0003713; GO:0005672; GO:0005737; GO:0006235; GO:0006352; GO:0006366; GO:0007289; GO:0045944",1e-07,1e-07,1e-07,0.0780440172778372,0.0783611299476151,0.0765258660312932,0.0776435710855818,0.0388218855427909,142.06586342786,4.52253255180545e-09,6.76076803332627e-06,10.9541934819423,20887,5.17000396475529,4,3,0,1e-07,0.0780440172778372,780440.172778372,19.5739285163208
"4",4,10,10,10,"O15020","SPTBN2","SPTN2_HUMAN","apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; spectrin [GO:0008091]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; axon guidance [GO:0007411]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; ER to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; multicellular organism growth [GO:0035264]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cell cortex.","Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)","GO:0000165; GO:0003779; GO:0005088; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0006888; GO:0007411; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0019886; GO:0021692; GO:0030054; GO:0030534; GO:0035264; GO:0043025; GO:0045296; GO:0051693",1e-07,0.00010598849850618,1e-07,0.0221601984959531,0.022201255265048,0.0227679118382602,0.022341059033585,0.0112059256829612,115.143730481293,1.11754015799778e-08,9.56614375246099e-06,9.84416837289779,271325,5.01926309718019,70,2,0,1e-07,0.022201255265048,222012.55265048,17.7602817236907
"5",5,12,12,12,"P14735","IDE","IDE_HUMAN","cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; ubiquitin recycling [GO:0010992]","SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Secreted {ECO:0000250}. Note=Present at the cell surface of neuron cells. The membrane-associated isoform is approximately 5 kDa larger than the known cytosolic isoform.","Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)","GO:0001540; GO:0001618; GO:0004222; GO:0005102; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006508; GO:0006625; GO:0008270; GO:0008286; GO:0008340; GO:0009986; GO:0010815; GO:0010992; GO:0016887; GO:0031597; GO:0031626; GO:0032461; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043559; GO:0045732; GO:0045861; GO:0050435; GO:0051260; GO:0051289; GO:0051291; GO:0051603; GO:0097242; GO:0140036; GO:1901142; GO:1901143",1e-07,1.62536767164862e-05,1e-07,0.0731544137500375,0.0759248963785487,0.0745902623315806,0.0745510395944834,0.0372810043561472,96.6347077040644,2.37637077298111e-08,1.69514448472652e-05,8.91722195714355,117968,4.77079327902716,16,2,0,1e-07,0.0745902623315806,745902.623315806,19.5086277751197
"6",6,13,13,13,"P47756","CAPZB","CAPZB_HUMAN","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; barbed-end actin filament capping [GO:0051016]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; ER to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril, sarcomere {ECO:0000250}.","F-actin-capping protein subunit beta (CapZ beta)","GO:0003779; GO:0005829; GO:0005856; GO:0005884; GO:0006888; GO:0007010; GO:0007596; GO:0008290; GO:0010591; GO:0015629; GO:0019886; GO:0022604; GO:0030017; GO:0030036; GO:0045296; GO:0051015; GO:0051016; GO:0051490; GO:0070062; GO:0071203",9.25272817276245e-05,0.00051825984407085,6.03203935480555e-05,0.0480859621203014,0.0463317875773475,0.0469968817643623,0.0469145079808882,0.0236809564968929,91.3389499099534,3.02888346972191e-08,1.76068014921297e-05,8.61895540415476,31350,4.75431953219197,15,0,0,9.25272817276245e-05,0.0469968817643623,507.92459139466,8.98847051414147
"7",7,14,14,14,"Q96B54","ZNF428","ZN428_HUMAN","metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]",NA,"Zinc finger protein 428 (Enzyme-like protein PIT13)","GO:0003676; GO:0046872",0.00026135065379903,0.00018183947663466,0.00053605450629791,0.165810440717696,0.172100796999935,0.166983732007965,0.167971908362955,0.0843123690603879,90.1015499272707,3.21204927257422e-08,1.76068014921297e-05,8.54676294690465,20481,4.75431953219197,3,0,0,0.00026135065379903,0.166983732007965,638.926015989116,9.31950507471053
"8",8,15,15,15,"Q96S90","LYSMD1","LYSM1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]",NA,"LysM and putative peptidoglycan-binding domain-containing protein 1","GO:0005634; GO:0005654",4.51956484368904e-05,1e-07,1e-07,0.0932829921447841,0.0966847035069641,0.0934793689322642,0.0944672229785252,0.0472487433720749,88.8576622658579,3.41012761540439e-08,1.76068014921297e-05,8.47318265423934,25003,4.75431953219197,3,2,0,1e-07,0.0934793689322642,934793.689322642,19.8342884691334
"9",9,17,17,17,"Q9UJ41","RABGEF1","RABX5_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein targeting to membrane [GO:0006612]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12505986}. Early endosome {ECO:0000269|PubMed:12505986}. Recycling endosome {ECO:0000269|PubMed:12505986}.","Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5)","GO:0003677; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006897; GO:0008270; GO:0017112; GO:0017137; GO:0031901; GO:0055037",0.00032846293568318,0.00117624982647159,0.00030259721043964,0.0283914575949019,0.0283383797167254,0.0288529118086565,0.0279251463825631,0.014565009848813,87.4032935442869,3.66118400931824e-08,1.76068014921297e-05,8.38583026755215,79371,4.75431953219197,11,0,0,0.00032846293568318,0.0283914575949019,86.4373252216408,6.43358252398923
"10",10,18,18,18,"Q86Y82","STX12","STX12_HUMAN","early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Endosome membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Golgi apparatus membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Endomembrane system {ECO:0000305}; Single-pass type IV membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Early endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000305}. Recycling endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}.","Syntaxin-12","GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038",1e-07,1e-07,1e-07,0.11478563959383,0.110721628132487,0.114918488445117,0.113475152057144,0.0567376760285722,85.4665520386547,4.03190969406643e-08,1.76068014921297e-05,8.26721514804784,31642,4.75431953219197,3,3,0,1e-07,0.11478563959383,1147856.3959383,20.1305107323947
"11",11,19,19,19,"Q8IWT6","LRRC8A","LRC8A_HUMAN","cell surface [GO:0009986]; cytoplasm [GO:0005737]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; anion transport [GO:0006820]; cell volume homeostasis [GO:0006884]; pre-B cell differentiation [GO:0002329]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transmembrane transport [GO:0055085]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24782309, ECO:0000269|PubMed:24790029, ECO:0000269|PubMed:26824658}; Multi-pass membrane protein {ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24782309, ECO:0000269|PubMed:24790029}. Note=The leucine-rich repeat (LRR) domain is on the cytoplasmic side of the cell membrane. {ECO:0000269|PubMed:24782309}.","Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (Swelling protein 1)","GO:0002329; GO:0005225; GO:0005737; GO:0005886; GO:0006820; GO:0006884; GO:0006970; GO:0007165; GO:0009986; GO:0016020; GO:0034702; GO:0042802; GO:0055085",1e-07,1e-07,1e-07,0.0581044373580106,0.0593711376008541,0.0568960599277814,0.0581237782955487,0.0290619891477744,84.3323806044688,4.27055196061424e-08,1.76068014921297e-05,8.19649560711456,94199,4.75431953219197,12,3,0,1e-07,0.0581044373580106,581044.373580106,19.1482888189607
"12",12,20,20,20,"P48634","PRRC2A","PRC2A_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15752841}. Nucleus {ECO:0000269|PubMed:15752841}.","Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)","GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062",0.00026755833299417,0.00039544508483622,0.00042645004558821,0.0841925222245985,0.0878487393352495,0.0864068651831615,0.0857862244265303,0.043256263367738,83.5967340067027,4.43467890547266e-08,1.76068014921297e-05,8.15011389601634,228863,4.75431953219197,28,0,0,0.00039544508483622,0.0864068651831615,218.505346245354,7.77152476884751
"13",13,21,21,21,"Q5VTL8","PRPF38B","PR38B_HUMAN","precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)","GO:0003723; GO:0006397; GO:0008380; GO:0071011",1e-07,1e-07,1e-07,0.0588398431189271,0.0606572538306174,0.0581752991202659,0.0592240320232702,0.0296121160116351,82.7785993344676,4.62643851232165e-08,1.76068014921297e-05,8.09804847338421,64468,4.75431953219197,4,3,0,1e-07,0.0588398431189271,588398.431189271,19.1664338744652
"14",14,23,23,23,"Q9Y3I1","FBXO7","FBX7_HUMAN","classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Note=Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria.","F-box only protein 7","GO:0000151; GO:0000209; GO:0000422; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043687; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:2000134",0.0015629129678563,1.32254608741598e-05,1.69098068040687e-05,0.103665333658607,0.0996342455362633,0.101468947640864,0.101058492866733,0.0510602625118782,82.2631344989673,4.75251440482932e-08,1.76068014921297e-05,8.06497921399558,58503,4.75431953219197,5,0,0,1.69098068040687e-05,0.101468947640864,6000.59768964654,12.5508904922072
"15",15,24,24,24,"Q9P0J7","KCMF1","KCMF1_HUMAN","cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]",NA,"E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (RING-type E3 ubiquitin transferase KCMF1) (ZZ-type zinc finger-containing protein 1)","GO:0003676; GO:0005576; GO:0005829; GO:0008270; GO:0016740; GO:0043312; GO:1904813",0.00014148227843341,0.00152335114328638,0.00022464304483378,0.068738642163282,0.0712989905338348,0.0705933348916595,0.0695804970407409,0.0354200740092216,81.5404448640635,4.93648639966253e-08,1.76068014921297e-05,8.01826424589888,41945,4.75431953219197,5,0,0,0.00022464304483378,0.0705933348916595,314.246697216438,8.29575377154221
"16",16,25,25,25,"Q14318","FKBP8","FKBP8_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; FK506 binding [GO:0005528]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; chaperone-mediated protein folding [GO:0061077]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16176796}. Mitochondrion membrane {ECO:0000305}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 1: Mitochondrion membrane {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane {ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.","Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase)","GO:0001708; GO:0001933; GO:0003755; GO:0005528; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0061077; GO:0097718",0.00103262810879975,0.00041218841173132,0.00038041899589778,0.178598338606027,0.174029215905572,0.170594318397465,0.173798879130878,0.0875078514042488,77.4582738753421,6.15773912121548e-08,2.10840987510418e-05,7.74634300299124,44562,4.67604495835861,9,0,0,0.00041218841173132,0.174029215905572,422.207929559676,8.72180986421771
"17",17,26,26,26,"P51513","NOVA1","NOVA1_HUMAN","intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; chemical synaptic transmission [GO:0007268]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA metabolic process [GO:0051252]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus.","RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Onconeural ventral antigen 1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1)","GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005730; GO:0006396; GO:0007268; GO:0007626; GO:0008380; GO:0043231; GO:0051252",1e-07,1.85729913603878e-05,1.74308305717775e-06,0.0208275094362251,0.0210960766232593,0.0218243510853692,0.0212425070234787,0.0106280588698785,73.6563240436446,7.64703070768068e-08,2.51763780222102e-05,7.47985530304537,52056,4.59900674913331,7,1,0,1.74308305717775e-06,0.0210960766232593,12102.7374664614,13.5630457809844
"18",18,27,27,27,"Q9BWM7","SFXN3","SFXN3_HUMAN","integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; iron ion homeostasis [GO:0055072]","SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000269|Ref.4}; Multi-pass membrane protein {ECO:0000269|Ref.4}.","Sideroflexin-3","GO:0005739; GO:0015075; GO:0016021; GO:0031966; GO:0055072",1e-07,1e-07,1e-07,0.0457283412290855,0.0450244098861572,0.0472676721846241,0.0460067077666223,0.0230034538833111,72.001129399707,8.43281327253065e-08,2.61167654324387e-05,7.35950692372737,35503,4.5830806115405,9,3,0,1e-07,0.0457283412290855,457283.412290855,18.8027290615464
"19",19,28,28,28,"Q9ULJ7","ANKRD50","ANR50_HUMAN","endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]","SUBCELLULAR LOCATION: Endosome {ECO:0000305}.","Ankyrin repeat domain-containing protein 50","GO:0005768; GO:0015031; GO:1990126",4.57745622530722e-05,0.00028182501407652,5.61321594644236e-05,0.0616020699121031,0.0647094680202797,0.062724824927278,0.0628842103746223,0.0315700157659091,71.5315799926489,8.67362950787763e-08,2.61167654324387e-05,7.32486168431955,155859,4.5830806115405,29,0,0,5.61321594644236e-05,0.062724824927278,1117.44899048526,10.1259932611682
"20",20,29,29,29,"Q86UU1","PHLDB1","PHLB1_HUMAN","basal cortex [GO:0045180]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]",NA,"Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha)","GO:0010470; GO:0010717; GO:0045180; GO:0070507; GO:1904261",5.35007749572897e-05,0.00016158962806725,0.00015075558179247,0.0829422386641533,0.085213475477771,0.08103459650432,0.0829414882204758,0.0415926927718435,71.2015582573691,8.84796959743836e-08,2.61167654324387e-05,7.30037486828924,151162,4.5830806115405,13,0,0,0.00015075558179247,0.0829422386641533,550.176900105308,9.10375175726758
"21",21,31,31,31,"O43924","PDE6D","PDE6D_HUMAN","cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; response to stimulus [GO:0050896]; visual perception [GO:0007601]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:9712853}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:9712853}; Peripheral membrane protein {ECO:0000269|PubMed:9712853}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:24166846}.","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)","GO:0004114; GO:0005095; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0017137; GO:0030659; GO:0031410; GO:0050896",1.88009331196325e-06,1e-07,0.00218056602812153,0.114991721868111,0.120055779398874,0.119545870400377,0.117470275181976,0.0594626529647992,69.0049924145471,1.01253030520054e-07,2.79589013306988e-05,7.13444236951542,17420,4.55347989856977,3,1,0,1.88009331196325e-06,0.119545870400377,63585.072953397,15.9564005019195
"22",22,32,32,32,"Q9Y6D9","MAD1L1","MD1L1_HUMAN","centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]","SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:22351768}. Nucleus envelope {ECO:0000269|PubMed:22351768}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:22351768}. Note=Detected at the nucleus envelope during interphase (PubMed:22351768). From the beginning to the end of mitosis, it is seen to move from a diffusely nuclear distribution to the centrosome, to the spindle midzone and finally to the midbody. Detected at kinetochores during prometaphase (PubMed:22351768). Colocalizes with NEK2 at the kinetochore (PubMed:14978040). Colocalizes with IK at spindle poles during metaphase and anaphase (PubMed:22351768). {ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:22351768}.","Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)","GO:0000776; GO:0000777; GO:0000922; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235",0.00528534687999708,1e-07,1e-07,0.128444485203157,0.127836331558838,0.125339284990199,0.125444851624066,0.064484274772032,65.0227014087881,1.30765657753694e-07,3.35303546489607e-05,6.81966999188222,83067,4.47456185303488,10,2,0,1e-07,0.127836331558838,1278363.31558838,20.2858664831579
"23",23,33,33,33,"Q96CX2","KCTD12","KCD12_HUMAN","cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260]","SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}.","BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain)","GO:0003723; GO:0030054; GO:0042734; GO:0042802; GO:0045211; GO:0051260",1e-07,1e-07,3.71722704243115e-05,0.131455500822337,0.125370945533637,0.131809303516011,0.129532792533853,0.0647788536904015,64.3118791321487,1.3709906459325e-07,3.35303546489607e-05,6.76146171864883,35701,4.47456185303488,11,2,0,1e-07,0.131455500822337,1314555.00822337,20.3261430828515
"24",24,34,34,34,"Q06455","RUNX1T1","MTG8_HUMAN","nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; generation of precursor metabolites and energy [GO:0006091]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00440, ECO:0000269|PubMed:10973986}. Note=Colocalizes with ATN1 in discrete nuclear dots.","Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2)","GO:0003677; GO:0003700; GO:0003714; GO:0005654; GO:0006091; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872",1e-07,1e-07,1e-07,0.405755255732936,0.390670457487173,0.412817087667939,0.40308083362935,0.201540516814675,64.0335621921355,1.39681497990279e-07,3.35303546489607e-05,6.73849526443954,67566,4.47456185303488,4,3,0,1e-07,0.405755255732936,4057552.55732936,21.9521783513944
"25",25,36,36,36,"Q75VX8","GAREM2","GARE2_HUMAN",NA,NA,"GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like)",NA,0.00011287854182737,8.72306945267435e-05,6.58712073448228e-05,0.0472854076455631,0.044865461962646,0.0468991841889557,0.0462613577844886,0.0232193390401439,63.8922630326542,1.41015510205909e-07,3.35303546489607e-05,6.7267971577356,92882,4.47456185303488,10,0,0,8.72306945267435e-05,0.0468991841889557,537.645429093508,9.070511235553
"26",26,41,41,41,"Q9HCG8","CWC22","CWC22_HUMAN","catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638}. Nucleus speckle {ECO:0000269|PubMed:22961380}. Note=Concentrates around speckles, which are sites of pre-mRNA synthesis and processing, where it colocalizes with EJC core proteins. {ECO:0000269|PubMed:22961380}.","Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb)","GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005829; GO:0016607; GO:0048024; GO:0071006; GO:0071007; GO:0071013",4.8924495418313e-05,0.00013030664553739,0.00049857415301172,0.0699025886323437,0.0699397488578563,0.0738553811439708,0.0710066377800678,0.035729253988023,55.8566739621581,2.51418666302043e-07,5.24913117937925e-05,6.01505769356201,105466,4.27991257378003,8,0,0,0.00013030664553739,0.0699397488578563,536.732018305144,9.06805814323362
"27",27,43,43,43,"Q24JP5","TMEM132A","T132A_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Transmembrane protein 132A (HSPA5-binding protein 1)","GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0043687; GO:0044267; GO:0070062",0.00409584655272037,0.00819962939744129,0.0106444181199801,0.15111602947003,0.145580357272988,0.151422668726637,0.141726387133171,0.0785098249232994,54.5972591066277,2.77331908216896e-07,5.52083984729448e-05,5.89430441366074,110110,4.25799485102054,13,0,0,0.00819962939744129,0.15111602947003,18.4296170162503,4.20395418568792
"28",28,45,45,45,"Q8NFZ8","CADM4","CADM4_HUMAN","cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2)","GO:0005102; GO:0005887; GO:0005913; GO:0007156; GO:0007157; GO:0008037; GO:0042803; GO:0050839",1e-07,1e-07,1e-07,0.135038353385351,0.143460208761724,0.143745759841508,0.140748007329528,0.0703741036647638,51.131172724398,3.67716244327337e-07,6.93166158950492e-05,5.54703472551513,42785,4.15916264812174,6,3,0,1e-07,0.143460208761724,1434602.08761724,20.4522192046031
"29",29,48,48,48,"Q9GZZ1","NAA50","NAA50_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16507339, ECO:0000269|PubMed:17502424, ECO:0000269|PubMed:25732826, ECO:0000269|PubMed:27422821}. Nucleus {ECO:0000269|PubMed:25732826}. Note=Localizes to the cytoplasm in interphase cells (PubMed:17502424). {ECO:0000269|PubMed:17502424}.","N-alpha-acetyltransferase 50 (hNaa50p) (EC 2.3.1.258) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)","GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0010485; GO:0034087; GO:0052858; GO:0070062; GO:0071962",0.00016769244575522,0.00211902099885777,0.0002934935093003,0.0552471652799759,0.0532396154384746,0.0564634515111862,0.0541233417585745,0.027921739863925,49.6015322919585,4.19022982135597e-07,7.47257651475148e-05,5.38623802742929,19398,4.126529629348,8,0,0,0.0002934935093003,0.0552471652799759,188.239819721013,7.55642803376807
"30",30,49,49,49,"O00571","DDX3X","DDX3X_HUMAN","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; transcription, DNA-templated [GO:0006351]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus speckle. Cytoplasm. Mitochondrion outer membrane. Note=Located predominantly in nuclear speckles and, at low levels, throughout the cytoplasm. Located to the outer side of nuclear pore complexes (NPC). Shuttles between the nucleus and the cytoplasm in a XPO1 and may be also in a NFX1-dependent manner. Associated with polyadenylated mRNAs in the cytoplasm and the nucleus. Predominantly located in nucleus during G(0) phase and in the cytoplasm during G1/S phase.","ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)","GO:0003677; GO:0003723; GO:0003924; GO:0004003; GO:0004004; GO:0005524; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005741; GO:0005829; GO:0006351; GO:0006413; GO:0007059; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016607; GO:0016887; GO:0017111; GO:0017148; GO:0030307; GO:0030308; GO:0031333; GO:0031369; GO:0032728; GO:0033592; GO:0034063; GO:0034774; GO:0035556; GO:0035613; GO:0042256; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0090263; GO:0097193; GO:1900087; GO:1903608; GO:1904813; GO:2001243",1e-07,9.26958052338398e-05,1e-07,0.11992402828366,0.111412395418168,0.115292216703035,0.115511914866543,0.0577869227016828,48.7091144209429,4.53047187161995e-07,7.91445698389118e-05,5.29012523004884,73243,4.10157887701005,6,2,0,1e-07,0.115292216703035,1152922.16703035,20.1368636902674
"31",31,50,50,50,"Q16718","NDUFA5","NDUA5_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}; Matrix side {ECO:0000305}.","NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit)","GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0032981",0.0148175377925867,0.0188069776364817,0.0174913455327015,0.076605657832326,0.0783575891493776,0.0782097910404747,0.0606857256868028,0.0473814831639914,48.3931503034753,4.65904058447007e-07,7.97627748061276e-05,5.25567447490308,13459,4.09819974609525,4,0,0,0.0174913455327015,0.0782097910404747,4.47134217857941,2.16070795528561
"32",32,52,52,52,"Q9H4M3","FBXO44","FBX44_HUMAN","cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; protein polyubiquitination [GO:0000209]",NA,"F-box only protein 44 (F-box protein FBX30) (F-box/G-domain protein 3)","GO:0000209; GO:0004842; GO:0005829; GO:0010498; GO:0019005; GO:0043687",0.00522866891745668,0.00265003308350982,0.00353120338371854,0.0959259176724397,0.100786707741967,0.0939369018472929,0.0930798739590049,0.0503432387743975,44.4900372785906,6.68823562528779e-07,0.0001100986479855,4.81056718884874,29747,3.95821801414395,3,0,0,0.00353120338371854,0.0959259176724397,27.1652202517502,4.76368883911065
"33",33,53,53,53,"Q96ST3","SIN3A","SIN3A_HUMAN","kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810, ECO:0000269|PubMed:16820529}. Nucleus, nucleolus {ECO:0000269|PubMed:16820529}. Note=Recruited to the nucleolus by SAP30L.","Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","GO:0000122; GO:0000776; GO:0000976; GO:0001102; GO:0001103; GO:0001106; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006351; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0031937; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678",0.00039845626386283,0.00030076051888541,0.0002587018677887,0.0899028610151859,0.0838765316217834,0.0838112867605584,0.0855442535823303,0.0430914330080108,43.9333329985222,7.06022918560809e-07,0.00011178066146623,4.74392746669137,145175,3.95163332475871,19,0,0,0.00030076051888541,0.0838765316217834,278.881456690598,8.12350820004665
"34",34,56,56,56,"O94813","SLIT2","SLIT2_HUMAN","cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]","SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10102268}. Note=The C-terminal cleavage protein is more diffusible than the larger N-terminal protein that is more tightly cell associated.","Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product]","GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288",1e-07,1e-07,1e-07,0.0396505125918014,0.0414110782143671,0.0430702491499975,0.0413771799853887,0.0206886899926943,43.465355236708,7.39282162230961e-07,0.00011300455908387,4.68725438288217,169870,3.94690403487916,17,3,0,1e-07,0.0414110782143671,414110.782143671,18.6596572408797
"35",35,58,58,58,"Q7Z5G4","GOLGA7","GOGA7_HUMAN","extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; tertiary granule lumen [GO:1904724]; Golgi to plasma membrane protein transport [GO:0043001]; neutrophil degranulation [GO:0043312]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:14522980, ECO:0000269|PubMed:16000296}; Lipid-anchor {ECO:0000269|PubMed:14522980, ECO:0000269|PubMed:16000296}.","Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa)","GO:0002178; GO:0005576; GO:0005795; GO:0006612; GO:0018230; GO:0031228; GO:0043001; GO:0043312; GO:0050821; GO:0070062; GO:1904724",1e-07,1e-07,1e-07,0.0666514238508866,0.0714511413218291,0.0722534292100638,0.0701185647942598,0.0350593823971299,41.5922553594756,8.93372856112336e-07,0.00013184951117795,4.45416302080338,15824,3.87992147598134,3,3,0,1e-07,0.0714511413218291,714511.413218291,19.4465975307711
"36",36,60,60,60,"Q53FT3","HIKESHI","HIKES_HUMAN","cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; Golgi organization [GO:0007030]; lung development [GO:0030324]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031]; regulation of cellular response to heat [GO:1900034]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9DD02}. Cytoplasm, cytosol {ECO:0000269|PubMed:22541429}. Nucleus {ECO:0000269|PubMed:22541429}.","Protein Hikeshi","GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0007030; GO:0008565; GO:0015031; GO:0030324; GO:0030544; GO:0034605; GO:1900034",3.38632335412007e-05,3.07103054855247e-05,6.17661132840814e-05,0.0212620012046211,0.0231539734036451,0.0227256407804243,0.0223384252454599,0.0112113258401669,40.4097586779705,1.01125649647638e-06,0.00013515545858903,4.30156465702242,21628,3.86916640954923,3,0,0,3.38632335412007e-05,0.0227256407804243,671.100730908479,9.39038551816018
"37",37,62,62,62,"Q12926","ELAVL2","ELAV2_HUMAN","nucleoplasm [GO:0005654]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription, DNA-templated [GO:0006355]",NA,"ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B) (HuB) (Nervous system-specific RNA-binding protein Hel-N1)","GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0006355",1e-07,1e-07,1e-07,0.0833879829661386,0.0890179261881929,0.0818046846031333,0.0847367645858216,0.0423684822929108,40.1666135801979,1.03782419058423e-06,0.00013515545858903,4.26963673926258,39504,3.86916640954923,5,3,0,1e-07,0.0833879829661386,833879.829661386,19.6694799664484
"38",38,63,63,63,"Q9H8M5","CNNM2","CNNM2_HUMAN","basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion homeostasis [GO:0010960]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2)","GO:0005524; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0043231",8.72492338699977e-05,0.00017516923407628,0.00033923818087563,0.0542065635434179,0.0553252701108509,0.0507620730898028,0.0532307500317499,0.0268159272321489,40.1570471382354,1.03888695484748e-06,0.00013515545858903,4.26837661807877,96623,3.86916640954923,8,0,0,0.00017516923407628,0.0542065635434179,309.452535025716,8.2735743302824
"39",39,65,65,65,"Q5TGI0","FAXC","FAXC_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","Failed axon connections homolog","GO:0016021",5.49520806298503e-05,4.84174379819211e-05,3.98511667076823e-05,0.0668477509189847,0.0730682248546805,0.0693126500417435,0.0696951350433631,0.0348953077501214,39.9809351556743,1.05869338988072e-06,0.00013515545858903,4.24512506274266,46843,3.86916640954923,9,0,0,4.84174379819211e-05,0.0693126500417435,1431.56376980592,10.4833762220854
"40",40,66,66,66,"O15173","PGRMC2","PGRC2_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; heme binding [GO:0020037]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6)","GO:0003707; GO:0005496; GO:0005635; GO:0016020; GO:0016021; GO:0020037",0.00010550711453626,0.0004249719407362,0.00026894867214045,0.0633324647802119,0.0597356562960523,0.0652671799685352,0.0625119577724622,0.0315224547953687,39.9515236485552,1.0620463278974e-06,0.00013515545858903,4.24123201379046,23818,3.86916640954923,3,0,0,0.00026894867214045,0.0633324647802119,235.481604263651,7.87947055120853
"41",41,67,67,67,"P42892","ECE1","ECE1_HUMAN","early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type II membrane protein.","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0070062",1e-07,1e-07,5.32810966519796e-06,0.148656764337501,0.142182287295146,0.155581280437905,0.148804934653629,0.0744043100300361,39.9094816390267,1.06686189638764e-06,0.00013515545858903,4.23566217411011,87164,3.86916640954923,3,2,0,1e-07,0.148656764337501,1486567.64337501,20.5035536811007
"42",42,68,68,68,"Q92993","KAT5","KAT5_HUMAN","NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; androgen receptor binding [GO:0050681]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to estradiol stimulus [GO:0071392]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone acetylation [GO:0016573]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein acetylation [GO:1901985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of growth [GO:0040008]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17360565}. Nucleus, nucleolus. Cytoplasm, perinuclear region. Note=Upon stimulation with EDN1, it is exported from the nucleus to the perinuclear region and UV irradiation induces translocation into punctuate subnuclear structures named nuclear bodies.","Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (cPLA(2)-interacting protein)","GO:0000122; GO:0000729; GO:0000812; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006302; GO:0006303; GO:0006351; GO:0006978; GO:0010212; GO:0016032; GO:0016407; GO:0016573; GO:0030521; GO:0032703; GO:0032777; GO:0035267; GO:0040008; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0050681; GO:0070491; GO:0071392; GO:1901985; GO:1904837",1e-07,1e-07,1e-07,0.0514601592481187,0.056258114936145,0.0533061943455744,0.0536747228432794,0.0268374614216397,39.8504855027499,1.07366485795031e-06,0.00013515545858903,4.22783634930599,58582,3.86916640954923,3,3,0,1e-07,0.0533061943455744,533061.943455744,19.0239436628133
"43",43,70,70,70,"Q07866","KLC1","KLC1_HUMAN","cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; stress granule disassembly [GO:0035617]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cell projection, growth cone {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000305|PubMed:14970196}.","Kinesin light chain 1 (KLC 1)","GO:0003774; GO:0003777; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0016020; GO:0016032; GO:0019886; GO:0030426; GO:0031410; GO:0035617",0.00019020606097077,0.00013813224766332,0.00017308526007906,0.0207757739430042,0.0189451808434405,0.0200432131546069,0.0197542481241128,0.0100442652516275,38.459821354787,1.25068005967179e-06,0.00015294030443986,4.03994694564226,65310,3.81547804964845,19,0,0,0.00017308526007906,0.0200432131546069,115.799653566409,6.8554871270503
"44",44,72,72,72,"Q9Y2H5","PLEKHA6","PKHA6_HUMAN",NA,NA,"Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3)",NA,1e-07,3.48140397027661e-06,1e-07,0.160489569770189,0.147958579427613,0.160988014764541,0.156477494186124,0.0782399742277188,38.090052143401,1.30367871308611e-06,0.0001549929136669,3.98885006155262,117128,3.80968815747947,15,2,0,1e-07,0.160489569770189,1604895.69770189,20.6140481088538
"45",45,73,73,73,"Q8IXH7","NELFCD","NELFD_HUMAN","membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Negative elongation factor C/D (NELF-C/D) (TH1-like protein)","GO:0003723; GO:0005654; GO:0006366; GO:0006368; GO:0016020; GO:0032021; GO:0045892",2.15085374508983e-05,0.00035648960185242,2.23872885759515e-05,0.0460596779136638,0.0425658478594055,0.0424216280379354,0.0435489227943752,0.0219079232064807,37.8150643319442,1.34489401733536e-06,0.00015770264093685,3.95052965840542,66247,3.80216103378142,9,0,0,2.23872885759515e-05,0.0425658478594055,1901.34002672972,10.8928008445338
"46",46,74,74,74,"O95297","MPZL1","MPZL1_HUMAN","cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; structural molecule activity [GO:0005198]; cell-cell signaling [GO:0007267]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Myelin protein zero-like protein 1 (Protein zero-related)","GO:0005198; GO:0005887; GO:0005925; GO:0007169; GO:0007267; GO:0009986",0.00104147433738215,9.42405655940191e-05,0.00015382686559655,0.0221613076199544,0.0235594171114995,0.02183976317725,0.0220903153800437,0.0114750049462128,37.5160824205416,1.39154240224195e-06,0.00016096760761069,3.90854980002473,29082,3.79326151062226,3,0,0,0.00015382686559655,0.0221613076199544,144.066561676411,7.17059170986985
"47",47,75,75,75,"Q9UHR5","SAP30BP","S30BP_HUMAN","intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15496587}.","SAP30-binding protein (Transcriptional regulator protein HCNGP)","GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006915; GO:0010942; GO:0045111",1e-07,1e-07,1e-07,0.0451267734965006,0.049483640693726,0.0462295700937348,0.0469465614279871,0.0234733807139936,37.2375718554713,1.43680193090864e-06,0.00016398699371437,3.86914386739755,33870,3.78519059574544,4,3,0,1e-07,0.0462295700937348,462295.700937348,18.818456420906
"48",48,76,76,76,"O15394","NCAM2","NCAM2_HUMAN","axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.","Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2)","GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802",7.28488764646994e-05,0.00011310106336496,0.00012898556905238,0.132596756062671,0.137624298216349,0.12492875335392,0.131611624041353,0.0659107905236371,36.9948418941699,1.47773364242208e-06,0.00016643947340964,3.83456067832883,93046,3.77874366692167,15,0,0,0.00011310106336496,0.132596756062671,1172.37408842746,10.1952172720035
"49",49,77,77,77,"Q9NQG5","RPRD1B","RPR1B_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II core binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22264791}.","Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor)","GO:0000993; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0008284; GO:0010564; GO:0016591; GO:0042795; GO:0042802; GO:0045944; GO:0070940",1e-07,1e-07,1e-07,0.0719777899008714,0.0663118227737577,0.0660650481350565,0.0681181202698952,0.0340591601349476,36.5968330138582,1.54800683406567e-06,0.00017209011038444,3.77736267241307,36900,3.76424408684196,9,3,0,1e-07,0.0663118227737577,663118.227737577,19.3389065866519
"50",50,80,80,80,"Q9HBE1","PATZ1","PATZ1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10713105}.","POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)","GO:0000978; GO:0000981; GO:0001077; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872",0.00015822748959571,0.00015977953885725,0.00016769049806011,0.306490298522909,0.303207901934068,0.279002806722751,0.296071769884405,0.148197784117707,35.4438397833821,1.77614649625014e-06,0.00019004767509876,3.6081065409255,74060,3.72113743886253,9,0,0,0.00015977953885725,0.303207901934068,1897.66414462467,10.8900089662943
"51",51,81,81,81,"Q9Y285","FARSA","SYFA_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q505J8}.","Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)","GO:0000049; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0016020; GO:0051290",0.00038040775857373,1e-07,1e-07,0.0289505306903067,0.027560745507659,0.0261903303038358,0.0274403329144093,0.0138470357100625,35.266579273477,1.81480038864096e-06,0.00019178631267613,3.58160085412269,57564,3.717182390603,20,2,0,1e-07,0.027560745507659,275607.45507659,18.0722553873577
"52",52,83,83,83,"Q9Y3C6","PPIL1","PPIL1_HUMAN","catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.","Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1)","GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718",2.26433162697624e-05,1.94523898647999e-05,3.32280383156579e-05,0.0124598163057496,0.0121786259546125,0.0112717504363201,0.0119449563174106,0.00599758607352206,34.4612369787423,2.00403680124168e-06,0.00020668138576661,3.45948712889435,18237,3.68469863523952,7,0,0,2.26433162697624e-05,0.0121786259546125,537.846391823608,9.0710503896997
"53",53,84,84,84,"O14730","RIOK3","RIOK3_HUMAN","cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22418843}.","Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)","GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0032463; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:1990786",0.0303340035042947,0.0124500873553358,0.0248953806503406,0.210361725971077,0.211890850641525,0.205396373033507,0.186656492712046,0.11588807019268,34.3125161846667,2.04159663005551e-06,0.00020804841849137,3.43662685173499,59093,3.68183558120764,4,0,0,0.0248953806503406,0.210361725971077,8.44982966621958,3.07892225948037
"54",54,85,85,85,"P13798","APEH","ACPH_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; translational termination [GO:0006415]","SUBCELLULAR LOCATION: Cytoplasm.","Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)","GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0043312; GO:0050435; GO:0070062; GO:1904813",8.8523286791498e-05,3.08303169926235e-05,0.00017372991619012,0.0528123619014592,0.0476458652941226,0.0494593483608533,0.0498748306788203,0.0250351098460682,34.1769816771998,2.07658391815451e-06,0.00020912421575767,3.41570759369425,81225,3.67959567468586,8,0,0,8.8523286791498e-05,0.0494593483608533,558.715679834015,9.12597049852443
"55",55,86,86,86,"Q9BRJ7","NUDT16L1","TIRR_HUMAN","nucleus [GO:0005634]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28241136}.","Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)","GO:0003723; GO:0005634; GO:0016787; GO:0030515; GO:2001033",0.00277186788625238,0.00307579627901896,0.00366479884692849,0.0640770851901239,0.0629310632737683,0.0582883697681059,0.0585946850732661,0.0324681635406997,33.9788407369751,2.12907184307413e-06,0.00021056353486759,3.38497650576522,23338,3.6766168372198,7,0,0,0.00307579627901896,0.0629310632737683,20.460088238952,4.35474046194636
"56",56,88,88,88,"O43292","GPAA1","GPAA1_HUMAN","endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:11483512}; Multi-pass membrane protein {ECO:0000269|PubMed:11483512}.","Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1)","GO:0005789; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003",0.00165448992761509,0.00531713263329784,0.00080251095622355,0.0637880649732279,0.0623588208452026,0.0668043493425581,0.0617257005479507,0.0334542281130209,33.5900821126022,2.23688738002536e-06,0.00021758813605701,3.32416056670225,67623,3.66236478813488,5,0,0,0.00165448992761509,0.0637880649732279,38.55451998138,5.26882810087621
"57",57,89,89,89,"Q8IWA4","MFN1","MFN1_HUMAN","integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTP metabolic process [GO:0046039]; macroautophagy [GO:0016236]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:12759376, ECO:0000305|PubMed:27920125}; Multi-pass membrane protein {ECO:0000305|PubMed:12759376}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:11751411}.","Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1)","GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0008053; GO:0016021; GO:0016236; GO:0031307; GO:0046039; GO:0051646; GO:0098799; GO:1990613",0.00216738062025448,2.2125280890141e-05,2.75969018289692e-05,0.0868152412125368,0.0784303614778685,0.0816517135490183,0.0815600711454834,0.0415190698403995,33.2589245974848,2.33407428738644e-06,0.00022449074044975,3.27180171348344,84160,3.64880156759835,10,0,0,2.75969018289692e-05,0.0816517135490183,2958.72754322394,11.5307611355916
"58",58,90,90,90,"Q2TAL8","QRICH1","QRIC1_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]",NA,"Glutamine-rich protein 1","GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0007010; GO:0007275; GO:0022604",0.0129340624833391,0.00644382784778587,0.0160006561042716,0.231348381655593,0.212347169226078,0.215080971130615,0.207799325192296,0.115692511407947,32.8380260738729,2.4652222614594e-06,0.00023344247287892,3.20450198632925,86436,3.63182012490238,3,0,0,0.0129340624833391,0.215080971130615,16.6290344899501,4.05563250061427
"59",59,92,92,92,"Q76G19","PDZD4","PDZD4_HUMAN","cell cortex [GO:0005938]","SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:15077175}. Note=Mainly localized under the plasma membrane.","PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein)","GO:0005938",5.97118980484613e-05,6.96384118236157e-05,5.43691982173314e-05,0.119500131982444,0.10862644073675,0.119812266261278,0.115918373157461,0.0580204264147602,32.7037468497855,2.50896115710992e-06,0.00023344247287892,3.18285109434716,86171,3.63182012490238,8,0,0,5.97118980484613e-05,0.119500131982444,2001.27840326662,10.9667061630869
"60",60,93,93,93,"Q8NI27","THOC2","THOC2_HUMAN","nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; generation of neurons [GO:0048699]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA export from nucleus [GO:0010793]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Nucleus speckle {ECO:0000305}.","THO complex subunit 2 (Tho2) (hTREX120)","GO:0000346; GO:0000347; GO:0000445; GO:0000902; GO:0001824; GO:0003729; GO:0005654; GO:0006405; GO:0006406; GO:0008380; GO:0010793; GO:0010977; GO:0016607; GO:0016973; GO:0017145; GO:0031124; GO:0046784; GO:0048666; GO:0048699",1e-07,1e-07,1e-07,0.0424277305601207,0.0474220347751051,0.0449673990042687,0.0449389547798315,0.0224695773899157,32.334371798545,2.6343042496726e-06,0.00024246929437846,3.12283557567015,182775,3.6153432513971,18,3,0,1e-07,0.0449673990042687,449673.990042687,18.7785199127652
"61",61,94,94,94,"P35222","CTNNB1","CTNB1_HUMAN","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intracellular [GO:0005622]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription factor complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; androgen receptor signaling pathway [GO:0030521]; anterior/posterior axis specification [GO:0009948]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; protein localization to cell surface [GO:0034394]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25183871}. Nucleus {ECO:0000269|PubMed:24342833, ECO:0000269|PubMed:25183871, ECO:0000269|PubMed:29367600}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:B6V8E6}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q02248}. Cell junction {ECO:0000250|UniProtKB:B6V8E6}. Cell membrane {ECO:0000269|PubMed:24342833}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle pole. Cell junction, synapse {ECO:0000250|UniProtKB:Q02248}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:Q02248}. Note=Colocalized with RAPGEF2 and TJP1 at cell-cell contacts (By similarity). Cytoplasmic when it is unstabilized (high level of phosphorylation) or bound to CDH1. Translocates to the nucleus when it is stabilized (low level of phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear translocation. Interaction with EMD inhibits nuclear localization. The majority of beta-catenin is localized to the cell membrane. In interphase, colocalizes with CROCC between CEP250 puncta at the proximal end of centrioles, and this localization is dependent on CROCC and CEP250. In mitosis, when NEK2 activity increases, it localizes to centrosomes at spindle poles independent of CROCC. Colocalizes with CDK5 in the cell-cell contacts and plasma membrane of undifferentiated and differentiated neuroblastoma cells. Interaction with FAM53B promotes translocation to the nucleus (PubMed:25183871). {ECO:0000250|UniProtKB:B6V8E6, ECO:0000269|PubMed:25183871}.","Catenin beta-1 (Beta-catenin)","GO:0000122; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001105; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003700; GO:0003713; GO:0005622; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007223; GO:0007268; GO:0007398; GO:0007403; GO:0008022; GO:0008134; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010718; GO:0010909; GO:0016020; GO:0016055; GO:0016323; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030521; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032481; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0035315; GO:0035635; GO:0036023; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0043065; GO:0043123; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0045177; GO:0045202; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0046982; GO:0048096; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050681; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051149; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060548; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070062; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097718; GO:0098609; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904837; GO:1904886; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234",0.00013730302397182,6.75288996204814e-06,9.14572131986289e-06,0.0774827607225462,0.0858999158689303,0.0852179918639263,0.082815822273383,0.0414589783484427,31.8290476563536,2.81853027636016e-06,0.00025487257165042,3.03961983224796,85497,3.59367689902192,17,0,0,9.14572131986289e-06,0.0852179918639263,9317.7988792254,13.1857734754781
"62",62,96,96,96,"Q9Y4C2","TCAF1","TCAF1_HUMAN","plasma membrane [GO:0005886]; ion channel binding [GO:0044325]; negative regulation of cell migration [GO:0030336]; positive regulation of anion channel activity [GO:1901529]; positive regulation of protein targeting to membrane [GO:0090314]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25559186}. Note=Colocalizes with TRPM8 on the plasma membrane. {ECO:0000269|PubMed:25559186}.","TRPM8 channel-associated factor 1 (TRP channel-associated factor 1)","GO:0005886; GO:0030336; GO:0044325; GO:0090314; GO:1901529",0.00027490217046511,0.00046083122285587,0.00101702675008962,0.197618374840916,0.179058554253777,0.197984006397507,0.19096939178293,0.0960689492726016,31.6917024316615,2.87132113682153e-06,0.00025487257165042,3.0167755130678,102126,3.59367689902192,15,0,0,0.00046083122285587,0.197618374840916,428.830263748694,8.74426291417925
"63",63,98,98,98,"P52292","KPNA2","IMA1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; modulation by virus of host process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of DNA recombination [GO:0000018]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7604027}. Nucleus {ECO:0000269|PubMed:7604027}.","Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)","GO:0000018; GO:0003723; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0008565; GO:0016020; GO:0019054; GO:0042826; GO:0061608",6.20300138779632e-05,0.00017425386115444,0.00192732484400432,0.124853019101349,0.131592144055849,0.117519692005269,0.123933748814477,0.062688077313584,31.3011731378468,3.02822340933924e-06,0.00026081899626206,2.95127902663232,57862,3.5836607807647,7,0,0,0.00017425386115444,0.124853019101349,716.500732174265,9.48482436851705
"64",64,99,99,99,"Q6P1R4","DUS1L","DUS1L_HUMAN","flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]",NA,"tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 1-like)","GO:0017150; GO:0050660",0.00024023474589952,0.00017673583742687,0.00016936077961476,0.109071069463687,0.097639779558555,0.100945757895519,0.102356758518273,0.0513738230467836,31.2695945044175,3.04136671861318e-06,0.00026081899626206,2.94594754024118,53230,3.5836607807647,5,0,0,0.00017673583742687,0.100945757895519,571.167451747235,9.15776995881126
"65",65,100,100,100,"P51116","FXR2","FXR2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]","SUBCELLULAR LOCATION: Cytoplasm.","Fragile X mental retardation syndrome-related protein 2","GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0016020; GO:0017148; GO:0022625; GO:0042802; GO:0042803; GO:0046982",0.00091167787473095,0.00232950903605502,0.0006930938619805,0.110298679918126,0.112478633426819,0.101052552088503,0.106631861553561,0.0546273577010358,31.2562285742638,3.04695089091201e-06,0.00026081899626206,2.94368933393964,74223,3.5836607807647,11,0,0,0.00091167787473095,0.110298679918126,120.98426755248,6.91867564554164
"66",66,101,101,101,"P78559","MAP1A","MAP1A_HUMAN","axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; primary dendrite [GO:0150001]; actin binding [GO:0003779]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.","Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2]","GO:0000226; GO:0003779; GO:0005198; GO:0005737; GO:0005874; GO:0005875; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0030424; GO:0032435; GO:0043198; GO:0044307; GO:0048167; GO:0099641; GO:0099642; GO:0150001; GO:1903829; GO:1904115; GO:2000010",0.00022031523533044,0.00024819573585748,0.0001869549828805,0.0266232667057466,0.0243394391691787,0.0271388974073849,0.0258153791094139,0.0131261782060631,31.1157867508863,3.10639642899457e-06,0.00026250216263946,2.91990328219817,305485,3.58086711428272,46,0,0,0.00022031523533044,0.0266232667057466,120.841696062534,6.91697452790915
"67",67,106,106,106,"Q13526","PIN1","PIN1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; motor activity [GO:0003774]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of type I interferon production [GO:0032480]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of signal transduction by p53 class mediator [GO:1901796]; synapse organization [GO:0050808]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16476580, ECO:0000269|PubMed:23623683}. Nucleus speckle {ECO:0000269|PubMed:21497122}. Cytoplasm {ECO:0000269|PubMed:21497122}. Note=Colocalizes with NEK6 in the nucleus (PubMed:16476580). Mainly localized in the nucleus but phosphorylation at Ser-71 by DAPK1 results in inhibition of its nuclear localization (PubMed:21497122). {ECO:0000269|PubMed:16476580}.","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)","GO:0000413; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007088; GO:0008013; GO:0016607; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0032091; GO:0032465; GO:0032480; GO:0032794; GO:0035307; GO:0042177; GO:0043005; GO:0043524; GO:0043525; GO:0043547; GO:0045944; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0061051; GO:0070373; GO:0090263; GO:1900180; GO:1901796; GO:2000146",1e-07,1e-07,1e-07,0.0431054618869861,0.043947531217749,0.0393005701333843,0.0421177544127065,0.0210589772063532,30.5659410653519,3.35332739471385e-06,0.00027079700470519,2.82574256405934,18243,3.56735614370624,3,3,0,1e-07,0.0431054618869861,431054.618869861,18.7175111590185
"68",68,107,107,107,"O43602","DCX","DCX_HUMAN","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cell projection {ECO:0000250|UniProtKB:Q9ESI7}. Note=Localizes at neurite tips. {ECO:0000250|UniProtKB:Q9ESI7}.","Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X)","GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035556; GO:0043005",0.00013147436341804,7.05740643627218e-05,0.00010321410481044,0.0756777352215822,0.0679510847033636,0.0689885527042856,0.0707707033655468,0.0354871058603038,30.3255468872589,3.46885507998534e-06,0.00027750840639882,2.78404647563145,40574,3.5567238565149,18,0,0,0.00010321410481044,0.0689885527042856,668.402374181203,9.38457304767018
"69",69,108,108,108,"Q8IV08","PLD3","PLD3_HUMAN","endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15794758}; Single-pass type II membrane protein {ECO:0000269|PubMed:15794758}.","Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3)","GO:0004630; GO:0005789; GO:0016021; GO:0016042; GO:0070062; GO:0070290",1e-07,1e-07,1e-07,0.0992059634103267,0.111956752279647,0.104707889217833,0.105290101635936,0.0526451508179678,29.5874455530668,3.85554574391039e-06,0.00030558769970252,2.65394587479007,54705,3.51486413065534,7,3,0,1e-07,0.104707889217833,1047078.89217833,19.9979387155724
"70",70,109,109,109,"Q7Z6M1","RABEPK","RABEK_HUMAN","cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904]","SUBCELLULAR LOCATION: Cytoplasm. Endosome membrane. Note=Interaction with PIP5K3 and subsequent phosphorylation recruits it to the endosomal membrane.","Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40)","GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588",0.00303251457932933,0.00010359671206881,0.00010818240176909,0.0546368264775926,0.0539291865078965,0.0497216660212802,0.0516811284378674,0.0269219954499894,29.4926769971962,3.90896031596574e-06,0.00030697890187767,2.63700913003637,40565,3.51289147179632,8,0,0,0.00010818240176909,0.0539291865078965,498.502396193844,8.96145662913976
"71",71,110,110,110,"Q9NP72","RAB18","RAB18_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; lipid particle organization [GO:0034389]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.","Ras-related protein Rab-18","GO:0001654; GO:0003924; GO:0005525; GO:0005622; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0015031; GO:0019003; GO:0030667; GO:0034389; GO:0043312; GO:0051170; GO:0071782; GO:0071786",0.00260721953807314,0.00148084060077253,0.00581571477569092,0.0626928028806655,0.0625706969274139,0.0678275985011635,0.0610624411315688,0.0338324788706299,29.2624620214811,4.04256106101219e-06,0.00030813463735073,2.5956402294159,22977,3.51125947998628,6,0,0,0.00260721953807314,0.0626928028806655,24.0458472963878,4.58771585781381
"72",72,111,111,111,"P35716","SOX11","SOX11_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; translation factor activity, RNA binding [GO:0008135]; cardiac ventricle formation [GO:0003211]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; signal transduction involved in cell cycle checkpoint [GO:0072395]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:24886874}.","Transcription factor SOX-11","GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001077; GO:0001105; GO:0001158; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005737; GO:0008135; GO:0008284; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:0072395; GO:2000648; GO:2000678; GO:2001111",0.0180673475878318,0.0251279470539765,0.0386938210718024,0.316853606807116,0.291782370905651,0.313678921035924,0.28014192767836,0.167367335743717,29.2515618597184,4.04902505891039e-06,0.00030813463735073,2.59367352065803,46679,3.51125947998628,3,0,0,0.0251279470539765,0.313678921035924,12.4832689420318,3.64192387114788
"73",73,114,114,114,"P63096","GNAI1","GNAI1_HUMAN","cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein coupled receptor binding [GO:0001664]; G-protein coupled serotonin receptor binding [GO:0031821]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of protein localization to cell cortex [GO:1904778]; protein folding [GO:0006457]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P10824}. Cytoplasm {ECO:0000269|PubMed:17635935}. Cell membrane {ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:26766442}; Peripheral membrane protein {ECO:0000250|UniProtKB:P10824}; Cytoplasmic side {ECO:0000250|UniProtKB:P10824}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:17635935}. Cytoplasm, cell cortex {ECO:0000269|PubMed:22327364}. Membrane {ECO:0000250|UniProtKB:P63096}; Lipid-anchor {ECO:0000250|UniProtKB:P63096}. Note=Localizes in the centrosomes of interphase and mitotic cells, but not in centrosomes during cytokinesis. Detected at the cleavage furrow or the midbody (PubMed:17635935). Localized at the plasma membrane throughout mitosis. Colocalizes with RIC8A and RGS14 at the plasma membrane. {ECO:0000250|UniProtKB:P10824, ECO:0000269|PubMed:17635935}.","Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein)","GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005765; GO:0005813; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0019003; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0043434; GO:0043949; GO:0045121; GO:0050805; GO:0051301; GO:0060236; GO:0070062; GO:0099738; GO:1904322; GO:1904778",1e-07,1e-07,1e-07,0.0593431366450266,0.0601815229060686,0.0535701839740841,0.0576981811750598,0.0288491905875299,28.8050806908429,4.32508711265393e-06,0.00032426042404472,2.51248516941248,40361,3.48910605369466,3,3,0,1e-07,0.0593431366450266,593431.366450266,19.1787216584614
"74",74,117,117,117,"Q8NCB2","CAMKV","CAMKV_HUMAN","cytoplasmic vesicle membrane [GO:0030659]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Predominantly observed in association with the plasma membrane of soma and in neurites, both axons and dendrites. May be associated with vesicular structures (By similarity). {ECO:0000250}.","CaM kinase-like vesicle-associated protein","GO:0004683; GO:0005516; GO:0005524; GO:0005622; GO:0005886; GO:0018105; GO:0018107; GO:0030659; GO:0035556",0.0002750373934231,0.00044790307542458,0.0012433332604308,0.0559794623207494,0.055125952262032,0.0498352479111185,0.0529914629215405,0.0271511560371964,28.2712706132998,4.68624806245325e-06,0.00033999115518074,2.4137655099613,54354,3.46853238091704,9,0,0,0.00044790307542458,0.055125952262032,123.0756279353,6.94340129003677
"75",75,118,118,118,"O60828","PQBP1","PQBP1_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10198427, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:23512658}. Nucleus speckle {ECO:0000250|UniProtKB:Q91VJ5}. Cytoplasmic granule {ECO:0000269|PubMed:21933836}. Note=Colocalizes with SRSF2 in nuclear speckles (By similarity). Colocalized with POU3F2 (PubMed:10332029). Colocalized with ATXN1 in nuclear inclusion bodies (PubMed:12062018). Localizes to cytoplasmic stress granules (PubMed:21933836). {ECO:0000250|UniProtKB:Q91VJ5, ECO:0000269|PubMed:10332029, ECO:0000269|PubMed:12062018, ECO:0000269|PubMed:21933836}.","Polyglutamine-binding protein 1 (PQBP-1) (38 kDa nuclear protein containing a WW domain) (Npw38) (Polyglutamine tract-binding protein 1)","GO:0000380; GO:0000398; GO:0002218; GO:0002230; GO:0003677; GO:0003690; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0010494; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598",0.0191947231902376,0.0119005081286133,0.0133436141555506,0.0898865716531365,0.0911328507747098,0.0859417478384472,0.074174108263964,0.0519000026234492,28.2499551469001,4.70142570651112e-06,0.00033999115518074,2.40978534859426,30472,3.46853238091704,4,0,0,0.0133436141555506,0.0898865716531365,6.73629877222926,2.75195612707037
"76",76,120,120,120,"Q12852","MAP3K12","M3K12_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.","Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase)","GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0046777; GO:2000672",1e-07,1e-07,1e-07,0.0690756496205955,0.0783098062603458,0.076105432006366,0.0744968626291024,0.0372485313145512,27.7603578981263,5.06731063651572e-06,0.00035870524295522,2.31753712346124,93219,3.44526227548494,5,3,0,1e-07,0.076105432006366,761054.32006366,19.5376399038419
"77",77,121,121,121,"Q16827","PTPRO","PTPRO_HUMAN","apical plasma membrane [GO:0016324]; axon [GO:0030424]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron projection development [GO:0010977]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2)","GO:0000902; GO:0002548; GO:0003093; GO:0003105; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0010812; GO:0010977; GO:0016021; GO:0016324; GO:0016328; GO:0016791; GO:0017147; GO:0030027; GO:0030032; GO:0030424; GO:0030426; GO:0032835; GO:0035335; GO:0036060; GO:0042803; GO:0043005; GO:0043197; GO:0070062; GO:0072112; GO:0090090; GO:0090260",0.00895241640056244,0.00136823555066345,0.00259630914991681,0.116267722640644,0.128447829098042,0.126669008415981,0.119489199684508,0.064050253542635,27.7563049633968,5.0704829903718e-06,0.00035870524295522,2.31676678479815,138344,3.44526227548494,9,0,0,0.00259630914991681,0.126669008415981,48.7881069248012,5.60845759981174
"78",78,124,124,124,"Q5JU69","TOR2A","TOR2A_HUMAN","endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260]","SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000250}.","Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1)","GO:0005524; GO:0005788; GO:0051085; GO:0051260",1e-07,1e-07,1e-07,0.0741429692264372,0.0823292962753298,0.0839998925600185,0.0801572860205952,0.0400787430102976,27.3073817741933,5.43752714104166e-06,0.00037536477683319,2.23074408937488,35714,3.42554648276603,3,3,0,1e-07,0.0823292962753298,823292.962753298,19.6510463688783
"79",79,125,125,125,"O00273","DFFA","DFFA_HUMAN","cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deoxyribonuclease inhibitor activity [GO:0060703]; protein binding involved in protein folding [GO:0044183]; protein domain specific binding [GO:0019904]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242]","SUBCELLULAR LOCATION: Cytoplasm.","DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD)","GO:0000790; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006309; GO:0019904; GO:0032076; GO:0043065; GO:0044183; GO:0060703; GO:0061077; GO:0070242; GO:1900118; GO:1902511",1e-07,1e-07,1e-07,0.0321179367818897,0.0355739506701494,0.0364451210812565,0.0347122361777652,0.0173562180888826,27.2517342375478,5.48527237419258e-06,0.0003756314521847,2.2199836095506,36522,3.42523805075529,5,3,0,1e-07,0.0355739506701494,355739.506701494,18.4404616764367
"80",80,126,126,126,"Q8IVU1","IGDCC3","IGDC3_HUMAN","integral component of plasma membrane [GO:0005887]; neuromuscular process controlling balance [GO:0050885]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule)","GO:0005887; GO:0050885",8.52905447622209e-06,8.30925063834818e-05,6.35141566997862e-05,0.0954915276098646,0.107100849853899,0.107651223619815,0.103362821788673,0.0517331228001897,27.0502353133766,5.66253287292794e-06,0.0003846927094624,2.18083746402717,86724,3.41488604418512,5,0,0,6.35141566997862e-05,0.107100849853899,1686.25162355749,10.7196041168925
"81",81,127,127,127,"O94910","ADGRL1","AGRL1_HUMAN","axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G-protein coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]","SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell projection, axon {ECO:0000250|UniProtKB:O88917}. Cell projection, growth cone {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:O88917}. Note=Colocalizes with TENM2 on the cell surface, across intercellular junctions and on nerve terminals near synaptic clefts. {ECO:0000250|UniProtKB:O88917}.","Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2)","GO:0004930; GO:0005622; GO:0005886; GO:0007157; GO:0007166; GO:0007186; GO:0016021; GO:0016524; GO:0030054; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0090129",1e-07,1e-07,1.13744553392717e-06,0.121403912502949,0.12160453235712,0.107992982758077,0.117000030057537,0.0585004608439467,26.9526384703,5.7509231282393e-06,0.00038758320138865,2.16177310749592,162717,3.41163505438265,16,2,0,1e-07,0.121403912502949,1214039.12502949,20.2113834856266
"82",82,128,128,128,"O94776","MTA2","MTA2_HUMAN","histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, transcription factor binding [GO:0000989]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}.","Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)","GO:0000118; GO:0000122; GO:0000790; GO:0000981; GO:0000989; GO:0001085; GO:0001103; GO:0003682; GO:0004407; GO:0005654; GO:0005667; GO:0006306; GO:0006333; GO:0008270; GO:0010762; GO:0016020; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:0043565; GO:0044212; GO:0045944",0.0001853773643852,0.00049767689625175,0.00041813252672138,0.130526374596177,0.149133545831718,0.141455895586288,0.140004876408942,0.0703695004669235,26.9039683414097,5.79563665627889e-06,0.00038758320138865,2.15224047214505,75023,3.41163505438265,11,0,0,0.00041813252672138,0.141455895586288,338.303974329522,8.40217631550791
"83",83,129,129,129,"Q92879","CELF1","CELF1_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8948631}. Cytoplasm {ECO:0000269|PubMed:8948631}. Note=RNA-binding activity is detected in both nuclear and cytoplasmic compartments.","CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2)","GO:0000900; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0007281; GO:0009792; GO:0016020; GO:0016246; GO:0036002; GO:0042835; GO:0043484; GO:1990904",1e-07,1e-07,1e-07,0.0775901387844565,0.0678471559964819,0.0732270663494327,0.0728880203767904,0.0364441101883952,26.8397895414468,5.85525431583363e-06,0.00038853470498865,2.13964418145489,52063,3.41057018275264,7,3,0,1e-07,0.0732270663494327,732270.663494327,19.4820174736376
"84",84,130,130,130,"O75190","DNAJB6","DNJB6_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:10954706}. Nucleus {ECO:0000269|PubMed:10954706}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:22366786}.","DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1)","GO:0001671; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0016020; GO:0030018; GO:0031072; GO:0032880; GO:0042802; GO:0043154; GO:0045109; GO:0048471; GO:0051082; GO:0051087; GO:0090084; GO:1900034",1e-07,1e-07,1e-07,0.100688558540646,0.110512423865209,0.097184098258657,0.102794926888171,0.0513975634440853,26.7373571268079,5.95197939926777e-06,0.00039191495121332,2.11947809111648,36087,3.40680816825043,3,3,0,1e-07,0.100688558540646,1006885.58540646,19.9414683254149
"85",85,131,131,131,"P22694","PRKACB","KAPCB_HUMAN","cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; cellular response to glucagon stimulus [GO:0071377]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; response to clozapine [GO:0097338]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21423175}. Cell membrane {ECO:0000269|PubMed:21423175}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Nucleus {ECO:0000250}. Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. {ECO:0000250}.","cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)","GO:0000287; GO:0001843; GO:0002223; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007596; GO:0016301; GO:0031625; GO:0034199; GO:0034380; GO:0045171; GO:0048471; GO:0051447; GO:0070062; GO:0070613; GO:0071377; GO:0097338; GO:0097546; GO:1901621",0.00065028859294236,0.00259694078644515,0.00054718272544193,0.0653775158144195,0.0613443385559798,0.0698053169478339,0.0642442530711346,0.0333869305705104,26.3182733643273,6.36880067195853e-06,0.00041615979963332,2.03616910842103,40623,3.38073987424606,5,0,0,0.00065028859294236,0.0653775158144195,100.536156598728,6.65157063212095
"86",86,132,132,132,"Q96SW2","CRBN","CRBN_HUMAN","Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of protein homodimerization activity [GO:0090073]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20223979}. Nucleus {ECO:0000269|PubMed:20223979}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.","Protein cereblon","GO:0005634; GO:0005730; GO:0005737; GO:0016020; GO:0016567; GO:0031464; GO:0032463; GO:0034766; GO:0043161; GO:0046872; GO:0090073",1e-07,1e-07,0.00610573051111219,0.0931093782534748,0.0847521027043979,0.085169864815999,0.0856418050875865,0.044856212714164,26.1646128721839,6.53058728402023e-06,0.00042349869053949,2.00529438152165,50546,3.37314792817236,8,2,0,1e-07,0.085169864815999,851698.64815999,19.699983534336
"87",87,133,133,133,"Q8IV32","CCDC71","CCD71_HUMAN",NA,NA,"Coiled-coil domain-containing protein 71",NA,0.00229509542347874,0.00510524143082336,0.00461529169232683,0.162201466287278,0.148828677239298,0.1424040872699,0.147139534083282,0.0775749765571842,25.8975612216301,6.82398067649213e-06,0.00043919755331408,1.95120755746744,49648,3.35734008792307,3,0,0,0.00461529169232683,0.148828677239298,32.2468626385486,5.01108689957878
"88",88,135,135,135,"A7MD48","SRRM4","SRRM4_HUMAN","nucleus [GO:0005634]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa) (Neural-specific SR-related protein of 100 kDa) (nSR100)","GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0043484",0.00029677335087821,0.00030468037784044,0.00661847084004464,0.205470770058768,0.179893902255862,0.190085297847573,0.189410015197813,0.0971116491218278,25.4361051400101,7.37022090583817e-06,0.00046490071490355,1.85643602211651,68559,3.33263978597774,5,0,0,0.00030468037784044,0.190085297847573,623.884278977493,9.28513464574094
"89",89,136,136,136,"O60216","RAD21","RAD21_HUMAN","chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear cohesin complex [GO:0000798]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10623634}. Chromosome {ECO:0000269|PubMed:11073952}. Chromosome, centromere {ECO:0000269|PubMed:11073952}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, it is cleaved by separase/ESPL1, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. Once cleaved by caspase-3, the C-terminal 64 kDa cleavage product translocates to the cytoplasm, where it may trigger apoptosis. {ECO:0000269|PubMed:11073952}.","Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog)","GO:0000775; GO:0000785; GO:0000798; GO:0001228; GO:0003682; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007059; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0044877; GO:0045841; GO:0045876; GO:0051301; GO:0071168",0.00011856158596556,0.00015166036278295,0.000215128025867,0.0608456310885952,0.0536749785012069,0.0543078052055313,0.0561143549402393,0.0282189607949915,25.3991119073801,7.41630206147593e-06,0.00046490071490355,1.84876519846035,71690,3.33263978597774,11,0,0,0.00015166036278295,0.0543078052055313,358.088324523227,8.48417167010018
"90",90,138,138,138,"Q13586","STIM1","STIM1_HUMAN","cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein {ECO:0000269|PubMed:11004585, ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:27185316, ECO:0000269|PubMed:28219928}. Endoplasmic reticulum membrane; Single-pass type I membrane protein {ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:26322679, ECO:0000269|PubMed:27185316}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19632184}. Sarcoplasmic reticulum {ECO:0000269|PubMed:25326555}. Note=Translocates from the endoplasmic reticulum to the cell membrane in response to a depletion of intracellular calcium and is detected at punctae corresponding to junctions between the endoplasmic reticulum and the cell membrane (PubMed:19249086, PubMed:16005298, PubMed:16208375, PubMed:18854159). Associated with the microtubule network at the growing distal tip of microtubules (PubMed:19632184). Colocalizes with ORAI1 at the cell membrane (PubMed:27185316). Colocalizes preferentially with CASQ1 at endoplasmic reticulum in response to a depletion of intracellular calcium (PubMed:27185316). {ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:27185316}.","Stromal interaction molecule 1","GO:0002020; GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006874; GO:0030176; GO:0032237; GO:0032541; GO:0033017; GO:0042802; GO:0045766; GO:0051010; GO:0051924; GO:0070166; GO:1903779; GO:2001256",1e-07,1e-07,1e-07,0.0351212349847031,0.040107520733903,0.0395158660278547,0.0382481072488203,0.0191241536244101,25.2290371123535,7.6327785389119e-06,0.00047345350937018,1.81335643049781,77423,3.32472265998755,3,3,0,1e-07,0.0395158660278547,395158.660278547,18.5920725009882
"91",91,139,139,139,"Q8NFG4","FLCN","FLCN_HUMAN","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}. Nucleus {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}. Note=Mainly localized in the nucleus. Colocalizes with FNIP1 and FNIP2 in the cytoplasm. {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}.","Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein)","GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032465; GO:0035024; GO:0035065; GO:0043065; GO:0044877; GO:0045785; GO:0045944; GO:0051898; GO:0070373; GO:0097009; GO:1900181; GO:1901723; GO:2000973; GO:2001170",9.29972229935398e-05,8.76649914745704e-05,0.00032043885281049,0.180156188988389,0.160858387232318,0.184307755030525,0.174940410061318,0.0876372387197518,25.1235511050079,7.77095769808989e-06,0.00047855681939316,1.79127618253655,64473,3.32006649073157,9,0,0,9.29972229935398e-05,0.180156188988389,1937.22116843106,10.9197729574384
"92",92,140,140,140,"Q969G2","LHX4","LHX4_HUMAN","nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; animal organ morphogenesis [GO:0009887]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.","LIM/homeobox protein Lhx4 (LIM homeobox protein 4)","GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0043066; GO:0043565; GO:0045944; GO:0046872",1e-07,1e-07,0.00012968832912367,0.185965687613085,0.201673837694879,0.17463890635033,0.18738284777639,0.0937347199979029,24.804297496093,8.20833900294685e-06,0.00050188129903732,1.7238885725251,43124,3.29939898657778,4,2,0,1e-07,0.185965687613085,1859656.87613085,20.8266050246522
"93",93,144,144,144,"O95336","PGLS","6PGL_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)","GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062",1e-07,1e-07,1e-07,0.0229561779480523,0.0243181824504486,0.0209913939777399,0.0227551514587469,0.0113776757293735,24.4411316078171,8.74334385462591e-06,0.00051974321802498,1.64618396258236,27547,3.28421116893934,8,3,0,1e-07,0.0229561779480523,229561.779480523,17.8085229372521
"94",94,146,146,146,"P54105","CLNS1A","ICLN_HUMAN","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Nucleus {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:18984161}. Note=A small fraction is also associated with the cytoskeleton (PubMed:18984161).","Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)","GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0046982",1e-07,1e-07,1e-07,0.0495080893921374,0.0547837706814964,0.0475528692337112,0.050614809769115,0.0253075048845575,24.3175792510318,8.93508578308078e-06,0.00052386530344638,1.61948836565849,26215,3.28078036471444,3,3,0,1e-07,0.0495080893921374,495080.893921374,18.9173047485667
"95",95,147,147,147,"O15379","HDAC3","HDAC3_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; protein deacetylase activity [GO:0033558]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to fluid shear stress [GO:0071498]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of lipid metabolic process [GO:0019216]; regulation of protein stability [GO:0031647]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21030595}. Cytoplasm {ECO:0000269|PubMed:25190803}. Cytoplasm, cytosol {ECO:0000269|PubMed:21030595}. Note=Colocalizes with XBP1 and AKT1 in the cytoplasm (PubMed:25190803). Predominantly expressed in the nucleus in the presence of CCAR2. {ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:25190803}.","Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45)","GO:0000118; GO:0000122; GO:0001934; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005876; GO:0005886; GO:0006325; GO:0006351; GO:0006476; GO:0007623; GO:0008134; GO:0017053; GO:0019216; GO:0019899; GO:0030332; GO:0031647; GO:0032008; GO:0032041; GO:0033558; GO:0042307; GO:0042826; GO:0043066; GO:0045892; GO:0045944; GO:0046329; GO:0051059; GO:0051225; GO:0071498",0.00514354420887498,0.00080098305721579,0.00049731326872495,0.0863841480015155,0.0849360388741032,0.0957792193472969,0.0868858552293666,0.0455902077929552,24.26407075489,9.01973051524765e-06,0.00052523056605795,1.60788542063352,48848,3.27965000786048,5,0,0,0.00080098305721579,0.0863841480015155,107.847659477076,6.7528510570709
"96",96,148,148,148,"Q9NWZ5","UCKL1","UCKL1_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12199906}. Nucleus {ECO:0000269|PubMed:12199906}. Note=EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location.","Uridine-cytidine kinase-like 1 (EC 2.7.1.48)","GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0006206; GO:0016032; GO:0043097; GO:0044206; GO:0044211",1e-07,1e-07,1e-07,0.060865401637295,0.0637821019926132,0.0703157766266267,0.0649876600855116,0.0324939300427558,24.1341018662688,9.22947361834258e-06,0.0005338127984663,1.57959720110062,61141,3.27261101796579,5,3,0,1e-07,0.0637821019926132,637821.019926132,19.2827921180343
"97",97,150,150,150,"Q9GZL7","WDR12","WDR12_HUMAN","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; cell proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03029, ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:16043514, ECO:0000269|PubMed:26601951}. Nucleus, nucleoplasm {ECO:0000255|HAMAP-Rule:MF_03029, ECO:0000269|PubMed:16043514}.","Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12)","GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0006364; GO:0007219; GO:0008283; GO:0030687; GO:0042273; GO:0070545",1e-07,1e-07,1e-07,1.43281823507615,1.66665096828851,1.54936402488425,1.54961097608297,0.774805588041484,23.8199771797014,9.76173279717093e-06,0.00055611448109136,1.51060200581107,47708,3.25483579584885,3,3,0,1e-07,1.54936402488425,15493640.2488425,23.8851728110472
"98",98,152,152,152,"Q9UL46","PSME2","PSME2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of endopeptidase activity [GO:0010950]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]",NA,"Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta)","GO:0000502; GO:0005654; GO:0005737; GO:0005829; GO:0008537; GO:0010950; GO:0016020; GO:0016579; GO:0035722; GO:0042802; GO:0043687; GO:0061133; GO:0061136; GO:0070062; GO:2000045",0.0015372643706411,0.00127193305916712,0.00061245314276549,0.0111327985190905,0.0123952604642805,0.0120773700973101,0.0107279261693691,0.00650451327554248,23.7240961907716,9.93167512978047e-06,0.00055611448109136,1.4893637825345,27402,3.25483579584885,3,0,0,0.00127193305916712,0.0120773700973101,9.49528751553838,3.24721168557344
"99",100,155,155,155,"Q13873","BMPR2","BMPR2_HUMAN","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spanning component of plasma membrane [GO:0044214]; activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cellular response to BMP stimulus [GO:0071773]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transcription by RNA polymerase II [GO:0006366]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25187962}; Single-pass type I membrane protein.","Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)","GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005913; GO:0006366; GO:0007178; GO:0007420; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030166; GO:0030308; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0036122; GO:0042127; GO:0043025; GO:0044214; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048010; GO:0048286; GO:0048842; GO:0060173; GO:0060350; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:2000279",1e-07,0.00741214677209649,3.51635363283453e-06,0.0879766892398967,0.0922657564214037,0.0824899222877663,0.0851055349411125,0.045024688512466,23.5119780961091,1.03207644464092e-05,0.00056997253975008,1.44207631475603,115201,3.24414606734907,7,1,0,3.51635363283453e-06,0.0879766892398967,25019.2951068402,14.6107535231622
"100",101,156,156,156,"A6QL63","BTBD11","BTBDB_HUMAN","cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; SCF ubiquitin ligase complex [GO:0019005]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; SMAD protein signal transduction [GO:0060395]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 (BTB/POZ domain-containing protein 11)","GO:0005737; GO:0016021; GO:0019005; GO:0030162; GO:0031625; GO:0043161; GO:0046982; GO:0060395",0.0390047453042095,0.0052609998726098,0.0104877037646024,0.314794957545225,0.300217199677828,0.290659969285967,0.2836395591892,0.16007092924174,23.3256394349389,1.06781492953979e-05,0.00058592921774747,1.40018790341577,120884,3.2321548450713,6,0,0,0.0104877037646024,0.300217199677828,28.6256368806971,4.83923588641666
"101",102,157,157,157,"Q08379","GOLGA2","GOGA2_HUMAN","cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane {ECO:0000269|PubMed:11781572}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q62839}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:26165940}. Note=Peripheral membrane protein associated with cis-Golgi stacks (By similarity). Associates with the mitotic spindle during mitosis (PubMed:26165940). {ECO:0000250|UniProtKB:Q62839, ECO:0000269|PubMed:26165940}.","Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95)","GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0048208; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307; GO:1904668",1e-07,1e-07,1e-07,0.125371987369792,0.139259767677073,0.146332704030368,0.136988053025744,0.0684941265128721,23.0875030217338,1.11573308686814e-05,0.00060832326264912,1.34617333304621,113086,3.21586557553613,17,3,0,1e-07,0.139259767677073,1392597.67677073,20.4093470910372
"102",103,161,161,161,"Q8IYB1","MB21D2","M21D2_HUMAN","cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]",NA,"Protein MB21D2 (Mab-21 domain-containing protein 2)","GO:0044877; GO:0045296",2.26384155758377e-05,1e-07,0.00065675739259015,0.0839167605401948,0.0757757935559124,0.088651519194699,0.0825548591608801,0.041503928183162,22.7439082422469,1.18962999747005e-05,0.00063238375583201,1.26726424348781,55800,3.19901929440575,11,1,0,2.26384155758377e-05,0.0839167605401948,3706.83011181049,11.8559702809994
"103",104,165,165,165,"O43252","PAPSS1","PAPS1_HUMAN","cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]",NA,"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428",2.39545729325481e-05,1.97495995909339e-05,3.43353749080633e-05,0.0936489077634574,0.0891937354402751,0.0798381581263497,0.0875342539275502,0.0437931401462523,22.3175912625234,1.28988633535041e-05,0.00066917739579391,1.16771098016892,70833,3.17445873753596,11,0,0,2.39545729325481e-05,0.0891937354402751,3723.45337532959,11.862425577058
"104",105,167,167,167,"Q8WYK1","CNTNAP5","CNTP5_HUMAN","integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Contactin-associated protein-like 5 (Cell recognition molecule Caspr5)","GO:0007155; GO:0016021",6.97168680854679e-05,0.00011078947285617,5.18008254725662e-05,0.0851888996023668,0.0922954310309426,0.10025037537818,0.0925007996150249,0.0463278355296505,22.0627705012443,1.35479181919655e-05,0.00069443221391152,1.10730870216902,145623,3.15837014094287,17,0,0,6.97168680854679e-05,0.0922954310309426,1323.86083261507,10.3705357552598
"105",106,168,168,168,"Q08629","SPOCK1","TICN1_HUMAN","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.","Testican-1 (Protein SPOCK)","GO:0001558; GO:0001764; GO:0004867; GO:0004869; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0007165; GO:0007399; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0014069; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268",0.00011162813538108,8.34881965487815e-05,0.0232929921606829,0.230637088817396,0.225672165164578,0.250430785249278,0.227750643579546,0.121704691287311,21.8500316786811,1.41208003291579e-05,0.00071948839772375,1.05635401260023,49124,3.14297620498683,6,0,0,0.00011162813538108,0.230637088817396,2066.11969312252,11.012708118571
"106",107,169,169,169,"Q99856","ARID3A","ARI3A_HUMAN","cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:17400556}. Cytoplasm {ECO:0000269|PubMed:17400556}. Note=Shuttles between nucleus and cytoplasm.","AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1)","GO:0000977; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006977; GO:0042803; GO:0043231; GO:0045121",0.0020958246791695,1e-07,1e-07,0.151003423159076,0.134450438156953,0.157966385179404,0.147108073938754,0.0742527118624337,21.7776598396371,1.43224589926286e-05,0.00072544526021834,1.03890851611518,62889,3.13939535246403,8,2,0,1e-07,0.151003423159076,1510034.23159076,20.526149824296
"107",108,170,170,170,"P55786","NPEPPS","PSA_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10978616}. Nucleus {ECO:0000305}.","Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955",1e-07,1e-07,1e-07,0.0159029772643102,0.0186626141084127,0.0181659752278504,0.0175770888668578,0.00878864443342889,21.4620650704878,1.5244385871753e-05,0.00076129020800622,0.962161670547895,103276,3.11844975622562,20,3,0,1e-07,0.0181659752278504,181659.752278504,17.4708792923574
"108",109,173,173,173,"P50148","GNAQ","GNAQ_HUMAN","cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; entrainment of circadian clock [GO:0009649]; forebrain neuron development [GO:0021884]; G-protein coupled acetylcholine receptor signaling pathway [GO:0007213]; G-protein coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Membrane {ECO:0000250}. Nucleus membrane {ECO:0000250}. Note=Colocalizes with the adrenergic receptors, ADREN1A and ADREN1B, at the nuclear membrane of cardiac myocytes. {ECO:0000250}.","Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q)","GO:0001501; GO:0001508; GO:0001750; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005765; GO:0005834; GO:0005886; GO:0006469; GO:0007186; GO:0007189; GO:0007202; GO:0007213; GO:0007215; GO:0007507; GO:0007596; GO:0007603; GO:0009649; GO:0009791; GO:0016322; GO:0021884; GO:0030168; GO:0030425; GO:0031683; GO:0031826; GO:0031965; GO:0042711; GO:0042733; GO:0044297; GO:0045634; GO:0046872; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0070062",1e-07,1e-07,1e-07,0.0278846893756318,0.0298731667333542,0.0329383144571362,0.0302319568553741,0.015116078427687,21.3374810212224,1.56283460834535e-05,0.00077020728708798,0.931559669758553,42142,3.11339237674532,7,3,0,1e-07,0.0298731667333542,298731.667333542,18.1884906544473
"109",110,174,174,174,"Q8IU81","IRF2BP1","I2BP1_HUMAN","nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12799427}.","Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1)","GO:0005654; GO:0006351; GO:0006355; GO:0016740; GO:0046872",9.85862532447672e-05,6.88572057753929e-05,0.0107229760661713,0.108048503422176,0.0983625917352485,0.0986037721635073,0.09804148259858,0.0526508811410205,21.3286274051629,1.56560827048258e-05,0.00077020728708798,0.929378256252695,61688,3.11339237674532,10,0,0,9.85862532447672e-05,0.0986037721635073,1000.17770143568,9.96604063086624
"110",111,175,175,175,"Q9BUZ4","TRAF4","TRAF4_HUMAN","bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase activity [GO:0045860]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, perinuclear region. Cell junction, tight junction. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, cytoskeleton {ECO:0000305}.","TNF receptor-associated factor 4 (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83)","GO:0003677; GO:0005164; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007250; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0090073",6.38779565995883e-05,6.6651530537337e-05,5.25959142147901e-05,0.0536552016313085,0.0581861951524771,0.0491317421042656,0.0535966711622332,0.0268593773815672,21.2751741279863,1.58248340247801e-05,0.00077201505027189,0.916189168118612,53543,3.11237423310167,4,0,0,6.38779565995883e-05,0.0536552016313085,839.964276998402,9.71418416231713
"111",112,177,177,177,"O00255","MEN1","MEN1_HUMAN","chromatin [GO:0000785]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; histone methyltransferase complex [GO:0035097]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; protein binding, bridging [GO:0030674]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; transcription regulatory region DNA binding [GO:0044212]; Y-form DNA binding [GO:0000403]; beta-catenin-TCF complex assembly [GO:1904837]; brain development [GO:0007420]; cellular protein metabolic process [GO:0044267]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone lysine methylation [GO:0034968]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; post-translational protein modification [GO:0043687]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; transcription, DNA-templated [GO:0006351]; type B pancreatic cell differentiation [GO:0003309]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12874027}. Note=Concentrated in nuclear body-like structures. Relocates to the nuclear matrix upon gamma irradiation.","Menin","GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000784; GO:0000785; GO:0000790; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006351; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0034968; GO:0035097; GO:0043433; GO:0043687; GO:0044212; GO:0044267; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071375; GO:0071559; GO:1902807; GO:1904837",7.86290132118906e-05,9.21762856595507e-05,0.00012641236162212,0.0402947693109736,0.0476769319874263,0.0435140437121612,0.0437295091166892,0.0219638271118424,21.2318054359135,1.59633953152016e-05,0.00077201505027189,0.905464437384147,68023,3.11237423310167,5,0,0,9.21762856595507e-05,0.0435140437121612,472.07417179814,8.88286974190098
"112",113,178,178,178,"P68106","FKBP1B","FKB1B_HUMAN","calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; ion transmembrane transport [GO:0034220]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Sarcoplasmic reticulum {ECO:0000250}.","Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12)","GO:0000413; GO:0003755; GO:0005102; GO:0005528; GO:0005737; GO:0005829; GO:0006458; GO:0006939; GO:0009749; GO:0010459; GO:0010880; GO:0010881; GO:0014808; GO:0016020; GO:0019227; GO:0019855; GO:0022417; GO:0030018; GO:0030073; GO:0030551; GO:0032515; GO:0033017; GO:0033197; GO:0034220; GO:0034704; GO:0035584; GO:0042026; GO:0042098; GO:0042542; GO:0044325; GO:0048680; GO:0051280; GO:0051284; GO:0051480; GO:0051775; GO:0060314; GO:0060315; GO:0061077; GO:0061179; GO:0086064; GO:1903779",0.00426073643034016,1e-07,1e-07,0.0763343302739662,0.0718803185816449,0.0656021546597229,0.069851955694998,0.0363462899909457,21.1816975344497,1.61253517586138e-05,0.00077546635423446,0.89304635433783,11783,3.11043704051614,3,2,0,1e-07,0.0718803185816449,718803.185816449,19.4552372774853
"113",114,179,179,179,"Q9UI30","TRMT112","TR112_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:25851604}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:25851604}. Note=Localizes to a polarized perinuclear structure, overlapping partially with the Golgi and lysosomes (PubMed:25851604). {ECO:0000269|PubMed:25851604}.","Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)","GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234",1e-07,1e-07,1e-07,0.0567240053122996,0.0669034441669204,0.0595850053583428,0.0610707182791876,0.0305354591395938,20.9055080788788,1.70552303241056e-05,0.00081275983017431,0.824077680274076,14199,3.09003776909158,6,3,0,1e-07,0.0595850053583428,595850.053583428,19.1845897947739
"114",115,181,181,181,"Q9NRN7","AASDHPPT","ADPPT_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12815048}.","L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.-) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog)","GO:0000287; GO:0005829; GO:0008897; GO:0015939; GO:0019878; GO:0070062",7.51775249477019e-05,1e-07,1e-07,0.107158899353112,0.0946928194778234,0.112235312727268,0.104670551344419,0.0523604015138586,20.8385621666193,1.7290480678098e-05,0.00081771555030121,0.807225724471422,35776,3.08739774329499,12,2,0,1e-07,0.107158899353112,1071588.99353112,20.0313202375324
"115",116,183,183,183,"Q9Y6M1","IGF2BP2","IF2B2_HUMAN","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of mRNA stability [GO:0043488]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Localizes at the connecting piece and the tail of the spermatozoa. In response to cellular stress, such as oxidative stress, recruited to stress granules.","Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)","GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0009653; GO:0017148; GO:0042035; GO:0043488; GO:0045182; GO:0048027; GO:0051028",0.00584315758303317,0.0028455495277744,0.00204470561297543,0.0274784693284847,0.0269371781780419,0.0265669580747797,0.0234163976191744,0.0152860030508482,20.481537927007,1.86147255808835e-05,0.00087034821230582,0.716447729281462,66121,3.06030695838456,14,0,0,0.0028455495277744,0.0269371781780419,9.46642394206028,3.24281953283187
"116",117,185,185,185,"Q13569","TDG","TDG_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; RNA polymerase II transcription cofactor activity [GO:0001104]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; embryo development [GO:0009790]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of gene expression, epigenetic [GO:0040029]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8662714}.","G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG)","GO:0000122; GO:0000287; GO:0001104; GO:0003677; GO:0003684; GO:0003690; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0006351; GO:0008134; GO:0008263; GO:0009790; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0080111; GO:1902544",0.014080469523151,0.00215523083486056,0.0041968514244679,0.133922825430494,0.135058403678781,0.15185845604978,0.133469044458858,0.0735453728235891,20.1614006364132,1.99097301820846e-05,0.00091705350579674,0.633720313833047,46053,3.03760532453241,4,0,0,0.0041968514244679,0.135058403678781,32.1808875318726,5.00813221026427
"117",118,186,186,186,"Q8N5A5","ZGPAT","ZGPAT_HUMAN","nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001078]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19644445}.; SUBCELLULAR LOCATION: Isoform 4: Nucleus {ECO:0000269|PubMed:20233718}.","Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein)","GO:0000122; GO:0000978; GO:0000981; GO:0001078; GO:0003700; GO:0005634; GO:0005886; GO:0006351; GO:0007175; GO:0043565; GO:0045892; GO:0046872",0.00025194244374587,0.00037249769049606,0.00023390294567705,0.0704813885610495,0.0782515510831761,0.065675626375243,0.0711834076465165,0.0358778181832313,20.1573935390306,1.99266299156768e-05,0.00091705350579674,0.632676698384085,57359,3.03760532453241,6,0,0,0.00025194244374587,0.0704813885610495,279.751944583592,8.12800434932798
"118",119,187,187,187,"O00560","SDCBP","SDCB1_HUMAN","adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytoskeletal adaptor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]","SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000269|PubMed:11179419}. Cell junction, adherens junction {ECO:0000269|PubMed:11179419}. Cell membrane {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:27386966}; Peripheral membrane protein {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:27386966}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}. Nucleus {ECO:0000269|PubMed:11179419}. Melanosome {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}. Cytoplasm, cytosol {ECO:0000269|PubMed:11179419}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11179419}. Secreted, exosome {ECO:0000269|PubMed:22660413}. Membrane raft {ECO:0000269|PubMed:25893292}. Note=Mainly membrane-associated. Localized to adherens junctions, focal adhesions and endoplasmic reticulum. Colocalized with actin stress fibers. Also found in the nucleus. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Associated to the plasma membrane in the presence of FZD7 and phosphatidylinositol 4,5-bisphosphate (PIP2) (PubMed:27386966). {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:27386966}.","Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)","GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0043231; GO:0043312; GO:0045121; GO:0045545; GO:0046330; GO:0046982; GO:0047485; GO:0048013; GO:0070062; GO:0072562; GO:1903543; GO:1903553; GO:1903561",1e-07,7.44294034248357e-07,1e-07,0.015108444712203,0.0168834585089097,0.0141676720103998,0.0153862103124928,0.00769341992092447,20.0377883208619,2.04392823988199e-05,0.00093561634937913,0.601432621113343,32444,3.02890219774029,4,2,0,1e-07,0.015108444712203,151084.44712203,17.2049956292163
"119",120,188,188,188,"Q99848","EBNA1BP2","EBP2_HUMAN","nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19170763, ECO:0000269|PubMed:2879624}. Note=Associated with the nucleolus in an RNA-dependent manner.","Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40)","GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273",1e-07,1e-07,1e-07,0.0397184698140131,0.0409848885183682,0.0468873414913728,0.0425301332745847,0.0212651666372923,19.975373123067,2.07132486862592e-05,0.00094311387635308,0.58505552860955,34852,3.02543586517798,3,3,0,1e-07,0.0409848885183682,409848.885183682,18.6447325481121
"120",121,189,189,189,"Q8N9I9","DTX3","DTX3_HUMAN","cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3)","GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872",0.00489708809381974,0.00244664229493801,0.0132112085254948,0.102934710793131,0.11709653273526,0.106855354241875,0.102110552952005,0.0579069227807532,19.8690848966528,2.11902681739987e-05,0.00095178440593364,0.55705099545073,37988,3.02146141497375,5,0,0,0.00489708809381974,0.106855354241875,21.820182156153,4.44759124030148
"121",122,193,193,193,"Q9P2N5","RBM27","RBM27_HUMAN","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus speckle. Note=Incorporated into the nuclear speckles and to speckles proximal to the nuclear periphery. Also localizes to punctate structures in the cytoplasm termed cytospeckles (By similarity). {ECO:0000250}.","RNA-binding protein 27 (RNA-binding motif protein 27)","GO:0003723; GO:0005737; GO:0006397; GO:0016607; GO:0046872",1e-07,1e-07,1e-07,0.0817794461998199,0.0941644080078487,0.0796685765608038,0.0852040435894908,0.0426021217947454,19.5530357780435,2.26907566540891e-05,0.00100266803105333,0.47290488652151,118718,2.99884283183078,5,3,0,1e-07,0.0817794461998199,817794.461998199,19.6413787675838
"122",123,194,194,194,"Q12824","SMARCB1","SNF5_HUMAN","fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; DNA integration [GO:0015074]; DNA repair [GO:0006281]; negative regulation of cell proliferation [GO:0008285]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of transcription by RNA polymerase II [GO:0006357]; single stranded viral RNA replication via double stranded DNA intermediate [GO:0039692]","SUBCELLULAR LOCATION: Nucleus.","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5)","GO:0000790; GO:0001164; GO:0001650; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006337; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0008285; GO:0015074; GO:0016514; GO:0030154; GO:0030957; GO:0032991; GO:0039692; GO:0043044; GO:0043231; GO:0043923; GO:0045944; GO:0051091; GO:0071564; GO:0071565; GO:0090240; GO:1900110; GO:1900113; GO:1901838; GO:1902661; GO:2000617",0.0136330150184738,0.0183447767899896,0.00679745198165231,0.138964435384439,0.147937039395951,0.128048046834647,0.12539142594164,0.075620794234192,19.5463232989097,2.2724018460788e-05,0.00100266803105333,0.471103338981194,44141,2.99884283183078,8,0,0,0.0136330150184738,0.138964435384439,10.1932283648284,3.34953914426049
"123",124,196,196,196,"Q9UGH3","SLC23A2","S23A2_HUMAN","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; nucleobase transport [GO:0015851]; nucleobase-containing compound metabolic process [GO:0006139]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19379732}; Multi-pass membrane protein {ECO:0000269|PubMed:19379732}.","Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2)","GO:0005737; GO:0005886; GO:0005887; GO:0006139; GO:0006979; GO:0009925; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070890; GO:0070904",0.00010499316826556,0.00015458689148495,0.00012786109438383,0.0957798837095003,0.0947580488777897,0.080738317106815,0.0902962695133236,0.0452772818080399,19.3075269245783,2.39473199669662e-05,0.00104586254549607,0.406616598562358,70337,2.98052538970891,5,0,0,0.00012786109438383,0.0947580488777897,741.101500299479,9.53352733547796
"124",125,198,198,198,"P63010","AP2B1","AP2B1_HUMAN","AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; signal sequence binding [GO:0005048]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; ephrin receptor signaling pathway [GO:0048013]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of neuron death [GO:1901215]; neurotransmitter receptor internalization [GO:0099590]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; regulation of defense response to virus by virus [GO:0050690]; ventricular septum development [GO:0003281]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14530274}. Membrane, coated pit {ECO:0000269|PubMed:14530274}; Peripheral membrane protein {ECO:0000269|PubMed:14530274}; Cytoplasmic side {ECO:0000269|PubMed:14530274}. Note=AP-2 appears to be excluded from internalizing CCVs and to disengage from sites of endocytosis seconds before internalization of the nascent CCV.","AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit)","GO:0003281; GO:0005048; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0019886; GO:0030122; GO:0030276; GO:0030666; GO:0030669; GO:0032802; GO:0034383; GO:0035904; GO:0036020; GO:0044877; GO:0045334; GO:0045807; GO:0048013; GO:0048268; GO:0050690; GO:0060071; GO:0060976; GO:0061024; GO:0072583; GO:0099590; GO:1901215; GO:1905477",9.02388605500766e-06,1.99465719559544e-06,1e-07,0.00391561242017264,0.00443132129696733,0.00370080099838625,0.00401220539075854,0.0020098088764628,19.0356477227067,2.54403001083827e-05,0.00109984327741291,0.332240037455319,104553,2.95866919539079,17,1,0,1.99465719559544e-06,0.00391561242017264,1963.05030699963,10.9388814298192
"125",126,200,200,200,"O75489","NDUFS3","NDUS3_HUMAN","mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762]","SUBCELLULAR LOCATION: Mitochondrion inner membrane.","NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)","GO:0003954; GO:0005739; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009055; GO:0016604; GO:0021762; GO:0030308; GO:0031966; GO:0032981; GO:0043209; GO:0045333; GO:0072593; GO:2001243",1e-07,1e-07,1e-07,0.0209743532241609,0.0173317329231046,0.0191322118377062,0.0191459993283239,0.00957309966416194,18.8849272271613,2.63173231627492e-05,0.00112638143136567,0.290559909935622,30242,2.94831451757865,11,3,0,1e-07,0.0191322118377062,191322.118377062,17.5456441449232
"126",127,203,203,203,"Q8TDN6","BRIX1","BRX1_HUMAN","nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosomal large subunit assembly [GO:0000027]","SUBCELLULAR LOCATION: Nucleus, nucleolus.","Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)","GO:0000027; GO:0003723; GO:0005634; GO:0005730",0.028380946923829,0.0171944847576249,0.025752826835614,0.105466230339494,0.114694048366726,0.104432842967782,0.0844216210523115,0.0659868966985117,18.6564442894804,2.77189342202372e-05,0.00116883781736567,0.22675199057487,41401,2.93224574539038,6,0,0,0.025752826835614,0.105466230339494,4.09532635048992,2.03397842267783
"127",128,204,204,204,"Q9Y4F3","MARF1","MARF1_HUMAN","Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468]","SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:15932519}.","Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1)","GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0016020; GO:0043231; GO:0048477",8.96053813091854e-05,8.20247336842061e-05,0.0001039436283023,0.0499818896364664,0.0534974261595916,0.0603754317068998,0.0545263912532207,0.0273550535410422,18.5353555202042,2.84989665060809e-05,0.00119583898672575,0.192625966109111,192859,2.9223272918225,7,0,0,8.96053813091854e-05,0.0534974261595916,597.033630993629,9.22166839078098
"128",129,207,207,207,"Q9Y5V3","MAGED1","MAGD1_HUMAN","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; circadian regulation of gene expression [GO:0032922]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus {ECO:0000250}. Note=Expression shifts from the cytoplasm to the plasma membrane upon stimulation with NGF. {ECO:0000250}.","Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog)","GO:0000785; GO:0003713; GO:0005634; GO:0005737; GO:0005886; GO:0006355; GO:0006357; GO:0032922; GO:0032991; GO:0042752; GO:0042802; GO:0042981; GO:0043406; GO:0045892; GO:0045893; GO:0050680; GO:0090190; GO:2001235",0.00092553785804158,0.00141352912941564,0.00110907797718682,0.199970533420791,0.228655470734505,0.244514618611847,0.223230825934166,0.112764794621965,17.7681561779581,3.41217717073044e-05,0.0014110259218093,-0.0287777822189632,86161,2.85046500779396,4,0,0,0.00110907797718682,0.228655470734505,206.167172586449,7.68767082453201
"129",130,208,208,208,"Q5JSZ5","PRRC2B","PRC2B_HUMAN","RNA binding [GO:0003723]; cell differentiation [GO:0030154]",NA,"Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B)","GO:0003723; GO:0030154",0.00276222924459815,0.00010408446583021,9.25004015673208e-05,0.13483439793865,0.122041658404999,0.110131636832132,0.121349626354595,0.0616610845479628,17.5178944882054,3.62457417406436e-05,0.00149165167932649,-0.103017667238632,242967,2.82633257861086,35,0,0,0.00010408446583021,0.122041658404999,1172.52519318379,10.1954032058598
"130",131,210,210,210,"P22307","SCP2","NLTP_HUMAN","cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylinositol transporter activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol transporter activity [GO:0015248]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; protein targeting to peroxisome [GO:0006625]; steroid biosynthetic process [GO:0006694]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17157249}. Mitochondrion {ECO:0000269|PubMed:17157249}. Note=Cytoplasmic in the liver and also associated with mitochondria especially in steroidogenic tissues.; SUBCELLULAR LOCATION: Isoform SCPx: Peroxisome. Note=Interaction with PEX5 is essential for peroxisomal import.; SUBCELLULAR LOCATION: Isoform SCP2: Mitochondrion {ECO:0000305}.","Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X)","GO:0000062; GO:0005102; GO:0005654; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006694; GO:0006699; GO:0006701; GO:0008526; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0032385; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0070538; GO:0072659; GO:1901373",2.95763563811955e-05,4.25768763497543e-05,0.00010551500582156,0.0280075421864638,0.0229072754635619,0.026779974844113,0.0258390414185287,0.0129787434554485,17.4395727204871,3.69436430412705e-05,0.00149879436835163,-0.126463793085383,58994,2.82425794741598,9,0,0,4.25768763497543e-05,0.026779974844113,628.979322581694,9.29686877969457
"131",132,211,211,211,"Q9H0E2","TOLLIP","TOLIP_HUMAN","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1, Type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Toll-interacting protein","GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0007267; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0033235; GO:0035325; GO:0035556; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0043312; GO:0045087; GO:0045092; GO:0045321; GO:0045323; GO:0048471; GO:0070062; GO:0070498",1e-07,0.00032969835031174,1e-07,0.0814669573411713,0.0769517745091297,0.0664400346238984,0.0748429560412959,0.0375314441374185,17.4394687065783,3.69445808086676e-05,0.00149879436835163,-0.126494998340865,30282,2.82425794741598,5,2,0,1e-07,0.0769517745091297,769517.745091297,19.5535950699442
"132",133,212,212,212,"Q92785","DPF2","REQU_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=30% nuclear. 70% cytoplasmic.","Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)","GO:0000790; GO:0000978; GO:0000981; GO:0005654; GO:0005813; GO:0005829; GO:0006351; GO:0006915; GO:0043231; GO:0046872; GO:0097190",0.00028547274198065,0.00031122026217538,0.00025780676337646,0.0898785000855751,0.0850685045302551,0.0732825865860426,0.0824583638114467,0.0415140151615676,17.3549035071167,3.77167849301694e-05,0.00152290414623703,-0.15192550135799,44155,2.81732743091897,10,0,0,0.00028547274198065,0.0850685045302551,297.991688943883,8.21912828392978
"133",134,213,213,213,"P48729","CSNK1A1","KC1A_HUMAN","beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; beta-catenin destruction complex assembly [GO:1904885]; beta-catenin destruction complex disassembly [GO:1904886]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1409656}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:1409656}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:1409656}. Nucleus speckle {ECO:0000303|PubMed:18305108}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:Q8BK63}. Note=Localizes to the centrosome in interphase cells, and to kinetochore fibers during mitosis. Also recruited to the keratin cytoskeleton (PubMed:23902688). {ECO:0000269|PubMed:1409656, ECO:0000269|PubMed:23902688}.","Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)","GO:0000777; GO:0000902; GO:0004672; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0006909; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0008360; GO:0016020; GO:0016055; GO:0016301; GO:0016607; GO:0018105; GO:0030877; GO:0032436; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:1904424; GO:1904885; GO:1904886; GO:1990904",1e-07,1e-07,1e-07,0.109661360022015,0.112124590636018,0.0921896322255377,0.104658427627857,0.0523293138139284,17.3060970825863,3.81714948103331e-05,0.00153402814824625,-0.166657474714981,38915,2.81416667134149,3,3,0,1e-07,0.109661360022015,1096613.60022015,20.0646238405104
"134",135,215,215,215,"Q92609","TBC1D5","TBCD5_HUMAN","autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; regulation of vesicle fusion [GO:0031338]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:20923837}. Cytoplasmic vesicle, autophagosome {ECO:0000269|PubMed:22354992}. Note=During starvation induced autophagy is relocalized from endosomal localization to LC3-positive autophagosomes. {ECO:0000269|PubMed:22354992}.","TBC1 domain family member 5","GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0010008; GO:0016236; GO:0017137; GO:0030904; GO:0031338; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0090630; GO:1905394",0.00351171091435041,0.0194750993248244,0.00704304043791154,0.125890017387177,0.134189479807774,0.116780675008181,0.115610107175349,0.0678150038133698,17.1876369888002,3.93034847970765e-05,0.00156081123001307,-0.202582645943959,89004,2.8066496188601,7,0,0,0.00704304043791154,0.125890017387177,17.8743851461553,4.15982171094068
"135",136,217,217,217,"Q96A35","MRPL24","RM24_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24) (Mitochondrial large ribosomal subunit protein uL24m)","GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126",8.70521774742656e-05,0.00021068381823073,0.00153054728450068,0.0251235693012729,0.0305005301676745,0.0294570010271991,0.0277509390719803,0.0144848972960587,16.8387298070684,4.28859661761731e-05,0.00169172290538268,-0.30980944202514,24915,2.77167077044492,5,0,0,0.00021068381823073,0.0294570010271991,139.816153298206,7.12738723816306
"136",137,218,218,218,"Q92945","KHSRP","FUBP2_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19198587}. Cytoplasm {ECO:0000269|PubMed:19198587}. Note=A small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites. {ECO:0000250}.","Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75)","GO:0000375; GO:0003677; GO:0003723; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006397; GO:0006402; GO:0008380; GO:0010494; GO:0010586; GO:0010989; GO:0016020; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345; GO:2000628",2.80646522476799e-05,6.0386979280118e-05,0.00044731089266739,0.0281672293568005,0.0267926370565915,0.0327341850563471,0.029052762981848,0.0147049689989891,16.7374005627359,4.40008393471355e-05,0.00172773937986917,-0.341354347848808,73115,2.7625217678878,13,0,0,6.0386979280118e-05,0.0281672293568005,466.445410791965,8.86556443872311
"137",139,223,223,223,"O15270","SPTLC2","SPTC2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.","Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)","GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:1904504",1e-07,1e-07,1e-07,0.0731068746595119,0.0812976903299684,0.0908894296658845,0.0817645648851216,0.0408823824425608,16.5097331942586,4.66385559397635e-05,0.00178401814627937,-0.412910557992722,62924,2.74860073247732,8,3,0,1e-07,0.0812976903299684,812976.903299684,19.6328548403062
"138",140,224,224,224,"Q68D91","MBLAC2","MBLC2_HUMAN","extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]",NA,"Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-)","GO:0016787; GO:0046872; GO:0070062",1e-07,1e-07,1e-07,0.0384832845989287,0.0335756464142819,0.0417867710419491,0.0379484673517199,0.01897433367586,16.5059016017195,4.66845870054415e-05,0.00178401814627937,-0.414122999501553,31372,2.74860073247732,7,3,0,1e-07,0.0384832845989287,384832.845989287,18.5538724147182
"139",141,225,225,225,"P16298","PPP3CB","PP2BB_HUMAN","calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; social behavior [GO:0035176]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19154138}.","Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)","GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0008144; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035176; GO:0035690; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796",1.3395282877886e-05,1e-07,1e-07,0.032064167531339,0.0321513512572533,0.0385941228096519,0.0342653487717888,0.0171372061468537,16.4414490276498,4.74673277091931e-05,0.00180586811195863,-0.434558886725485,59024,2.74331397071141,9,2,0,1e-07,0.0321513512572533,321513.512572533,18.2945198468632
"140",142,227,227,227,"Q9BX66","SORBS1","SRBS1_HUMAN","cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; SH3/SH2 adaptor activity [GO:0005070]; cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149]","SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell membrane. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Nucleus {ECO:0000250}. Nucleus matrix {ECO:0000250}. Note=Colocalizes with the Ten-1 ICD form of TENM1 in the nucleus (By similarity). Colocalizes with actin stress fibers. Also detected at the plasma membrane and in neuronal intranuclear inclusions. Colocalized with PXN at focal adhesions during myogenic differentiation. {ECO:0000250}.","Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP)","GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:1903078; GO:2001275",7.54426161252248e-06,6.5975053782391e-06,8.71207129658241e-06,0.0634436670314961,0.0784813170879882,0.0681499523456907,0.0700173608756292,0.0350162983839104,16.3584530159556,4.84991753813603e-05,0.00182886758266275,-0.460988930814469,142513,2.73781773804504,23,0,0,7.54426161252248e-06,0.0681499523456907,9033.34956366979,13.1410453225187
"141",143,228,228,228,"Q9NZ63","C9orf78","TLS1_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]",NA,"Telomere length and silencing protein 1 homolog (Hepatocellular carcinoma-associated antigen 59)","GO:0005654; GO:0005829",1.80588101388253e-05,4.09246182960351e-05,3.22472498239996e-05,0.101936075394988,0.0895524056945405,0.0820797198551042,0.0911589900887913,0.0456099052704819,16.3356305228677,4.87877359253411e-05,0.00183167991017947,-0.468279512055689,33688,2.73715041788896,6,0,0,3.22472498239996e-05,0.0895524056945405,2777.05559957216,11.4393403463792
"142",144,230,230,230,"O60927","PPP1R11","PP1RB_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; ubiquitin-dependent protein catabolic process [GO:0006511]",NA,"E3 ubiquitin-protein ligase PPP1R11 (EC 2.3.2.27) (Hemochromatosis candidate gene V protein) (HCG V) (Protein phosphatase 1 regulatory subunit 11) (Protein phosphatase inhibitor 3)","GO:0000164; GO:0004865; GO:0005634; GO:0005737; GO:0006511; GO:0008157; GO:0032515; GO:0050710; GO:0050830; GO:0061630",0.00146569866350432,0.00085334098640416,0.00735935496147252,0.0618682744894261,0.0741098751731268,0.0704547326509981,0.0655848292340567,0.0360185461541553,16.2829907764443,4.94613845353235e-05,0.00184082370270595,-0.485132811506109,13953,2.73498780226633,4,0,0,0.00146569866350432,0.0704547326509981,48.0690433888701,5.58703618790206
"143",145,231,231,231,"Q15717","ELAVL1","ELAV1_HUMAN","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19029303}. Nucleus {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462}. Note=Translocates into the cytoplasm following phosphorylation by MAPKAPK2 (PubMed:14517288). Likewise, phosphorylation by PRKCD promotes translocation from the nucleus into the cytoplasm, where it is associated with free and cytoskeleton-bound polysomes (PubMed:18285462). {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:18285462}.","ELAV-like protein 1 (Hu-antigen R) (HuR)","GO:0000398; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0010494; GO:0016020; GO:0017091; GO:0019901; GO:0035198; GO:0035925; GO:0042803; GO:0043488; GO:0045727; GO:0048255; GO:0051260; GO:0060965; GO:0070935; GO:1990904; GO:2000036",0.00037868973042657,0.0007575359619204,0.0002149228768756,0.0478395985836349,0.0490976876008175,0.0397888853987816,0.0451250076713371,0.0230128866920761,16.0321022903779,5.28337474656476e-05,0.00193961332457788,-0.566189660495414,36092,2.71228484106983,8,0,0,0.00037868973042657,0.0478395985836349,126.329273650349,6.98104517614163
"144",146,233,233,233,"Q96SU4","OSBPL9","OSBL9_HUMAN","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]","SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000269|PubMed:20599956}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:20599956}. Note=Localizes at the Golgi-late endosome interface.","Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9)","GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0031902; GO:0043231",0.0001188530486215,0.00016350366699057,0.00017609625221383,0.0665372721545528,0.0784707813092073,0.0638228120341754,0.0694574708433699,0.0348815530776269,16.0185695888753,5.30235591503503e-05,0.00193961332457788,-0.570596603873703,83185,2.71228484106983,11,0,0,0.00016350366699057,0.0665372721545528,406.946665963096,8.66869591843705
"145",147,235,235,235,"P11413","G6PD","G6PD_HUMAN","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]",NA,"Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)","GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034599; GO:0042802; GO:0042803; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:0070062; GO:1904879; GO:2000378",0.00020980574848882,0.00029227539469147,0.00015597357063969,0.0317667811995541,0.0393453969015363,0.0338817083094644,0.0347786105655783,0.0176086568540625,15.979119809824,5.35816899851697e-05,0.00193961332457788,-0.583464057016403,59257,2.71228484106983,14,0,0,0.00020980574848882,0.0338817083094644,161.490848337122,7.33530859969237
"146",148,236,236,236,"Q9NRW7","VPS45","VPS45_HUMAN","endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Associated with Golgi/endosomal vesicles and the trans-Golgi network. {ECO:0000250}.","Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45)","GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021",0.00031015710868567,0.00046175754970963,0.00067415008323402,0.0491815814923788,0.0544524783838307,0.0435221035539351,0.0485700328961717,0.024767038028629,15.9589973132593,5.38691610363538e-05,0.00193961332457788,-0.590039307702039,65077,2.71228484106983,12,0,0,0.00046175754970963,0.0491815814923788,106.509534112233,6.73483876765113
"147",149,237,237,237,"O15213","WDR46","WDR46_HUMAN","90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:23848194}.","WD repeat-containing protein 46 (WD repeat-containing protein BING4)","GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030686; GO:0032040",0.00153947877794083,0.00268733257873383,0.0022294163327824,0.0398553644911589,0.048166450748488,0.0407390751275078,0.0407682208925659,0.0225361863427686,15.922931766556,5.4389153837854e-05,0.00193961332457788,-0.601844211798298,68071,2.71228484106983,5,0,0,0.0022294163327824,0.0407390751275078,18.2734263351627,4.19167526488389
"148",150,238,238,238,"Q6UXD5","SEZ6L2","SE6L2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16863507}; Single-pass type I membrane protein {ECO:0000269|PubMed:16863507}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Note=Detected on cell surface of lung-cancer.","Seizure 6-like protein 2","GO:0005789; GO:0005886; GO:0016021",0.00215435113858522,0.0426241112706557,0.00324817613210759,0.274818613107209,0.311637959200926,0.315221502950504,0.284550478905764,0.158284118966665,15.9210291885519,5.44167560991513e-05,0.00193961332457788,-0.602467677478348,97560,2.71228484106983,7,0,0,0.00324817613210759,0.311637959200926,95.9424447832263,6.58409729731709
"149",151,240,240,240,"O14775","GNB5","GNB5_HUMAN","cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P62881}.","Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)","GO:0001750; GO:0001917; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0007212; GO:0031682; GO:0043209; GO:0043547; GO:0051087; GO:1901386; GO:1902773",0.00195855459669664,0.00307958464778847,0.00096669654956062,0.0465906989426205,0.0476673303095494,0.0390775464007504,0.0424435799529582,0.0232234019078277,15.8989528589173,5.47382977252834e-05,0.00193961332457788,-0.60970725579843,43566,2.71228484106983,4,0,0,0.00195855459669664,0.0465906989426205,23.7883074698055,4.57218072302775
"150",152,243,243,243,"Q9P258","RCC2","RCC2_HUMAN","chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]","SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome, centromere. Cytoplasm, cytoskeleton, spindle. Note=Appears in the nucleus at G2, then concentrates at the inner centromere region of chromosomes during prophase. Redistributes to the midzone of the mitotic spindle during anaphase. Here, the protein covers the entire equatorial diameter from cortex to cortex.","Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa)","GO:0003723; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0048365; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023",7.03642298351291e-05,6.39748014613092e-05,5.28259493156908e-05,0.0345708488406026,0.0394212351306976,0.0434007080575739,0.0390685423494207,0.019596659501581,15.876925722985,5.50614530224794e-05,0.00193961332457788,-0.61694039280732,56085,2.71228484106983,14,0,0,6.39748014613092e-05,0.0394212351306976,616.199413366509,9.26725349867969
"151",153,244,244,244,"Q6P1X6","C8orf82","CH082_HUMAN",NA,NA,"UPF0598 protein C8orf82",NA,0.00052520793880278,0.00025861652180091,0.00257072957831435,0.0299456593649287,0.0247402559045131,0.0289877374076926,0.0267730328794054,0.0145047011193421,15.796217481064,5.62657198233993e-05,0.00196592483885483,-0.643526000589018,23889,2.70643309011252,5,0,0,0.00052520793880278,0.0289877374076926,55.1928774606313,5.78641019675993
"152",154,245,245,245,"Q9HCM3","KIAA1549","K1549_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","UPF0606 protein KIAA1549","GO:0000981; GO:0005886; GO:0016021",7.17881382851845e-05,4.00922139049349e-05,4.28893282241362e-05,0.133905366996517,0.125953069881758,0.156388992508367,0.138697553235409,0.069400366511176,15.7907188164304,5.63489386877147e-05,0.00196592483885483,-0.645342054846491,210755,2.70643309011252,9,0,0,4.28893282241362e-05,0.133905366996517,3122.11388102743,11.6083074461282
"153",155,246,246,246,"P60510","PPP4C","PP4C_HUMAN","cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.","Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)","GO:0004704; GO:0004722; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0010569; GO:0030289; GO:0046872",0.00152654744672122,0.00012930155942225,0.00014664335284335,0.0564067389715843,0.0673190974378444,0.0701211096105165,0.0640148178869862,0.032608239729822,15.7809358076047,5.64973727054075e-05,0.00196592483885483,-0.648574618546085,35080,2.70643309011252,3,0,0,0.00014664335284335,0.0673190974378444,459.066818458231,8.84256034699211
"154",156,247,247,247,"Q9UI10","EIF2B4","EI2BD_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of translation [GO:0006417]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]",NA,"Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta)","GO:0001541; GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0006417; GO:0009408; GO:0009749; GO:0014003; GO:0031369; GO:0042552; GO:0043434; GO:0050852",1e-07,1.92166474228777e-05,1e-07,0.0320738086953164,0.0403899186692921,0.0364556528542945,0.0362999878571601,0.0181564661443876,15.680807745042,5.80445506574681e-05,0.00200998032125684,-0.681771317457683,57557,2.69680819452548,16,2,0,1e-07,0.0364556528542945,364556.528542945,18.4757830122411
"155",157,250,250,250,"Q9H1B7","IRF2BPL","I2BPL_HUMAN","extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1)","GO:0000122; GO:0005615; GO:0005634; GO:0005654; GO:0045944; GO:0046543; GO:0046872",3.5225985899605e-05,1e-07,7.04674132796062e-06,0.0686949185525985,0.0601690925912778,0.0760602995513098,0.0682939793226528,0.0341611139037356,15.4331588813057,6.21007443453221e-05,0.00211909621960788,-0.764764707265524,82659,2.67384932328164,12,1,0,7.04674132796062e-06,0.0686949185525985,9748.46604344981,13.2509595080768
"156",158,251,251,251,"Q9Y4G8","RAPGEF2","RPGF2_HUMAN","apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591]","SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region. Cell membrane. Late endosome. Cell junction {ECO:0000250}. Note=Associated with the synaptic plasma membrane. Colocalizes with ADRB1 at the plasma membrane. Synaptosome. Enriched in synaptic plasma membrane and neuronal cell body. Colocalized with CTNNB1 at cell-cell contacts (By similarity). Localized diffusely in the cytoplasm before neuronal growth factor (NGF) stimulation. Recruited to late endosomes after NGF stimulation. Colocalized with the high affinity nerve growth factor receptor NTRK1 at late endosomes. Translocated to the perinuclear region in a RAP1A-dependent manner. Translocated to the cell membrane. {ECO:0000250}.","Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)","GO:0000165; GO:0001568; GO:0001764; GO:0005088; GO:0005096; GO:0005509; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007186; GO:0007218; GO:0007264; GO:0008285; GO:0010976; GO:0016020; GO:0016324; GO:0017034; GO:0019933; GO:0019992; GO:0021591; GO:0021884; GO:0030033; GO:0030139; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0035556; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070300; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:0072659; GO:0090557; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224",3.07098128568123e-06,1.19950998078428e-05,4.87917528255999e-05,0.09298816403886,0.0922624631728271,0.0751325350991324,0.0867731014923001,0.0434078366907898,15.4310327213105,6.21370503646703e-05,0.00211909621960788,-0.765482786311336,167417,2.67384932328164,23,0,0,1.19950998078428e-05,0.0922624631728271,7691.67949002832,12.9090829319238
"157",159,252,252,252,"P78356","PIP4K2B","PI42B_HUMAN","autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; cell surface receptor signaling pathway [GO:0007166]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus {ECO:0000269|PubMed:20583997}. Cytoplasm {ECO:0000269|PubMed:20583997}. Note=Associated with the plasma membrane and the endoplasmic reticulum. {ECO:0000250}.","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta)","GO:0005524; GO:0005654; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006644; GO:0006661; GO:0007166; GO:0010506; GO:0014066; GO:0016308; GO:0016309; GO:0042803; GO:0052811; GO:2000786",0.0021265032975139,0.00012146466608951,0.00013602606040779,0.0354520408591464,0.0396100149912338,0.0442414724699587,0.0389731780987759,0.0202812537240584,15.407835717651,6.25348587166297e-05,0.00212419996275536,-0.773323437218105,47378,2.67280460311146,12,0,0,0.00013602606040779,0.0396100149912338,291.194311387742,8.18583836188806
"158",160,255,255,255,"O94953","KDM4B","KDM4B_HUMAN","nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959}.","Lysine-specific demethylase 4B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B)","GO:0005654; GO:0006351; GO:0006355; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544",3.64620111503343e-05,2.89017174544432e-05,3.96236606926757e-05,0.181128638268222,0.169254929801972,0.212224015769336,0.187500865483411,0.0937854285381379,15.1861928103537,6.64981624672232e-05,0.00223225204203698,-0.848818569138933,121897,2.65125677107582,8,0,0,3.64620111503343e-05,0.181128638268222,4967.59867472536,12.2783329096354
"159",161,258,258,258,"P60880","SNAP25","SNP25_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; growth cone [GO:0030426]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule membrane [GO:0035579]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; calcium-dependent protein binding [GO:0048306]; SNAP receptor activity [GO:0005484]; syntaxin-1 binding [GO:0017075]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter uptake [GO:0001504]; neutrophil degranulation [GO:0043312]; positive regulation of synaptic plasticity [GO:0031915]; regulation of insulin secretion [GO:0050796]; regulation of neuron projection development [GO:0010975]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:P60879}. Cell membrane {ECO:0000250|UniProtKB:P60881}; Lipid-anchor {ECO:0000250|UniProtKB:P60879}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:P60879}. Note=Membrane association requires palmitoylation. Expressed throughout cytoplasm, concentrating at the perinuclear region. Colocalizes with KCNB1 at the cell membrane. {ECO:0000250|UniProtKB:P60879, ECO:0000250|UniProtKB:P60881}.","Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein)","GO:0001504; GO:0005484; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0007268; GO:0007626; GO:0008021; GO:0008306; GO:0010975; GO:0016020; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0030054; GO:0030426; GO:0031201; GO:0031234; GO:0031629; GO:0031915; GO:0035579; GO:0036477; GO:0042734; GO:0043005; GO:0043209; GO:0043312; GO:0048306; GO:0048471; GO:0050796; GO:0060291; GO:0070032; GO:0070821; GO:0098794; GO:0098967; GO:0099590; GO:1990926",1e-07,2.88995293006602e-06,1.04189307410414e-05,0.0402473329665108,0.0474797096555776,0.0511896318255911,0.0463010885213362,0.0231550138885584,14.9525557877632,7.1015497327603e-05,0.002356173089629,-0.929557152253592,23315,2.6277928084904,12,1,0,2.88995293006602e-06,0.0474797096555776,16429.2328645273,14.0039774971849
"160",162,259,259,259,"Q5T3F8","TMEM63B","CSCL2_HUMAN","actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion transport [GO:0006811]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","CSC1-like protein 2 (Transmembrane protein 63B)","GO:0005886; GO:0006811; GO:0015629; GO:0016021",0.00290839866116431,0.00582150223364754,0.00767603217695318,0.107128262623836,0.113806878934795,0.0911814076513359,0.0985702053794004,0.0547537470469552,14.9232038517669,7.16093226686167e-05,0.00235809364843203,-0.939786129781243,94958,2.62743895149298,7,0,0,0.00582150223364754,0.107128262623836,18.4021680872419,4.20180384510692
"161",163,260,260,260,"P00367","GLUD1","DHE3_HUMAN","cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350]","SUBCELLULAR LOCATION: Mitochondrion matrix.","Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)","GO:0004352; GO:0004353; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006537; GO:0006538; GO:0006541; GO:0008652; GO:0021762; GO:0032024; GO:0042802; GO:0043531; GO:0070403; GO:0070728; GO:0072350",0.00220417351562667,0.00100796065622686,0.00100946901193803,0.0143946575343343,0.0124304803888746,0.0149952215392162,0.0125329187595445,0.0076736604410361,14.9224654569871,7.16243397888234e-05,0.00235809364843203,-0.940043705581829,61398,2.62743895149298,8,0,0,0.00100946901193803,0.0143946575343343,14.2596329001707,3.83386493642229
"162",164,261,261,261,"Q9H5H4","ZNF768","ZN768_HUMAN","DNA-directed RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Zinc finger protein 768","GO:0000981; GO:0003677; GO:0003723; GO:0005665; GO:0006366; GO:0046872",1e-07,1e-07,1e-07,0.0778336605074562,0.0786717334666892,0.0959429451847607,0.084149346386302,0.042074773193151,14.7945499609189,7.4285250697843e-05,0.00243632852863424,-0.984850810482282,60229,2.61326414930977,6,3,0,1e-07,0.0786717334666892,786717.334666892,19.5854858469851
"163",165,262,262,262,"Q9NYY8","FASTKD2","FAKD2_HUMAN","intercellular bridge [GO:0045171]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cellular respiration [GO:0045333]; mitochondrial large ribosomal subunit assembly [GO:1902775]","SUBCELLULAR LOCATION: Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:20869947, ECO:0000269|PubMed:25683715}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. {ECO:0000269|PubMed:25683715}.","FAST kinase domain-containing protein 2, mitochondrial","GO:0003723; GO:0004672; GO:0005634; GO:0005739; GO:0019843; GO:0035770; GO:0042645; GO:0045171; GO:0045333; GO:1902775",0.00010881467812941,0.00022219349123034,0.00014090458130257,0.0443474230153198,0.0466434246520918,0.0367817366648568,0.0424335571938687,0.0213740828471551,14.777190515702,7.46556563111546e-05,0.00243913136650184,-0.990960285406285,81463,2.61276480886606,8,0,0,0.00014090458130257,0.0443474230153198,314.733719836198,8.29798794367125
"164",166,264,264,264,"Q96GD3","SCMH1","SCMH1_HUMAN","chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Polycomb protein SCMH1 (Sex comb on midleg homolog 1)","GO:0005654; GO:0006338; GO:0006351; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0045892",7.74405820863913e-05,9.96019774287651e-05,0.00014541234332714,0.567008329375119,0.516611488593964,0.656999907282907,0.580099090116382,0.290157030025805,14.6592864019745,7.7232379127059e-05,0.00250420138381676,-1.03263887935424,73354,2.60133074879884,4,0,0,9.96019774287651e-05,0.567008329375119,5692.74169060188,12.4749079232736
"165",167,265,265,265,"Q8NFT8","DNER","DNER_HUMAN","dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Note=Present on the membrane of dendrites and cell bodies but excluded from axonal membrane. Also found in early endosomes in the somatodendritic region (By similarity). {ECO:0000250}.","Delta and Notch-like epidermal growth factor-related receptor","GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741",0.00299779358766243,0.0103106372202326,0.00596213356547506,0.175932880552757,0.143047702622012,0.176411842127525,0.158707286976308,0.0857771649459441,14.6446576270243,7.75596489308513e-05,0.00250532299942674,-1.03783253583732,78475,2.60113627465674,8,0,0,0.00596213356547506,0.175932880552757,29.5083762583804,4.88305263143388
"166",168,266,266,266,"Q9UMN6","KMT2B","KMT2B_HUMAN","histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; chromatin-mediated maintenance of transcription [GO:0048096]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of megakaryocyte differentiation [GO:0045652]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)","GO:0000981; GO:0001541; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0018024; GO:0030728; GO:0035097; GO:0042800; GO:0045652; GO:0048096; GO:0051568; GO:0051569; GO:0080182",1e-07,1e-07,1e-07,0.0812976556344923,0.0637183432750151,0.0703914763067122,0.0718023917387399,0.0359012958693699,14.541122152365,7.99252619402479e-05,0.00257192049021256,-1.0747338409186,293515,2.58974246156262,7,3,0,1e-07,0.0703914763067122,703914.763067122,19.4250412181498
"167",169,271,271,271,"P98175","RBM10","RBM10_HUMAN","nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18315527}. Note=In the extranucleolar nucleoplasm constitutes hundreds of nuclear domains, which dynamically change their structures in a reversible manner. Upon globally reducing RNA polymerase II transcription, the nuclear bodies enlarge and decrease in number. They occur closely adjacent to nuclear speckles or IGCs (interchromatin granule clusters) but coincide with TIDRs (transcription-inactivation-dependent RNA domains).","RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1)","GO:0000381; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016607; GO:0035198; GO:0042802; GO:0042981; GO:0044877; GO:0046872",0.000156047127501,0.00020627751587558,7.9346167138892e-05,0.0686101543382029,0.0533292595925456,0.0620383205973527,0.061178687905862,0.0307365675564361,14.3430138943799,8.47038560698158e-05,0.00267551663452998,-1.14605055263215,103533,2.57259234453569,16,0,0,0.000156047127501,0.0620383205973527,397.561439232229,8.63503402181002
"168",170,272,272,272,"P17405","SMPD1","ASM_HUMAN","endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]","SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:18815062, ECO:0000269|PubMed:27659707}. Secreted {ECO:0000269|PubMed:25920558, ECO:0000269|PubMed:27659707, ECO:0000269|PubMed:8702487}.","Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase)","GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006684; GO:0006685; GO:0006687; GO:0007165; GO:0007399; GO:0008270; GO:0016798; GO:0023021; GO:0035307; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043407; GO:0046513; GO:0061750; GO:0070062",0.00095973775774536,0.00216409244007662,0.0019604820641305,0.0275553967009803,0.0313366018629241,0.0348594444254883,0.0295557102424801,0.0164726258752242,14.318991547758,8.53068802519772e-05,0.00268465770204752,-1.15476248696661,69752,2.5711110796436,3,0,0,0.0019604820641305,0.0313366018629241,15.9841308606015,3.99856839438959
"169",171,273,273,273,"O75044","SRGAP2","SRGP2_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine head [GO:0044327]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; actin filament severing [GO:0051014]; dendritic spine development [GO:0060996]; extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration [GO:0021816]; filopodium assembly [GO:0046847]; lamellipodium assembly involved in ameboidal cell migration [GO:0003363]; negative regulation of neuron migration [GO:2001223]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]","SUBCELLULAR LOCATION: Cell membrane. Cell projection, dendritic spine. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}. Cell projection, lamellipodium. Cytoplasmic vesicle, phagosome {ECO:0000250}. Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Recruited to actin-rich phagosomes during phagocytosis. Translocates from nucleus to cytoplasm during development. {ECO:0000250}.","SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34)","GO:0003363; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0014069; GO:0021816; GO:0030027; GO:0030054; GO:0034446; GO:0042802; GO:0042803; GO:0043547; GO:0044327; GO:0045211; GO:0045335; GO:0046847; GO:0048365; GO:0048812; GO:0051014; GO:0051056; GO:0060996; GO:2001223",0.0147853015295999,0.00832540345225942,0.00645188584980757,0.0572229016336578,0.0531179494010179,0.0612542017023308,0.0473441539684466,0.0335262739281122,14.2471493851167,8.71420389527048e-05,0.00273236576349873,-1.18090061496399,120871,2.56346116500636,9,0,0,0.00832540345225942,0.0572229016336578,6.87328871949481,2.78100056251154
"170",172,274,274,274,"Q86VW0","SESTD1","SESD1_HUMAN","intermediate filament cytoskeleton [GO:0045111]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]",NA,"SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein) (Protein Solo)","GO:0005546; GO:0010314; GO:0032266; GO:0043325; GO:0045111; GO:0070273; GO:0070300; GO:0080025; GO:1904878",0.00281121707361476,0.0123464728589939,0.0031834373703855,0.0720464506898307,0.0851974745615429,0.073731514045582,0.0708781039979872,0.0415527610999916,14.2078039869231,8.81676415212442e-05,0.00275443434825493,-1.19526913464666,79348,2.55996757454512,13,0,0,0.0031834373703855,0.073731514045582,23.1609752186372,4.5336240957737
"171",173,275,275,275,"P17612","PRKACA","KAPCA_HUMAN","acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; G2/M transition of mitotic cell cycle [GO:0000086]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Nucleus {ECO:0000250}. Mitochondrion {ECO:0000250}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. Distributed throughout the cytoplasm in meiotically incompetent oocytes. Associated to mitochondrion as meiotic competence is acquired. Aggregates around the germinal vesicles (GV) at the immature GV stage oocytes (By similarity). Colocalizes with HSF1 in nuclear stress bodies (nSBs) upon heat shock (PubMed:21085490). {ECO:0000250, ECO:0000269|PubMed:21085490}.; SUBCELLULAR LOCATION: Isoform 2: Cell projection, cilium, flagellum {ECO:0000269|PubMed:10906071}. Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250|UniProtKB:P05132}. Note=Expressed in the midpiece region of the sperm flagellum (PubMed:10906071). Colocalizes with MROH2B and TCP11 on the acrosome and tail regions in round spermatids and spermatozoa regardless of the capacitation status of the sperm (By similarity). {ECO:0000250|UniProtKB:P05132, ECO:0000269|PubMed:10906071}.","cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)","GO:0000086; GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0002223; GO:0003091; GO:0004672; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0007596; GO:0010389; GO:0010881; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034199; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045171; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070613; GO:0071158; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097711; GO:1901621; GO:1903779; GO:2000810",1e-07,1e-07,3.00160512116756e-06,0.00296307655255358,0.00370163180285895,0.00373581810765188,0.00346577495264775,0.00173395467803093,14.1730034383572,8.9087154195558e-05,0.00277304014514173,-1.20800973916096,40590,2.55704384312054,3,2,0,1e-07,0.00370163180285895,37016.3180285895,15.1758737786457
"172",174,276,276,276,"Q5T7P8","SYT6","SYT6_HUMAN","cell junction [GO:0030054]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q9R0N8}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q9R0N8}.; SUBCELLULAR LOCATION: Isoform 1: Membrane {ECO:0000250|UniProtKB:Q9R0N8}; Single-pass membrane protein {ECO:0000250}. Note=Localized predominantly to endoplasmic reticulum (ER) and/or Golgi-like perinuclear compartment (By similarity). {ECO:0000250|UniProtKB:Q9R0N8}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9R0N8}. Cell membrane {ECO:0000250|UniProtKB:Q9R0N8}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9R0N8}.","Synaptotagmin-6 (Synaptotagmin VI) (SytVI)","GO:0001786; GO:0005509; GO:0005829; GO:0005886; GO:0006906; GO:0016021; GO:0017158; GO:0019898; GO:0019905; GO:0030054; GO:0030276; GO:0030672; GO:0042803; GO:0048306; GO:0048791; GO:0060478; GO:0097038",0.00448382918217836,1e-07,1e-07,0.060617271152321,0.0515158309297489,0.0650057770751629,0.0575516166583515,0.0302704847232352,14.0687893208521,9.19120616607123e-05,0.0028338108073891,-1.24634293602513,57325,2.54762914775463,7,2,0,1e-07,0.060617271152321,606172.71152321,19.2093693812666
"173",175,277,277,277,"Q9Y2I1","NISCH","NISCH_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]","SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Early endosome. Recycling endosome. Note=Enriched in the early/sorting and recycling endosomes. Colocalized in early/sorting endosomes with EEA1 and SNX2 and in recycling endosomes with transferrin receptor. Detected in the perinuclear region partially associated with punctate structures (By similarity). Colocalizes with PAK1 in cytoplasm, vesicular structures in the perinuclear area and membrane ruffles (By similarity). Colocalizes with RAC1 in the cytoplasm and vesicles structures (By similarity). Colocalized with MAPK1 and MAPK3 in RVLM neurons (By similarity). {ECO:0000250}.","Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)","GO:0005178; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037",1e-07,1e-07,1e-07,0.0782508947279525,0.0999994472902093,0.0966292867966904,0.0916264429382841,0.045813321469142,14.0675627948532,9.1945958589095e-05,0.0028338108073891,-1.24679570762064,166629,2.54762914775463,12,3,0,1e-07,0.0966292867966904,966292.867966904,19.8821009876465
"174",176,278,278,278,"Q8N5J2","MINDY1","MINY1_HUMAN","nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type carboxypeptidase activity [GO:0016807]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]",NA,"Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A)","GO:0004843; GO:0005634; GO:0005654; GO:0016604; GO:0016807; GO:0036435; GO:1990380",2.98301739628996e-05,0.00267003201489514,8.98227205077306e-05,0.0961903891560433,0.0952967667289975,0.118233385308382,0.102310285428019,0.0520850376837981,14.0580639933969,9.22089930183182e-05,0.0028338108073891,-1.2503034668997,51778,2.54762914775463,5,0,0,8.98227205077306e-05,0.0961903891560433,1070.89151399912,10.064596620826
"175",177,279,279,279,"Q6PID6","TTC33","TTC33_HUMAN",NA,NA,"Tetratricopeptide repeat protein 33 (TPR repeat protein 33) (Osmosis-responsive factor)",NA,1e-07,1e-07,1e-07,0.100625412378436,0.114712090709063,0.0888133947378557,0.101383532608452,0.0506918663042259,14.0524929200118,9.23636933716774e-05,0.0028338108073891,-1.25236183336738,29411,2.54762914775463,3,3,0,1e-07,0.100625412378436,1006254.12378436,19.94056326495
"176",178,280,280,280,"Q9ULI4","KIF26A","KI26A_HUMAN","cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; enteric nervous system development [GO:0048484]; microtubule-based movement [GO:0007018]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.","Kinesin-like protein KIF26A","GO:0001560; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0009968; GO:0019886; GO:0048484",0.00021899555155734,4.0317354040151e-05,9.59695058546089e-05,0.134309645558599,0.142556799733469,0.170920129781419,0.149143764220678,0.0746903095808232,13.9571215413849,9.50621174088807e-05,0.00290618473221435,-1.28772075017228,194590,2.53667678314488,18,0,0,9.59695058546089e-05,0.142556799733469,1485.4385094932,10.536673169953
"177",179,282,282,282,"Q14728","MFSD10","MFS10_HUMAN","brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]","SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane protein {ECO:0000255}.","Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)","GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252",6.7738305869013e-05,9.65065252411282e-06,6.58595202730473e-05,0.0212923171454626,0.0227225378511672,0.0272699212182683,0.0237138425787439,0.0119046707822607,13.6514150563019,0.00010438966494221,0.00316870755994793,-1.40263959002383,48339,2.49911784000231,4,0,0,6.58595202730473e-05,0.0227225378511672,345.01523480526,8.43051625802125
"178",180,283,283,283,"Q52WX2","SBK1","SBK1_HUMAN","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (SH3-binding kinase 1)","GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107",1e-07,1e-07,1.75881143781795e-05,0.088231382972287,0.0679789595437639,0.0757318645371229,0.0773081396462652,0.038659999194592,13.5965112284875,0.00010618197624268,0.00321172338034403,-1.42353874495647,46252,2.49326186674438,5,2,0,1e-07,0.0757318645371229,757318.645371229,19.5305409230905
"179",181,284,284,284,"Q8N1G4","LRRC47","LRC47_HUMAN","RNA binding [GO:0003723]",NA,"Leucine-rich repeat-containing protein 47","GO:0003723",1e-07,1e-07,1e-07,0.0355635627211806,0.0329671006665122,0.0272524336975066,0.0319275990283998,0.0159638995141999,13.494098547882,0.00010962728405274,0.00329750923639615,-1.46273832079426,63473,2.48181397931147,15,3,0,1e-07,0.0329671006665122,329671.006665122,18.3306674873786
"180",182,285,285,285,"Q9BWF3","RBM4","RBM4_HUMAN","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Nucleus speckle. Cytoplasm. Cytoplasmic granule. Note=Undergoes continuous nucleocytoplasmic shuttling. Upon nuclear import colocalizes with SR proteins in nuclear speckles. Arsenite stress-induced phosphorylation increases its subcellular relocalization from the nucleus to the cytoplasm and to cytoplasmic stress granules (SG) via a p38 MAPK signaling pathway. Primarily localized in nucleus and nucleoli under cell growth conditions and accumulated in the cytoplasm and cytoplasm perinuclear granules upon muscle cell differentiation.","RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)","GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0030332; GO:0032055; GO:0035198; GO:0035278; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0097157; GO:0097158; GO:0097167",1e-07,0.00024769432820894,7.82031383105872e-06,0.167177473792995,0.205114618383887,0.161479626464825,0.177838701333222,0.0890045555472912,13.4742866818046,0.00011030954280587,0.00329750923639615,-1.47035428325004,40314,2.48181397931147,5,1,0,7.82031383105872e-06,0.167177473792995,21377.3356676611,14.3837944356679
"181",183,286,286,286,"Q643R3","LPCAT4","LPCT4_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}; Multi-pass membrane protein {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}.","Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (EC 2.3.1.n7) (Plasmalogen synthase)","GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047166; GO:0047184; GO:0047192; GO:0071617",7.32824240223275e-05,1e-07,1e-07,0.050066168589019,0.064077754972058,0.0633603446458394,0.0591435952609647,0.0295962917718231,13.4702168255174,0.00011045034066995,0.00329750923639615,-1.47192011607,57219,2.48181397931147,8,2,0,1e-07,0.0633603446458394,633603.446458394,19.2732206573526
"182",184,288,288,288,"P45954","ACADSB","ACDSB_HUMAN","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid metabolic process [GO:0006631]","SUBCELLULAR LOCATION: Mitochondrion matrix.","Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)","GO:0003995; GO:0005739; GO:0005759; GO:0006631; GO:0009083; GO:0050660",0.00079683652641903,0.00136498704720741,0.00563825699082625,0.0358800123020352,0.0332640749512211,0.0405413748569111,0.0339617938485716,0.0195809237791034,13.4495267482848,0.00011116954117845,0.00330420580724842,-1.47988738141651,47485,2.48093290984783,13,0,0,0.00136498704720741,0.0358800123020352,26.2859727317128,4.71622121877382
"183",185,289,289,289,"P62937","PPIA","PPIA_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; entry into host cell [GO:0030260]; establishment of integrated proviral latency [GO:0075713]; fusion of virus membrane with host plasma membrane [GO:0019064]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte migration [GO:0050900]; lipid particle organization [GO:0034389]; neutrophil degranulation [GO:0043312]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of viral genome replication [GO:0045069]; RNA-dependent DNA biosynthetic process [GO:0006278]; uncoating of virus [GO:0019061]; viral life cycle [GO:0019058]; viral release from host cell [GO:0019076]; virion assembly [GO:0019068]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16527992}. Secreted {ECO:0000269|PubMed:16527992}. Note=Secretion occurs in response to oxidative stress in vascular smooth muscle through a vesicular secretory pathway that involves actin remodeling and myosin II activation, and mediates ERK1/2 activation.","Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]","GO:0000413; GO:0003723; GO:0003755; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0005925; GO:0006278; GO:0006457; GO:0016018; GO:0016020; GO:0019058; GO:0019061; GO:0019064; GO:0019068; GO:0019076; GO:0030260; GO:0031982; GO:0032991; GO:0034389; GO:0034774; GO:0035722; GO:0043312; GO:0045069; GO:0045070; GO:0046790; GO:0050714; GO:0050900; GO:0051082; GO:0070062; GO:0075713; GO:1904813",5.639258148766e-05,6.9582211841194e-06,0.00045753558344725,0.0225438214122655,0.0238564542813922,0.0183849115763294,0.021421433627956,0.010884345609351,13.42532668739,0.00011201806031409,0.00331790517746943,-1.48922110259591,18012,2.47913602985181,10,0,0,5.639258148766e-05,0.0225438214122655,399.765728355575,8.64301098589235
"184",186,290,290,290,"P26378","ELAVL4","ELAV4_HUMAN","AU-rich element binding [GO:0017091]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]",NA,"ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD)","GO:0003723; GO:0003730; GO:0006396; GO:0006397; GO:0017091",1e-07,4.82261814132281e-05,1e-07,0.103152247529858,0.100609949421105,0.0799768040450814,0.0945635249382104,0.0472979045295763,13.3709566448047,0.00011395360108102,0.00336359594915016,-1.51024971953892,41770,2.47319617922182,5,2,0,1e-07,0.100609949421105,1006099.49421105,19.940341551115
"185",187,291,291,291,"Q9UI36","DACH1","DACH1_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly [GO:0001075]; transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001078]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; multicellular organism development [GO:0007275]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14525983}.","Dachshund homolog 1 (Dach1)","GO:0001075; GO:0001078; GO:0001967; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007275; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279",0.00031738891507248,0.00067060123141994,0.00270184236159046,0.198676871454847,0.151959258943683,0.174601262361234,0.17384918675056,0.0881545375446411,13.353335176108,0.00011458970865216,0.00337074881808434,-1.5170826380255,78676,2.47227360908814,8,0,0,0.00067060123141994,0.174601262361234,260.365257593594,8.02439314195954
"186",188,292,292,292,"Q9NVG8","TBC1D13","TBC13_HUMAN","cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular [GO:0005622]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of vesicle fusion [GO:0031338]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q8R3D1}. Cytoplasm {ECO:0000250|UniProtKB:Q8R3D1}.","TBC1 domain family member 13","GO:0005096; GO:0005622; GO:0005829; GO:0006886; GO:0012505; GO:0016020; GO:0017137; GO:0031338; GO:0090630",3.00916879454086e-05,7.9981515703066e-05,7.44426366535168e-05,0.0615785268848558,0.070402521945639,0.0806382144613863,0.0708115824838597,0.0354672965220305,13.3416259340382,0.00011501480539481,0.00337166689787534,-1.52162777899993,46554,2.47215533783153,11,0,0,7.44426366535168e-05,0.070402521945639,945.728484515104,9.8852822398636
"187",189,293,293,293,"Q96K37","SLC35E1","S35E1_HUMAN","Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Solute carrier family 35 member E1","GO:0005794; GO:0016021",0.00357174070822772,1e-07,1e-07,0.0725863593893808,0.0565081023683812,0.0616929220042661,0.0624051476846001,0.0323932207450426,13.2545419410544,0.00011823783177301,0.00343958129599846,-1.55555062960052,44773,2.46349442135429,3,2,0,1e-07,0.0616929220042661,616929.220042661,19.2347454536803
"188",190,294,294,294,"Q86UK7","ZNF598","ZN598_HUMAN","metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]",NA,"E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598)","GO:0003723; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344",0.00018582492806552,0.00027329908574381,0.0004838933068733,0.0820298001792724,0.105995979520766,0.103316376313999,0.0967997128977849,0.0487141955557867,13.2467534565345,0.00011853145682205,0.00343958129599846,-1.55859490303001,98637,2.46349442135429,14,0,0,0.00027329908574381,0.103316376313999,378.034108796279,8.56237259980628
"189",191,295,295,295,"Q7Z5K2","WAPL","WAPL_HUMAN","chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Isoform 2: Nucleus.; SUBCELLULAR LOCATION: Nucleus. Chromosome. Cytoplasm. Note=Associates with chromatin through the cohesin complex during interphase. Released in the cytoplasm from nuclear envelope breakdown until anaphase, it reaccumulates in nucleus at telophase.","Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor)","GO:0000775; GO:0000785; GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0007064; GO:0008156; GO:0008278; GO:0009636; GO:0016032; GO:0035562; GO:0045132; GO:0045875; GO:0048146; GO:0051301; GO:0060623; GO:0071168; GO:0071922",0.00043452866037492,0.00028825301810117,0.00041969355060351,0.113143969268598,0.112936727363854,0.0884746459007837,0.104470955768052,0.0526163029603858,13.2373316297733,0.00011888785593079,0.00343958129599846,-1.56227987723721,132946,2.46349442135429,11,0,0,0.00041969355060351,0.112936727363854,269.09331153994,8.07196272223177
"190",192,296,296,296,"A6NGN9","IGLON5","IGLO5_HUMAN","extracellular region [GO:0005576]","SUBCELLULAR LOCATION: Secreted {ECO:0000305}.","IgLON family member 5","GO:0005576",7.83816799786984e-06,7.57950554556001e-06,1.65979749299529e-05,0.0681166300353524,0.0708556371703051,0.0545080412803877,0.0644827642791906,0.0322520540224198,13.2359878943238,0.00011893879247845,0.00343958129599846,-1.56280562958007,36795,2.46349442135429,4,0,0,7.83816799786984e-06,0.0681166300353524,8690.37638053488,13.0852029462325
"191",193,298,298,298,"P23470","PTPRG","PTPRG_HUMAN","extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48)","GO:0004725; GO:0005001; GO:0005887; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062",1e-07,1e-07,2.02270240884695e-06,0.0782796423745048,0.0812410271475866,0.100112921355984,0.086543789391889,0.0432726355967474,13.1324837488088,0.00012294408404951,0.00351366683090891,-1.60345630229271,162003,2.45423942108704,13,2,0,1e-07,0.0812410271475866,812410.271475866,19.6318489544865
"192",194,299,299,299,"Q9H496","TOR1AIP2","IFG15_HUMAN",NA,NA,"Torsin-1A-interacting protein 2, isoform IFRG15 (15 kDa interferon-responsive protein) (IFRG15)",NA,4.25410831394109e-05,1.65021849828011e-05,2.25479390980297e-05,0.0880499094407295,0.0668205742758294,0.0778905084020071,0.0775598003037819,0.0388070972209644,13.1276418249049,0.00012313547334044,0.00351366683090891,-1.60536539710041,15348,2.45423942108704,7,0,0,2.25479390980297e-05,0.0778905084020071,3454.44025120741,11.7542362435448
"193",195,300,300,300,"O95721","SNAP29","SNP29_HUMAN","autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle targeting [GO:0006903]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23217709}. Golgi apparatus membrane {ECO:0000250|UniProtKB:Q9Z2P6}; Peripheral membrane protein {ECO:0000305}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000269|PubMed:25686604}; Peripheral membrane protein {ECO:0000305}. Cell projection, cilium membrane {ECO:0000269|PubMed:25686250}; Peripheral membrane protein {ECO:0000305}. Note=Appears to be mostly membrane-bound, probably via interaction with syntaxins, but a significant portion is cytoplasmic. Localizes to the ciliary pocket from where the cilium protrudes. {ECO:0000269|PubMed:23217709, ECO:0000269|PubMed:25686250}.","Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)","GO:0000139; GO:0000421; GO:0005484; GO:0005654; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006903; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0035577; GO:0043312; GO:0060271; GO:0061025; GO:0097352; GO:0098793",0.0004344028741808,0.00594190265459189,0.00057150046360403,0.0482420137374584,0.046278241465775,0.0571864750749878,0.0482529747619482,0.0264424227117663,13.1218962125971,0.0001233630578608,0.00351366683090891,-1.60763167135866,28970,2.45423942108704,4,0,0,0.00057150046360403,0.0482420137374584,84.4129039427751,6.3993916510622
"194",196,302,302,302,"P11117","ACP2","PPAL_HUMAN","extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501]","SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:2684640, ECO:0000269|PubMed:3056714}; Single-pass membrane protein {ECO:0000255}; Lumenal side {ECO:0000305|PubMed:2684640, ECO:0000305|PubMed:3056714}. Lysosome lumen. Note=The soluble form arises by proteolytic processing of the membrane-bound form. {ECO:0000269|PubMed:2684640, ECO:0000269|PubMed:3056714}.","Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)","GO:0001501; GO:0003993; GO:0005764; GO:0005765; GO:0007040; GO:0016020; GO:0016021; GO:0043202; GO:0070062",5.57271927699779e-05,3.07011621395248e-05,7.84863135608509e-05,0.0147935393647571,0.015825106314586,0.012062438679198,0.0141720565633569,0.00714099983783523,13.0947777066856,0.00012444422077851,0.00352529004912279,-1.61834093433759,48344,2.45280514489916,7,0,0,5.57271927699779e-05,0.0147935393647571,265.463566876939,8.05237006401438
"195",197,304,304,304,"Q8NEZ5","FBXO22","FBX22_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; Z disc [GO:0030018]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to starvation [GO:0009267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of skeletal muscle fiber development [GO:0048742]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250}.","F-box only protein 22 (F-box protein FBX22p44)","GO:0000209; GO:0004842; GO:0005634; GO:0005829; GO:0006464; GO:0006511; GO:0006913; GO:0009267; GO:0030018; GO:0032436; GO:0043687; GO:0048742",6.7720395963925e-05,1e-07,1e-07,0.0431407467260414,0.0391268923830013,0.0326921397110579,0.0382972861413789,0.0191712832026774,13.0572427982708,0.00012595992333306,0.00352529004912279,-1.63319855220127,44508,2.45280514489916,6,2,0,1e-07,0.0391268923830013,391268.923830013,18.5778010045153
"196",198,308,308,308,"P43034","PAFAH1B1","LIS1_HUMAN","astral microtubule [GO:0000235]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; phospholipase A2 activity [GO:0004623]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; acrosome assembly [GO:0001675]; actin cytoskeleton organization [GO:0030036]; adult locomotory behavior [GO:0008344]; ameboidal-type cell migration [GO:0001667]; auditory receptor cell development [GO:0060117]; brain morphogenesis [GO:0048854]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; chemical synaptic transmission [GO:0007268]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum morphogenesis [GO:0021540]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G2/M transition of mitotic cell cycle [GO:0000086]; germ cell development [GO:0007281]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; lipid catabolic process [GO:0016042]; maintenance of centrosome location [GO:0051661]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; microtubule organizing center organization [GO:0031023]; microtubule-based process [GO:0007017]; negative regulation of JNK cascade [GO:0046329]; negative regulation of neuron projection development [GO:0010977]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear envelope disassembly [GO:0051081]; nuclear migration [GO:0007097]; osteoclast development [GO:0036035]; platelet activating factor metabolic process [GO:0046469]; positive regulation of axon extension [GO:0045773]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of embryonic development [GO:0040019]; positive regulation of mitotic cell cycle [GO:0045931]; protein secretion [GO:0009306]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; stem cell division [GO:0017145]; transmission of nerve impulse [GO:0019226]; vesicle transport along microtubule [GO:0047496]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-Rule:MF_03141}. Nucleus membrane {ECO:0000255|HAMAP-Rule:MF_03141}. Note=Redistributes to axons during neuronal development. Also localizes to the microtubules of the manchette in elongating spermatids and to the meiotic spindle in spermatocytes (By similarity). Localizes to the plus end of microtubules and to the centrosome. May localize to the nuclear membrane. {ECO:0000250}.","Platelet-activating factor acetylhydrolase IB subunit alpha (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha)","GO:0000086; GO:0000132; GO:0000226; GO:0000235; GO:0000776; GO:0001667; GO:0001675; GO:0001764; GO:0001961; GO:0004623; GO:0005635; GO:0005813; GO:0005829; GO:0005871; GO:0005875; GO:0005938; GO:0007017; GO:0007097; GO:0007268; GO:0007281; GO:0007405; GO:0007611; GO:0008017; GO:0008090; GO:0008201; GO:0008344; GO:0009306; GO:0010389; GO:0010977; GO:0016042; GO:0017145; GO:0019226; GO:0021540; GO:0021766; GO:0021819; GO:0021895; GO:0021987; GO:0030036; GO:0031023; GO:0031252; GO:0031514; GO:0031965; GO:0032420; GO:0034452; GO:0036035; GO:0040019; GO:0042249; GO:0042803; GO:0043025; GO:0043087; GO:0043274; GO:0043622; GO:0045505; GO:0045773; GO:0045931; GO:0046329; GO:0046469; GO:0047496; GO:0048471; GO:0048854; GO:0050885; GO:0051081; GO:0051219; GO:0051660; GO:0051661; GO:0060117; GO:0061003; GO:0070062; GO:0070507; GO:0070840; GO:0090102; GO:0090176; GO:0090724; GO:0097711; GO:1904115; GO:2000574",0.00028829260648478,0.00030506590879253,0.00031290457978655,0.00096127219770847,0.00113404143231707,0.00110097420218809,0.00076334157904991,0.00068375848787958,13.0355911598243,0.00012684454849647,0.00352529004912279,-1.64178750152852,46638,2.45280514489916,27,0,0,0.00030506590879253,0.00110097420218809,3.60897160402424,1.8515877919205
"197",199,309,309,309,"Q9UJC5","SH3BGRL2","SH3L2_HUMAN","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; SH3 domain binding [GO:0017124]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12095696}.","SH3 domain-binding glutamic acid-rich-like protein 2 (Fovea-associated SH3 domain-binding protein)","GO:0005654; GO:0005737; GO:0017124; GO:0031965",1e-07,1e-07,0.00119114518906318,0.00683520057719971,0.006197007860016,0.00597999690570299,0.00594028671795184,0.00336725842199698,13.0135472600039,0.00012775304676012,0.00353904880345208,-1.65054600029297,12326,2.45111344840408,3,2,0,1e-07,0.006197007860016,61970.07860016,15.919284177712
"198",200,310,310,310,"Q96PB7","OLFM3","NOE3_HUMAN","AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; eye photoreceptor cell development [GO:0042462]","SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Cell junction, synapse {ECO:0000250}.","Noelin-3 (Olfactomedin-3) (Optimedin)","GO:0005615; GO:0005794; GO:0030054; GO:0032281; GO:0042462; GO:0045202",0.0690147618512916,0.0739736122877707,0.0755084231085009,0.19100251162319,0.226670758812565,0.221049805513157,0.140075426233783,0.142869978866079,12.9260690399035,0.00013143797172353,0.00362331318685888,-1.6854424729489,54930,2.44089412540623,4,0,0,0.0739736122877707,0.221049805513157,2.98822510726167,1.5792888324971
"199",201,311,311,311,"Q8IXK0","PHC2","PHC2_HUMAN","heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}.","Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2)","GO:0000792; GO:0003677; GO:0005634; GO:0005654; GO:0007275; GO:0007283; GO:0008270; GO:0031519; GO:0035102; GO:0042802",0.00417449421342641,0.0164399235909651,0.00764561459198376,0.203072806929264,0.159219000617119,0.171788224047926,0.168606666399311,0.0937233439984475,12.9213275956673,0.00013164140199919,0.00362331318685888,-1.68734031551035,90713,2.44089412540623,5,0,0,0.00764561459198376,0.171788224047926,22.4688574059228,4.48985485684528
"200",202,313,313,313,"P18615","NELFE","NELFE_HUMAN","NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus.","Negative elongation factor E (NELF-E) (RNA-binding protein RD)","GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0006366; GO:0006368; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571; GO:0070374; GO:1900364",0.00053440029372356,0.00038118845503947,0.00506048274566903,0.150830500317552,0.118805022065421,0.121699297423028,0.128452916103856,0.0662184818834055,12.8882151851914,0.00013307290414471,0.00363612178919511,-1.70061258045475,43240,2.43936157883577,10,0,0,0.00053440029372356,0.121699297423028,227.73059605761,7.83118432321347
"201",203,315,315,315,"Q8N5H7","SH2D3C","SH2D3_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3/SH2 adaptor activity [GO:0005070]; JNK cascade [GO:0007254]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Associated with the membrane when EGF-stimulated. Found at ruffling membranes (By similarity). {ECO:0000250}.","SH2 domain-containing protein 3C (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1)","GO:0005070; GO:0005085; GO:0005737; GO:0007254; GO:0007264; GO:0016020",0.00033030260141081,0.00021042894827093,0.00018833706498173,0.110193958778872,0.14223445102199,0.141542482247415,0.131080607811205,0.0657833267771568,12.8714292258787,0.00013380588359771,0.00363612178919511,-1.70735317683059,94411,2.43936157883577,10,0,0,0.00021042894827093,0.141542482247415,672.637882812479,9.39368622318373
"202",204,316,316,316,"Q14BN4","SLMAP","SLMAP_HUMAN","integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]","SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Note=Membrane-associated. Distributed in the transverse tubules and near the junctional sarcoplasmic reticulum. Detected along the Z- and M-lines in cardiomyocytes. Centrosome. Localizes to the centrosomes in a microtubule- dependent manner (By similarity). {ECO:0000250}.","Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein)","GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150",4.71147201932719e-05,3.02836122247329e-05,1.40880562337177e-05,0.0250837552177409,0.0317273163664988,0.0327879413503798,0.0298358421819893,0.0149484165538785,12.8402751664021,0.00013517944102104,0.00366182283272206,-1.71988559805562,95198,2.43630267167618,14,0,0,3.02836122247329e-05,0.0317273163664988,1047.6727852362,10.0329724816622
"203",205,317,317,317,"Q96S59","RANBP9","RANB9_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; Ran GTPase binding [GO:0008536]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein-containing complex assembly [GO:0065003]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Nucleus {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Cell membrane; Peripheral membrane protein {ECO:0000269|PubMed:14722085}. Note=The unphosphorylated form is predominantly cytoplasmic. A phosphorylated form is associated with the plasma membrane. {ECO:0000269|PubMed:14722085}.","Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7)","GO:0000165; GO:0005088; GO:0005634; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007020; GO:0007411; GO:0008536; GO:0019899; GO:0065003; GO:0070373",0.0045929561594038,0.00921217112117963,0.0153386500681327,0.120828552106491,0.155117415844047,0.144116686049622,0.130306292217148,0.0748677385581461,12.784004330454,0.0001377045066505,0.00371845607863824,-1.74259512447245,77847,2.42963734391099,6,0,0,0.00921217112117963,0.144116686049622,15.6441607688208,3.96755236215042
"204",206,319,319,319,"Q59EK9","RUNDC3A","RUN3A_HUMAN","cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanylate cyclase activator activity [GO:0030250]; peptide hormone receptor binding [GO:0051428]; small GTPase mediated signal transduction [GO:0007264]",NA,"RUN domain-containing protein 3A (Rap2-interacting protein 8) (RPIP-8)","GO:0005829; GO:0005886; GO:0007264; GO:0030250; GO:0030695; GO:0051428",1e-07,1.10663303668247e-05,5.9564336588315e-06,0.0694805333426633,0.0909746212374803,0.0754595578613583,0.0786325298924921,0.0393219725342546,12.73808467649,0.00013980807740964,0.00373810701075696,-1.76119755218515,49747,2.42734827023486,6,1,0,5.9564336588315e-06,0.0754595578613583,12668.5802585035,13.6289672332481
"205",207,320,320,320,"P50607","TUB","TUB_HUMAN","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Secreted {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Binds phospholipid and is anchored to the plasma membrane through binding phosphatidylinositol 4,5-bisphosphate. Is released upon activation of phospholipase C. Translocates from the plasma membrane to the nucleus upon activation of guanine nucleotide-binding protein G(q) subunit alpha. Does not have a cleavable signal peptide and is secreted by a non-conventional pathway (By similarity). {ECO:0000250}.","Tubby protein homolog","GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007605; GO:0009725; GO:0035091; GO:0044877; GO:0045494; GO:0050766; GO:0060041; GO:0097500; GO:1903546",0.362241787505368,0.334475070545505,0.298164761223638,0.572032676877433,0.60529772668655,0.587064173652439,0.25650431931397,0.459879366081822,12.7363796529768,0.00013988694068833,0.00373810701075696,-1.76188949520634,55651,2.42734827023486,3,0,0,0.334475070545505,0.587064173652439,1.75518065575105,0.811619530668115
"206",208,321,321,321,"Q86WA8","LONP2","LONP2_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; peroxisome organization [GO:0007031]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]","SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000255|HAMAP-Rule:MF_03121, ECO:0000269|PubMed:14561759, ECO:0000269|PubMed:18281296, ECO:0000269|PubMed:22002062}.","Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)","GO:0002020; GO:0004176; GO:0004252; GO:0005102; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0019899; GO:0031998",1e-07,1e-07,1e-07,0.0362817150145067,0.0314149025062198,0.0417061152836687,0.0364674776014651,0.0182338388007325,12.7300753118342,0.00014017901290338,0.00373810701075696,-1.76444872443515,94617,2.42734827023486,11,3,0,1e-07,0.0362817150145067,362817.150145067,18.4688831272284
"207",209,322,322,322,"Q9UBU9","NXF1","NXF1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10924507, ECO:0000269|PubMed:19864460, ECO:0000269|PubMed:25662211}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:23826332}. Nucleus speckle {ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:23826332}. Cytoplasm {ECO:0000269|PubMed:10924507, ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:19864460}. Note=Localized predominantly in the nucleoplasm and at both the nucleoplasmic and cytoplasmic faces of the nuclear pore complex. Shuttles between the nucleus and the cytoplasm. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. The association with the TREX complex seems to occur in regions surrounding nuclear speckles known as perispeckles (PubMed:23826332). Nucleus; nuclear rim (PubMed:25662211). {ECO:0000269|PubMed:23826332, ECO:0000269|PubMed:25662211}.","Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP)","GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016032; GO:0016607; GO:0016973; GO:0042405",0.00011880515390093,6.26954894243217e-05,0.00122795229678538,0.0340813535437573,0.0381349906199239,0.0288621185855142,0.0332230032696949,0.017081319281551,12.7170729412028,0.00014078376323251,0.00374257457537361,-1.76973079734419,70182,2.42682953705022,9,0,0,0.00011880515390093,0.0340813535437573,286.867635154762,8.16424140000193
"208",210,323,323,323,"Q5SQI0","ATAT1","ATAT_HUMAN","axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Membrane, clathrin-coated pit {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell junction, focal adhesion {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell projection, axon {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-Rule:MF_03130}.","Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog)","GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0045598; GO:0050662; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227",0.00046560972436798,1e-07,1e-07,0.00800251355516947,0.010490458758993,0.00906847942091208,0.00903188067023552,0.00467121024324042,12.7031179877388,0.00014143638470338,0.00374828313641168,-1.77540554712887,46810,2.42616761097079,15,2,0,1e-07,0.00906847942091208,90684.7942091208,16.4685730432229
"209",211,324,324,324,"P52701","MSH6","MSH6_HUMAN","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching [GO:0045830]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23622243}. Chromosome {ECO:0000269|PubMed:23622243}. Note=Associates with H3K36me3 via its PWWP domain.","DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)","GO:0000710; GO:0000790; GO:0003682; GO:0003684; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006298; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016032; GO:0016446; GO:0016447; GO:0030983; GO:0032137; GO:0032301; GO:0035064; GO:0043231; GO:0045190; GO:0045830; GO:0045910; GO:0051096; GO:0097193",8.40693825263492e-06,1e-07,2.61359850748093e-07,0.00057275508764995,0.00051259043295311,0.00063979001353842,0.0005721224120127,0.00028898397204081,12.6766077609659,0.00014268642564435,0.00376974013430773,-1.78620216722978,152786,2.42368858669766,30,1,0,2.61359850748093e-07,0.00057275508764995,2191.44251119882,11.097665117348
"210",212,325,325,325,"Q6NTF9","RHBDD2","RHBD2_HUMAN","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; serine-type endopeptidase activity [GO:0004252]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","Rhomboid domain-containing protein 2","GO:0000139; GO:0004252; GO:0005634; GO:0005654; GO:0005794; GO:0016021; GO:0048471",1e-07,0.00139809664947493,1e-07,0.00888366009602303,0.010856534855678,0.00933589974424329,0.00922593268215646,0.00507906522423654,12.634820513864,0.00014468447499519,0.00381076647987335,-1.803264074957,39202,2.4189876635631,5,2,0,1e-07,0.00933589974424329,93358.9974424329,16.5105014479576
"211",213,326,326,326,"O15260","SURF4","SURF4_HUMAN","azurophil granule membrane [GO:0035577]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]; positive regulation of organelle organization [GO:0010638]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15308636, ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane {ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Note=Cycles between the endoplasmic reticulum and the Golgi. {ECO:0000269|PubMed:18287528}.","Surfeit locus protein 4","GO:0000139; GO:0005789; GO:0005793; GO:0005886; GO:0006890; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0033116; GO:0035577; GO:0043312",7.31357468394752e-05,1e-07,3.28796403900741e-06,0.011658763346846,0.013283929835864,0.00997245267520735,0.011612874049013,0.00583194492813264,12.5946098505945,0.0001466396464523,0.00385041525653898,-1.81973281338038,30394,2.41449243051791,4,1,0,3.28796403900741e-06,0.011658763346846,3545.89138096705,11.7919326284169
"212",214,328,328,328,"P34931","HSPA1L","HS71L_HUMAN","blood microparticle [GO:0072562]; cell body [GO:0044297]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986]",NA,"Heat shock 70 kDa protein 1-like (Heat shock 70 kDa protein 1L) (Heat shock 70 kDa protein 1-Hom) (HSP70-Hom)","GO:0002199; GO:0005524; GO:0005654; GO:0005829; GO:0006986; GO:0007339; GO:0031072; GO:0031625; GO:0042026; GO:0044297; GO:0051082; GO:0072562; GO:1900034; GO:1903955",6.83530104616538e-05,4.18128027470441e-06,3.18862439822592e-06,0.0234744220321556,0.0308141291520559,0.0299804397420727,0.0280644226703832,0.0140574523069031,12.5494361908546,0.00014887495063784,0.00388155678385916,-1.83829371258789,70375,2.4109940560969,6,0,0,4.18128027470441e-06,0.0299804397420727,7170.15788763219,12.8077891722359
"213",215,329,329,329,"Q5VTB9","RNF220","RN220_HUMAN","cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q6PDX6}.","E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220)","GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0061630; GO:0090263",0.0110311165871091,0.000555545860693,0.00068563502041328,0.05897698576884,0.0551867544544897,0.0656161798814492,0.0558358742121878,0.0320087029288324,12.5432160713981,0.0001491860025572,0.00388155678385916,-1.84085438189521,62765,2.4109940560969,8,0,0,0.00068563502041328,0.05897698576884,86.018047522267,6.42656747957714
"214",216,330,330,330,"O60858","TRIM13","TRI13_HUMAN","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; endoplasmic reticulum mannose trimming [GO:1904380]; innate immune response [GO:0045087]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; response to gamma radiation [GO:0010332]; ubiquitin-dependent ERAD pathway [GO:0030433]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22178386, ECO:0000269|PubMed:25152375}; Single-pass membrane protein {ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22178386}. Note=Concentrates and colocalizes with p62/SQSTM1 and ZFYVE1 at the perinuclear endoplasmic reticulum.","E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13)","GO:0004842; GO:0005737; GO:0005789; GO:0008270; GO:0009653; GO:0010332; GO:0010942; GO:0016021; GO:0016239; GO:0030433; GO:0032897; GO:0043123; GO:0043161; GO:0044322; GO:0045087; GO:0051092; GO:0051865; GO:0097038; GO:1902187; GO:1904380",0.00509161676841479,0.0026189212917205,0.0163290439395841,0.162103688137246,0.140266474333931,0.181910403963436,0.153413661478298,0.0847200247390555,12.4900245416037,0.00015187880224,0.00393964408234681,-1.86280124376811,46988,2.40454301169088,8,0,0,0.00509161676841479,0.162103688137246,31.8373702323466,4.99264926904034
"215",217,331,331,331,"Q92558","WASF1","WASF1_HUMAN","actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; protein kinase A binding [GO:0051018]; protein-containing complex binding [GO:0044877]; actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; lamellipodium morphogenesis [GO:0072673]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:9889097}. Cell junction, synapse {ECO:0000250|UniProtKB:Q5BJU7}. Cell junction, focal adhesion {ECO:0000269|PubMed:18559503}. Note=Dot-like pattern in the cytoplasm. Concentrated in Rac-regulated membrane-ruffling areas (PubMed:9889097). Partial translocation to focal adhesion sites might be mediated by interaction with SORBS2 (PubMed:18559503). In neurons, colocalizes with activated NTRK2 after BDNF addition in endocytic sites through the association with TMEM108 (By similarity). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:9889097}.","Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1) (Verprolin homology domain-containing protein 1)","GO:0003779; GO:0005741; GO:0005856; GO:0005925; GO:0006898; GO:0015629; GO:0016601; GO:0030027; GO:0030041; GO:0031209; GO:0032991; GO:0044877; GO:0045202; GO:0051018; GO:0051388; GO:0065003; GO:0072673; GO:0097484; GO:1990416; GO:2000601",0.00020082065048651,0.00010354759721506,0.00028274572292575,0.0501757652752317,0.0384544297945521,0.0496340625163014,0.0458923812051526,0.0231418952594521,12.4639462792777,0.00015322078064013,0.00396244677425857,-1.8735934878669,61652,2.40203655841484,13,0,0,0.00020082065048651,0.0496340625163014,247.156168432168,7.94927910295056
"216",218,332,332,332,"O75376","NCOR1","NCOR1_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; transcriptional repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; ligand-dependent nuclear receptor binding [GO:0016922]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624}.","Nuclear receptor corepressor 1 (N-CoR) (N-CoR1)","GO:0000122; GO:0000790; GO:0000981; GO:0001102; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005876; GO:0006325; GO:0006366; GO:0007623; GO:0016020; GO:0016922; GO:0017053; GO:0019216; GO:0035257; GO:0042826; GO:0044212; GO:0046329; GO:0046966; GO:0051225; GO:0072362; GO:0072368; GO:1903799; GO:2000191",0.054698829286835,0.0336725595595308,0.0607374128553977,0.179272169634003,0.199235366758646,0.174191365621022,0.134530033437302,0.116967950619239,12.450371145852,0.00015392510939302,0.00396867149519365,-1.87921988779667,270210,2.40135484811454,19,0,0,0.054698829286835,0.179272169634003,3.27744070524651,1.71256967975424
"217",220,334,334,334,"P26196","DDX6","DDX6_HUMAN","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P granule [GO:0043186]; P-body [GO:0000932]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; negative regulation of neuron differentiation [GO:0045665]; regulation of translation [GO:0006417]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]; viral RNA genome packaging [GO:0019074]","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:16364915, ECO:0000269|PubMed:16699599, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:22915799, ECO:0000269|PubMed:26184334}. Cytoplasm {ECO:0000269|PubMed:26184334}. Nucleus {ECO:0000269|PubMed:26184334}. Note=Upon cellular stress, relocalizes to stress granules (PubMed:26184334). {ECO:0000269|PubMed:26184334}.","Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)","GO:0000792; GO:0000932; GO:0001520; GO:0003723; GO:0003724; GO:0004004; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006417; GO:0007283; GO:0010494; GO:0010501; GO:0016020; GO:0016442; GO:0019074; GO:0019827; GO:0019904; GO:0033962; GO:0036464; GO:0043186; GO:0043928; GO:0045296; GO:0045665; GO:0097227",7.28660780672823e-05,3.40215571124832e-05,8.02844051252515e-05,0.0217899926533641,0.0178002437708438,0.0238107978367883,0.0210712874068971,0.0105980343835502,12.3793302290971,0.00015767644444201,0.00404104899528031,-1.90875873863536,54417,2.39350588396693,28,0,0,7.28660780672823e-05,0.0217899926533641,299.041656026058,8.22420265331623
"218",221,335,335,335,"P18669","PGAM1","PGAM1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]",NA,"Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)","GO:0004082; GO:0004619; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006094; GO:0006096; GO:0006110; GO:0016020; GO:0016787; GO:0019901; GO:0034774; GO:0043209; GO:0043312; GO:0043456; GO:0045730; GO:0046538; GO:0061621; GO:0070062; GO:1904813",0.00098647459235748,0.00127602103867613,0.00112344590059572,0.00264263368549854,0.00258522745906524,0.00290873740977652,0.00158355234090365,0.00192042334766161,12.3293270415737,0.00016038426817826,0.00409207418920658,-1.92964635111695,28804,2.38805650113999,5,0,0,0.00112344590059572,0.00264263368549854,2.35225717953775,1.23404580309944
"219",222,336,336,336,"Q96CU9","FOXRED1","FXRD1_HUMAN","integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:20858599, ECO:0000305|PubMed:25678554}; Single-pass membrane protein {ECO:0000255}. Note=According to a report, it is associated with the matrix face of the mitochondrial inner membrane and does not contain any transmembrane region. However, one transmembrane domain is clearly predicted by different methods (Probable). {ECO:0000305|PubMed:25678554}.","FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","GO:0005739; GO:0005743; GO:0005747; GO:0016021; GO:0016491; GO:0032981",6.19580423820067e-06,6.24806463743084e-06,6.45593495150445e-06,0.0170101661930783,0.0150448683180609,0.0200729586469129,0.0173696977847417,0.00869114882697988,12.317078717805,0.0001610562294442,0.00409207418920658,-1.93477499623164,53812,2.38805650113999,6,0,0,6.24806463743084e-06,0.0170101661930783,2722.46962542192,11.4107002375537
"220",223,338,338,338,"Q9H6U8","ALG9","ALG9_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:15148656}; Multi-pass membrane protein {ECO:0000305}.","Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926",0.00019641623052523,1e-07,1e-07,0.0413126646215895,0.0309146162942223,0.0385749424984747,0.0368685357279204,0.0184998066074686,12.2904809757699,0.00016252735343489,0.00410789863373221,-1.94592867505693,69863,2.38638028156792,8,2,0,1e-07,0.0385749424984747,385749.424984747,18.557304480689
"221",224,340,340,340,"Q9BRX2","PELO","PELO_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]; translation [GO:0006412]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000250}.","Protein pelota homolog (EC 3.1.-.-)","GO:0004519; GO:0005634; GO:0005737; GO:0006412; GO:0007049; GO:0007492; GO:0008283; GO:0019827; GO:0030513; GO:0032790; GO:0043022; GO:0046872; GO:0051276; GO:0051301; GO:0060231; GO:0070481; GO:0070651; GO:0070966; GO:0071025",0.00282933606115271,0.0223415240032552,0.0056274471066033,0.102169722002677,0.0890693939576475,0.0943599250655859,0.0849335779516329,0.0527328913661535,12.2701944483946,0.00016366049561673,0.00412039365435064,-1.95445110451639,43359,2.38506129033936,4,0,0,0.0056274471066033,0.0943599250655859,16.7678031046908,4.06762177618154
"222",225,341,341,341,"Q9Y5W9","SNX11","SNX11_HUMAN","endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; phosphatidylinositol phosphate binding [GO:1901981]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Endosome {ECO:0000269|PubMed:23615901}.","Sorting nexin-11","GO:0005768; GO:0006886; GO:0006897; GO:0016050; GO:0019898; GO:1901981",4.3805611379806e-06,1.1163260192151e-05,1.81654294344607e-05,0.0109137989426334,0.0108879137201865,0.0139235365064874,0.0118971799728476,0.00595982640334532,12.2465330667644,0.00016499441635294,0.00414066128017407,-1.96440814872012,30433,2.38293029477363,4,0,0,1.1163260192151e-05,0.0109137989426334,977.653369604966,9.93317923307661
"223",226,342,342,342,"Q9Y496","KIF3A","KIF3A_HUMAN","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; neurogenesis [GO:0022008]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}. Cell projection, cilium {ECO:0000250|UniProtKB:P28741}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:23386061}. Note=Localizes to the subdistal appendage region of the centriole. {ECO:0000269|PubMed:23386061}.","Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0006890; GO:0006996; GO:0007018; GO:0008017; GO:0008574; GO:0010457; GO:0015630; GO:0016939; GO:0017137; GO:0019886; GO:0022008; GO:0030507; GO:0034454; GO:0035735; GO:0060271; GO:0070062; GO:0072383; GO:0097542",2.8608098796857e-05,5.02619669528351e-05,4.22612713885229e-05,0.0004549134689873,0.00052494162516777,0.00053993235741421,0.00046621870481035,0.00027348646478458,12.2388052469698,0.00016543296236209,0.00414066128017407,-1.9676640603502,80041,2.38293029477363,20,0,0,4.22612713885229e-05,0.00052494162516777,12.4213401045557,3.63474892528154
"224",227,343,343,343,"Q9HBU6","ETNK1","EKI1_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]","SUBCELLULAR LOCATION: Cytoplasm.","Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82)","GO:0004305; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006646; GO:0016020",1e-07,3.96897448915736e-06,1.84115708592235e-05,0.141746066540509,0.172609956411908,0.190684646826248,0.168339396411106,0.0841771917206689,12.2256042519993,0.00016618541797781,0.00414736786556867,-1.97323044161671,50968,2.38222744163116,8,1,0,3.96897448915736e-06,0.172609956411908,43489.8125154123,15.4083898689063
"225",228,344,344,344,"P46109","CRKL","CRKL_HUMAN","cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]; SH3/SH2 adaptor activity [GO:0005070]; activation of MAPKK activity [GO:0000186]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cytokine-mediated signaling pathway [GO:0019221]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; parathyroid gland development [GO:0060017]; positive regulation of cell proliferation [GO:0008284]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Ras protein signal transduction [GO:0007265]; thymus development [GO:0048538]",NA,"Crk-like protein","GO:0000186; GO:0001568; GO:0001784; GO:0003723; GO:0005070; GO:0005654; GO:0005768; GO:0005829; GO:0007254; GO:0007265; GO:0007507; GO:0008284; GO:0009887; GO:0009952; GO:0019221; GO:0035556; GO:0042802; GO:0045296; GO:0048538; GO:0060017; GO:1900026",3.01174271026699e-06,3.39113391991168e-05,0.00022412225228032,0.00632416709606704,0.00622629997100752,0.00798338732850327,0.0067576030204627,0.00346581662162792,12.1945975432538,0.00016796937468279,0.00417970304443243,-1.98632719469644,33777,2.37885457247032,11,0,0,3.39113391991168e-05,0.00632416709606704,186.49122227033,7.54296391738615
"226",229,346,346,346,"O14828","SCAMP3","SCAM3_HUMAN","extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ubiquitin protein ligase binding [GO:0031625]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.","Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3)","GO:0006892; GO:0015031; GO:0016021; GO:0031625; GO:0043231; GO:0070062",0.0433866379875317,0.0442936945918819,0.0494734479770684,0.103619339480538,0.0899911230588476,0.0986050781234775,0.0516872533687935,0.0715615535365574,12.1660955997622,0.00016962998284222,0.00418530527255448,-1.99839372651163,38287,2.37827285945072,4,0,0,0.0442936945918819,0.0986050781234775,2.22616512422402,1.15456060753336
"227",230,347,347,347,"O00506","STK25","STK25_HUMAN","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15037601}. Golgi apparatus {ECO:0000269|PubMed:15037601}. Note=Localizes to the Golgi apparatus.","Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)","GO:0000139; GO:0004672; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0007346; GO:0008349; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0042981; GO:0046777; GO:0046872; GO:0048812; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168",0.00022463425474581,4.2373442252058e-05,0.00011648817134582,0.0398819113237706,0.0478424171414381,0.0359264832176728,0.0410891052715126,0.0206723845918709,12.165560976025,0.00016966132354864,0.00418530527255448,-1.99862031863041,48112,2.37827285945072,4,0,0,0.00011648817134582,0.0398819113237706,342.368764682318,8.41940727617069
"228",231,348,348,348,"O14735","CDIPT","CDIPT_HUMAN","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Membrane {ECO:0000269|PubMed:8110188}.","CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)","GO:0000139; GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341",8.96178508335309e-05,0.00134931439068898,0.00024097179690936,0.0324665347598984,0.0319465493372981,0.0248310064230625,0.029188062160609,0.0151539990931151,12.13831413024,0.00017126803529711,0.00421279994868772,-2.01018093676618,23539,2.37542916352775,6,0,0,0.00024097179690936,0.0319465493372981,132.573810491668,7.05065199384101
"229",232,349,349,349,"Q2TAY7","SMU1","SMU1_HUMAN","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q99M63}. Nucleus {ECO:0000269|PubMed:24945353}. Nucleus speckle {ECO:0000250|UniProtKB:Q76B40}. Note=Colocalizes with SRSF1 in nuclear speckles. {ECO:0000250|UniProtKB:Q76B40}.","WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]","GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0016607; GO:0071005",1e-07,1e-07,1.54148534646943e-05,0.0189625940156535,0.0248551161596576,0.0199768092604106,0.0212596348607523,0.0106350223815311,12.1264814622496,0.00017197160237755,0.00421552257197699,-2.01520906845269,57544,2.37514858093043,14,2,0,1e-07,0.0199768092604106,199768.092604106,17.6079666455659
"230",233,350,350,350,"Q9UPU3","SORCS3","SORC3_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; neuropeptide receptor activity [GO:0008188]; learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long term synaptic depression [GO:1900452]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","VPS10 domain-containing receptor SorCS3","GO:0007218; GO:0007612; GO:0007613; GO:0008188; GO:0014069; GO:0016020; GO:0016021; GO:1900452",0.0143589680030575,0.0286692414857313,0.0428389994919556,0.158343613212651,0.14970132971657,0.137215062702349,0.119797598883609,0.0885212024353857,12.1188758177702,0.00017242570386917,0.00421552257197699,-2.01844342757946,135755,2.37514858093043,3,0,0,0.0286692414857313,0.14970132971657,5.22167040209545,2.38451139593696
"231",234,351,351,351,"Q14CW9","ATXN7L3","AT7L3_HUMAN","DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; histone monoubiquitination [GO:0010390]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03047, ECO:0000269|PubMed:27601583}.","Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog)","GO:0000124; GO:0003713; GO:0005634; GO:0006351; GO:0010390; GO:0016578; GO:0030374; GO:0045893; GO:0046872; GO:0071819",0.0360442683868391,0.071918474510359,0.0837211595197756,0.478081270393148,0.389934965184201,0.480432920256114,0.385588417805496,0.256688843041739,12.1046544679413,0.00017327875448932,0.00421552257197699,-2.02449630611399,38651,2.37514858093043,4,0,0,0.071918474510359,0.478081270393148,6.64754464896619,2.73282156213571
"232",235,353,353,353,"Q9H254","SPTBN4","SPTN4_HUMAN","adherens junction [GO:0005912]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; cytoskeletal anchoring at plasma membrane [GO:0007016]; ER to Golgi vesicle-mediated transport [GO:0006888]; fertilization [GO:0009566]; MAPK cascade [GO:0000165]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, cell cortex {ECO:0000250}.","Spectrin beta chain, non-erythrocytic 4 (Beta-IV spectrin) (Spectrin, non-erythroid beta chain 3)","GO:0000165; GO:0002028; GO:0003779; GO:0005088; GO:0005200; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006888; GO:0007016; GO:0007409; GO:0007411; GO:0007605; GO:0007628; GO:0008091; GO:0009566; GO:0010459; GO:0014704; GO:0016020; GO:0016192; GO:0016363; GO:0016605; GO:0019226; GO:0019902; GO:0021952; GO:0030506; GO:0030507; GO:0033135; GO:0033268; GO:0033270; GO:0040018; GO:0043025; GO:0043194; GO:0043203; GO:0045162; GO:0051693; GO:0061337; GO:0070062; GO:0070852; GO:0072659",0.12818449555555,0.091404122548759,0.119544184840873,0.25488130669495,0.272519742115924,0.280194032790042,0.156154092885245,0.191121314091016,12.0953270640139,0.00017384105933503,0.00421552257197699,-2.02846987014827,288985,2.37514858093043,12,0,0,0.119544184840873,0.272519742115924,2.2796570362555,1.18881679399041
"233",236,354,354,354,"Q9GZM8","NDEL1","NDEL1_HUMAN","axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, spindle. Note=Localizes to the cell body of the motor neurons and colocalizes with assembled neurofilaments within axonal processes. Localizes to the microtubules of the manchette in elongated spermatids. Colocalizes with DISC1 in the perinuclear region, including the centrosome (By similarity). Localizes to the interphase centrosome and the mitotic spindle. Localizes to the kinetochore in a CENPF-dependent manner. {ECO:0000250}.","Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1)","GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:1900029; GO:1904115; GO:1990138; GO:2000574",1.4322491780589e-05,0.0097576804640626,2.01656674090568e-05,0.0870241185301595,0.0994276285128857,0.0769809866361104,0.0845468550186345,0.045537483717068,12.0861488226538,0.00017439655808578,0.00421704671529467,-2.03238271078422,38375,2.37499158796253,8,0,0,2.01656674090568e-05,0.0870241185301595,4315.45937780741,12.0752984261774
"234",237,355,355,355,"Q9BRL6","SRSF8","SRSF8_HUMAN","cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9671500}.","Serine/arginine-rich splicing factor 8 (Pre-mRNA-splicing factor SRP46) (Splicing factor SRp46) (Splicing factor, arginine/serine-rich 2B)","GO:0003723; GO:0005634; GO:0005829; GO:0006397; GO:0008380; GO:0016607",1e-07,1e-07,1e-07,0.038230775158416,0.0504343357528291,0.0407727922353875,0.0431458677155442,0.0215730338577721,12.0428343240548,0.00017704767273727,0.0042564655838507,-2.0508863045294,32288,2.37095087379614,4,3,0,1e-07,0.0407727922353875,407727.922353875,18.637247234457
"235",238,357,357,357,"O95372","LYPLA2","LYPA2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II)","GO:0002084; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0007411; GO:0008474; GO:0045296; GO:0052689; GO:0070062",0.00050203337004823,1e-07,1e-07,0.00948280238789213,0.00725385999674267,0.00930161582038659,0.00851201494499105,0.00442341859584494,12.0232189858599,0.00017826450353879,0.0042564655838507,-2.05928645671012,24737,2.37095087379614,4,2,0,1e-07,0.00930161582038659,93016.1582038659,16.5051937337886
"236",239,358,358,358,"Q86U90","YRDC","YRDC_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; double-stranded RNA binding [GO:0003725]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}. Membrane; Peripheral membrane protein. Note=Predominantly localized in the plasma membrane. {ECO:0000250}.","YrdC domain-containing protein, mitochondrial (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP)","GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0006450; GO:0016020; GO:0016779; GO:0051051",5.34436991784303e-07,4.71115824689222e-05,4.00588868779707e-05,0.0189200033334411,0.0152422411496809,0.0143729560890875,0.0161491652219569,0.00810381757975802,12.0208454964425,0.00017841243683986,0.0042564655838507,-2.06030376512786,29328,2.37095087379614,7,0,0,4.00588868779707e-05,0.0152422411496809,380.495873390405,8.57173699706076
"237",240,359,359,359,"Q15788","NCOA1","NCOA1_HUMAN","cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; ligand-dependent nuclear receptor binding [GO:0016922]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; nuclear hormone receptor binding [GO:0035257]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; bile acid and bile salt transport [GO:0015721]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; intracellular receptor signaling pathway [GO:0030522]; labyrinthine layer morphogenesis [GO:0060713]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of lipid metabolic process [GO:0019216]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981}.","Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1)","GO:0000435; GO:0000790; GO:0000981; GO:0001105; GO:0002155; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005654; GO:0005829; GO:0005886; GO:0006351; GO:0015721; GO:0016922; GO:0017162; GO:0019216; GO:0019899; GO:0030331; GO:0030374; GO:0030521; GO:0030522; GO:0032870; GO:0032991; GO:0035257; GO:0043065; GO:0043967; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0047485; GO:0050681; GO:0060713; GO:1904017; GO:2001038",0.00727952546474606,0.0156970629291033,0.00386747464197411,0.151233082583127,0.121225970116036,0.15671976615767,0.13411158527367,0.076003813648776,12.0192336599108,0.00017851298418252,0.0042564655838507,-2.06099472712465,156757,2.37095087379614,8,0,0,0.00727952546474606,0.151233082583127,20.7751292739523,4.37678554913014
"238",241,360,360,360,"P49840","GSK3A","GSK3A_HUMAN","apical dendrite [GO:0097440]; beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]; ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau-protein kinase activity [GO:0050321]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of systemic arterial blood pressure [GO:0003073]; Wnt signaling pathway [GO:0016055]",NA,"Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)","GO:0003073; GO:0003214; GO:0004674; GO:0005102; GO:0005524; GO:0005739; GO:0005829; GO:0005874; GO:0005977; GO:0006349; GO:0006468; GO:0007212; GO:0007568; GO:0008286; GO:0010628; GO:0010800; GO:0010905; GO:0016055; GO:0016477; GO:0018105; GO:0018107; GO:0030877; GO:0031398; GO:0032007; GO:0032436; GO:0032869; GO:0033138; GO:0034236; GO:0036016; GO:0036498; GO:0043025; GO:0043161; GO:0043525; GO:0044027; GO:0045719; GO:0045732; GO:0045823; GO:0045944; GO:0046325; GO:0046627; GO:0050321; GO:0060079; GO:0061052; GO:0071285; GO:0071407; GO:0071879; GO:0090090; GO:0097191; GO:0097192; GO:0097440; GO:0098794; GO:0106071; GO:1901030; GO:1902004; GO:1903146; GO:1903955; GO:1904227; GO:1990635; GO:2000077; GO:2000171; GO:2000466; GO:2000467",0.00574576937828337,4.06529481851945e-05,4.39011447126805e-05,0.0483524669320042,0.0474932773218004,0.0595056870151366,0.04984036926592,0.0268636257900204,11.9963784984614,0.00017994621017005,0.00427872099737696,-2.07080168277796,50981,2.36868603163948,6,0,0,4.39011447126805e-05,0.0483524669320042,1101.39421758718,10.1051152240124
"239",242,361,361,361,"Q9HAT8","PELI2","PELI2_HUMAN","cytosol [GO:0005829]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; immune response [GO:0006955]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063]",NA,"E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2)","GO:0000209; GO:0001934; GO:0004674; GO:0005829; GO:0006955; GO:0008063; GO:0034450; GO:0043123; GO:0043410; GO:0061630; GO:0070498",1.98075690794172e-06,1.55242091949406e-05,1.10261834899328e-05,0.114296609985683,0.0864277785406871,0.112784292647813,0.10449338334153,0.0522562020539626,11.9829416596211,0.00018079541063683,0.0042870047508347,-2.07657553472775,46435,2.36784603520638,4,0,0,1.10261834899328e-05,0.112784292647813,10228.7697960757,13.3203450235746
"240",243,362,362,362,"Q5M775","SPECC1","CYTSB_HUMAN","membrane [GO:0016020]; nucleus [GO:0005634]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15602574}.; SUBCELLULAR LOCATION: Isoform 3: Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 4: Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 5: Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.","Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1)","GO:0005634; GO:0016020",3.76958997246158e-06,2.21111006753342e-05,3.53084112418752e-05,0.0407109693694859,0.0321198565190363,0.0313051346167523,0.0346915904677949,0.017366191601194,11.9634847551232,0.00018203380517038,0.00430444577971964,-2.0849470446584,118585,2.36608275833442,7,0,0,2.21111006753342e-05,0.0321198565190363,1452.65751310459,10.5044788896374
"241",244,363,363,363,"A1A5C7","SLC22A23","S22AN_HUMAN","integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Solute carrier family 22 member 23","GO:0008514; GO:0016021",1.5349387418572e-05,1e-07,1.37714972057275e-05,0.0104584930275574,0.00775126032021703,0.00970938446503926,0.00929663897606314,0.00465805978290634,11.9443482743652,0.00018326196798537,0.00432154943789212,-2.09319320443463,73748,2.36436051437027,5,1,0,1.37714972057275e-05,0.00970938446503926,705.034777264535,9.46155061288845
"242",245,364,364,364,"Q6DKJ4","NXN","NXN_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P97346}. Nucleus {ECO:0000250|UniProtKB:P97346}.","Nucleoredoxin (EC 1.8.1.8)","GO:0004791; GO:0005634; GO:0005737; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0045454; GO:0047134; GO:0072358",0.00988525633167935,0.0165956728984449,0.00511943415123834,0.0639348055143682,0.0562756956351853,0.0662812298027152,0.0516304558569687,0.0363486823889386,11.9173761166501,0.00018501032269681,0.00435079220407896,-2.10483700460807,48392,2.36143165832459,12,0,0,0.00988525633167935,0.0639348055143682,6.46769323618609,2.69325125315783
"243",246,365,365,365,"Q9H1D9","POLR3F","RPC6_HUMAN","cytosol [GO:0005829]; DNA-directed RNA polymerase III complex [GO:0005666]; nucleoplasm [GO:0005654]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit) (RPC39)","GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607",0.00152529213123048,6.95401485502703e-06,2.64928978044815e-05,0.0927181229939559,0.0950389366733066,0.0714978804389578,0.0858987336874435,0.0434689465250184,11.8725868870836,0.00018795901478515,0.00439624941958585,-2.12422728232896,35684,2.35691767601266,4,0,0,2.64928978044815e-05,0.0927181229939559,3499.7350489259,11.7730299901284
"244",248,367,367,367,"Q9Y2U8","LEMD3","MAN1_HUMAN","integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; chromatin DNA binding [GO:0031490]; angiogenesis [GO:0001525]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531]","SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000269|PubMed:15647271}; Multi-pass membrane protein {ECO:0000269|PubMed:15647271}.","Inner nuclear membrane protein Man1 (LEM domain-containing protein 3)","GO:0001525; GO:0005637; GO:0005639; GO:0006998; GO:0016020; GO:0016021; GO:0030512; GO:0030514; GO:0031490; GO:0031965; GO:0032926; GO:0070197; GO:1902531",1e-07,0.0544476440140489,7.13510672230828e-06,0.268902910813149,0.273081306288971,0.238445467753699,0.241991601911683,0.139147427329432,11.8563538657425,0.00018904192369153,0.00440926121743735,-2.13127192309556,99997,2.35563417154539,6,1,0,7.13510672230828e-06,0.268902910813149,37687.3004537424,15.2017908378183
"245",249,368,368,368,"O94856","NFASC","NFASC_HUMAN","axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; myelination [GO:0042552]; neutrophil degranulation [GO:0043312]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.","Neurofascin","GO:0002175; GO:0005622; GO:0005886; GO:0005925; GO:0007411; GO:0007422; GO:0016021; GO:0019226; GO:0019904; GO:0030425; GO:0030913; GO:0033010; GO:0033268; GO:0033270; GO:0042552; GO:0043194; GO:0043209; GO:0043312; GO:0045162; GO:0050808; GO:0071205; GO:0072659; GO:0086080; GO:0097454; GO:0101003",1e-07,1e-07,1e-07,0.0398378847417791,0.0495090212660321,0.0540506833008796,0.0477990964362303,0.0238996482181151,11.8338324235146,0.00019055703568095,0.00442883315990374,-2.14106058792197,150027,2.35371067986379,20,3,0,1e-07,0.0495090212660321,495090.212660321,18.9173319036682
"246",250,370,370,370,"Q9H165","BCL11A","BC11A_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001078]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11161790}. Nucleus {ECO:0000269|PubMed:11161790}. Note=Associates with the nuclear body. Colocalizes with SUMO1 and SENP2 in nuclear speckles (By similarity). {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:27453576}. Nucleus {ECO:0000269|PubMed:27453576}. Note=Predominantly localized in the nucleus in nuclear paraspeckles. {ECO:0000269|PubMed:27453576}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm {ECO:0000269|PubMed:27453576}. Nucleus {ECO:0000269|PubMed:27453576}. Note=Predominantly localized in the cytoplasm in the absence of interaction with isoform 1 and isoform 2. In presence of isoform 1 or isoform 2, translocates from the cytoplasm into nuclear paraspeckles. {ECO:0000269|PubMed:27453576}.","B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856)","GO:0000122; GO:0000978; GO:0000981; GO:0001078; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0007165; GO:0010976; GO:0010977; GO:0016925; GO:0022008; GO:0030517; GO:0032463; GO:0042803; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:2000171",5.29759502213179e-05,4.27613736253695e-05,4.10599074423051e-05,0.144904615322652,0.108087305367391,0.119327137176371,0.124060753545042,0.0620759758496171,11.8167201760701,0.00019171821274301,0.00443542675967623,-2.14850993343157,91197,2.35306458767986,5,0,0,4.27613736253695e-05,0.119327137176371,2790.5356413896,11.4463263576146
"247",251,371,371,371,"Q12765","SCRN1","SCRN1_HUMAN","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Secernin-1","GO:0005634; GO:0005737; GO:0006887; GO:0016805; GO:0031965",1e-07,1e-07,1e-07,0.036521608843973,0.0421246894358247,0.0309994067646977,0.0365484683481651,0.0182743341740826,11.8075946522746,0.000192340986016,0.00443784053988414,-2.15248662666717,46382,2.35282830685673,11,3,0,1e-07,0.036521608843973,365216.08843973,18.4783907945261
"248",252,372,372,372,"P60763","RAC3","RAC3_HUMAN","cell periphery [GO:0071944]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cell projection assembly [GO:0030031]; cerebral cortex GABAergic interneuron development [GO:0021894]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of neuron maturation [GO:0014041]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; synaptic transmission, GABAergic [GO:0051932]","SUBCELLULAR LOCATION: Cytoplasm. Endomembrane system. Cell projection, lamellipodium. Cytoplasm, perinuclear region. Cell membrane. Cytoplasm, cytoskeleton. Note=Membrane-associated when activated. Colocalizes with NRBP to endomembranes and at the cell periphery in lamellipodia. Colocalized with CIB1 in the perinuclear area and at the cell periphery.","Ras-related C3 botulinum toxin substrate 3 (p21-Rac3)","GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0007264; GO:0012505; GO:0014041; GO:0021894; GO:0030027; GO:0030031; GO:0030036; GO:0030426; GO:0031175; GO:0031941; GO:0033630; GO:0035556; GO:0043005; GO:0043025; GO:0048306; GO:0048471; GO:0048873; GO:0050885; GO:0051056; GO:0051932; GO:0070062; GO:0071944; GO:1900026",1e-07,0.00013408741087111,1e-07,0.0490671547500292,0.0425281219373342,0.0360838712770124,0.0425149535178349,0.0213022392292078,11.7688571187426,0.0001950124146141,0.00448414609291031,-2.16939977902085,21379,2.3483202465875,3,2,0,1e-07,0.0425281219373342,425281.219373342,18.6980576206885
"249",253,373,373,373,"P48454","PPP3CC","PP2BC_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-NFAT signaling cascade [GO:0033173]; protein dephosphorylation [GO:0006470]",NA,"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)","GO:0005516; GO:0005737; GO:0005829; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872",0.00029910927573226,0.00037620225930259,0.00029070949437414,0.00896810928217271,0.00670742383311494,0.00838918276650629,0.00769956495079499,0.00417178948520049,11.7633537854887,0.00019539561830088,0.00448414609291031,-2.17180682686547,58129,2.3483202465875,5,0,0,0.00029910927573226,0.00838918276650629,28.0472170111356,4.80978572121442
"250",254,374,374,374,"Q86WR0","CCDC25","CCD25_HUMAN",NA,NA,"Coiled-coil domain-containing protein 25",NA,1e-07,1.76531226986292e-05,2.04118165248928e-05,0.0447161023704589,0.0329756201939889,0.0378345779744028,0.0384960451998757,0.0192607442463457,11.7273774559475,0.00019792357066932,0.00453001541424979,-2.18756827022788,24479,2.34390032021405,3,1,0,1.76531226986292e-05,0.0378345779744028,2143.2229651551,11.0655662298659
"251",255,375,375,375,"P13489","RNH1","RINI_HUMAN","angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765]","SUBCELLULAR LOCATION: Cytoplasm.","Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI)","GO:0005654; GO:0005829; GO:0006402; GO:0008428; GO:0032311; GO:0045765; GO:0070062",4.13039557279289e-05,0.0001464729103836,0.00013512021842477,0.0245349582614192,0.0318030815306765,0.0329154852998064,0.0296435426691219,0.0149294036960731,11.703349597353,0.00019963429344725,0.00454701176597001,-2.1981203355521,49973,2.34227392200135,9,0,0,0.00013512021842477,0.0318030815306765,235.368784194079,7.87877918528003
"252",256,376,376,376,"P50579","METAP2","MAP2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein processing [GO:0016485]; regulation of rhodopsin mediated signaling pathway [GO:0022400]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03175, ECO:0000269|PubMed:21537465}. Note=About 30% of expressed METAP2 associates with polysomes.","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","GO:0003723; GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0022400; GO:0031365; GO:0046872",2.66781410559536e-05,0.00010874990666297,8.41430109784882e-05,0.0340502337980131,0.0251230233391963,0.0318237982056446,0.0302591614280522,0.0152027710669253,11.702033007457,0.00019972855420615,0.00454701176597001,-2.19869911648602,52892,2.34227392200135,12,0,0,8.41430109784882e-05,0.0318237982056446,378.210832195922,8.56304687334676
"253",257,377,377,377,"P57771","RGS8","RGS8_HUMAN","cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; G-protein coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of dopamine receptor signaling pathway [GO:0060159]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P49804}; Peripheral membrane protein {ECO:0000250|UniProtKB:P49804}; Cytoplasmic side {ECO:0000250|UniProtKB:P49804}. Membrane {ECO:0000250|UniProtKB:P49804}; Peripheral membrane protein {ECO:0000250|UniProtKB:P49804}; Cytoplasmic side {ECO:0000250|UniProtKB:P49804}. Perikaryon {ECO:0000250|UniProtKB:P49804}. Cell projection, dendrite {ECO:0000250|UniProtKB:P49804}. Nucleus {ECO:0000250|UniProtKB:P49804}. Note=Detected in Purkinje cell soma and dendrites. Associated with Purkinje cell membranes. Not detected in Purkinje cell nuclei. Detected in the nucleus after heterologous expression. Recruited to the cell membrane in the presence of GNAO1. {ECO:0000250|UniProtKB:P49804}.","Regulator of G-protein signaling 8 (RGS8)","GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0007213; GO:0009968; GO:0030425; GO:0031234; GO:0032809; GO:0043204; GO:0043547; GO:0060159",1e-07,1e-07,1e-07,0.0468384374513656,0.0555349770820643,0.0409276340197652,0.0477669161843984,0.0238835580921992,11.6829881542174,0.00020109818682891,0.00456604901659275,-2.20707819669757,20917,2.34045943066412,3,3,0,1e-07,0.0468384374513656,468384.374513656,18.8373334222066
"254",258,378,378,378,"Q9H1V8","SLC6A17","S6A17_HUMAN","cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter:sodium symporter activity [GO:0005328]; alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:P31662}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P31662}. Note=Localizes at synaptic junctions - at both pre- and post-synaptic sites - particularly in excitatory glutamatergic terminals. {ECO:0000250|UniProtKB:Q8BJI1}.","Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17)","GO:0005328; GO:0005887; GO:0007420; GO:0008021; GO:0015171; GO:0015804; GO:0015816; GO:0015820; GO:0015824; GO:0030054; GO:0030672; GO:0032328",0.106107923041083,0.110602895238979,0.101057083170497,0.20351489978851,0.225231979926155,0.237749557134771,0.116242845132959,0.164044056383332,11.6265505632196,0.00020522513767912,0.0046452998517289,-2.23198431142287,81001,2.3329862472789,6,0,0,0.106107923041083,0.225231979926155,2.12266882124297,1.08587929954246
"255",259,380,380,380,"Q969R2","OSBP2","OSBP2_HUMAN","apical dendrite [GO:0097440]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid transport [GO:0006869]; spermatid development [GO:0007286]","SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.","Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4)","GO:0006869; GO:0007286; GO:0015485; GO:0016020; GO:0097440",1e-07,1e-07,1e-07,0.0162184232159126,0.0193351022722768,0.0142232392036628,0.0165921548972841,0.00829617744864202,11.5720423818136,0.0002093100017806,0.00471498319800516,-2.2561468969067,101266,2.3265198505463,4,3,0,1e-07,0.0162184232159126,162184.232159126,17.3072740394198
"256",260,381,381,381,"Q9UBB4","ATXN10","ATX10_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; protein homotrimerization [GO:0070207]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16498633}.","Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein)","GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0019899; GO:0030425; GO:0031175; GO:0042802; GO:0043025; GO:0048471; GO:0060271; GO:0070207",1e-07,1e-07,1e-07,0.058692715325847,0.0708076105627014,0.0804004365277706,0.0699668208054397,0.0349835104027198,11.5590773993799,0.00021029623581024,0.00472476582292843,-2.26190977438007,53489,2.32561971188071,18,3,0,1e-07,0.0708076105627014,708076.105627014,19.4335449072166
"257",261,382,382,382,"O43310","CTIF","CTIF_HUMAN","cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:19648179}.","CBP80/20-dependent translation initiation factor","GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0048471",0.00156689402269719,0.00164863565379805,0.00153732300835655,0.147754947118681,0.135488833474796,0.108502673999917,0.128997867302847,0.0660832178797077,11.5449301000349,0.00021137891593886,0.00473665843046261,-2.26820510536698,67587,2.32452793195217,11,0,0,0.00156689402269719,0.135488833474796,86.4696855768017,6.43412253823436
"258",262,383,383,383,"O15400","STX7","STX7_HUMAN","azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}.","Syntaxin-7","GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076",1e-07,1e-07,7.79161097003734e-05,0.0481724602004182,0.0623923543993701,0.065316209743945,0.0586009694113443,0.0293265234089056,11.4832011243289,0.00021618370542557,0.0048106190818587,-2.29575843194139,29816,2.31779903037581,7,2,0,1e-07,0.0623923543993701,623923.543993701,19.2510097255449
"259",263,384,384,384,"Q14331","FRG1","FRG1_HUMAN","Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, Cajal body {ECO:0000269|PubMed:15060122, ECO:0000269|PubMed:21699900}. Nucleus, nucleolus {ECO:0000269|PubMed:15060122, ECO:0000269|PubMed:20970242, ECO:0000269|PubMed:21699900}. Cytoplasm {ECO:0000269|PubMed:20970242, ECO:0000269|PubMed:21699900}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:20970242}. Note=Localization changes during myogenesis from mainly cytoplasmic in undifferentiated myoblasts, to strongly nucleolar in early myotubes and back to cytoplasmic 5 days post-differentiation (PubMed:20970242). Localized at the Z-line in the sarcomere of matured myotubes 8 days post-differentiation (PubMed:20970242). {ECO:0000269|PubMed:20970242}.","Protein FRG1 (FSHD region gene 1 protein)","GO:0000398; GO:0003723; GO:0005730; GO:0006364; GO:0007517; GO:0015030; GO:0030018; GO:0051015; GO:0055120; GO:0071013",0.00167692171057939,1e-07,1e-07,0.0177032123721056,0.0185176134264664,0.0141084567574431,0.0162173869484786,0.00866773404443241,11.4813772887191,0.00021632769227886,0.0048106190818587,-2.29657462773791,29172,2.31779903037581,7,2,0,1e-07,0.0177032123721056,177032.123721056,17.4336516456379
"260",264,385,385,385,"P57678","GEMIN4","GEMI4_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; rRNA processing [GO:0006364]; spliceosomal snRNP assembly [GO:0000387]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus, nucleolus. Nucleus, gem. Note=Localized in subnuclear structures next to coiled bodies, called gems, which are highly enriched in spliceosomal snRNPs and in the nucleolus.","Gem-associated protein 4 (Gemin-4) (Component of gems 4) (p97)","GO:0000387; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0016020; GO:0016604; GO:0030532; GO:0032797; GO:0034719; GO:0051170; GO:0070062; GO:0097504",0.00239084357730621,0.00168812810905215,0.00415615069608725,0.0356669008980177,0.0316584126736482,0.0418010481621238,0.0336304131171147,0.0195602473527059,11.4808991301952,0.00021636546104154,0.0048106190818587,-2.29678863147089,120037,2.31779903037581,11,0,0,0.00239084357730621,0.0356669008980177,14.918123977899,3.89899421640856
"261",265,387,387,387,"O43505","B4GAT1","B4GA1_HUMAN","extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; axon guidance [GO:0007411]; keratan sulfate biosynthetic process [GO:0018146]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:19587235, ECO:0000269|PubMed:23359570, ECO:0000269|PubMed:25279699}; Single-pass type II membrane protein {ECO:0000269|PubMed:23359570}. Note=Localizes near the trans-Golgi apparatus. {ECO:0000269|PubMed:25279699}.","Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)","GO:0000139; GO:0005794; GO:0006493; GO:0007411; GO:0008532; GO:0015020; GO:0018146; GO:0030173; GO:0035269; GO:0046872; GO:0070062",1e-07,1e-07,1e-07,0.161445680145028,0.121429156324339,0.162544178775125,0.148472905081497,0.0742365525407487,11.3899659650368,0.000223697414133,0.00494793246764466,-2.3376390127373,47119,2.30557623651451,3,3,0,1e-07,0.161445680145028,1614456.80145028,20.6226174081285
"262",266,388,388,388,"Q9HD20","ATP13A1","AT131_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:24392018}; Multi-pass membrane protein {ECO:0000269|PubMed:24392018}.","Manganese-transporting ATPase 13A1 (EC 3.6.3.-)","GO:0005388; GO:0005524; GO:0005789; GO:0005887; GO:0006874; GO:0015410; GO:0016020; GO:0034220; GO:0043231; GO:0046872",0.00029051613192314,0.00034043059355135,0.00019783394551011,0.0376403789249228,0.0354201932272075,0.0276177983483576,0.0332831966098344,0.0169178585285788,11.3616789098855,0.000226040087087,0.00498686377697101,-2.35040881795675,132955,2.30217249496949,20,0,0,0.00029051613192314,0.0354201932272075,121.921605498239,6.92980999566067
"263",267,389,389,389,"Q6IAA8","LAMTOR1","LTOR1_HUMAN","azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; GTPase binding [GO:0051020]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of macroautophagy [GO:0016241]; regulation of receptor recycling [GO:0001919]","SUBCELLULAR LOCATION: Late endosome membrane; Lipid-anchor; Cytoplasmic side. Lysosome membrane; Lipid-anchor; Cytoplasmic side. Cell membrane.","Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho)","GO:0001558; GO:0001919; GO:0005764; GO:0005765; GO:0005886; GO:0007032; GO:0007040; GO:0007050; GO:0010872; GO:0010874; GO:0016197; GO:0016241; GO:0031902; GO:0032008; GO:0032418; GO:0034613; GO:0035577; GO:0035579; GO:0042632; GO:0043312; GO:0043410; GO:0045121; GO:0051020; GO:0060620; GO:0070062; GO:0071230; GO:0071986; GO:0101003",1e-07,1e-07,1e-07,0.0442066270780454,0.0328576401217804,0.0436835157033925,0.0402491609677394,0.0201246804838697,11.2903072531696,0.00023208595097074,0.00508396009992232,-2.3827612284279,17745,2.29379786654674,3,3,0,1e-07,0.0436835157033925,436835.157033925,18.7367294452491
"264",268,392,392,392,"Q9H444","CHMP4B","CHM4B_HUMAN","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; autophagy [GO:0006914]; cell separation after cytokinesis [GO:0000920]; endosomal transport [GO:0016197]; exit from mitosis [GO:0010458]; macroautophagy [GO:0016236]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of viral release from host cell [GO:1902188]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuolar transport [GO:0007034]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:15511219}. Late endosome membrane {ECO:0000269|PubMed:15511219, ECO:0000305|PubMed:12860994}; Peripheral membrane protein {ECO:0000305}. Midbody {ECO:0000269|PubMed:21310966, ECO:0000269|PubMed:22422861}. Nucleus envelope {ECO:0000269|PubMed:26040712}. Note=Recruited to the nuclear envelope by CHMP7 during late anaphase (PubMed:26040712). Localizes transiently to the midbody arms immediately before abscission (PubMed:22422861). {ECO:0000269|PubMed:22422861, ECO:0000269|PubMed:26040712}.","Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2)","GO:0000281; GO:0000815; GO:0000920; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0006620; GO:0006914; GO:0006997; GO:0007034; GO:0007080; GO:0009898; GO:0010458; GO:0010824; GO:0016197; GO:0016236; GO:0019058; GO:0030117; GO:0030496; GO:0031468; GO:0031902; GO:0031982; GO:0036258; GO:0036438; GO:0039702; GO:0042802; GO:0042803; GO:0045296; GO:0046755; GO:0050792; GO:0051260; GO:0060548; GO:0070062; GO:0090148; GO:0090611; GO:1901215; GO:1901673; GO:1902188; GO:1902902",0.00281641692847688,0.00138130573439177,0.00254526311183992,0.0194909472717408,0.0168055694685658,0.0220767787530766,0.0172101032395582,0.010852713544682,11.2706838817209,0.00023378286353013,0.00510505436688253,-2.39168991531197,24950,2.2919996284818,4,0,0,0.00254526311183992,0.0194909472717408,7.65773376476241,2.93691750310609
"265",269,394,394,394,"Q8N9V3","WDSUB1","WSDU1_HUMAN","ubiquitin-protein transferase activity [GO:0004842]",NA,"WD repeat, SAM and U-box domain-containing protein 1","GO:0004842",1e-07,1e-07,1e-07,0.140339858984331,0.12273439725159,0.168414883255779,0.1438296131639,0.0719149065819499,11.2194627026469,0.00023828434574654,0.00516990509516596,-2.41506430911704,52817,2.28651742925113,3,3,0,1e-07,0.140339858984331,1403398.58984331,20.4204933872067
"266",270,395,395,395,"Q7L3B6","CDC37L1","CD37L_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; platelet degranulation [GO:0002576]; protein folding [GO:0006457]; protein stabilization [GO:0050821]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11413142}.","Hsp90 co-chaperone Cdc37-like 1 (Hsp90-associating relative of Cdc37)","GO:0002576; GO:0005576; GO:0005737; GO:0005829; GO:0006457; GO:0031072; GO:0031089; GO:0050821; GO:0051082; GO:0051087",5.19826591681537e-05,0.0106375634512826,5.66952519641827e-05,0.850417591650376,0.826767698714702,0.62762685904404,0.764688636015568,0.385926398461922,11.2163136495125,0.00023856454586338,0.00516990509516596,-2.41650460590691,38835,2.28651742925113,3,0,0,5.66952519641827e-05,0.826767698714702,14582.6620408533,13.8319664848506
"267",271,396,396,396,"Q96JQ0","DCHS1","PCD16_HUMAN","apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Note=In the embryonic cortex, FAT4 and DCHS1 accumulated at the cell-cell boundaries located apical to the adherens junction. {ECO:0000250}.","Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1)","GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005622; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102",0.0148167514510844,0.0284791995850752,0.0588798564257231,0.214180813698806,0.187363982506502,0.215476978454444,0.17161532239929,0.119866263686939,11.1833712831893,0.00024152007516226,0.00522073697825507,-2.43159428310391,346181,2.28226818607866,15,0,0,0.0284791995850752,0.214180813698806,7.52060510194428,2.91084874467602
"268",272,398,398,398,"Q147X3","NAA30","NAA30_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19398576, ECO:0000269|PubMed:25732826}. Nucleus {ECO:0000269|PubMed:25732826}.","N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)","GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417",1e-07,1e-07,0.00190522960002847,0.0714174260237827,0.0811716285633811,0.0586499135575898,0.0697778461815751,0.035524066290797,11.0508313096543,0.00025387442851168,0.00546021383934679,-2.49272807089159,39320,2.26279034860849,7,2,0,1e-07,0.0714174260237827,714174.260237827,19.4459166127063
"269",273,399,399,399,"O14782","KIF3C","KIF3C_HUMAN","ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; organelle transport along microtubule [GO:0072384]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.","Kinesin-like protein KIF3C","GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0035735; GO:0072384; GO:0097542",1e-07,1e-07,1e-07,0.181608379563719,0.134804345183603,0.143180353788258,0.153197592845193,0.0765988964225967,11.0314221636029,0.00025574799643082,0.00548672393345328,-2.50173782838202,89426,2.2606868909419,6,3,0,1e-07,0.143180353788258,1431803.53788258,20.4494021189325
"270",274,401,401,401,"A1L0T0","ILVBL","ILVBL_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; transferase activity [GO:0016740]","SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein.","Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein)","GO:0000287; GO:0016020; GO:0016021; GO:0016740; GO:0030976",0.00013463481934808,0.00085310873572574,7.69649787491257e-05,0.0492626993902516,0.0452206837421006,0.0355597131188483,0.0429927959057925,0.0218513007975039,10.9530463879607,0.00026348814156002,0.0056245847674658,-2.53827083408807,67868,2.24990953363521,8,0,0,0.00013463481934808,0.0452206837421006,335.876587951507,8.39178742677788
"271",275,402,402,402,"Q8NC96","NECAP1","NECP1_HUMAN","clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, clathrin-coated vesicle membrane {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Colocalizes with AP-2 at the plasma membrane. {ECO:0000250}.","Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1) (NECAP-1)","GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0015031; GO:0030125; GO:0061024",0.00014449856487617,0.00181475760318591,0.00031273528250158,0.00639032744744406,0.006285483272018,0.00667452211681068,0.00569278046190303,0.00360372071447273,10.8526972523013,0.00027382192479341,0.0058306360105264,-2.5854030161974,29737,2.23428406946113,6,0,0,0.00031273528250158,0.00639032744744406,20.4336632449259,4.3528759612948
"272",276,403,403,403,"Q7Z7K6","CENPV","CENPV_HUMAN","condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; metabolic process [GO:0008152]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]","SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000269|PubMed:18772885}. Nucleus {ECO:0000269|PubMed:12196509}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:18772885}. Note=Enriched at the nuclear periphery and around the nucleolus (PubMed:12196509). In mitotic cells, localizes to kinetochores from prometaphase to metaphase (PubMed:18772885). At anaphase onset, transfers to the spindle midzone and then to the mid-body in telophase and cytokinesis (PubMed:18772885).","Centromere protein V (CENP-V) (Nuclear protein p30) (Proline-rich protein 6)","GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005737; GO:0007049; GO:0008152; GO:0015630; GO:0016846; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0051233; GO:0051301",0.00250003315701299,0.00483284358859615,0.00503853620997038,0.0133790891740869,0.0148496643454681,0.0152425267755053,0.0103666224464936,0.00930711554177329,10.8372811585131,0.00027545313578925,0.00584538987145142,-2.59267956105218,29946,2.23318651728686,8,0,0,0.00483284358859615,0.0148496643454681,3.07265568877673,1.61948611254605
"273",277,405,405,405,"Q8IZD9","DOCK3","DOCK3_HUMAN","cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)","GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997",0.00012590662530732,9.89873782024281e-05,0.0001518152900681,0.0236557975605488,0.0179971880575101,0.0248832835753652,0.0220531866332821,0.011152163081167,10.7893527815832,0.00028060115244876,0.00593073053076891,-2.61536380955926,233103,2.22689180816338,29,0,0,0.00012590662530732,0.0236557975605488,187.883659837665,7.55369579141165
"274",278,406,406,406,"O00750","PIK3C2B","P3C2B_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein kinase B signaling [GO:0043491]","SUBCELLULAR LOCATION: Microsome {ECO:0000269|PubMed:14563213}. Cell membrane {ECO:0000269|PubMed:14563213}. Cytoplasm, cytosol {ECO:0000269|PubMed:14563213}. Nucleus {ECO:0000269|PubMed:14563213}. Endoplasmic reticulum {ECO:0000269|PubMed:14563213}. Note=Found mostly in the microsome, but also in the plasma membrane and cytosol. Nuclear in testis.","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)","GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0014065; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0043491; GO:1905037",9.42249184118852e-06,1e-07,1e-07,0.0480054122357372,0.0342420200013612,0.0437971489980682,0.0420116529144418,0.0210090339545013,10.7053250611253,0.00028991424068472,0.00611247758685043,-2.65536046568972,184768,2.2137827203305,21,2,0,1e-07,0.0437971489980682,437971.489980682,18.7404774342126
"275",279,408,408,408,"Q8IUH5","ZDHHC17","ZDH17_HUMAN","aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:15603740, ECO:0000269|PubMed:18794299}; Multi-pass membrane protein {ECO:0000255}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:18794299}; Multi-pass membrane protein {ECO:0000255}. Cell junction, synapse, presynaptic cell membrane {ECO:0000269|PubMed:18032660}; Multi-pass membrane protein {ECO:0000255}. Note=Low extracellular Mg(2+) induces increase in Golgi and in post-Golgi membrane vesicles. {ECO:0000269|PubMed:18794299}.","Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17)","GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231",1e-07,1e-07,0.0100241450239323,0.0891774704976047,0.108981831683042,0.121809272712515,0.103314743289743,0.0549988199861824,10.6534613012212,0.00029585171417613,0.0062070849836954,-2.68019289931084,72640,2.20711230847358,3,2,0,1e-07,0.108981831683042,1089818.31683042,20.0556562132668
"276",280,409,409,409,"Q8NFP9","NBEA","NBEA_HUMAN","cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.","Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B)","GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0019901",0.00098898156973629,0.0005958602755409,0.00062301315914071,0.0378350225909265,0.0451717987356528,0.0529034161552729,0.0445674608258115,0.023019682081045,10.6250777623108,0.00029916419341867,0.00626123593071845,-2.69383046317825,327822,2.20333993118076,52,0,0,0.00062301315914071,0.0451717987356528,72.5053685831547,6.18001591679484
"277",281,410,410,410,"Q99497","PARK7","PARK7_HUMAN","axon [GO:0030424]; cell body [GO:0044297]; cell-cell adherens junction [GO:0005913]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O88767}; Lipid-anchor {ECO:0000250|UniProtKB:O88767}. Cytoplasm {ECO:0000269|PubMed:12851414, ECO:0000269|PubMed:14579415, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:28596309}. Nucleus {ECO:0000269|PubMed:12851414, ECO:0000269|PubMed:14579415, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:16390825, ECO:0000269|PubMed:28596309}. Membrane raft {ECO:0000250|UniProtKB:O88767}. Mitochondrion {ECO:0000269|PubMed:15181200, ECO:0000269|PubMed:18711745, ECO:0000269|PubMed:19229105}. Note=Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage (PubMed:18711745). Detected in tau inclusions in brains from neurodegenerative disease patients (PubMed:14705119). Membrane raft localization in astrocytes and neuronal cells requires palmitoylation. {ECO:0000269|PubMed:14705119, ECO:0000269|PubMed:18711745}.","Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Oncogene DJ1) (Parkinson disease protein 7) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1)","GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005913; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007265; GO:0007338; GO:0008134; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0018323; GO:0019249; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0070062; GO:0070301; GO:0070491; GO:0090073; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268",1e-07,1e-07,1e-07,0.0132853388049161,0.0159052285195238,0.0113489338905284,0.0135130670716561,0.00675663353582806,10.6179342629736,0.00030000501442642,0.00626351932558579,-2.6972680488955,19891,2.20318157825784,13,3,0,1e-07,0.0132853388049161,132853.388049161,17.0194754945829
"278",282,411,411,411,"O43929","ORC4","ORC4_HUMAN","cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]","SUBCELLULAR LOCATION: Nucleus.","Origin recognition complex subunit 4","GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006260; GO:0006270",0.0103976926483355,0.0150150671661777,0.00758952658206434,0.156554695372799,0.214264388977784,0.201003605973999,0.179606801309335,0.10080416278686,10.597635052882,0.00030241016855723,0.00629837236703142,-2.70704811660157,50377,2.20077166695028,5,0,0,0.0103976926483355,0.201003605973999,19.3315587190564,4.27288606278265
"279",283,412,412,412,"Q9BRQ0","PYGO2","PYGO2_HUMAN","beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; beta-catenin-TCF complex assembly [GO:1904837]; brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; positive regulation of chromatin binding [GO:0035563]; post-embryonic development [GO:0009791]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Pygopus homolog 2","GO:0001701; GO:0001822; GO:0002088; GO:0003682; GO:0005654; GO:0007289; GO:0007420; GO:0009791; GO:0030879; GO:0033599; GO:0035034; GO:0035563; GO:0042393; GO:0046872; GO:0048589; GO:0051569; GO:0060021; GO:0060070; GO:1904837; GO:1990907",0.0104988242279994,0.00586089828817651,0.030201617543034,0.101844961791485,0.0957543265504615,0.092445200607556,0.0811610496300974,0.056100971501452,10.5884613434012,0.0003035048624122,0.00630582918021474,-2.71147366230965,41244,2.20025779811316,3,0,0,0.0104988242279994,0.0957543265504615,9.12048096729665,3.18910990671867
"280",284,413,413,413,"P26358","DNMT1","DNMT1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12145218}.","DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT)","GO:0000122; GO:0000981; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006325; GO:0006351; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010628; GO:0010629; GO:0016458; GO:0043045; GO:0045814; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1904707; GO:1905460; GO:1905931; GO:1990841",0.00057735941207305,9.32737027958879e-05,8.1312984877384e-05,0.0973998353775245,0.132253821108619,0.133642192940084,0.120847967775494,0.0606746325876623,10.5751524225303,0.0003051016509551,0.00632365649437211,-2.71790041722353,183165,2.19903172929177,18,0,0,9.32737027958879e-05,0.132253821108619,1417.91112762009,10.4695513942777
"281",285,415,415,415,"Q9HCD6","TANC2","TANC2_HUMAN","in utero embryonic development [GO:0001701]",NA,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)","GO:0001701",0.00077948014173808,0.00934722749592745,0.00047999277371524,0.0983152217151474,0.102527071633905,0.0758804593157783,0.08870535075115,0.0478882421793686,10.4995709515874,0.00031436753934981,0.00648430394417925,-2.75454061526793,219650,2.18813663629945,29,0,0,0.00077948014173808,0.0983152217151474,126.129219271609,6.97875872091339
"282",286,416,416,416,"Q8WWI5","SLC44A1","CTL1_HUMAN","extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19357133}; Multi-pass membrane protein {ECO:0000269|PubMed:19357133}. Mitochondrion outer membrane {ECO:0000269|PubMed:19357133}; Multi-pass membrane protein {ECO:0000269|PubMed:19357133}.","Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92)","GO:0005654; GO:0005739; GO:0005741; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0042426; GO:0055085; GO:0070062",1e-07,1e-07,1e-07,0.0377258058698395,0.0341043866272029,0.0266829658595688,0.0328376194522037,0.0164189097261019,10.4831577115354,0.0003164250527942,0.00651105397095765,-2.76252962394384,73302,2.18634870471578,6,3,0,1e-07,0.0341043866272029,341043.866272029,18.3795977901758
"283",287,418,418,418,"Q6Y7W6","GIGYF2","GGYF2_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]",NA,"GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein)","GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016021; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0032991; GO:0035264; GO:0043204; GO:0044267; GO:0045296; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635",1.1083218555429e-05,1e-07,1.99569898102302e-06,0.0722987087805239,0.0982638443864343,0.0755866552906566,0.0820453431800261,0.0410270645625252,10.4295600454432,0.00032325974464616,0.00661986462720375,-2.78869862025408,150070,2.17915089156627,19,1,0,1.99569898102302e-06,0.0755866552906566,37874.7777141771,15.2089498010302
"284",288,419,419,419,"Q9NX40","OCIAD1","OCAD1_HUMAN","endosome [GO:0005768]; membrane [GO:0016020]; regulation of stem cell differentiation [GO:2000736]","SUBCELLULAR LOCATION: Endosome {ECO:0000250|UniProtKB:Q9CRD0}.","OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen)","GO:0005768; GO:0016020; GO:2000736",1e-07,1e-07,0.00017021822251119,0.0488062755032465,0.0646873467752288,0.0685315909360957,0.0606182649973533,0.030365938572847,10.4177295455272,0.0003247926286419,0.00663538162571531,-2.79449158710863,27626,2.17813409417466,8,2,0,1e-07,0.0646873467752288,646873.467752288,19.3031240146317
"285",289,420,420,420,"Q6N022","TENM4","TEN4_HUMAN","cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell proliferation [GO:0060038]; cell morphogenesis [GO:0000902]; central nervous system myelin formation [GO:0032289]; gastrulation with mouth forming second [GO:0001702]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron development [GO:0048666]; positive regulation of gastrulation [GO:2000543]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; self proteolysis [GO:0097264]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26188006}; Single-pass membrane protein {ECO:0000255}. Cell projection {ECO:0000250|UniProtKB:Q3UHK6}. Nucleus {ECO:0000250|UniProtKB:Q3UHK6}. Cytoplasm {ECO:0000250|UniProtKB:Q3UHK6}.","Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4)","GO:0000902; GO:0001702; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007157; GO:0007165; GO:0031641; GO:0031643; GO:0032289; GO:0042803; GO:0043005; GO:0046982; GO:0048666; GO:0048714; GO:0050839; GO:0060038; GO:0060912; GO:0097264; GO:2000543",2.16108933472159e-05,2.37025502292672e-05,2.13417734237328e-05,0.00063763234942365,0.00087068969487527,0.00078942235972094,0.00074369639567322,0.00039406660350334,10.4043178757699,0.00032654116556422,0.00665521994578515,-2.80106614931402,307957,2.17683758712208,36,0,0,2.16108933472159e-05,0.00078942235972094,36.5289091495443,5.19096676651664
"286",290,422,422,422,"Q8IWZ3","ANKHD1","ANKH1_HUMAN","cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16098192, ECO:0000269|PubMed:16956752}.","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","GO:0003723; GO:0005737; GO:0045087",0.00027786556576764,0.00038750820324849,0.00026668259029128,0.0375514880758608,0.0298955693489185,0.0424143660923213,0.0363097890525977,0.0184655799794013,10.3389034111209,0.00033523663021216,0.00678919305665727,-2.83324569202781,269458,2.16818184160564,12,0,0,0.00027786556576764,0.0375514880758608,135.142647028321,7.07833920823734
"287",291,424,424,424,"Q9HCK5","AGO4","AGO4_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; single-stranded RNA binding [GO:0003727]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell morphogenesis [GO:0022604]; regulation of megakaryocyte differentiation [GO:0045652]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-Rule:MF_03033, ECO:0000269|PubMed:16081698, ECO:0000269|PubMed:19167051}.","Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4)","GO:0000932; GO:0003725; GO:0003727; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0007130; GO:0007140; GO:0007223; GO:0008584; GO:0010501; GO:0010586; GO:0016020; GO:0016442; GO:0016604; GO:0022604; GO:0031054; GO:0035068; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0043066; GO:0045652; GO:0070578",1e-07,1e-07,0.00858000752301531,0.0624820836244593,0.0617779756433673,0.0480688959881366,0.0545829159109826,0.0301515271298298,10.3076477823888,0.00033949143098524,0.0068538836066832,-2.84868775508768,97097,2.16406327507458,8,2,0,1e-07,0.0617779756433673,617779.756433673,19.2367330715739
"288",292,425,425,425,"O00213","APBB1","APBB1_HUMAN","cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; main axon [GO:0044304]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; proline-rich region binding [GO:0070064]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; histone H4 acetylation [GO:0043967]; negative regulation of cell growth [GO:0030308]; negative regulation of thymidylate synthase biosynthetic process [GO:0050760]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to iron ion [GO:0010039]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Nucleus. Cell projection, growth cone {ECO:0000250}. Nucleus speckle. Note=Colocalizes with TSHZ3 in axonal growth cone (By similarity). In normal conditions, it mainly localizes to the cytoplasm, while a small fraction is tethered to the cell membrane via its interaction with APP. Following exposure to DNA damaging agents, it is released from cell membrane and translocates to the nucleus. Nuclear translocation is under the regulation of APP. Colocalizes with TSHZ3 in the nucleus. Colocalizes with NEK6 at the nuclear speckles. Phosphorylation at Ser-610 by SGK1 promotes its localization to the nucleus (By similarity). {ECO:0000250}.","Amyloid-beta A4 precursor protein-binding family B member 1 (Protein Fe65)","GO:0000122; GO:0001540; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006302; GO:0006351; GO:0006355; GO:0006915; GO:0006974; GO:0007050; GO:0007165; GO:0007409; GO:0008134; GO:0010039; GO:0010976; GO:0016607; GO:0030027; GO:0030308; GO:0030426; GO:0032991; GO:0042393; GO:0042734; GO:0043025; GO:0043065; GO:0043197; GO:0043967; GO:0044304; GO:0044877; GO:0045202; GO:0045211; GO:0045739; GO:0045893; GO:0045944; GO:0048156; GO:0048471; GO:0050714; GO:0050760; GO:0070064; GO:1990761; GO:1990812",6.2986912932481e-05,0.00637523684948906,0.00012036389857363,0.102177127190274,0.130768548923119,0.143685873396373,0.12335765394959,0.0638650228617936,10.2878206512756,0.00034222477668962,0.00687669780039288,-2.85850588848752,77244,2.16262006050683,10,0,0,0.00012036389857363,0.130768548923119,1086.44328135586,10.0853971440938
"289",293,426,426,426,"O14628","ZNF195","ZN195_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Zinc finger protein 195","GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0008270",0.0397691952459066,0.0502812322983873,0.0539672915921693,0.214693611385558,0.231577647633051,0.178681060421311,0.160311533434486,0.128161673096064,10.2877960497828,0.00034222818492609,0.00687669780039288,-2.8585180816544,72332,2.16262006050683,4,0,0,0.0502812322983873,0.214693611385558,4.26985580050002,2.09418734867098
"290",294,427,427,427,"P48664","SLC1A6","EAA4_HUMAN","Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; metal ion binding [GO:0046872]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; regulation of membrane potential [GO:0042391]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7791878}; Multi-pass membrane protein {ECO:0000305}.","Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)","GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0014047; GO:0015171; GO:0015183; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0098712",1e-07,0.000834455292299,1e-07,0.161200716148206,0.209502403643076,0.15287922773412,0.174249230744368,0.0874028338029501,10.2415100480877,0.0003487148081024,0.00697318068488195,-2.88150640379074,61565,2.15656908147075,4,2,0,1e-07,0.161200716148206,1612007.16148206,20.6204267225025
"291",295,428,428,428,"O75182","SIN3B","SIN3B_HUMAN","autosome [GO:0030849]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; RNA polymerase II transcription corepressor activity [GO:0001106]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810}.","Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","GO:0000122; GO:0000805; GO:0000806; GO:0001106; GO:0001741; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016575; GO:0016580; GO:0019216; GO:0030849",1.4858747767043e-06,1e-07,1e-07,0.0915835467007481,0.0851962456407521,0.117723827765113,0.0981673114106122,0.049084217663565,10.2367624252178,0.0003493886288416,0.00697318068488195,-2.88386975978052,133066,2.15656908147075,19,2,0,1e-07,0.0915835467007481,915835.467007481,19.8047289109104
"292",296,429,429,429,"Q96M27","PRRC1","PRRC1_HUMAN","Golgi apparatus [GO:0005794]","SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:15541471}.","Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1)","GO:0005794",0.00529054513871302,1e-07,1e-07,0.0193047033511948,0.0189088958111946,0.0197653022762736,0.01756271876665,0.0105449410962293,10.2320676412386,0.00035005651846746,0.00697318068488195,-2.88620780571207,46701,2.15656908147075,4,2,0,1e-07,0.0193047033511948,193047.033511948,17.5585928594833
"293",297,431,431,431,"Q674X7","KAZN","KAZRN_HUMAN","cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cornification [GO:0070268]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.","Kazrin","GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0070268",1e-07,1e-07,1e-07,0.0472473982004932,0.0548399568725596,0.0669318236768688,0.0563396262499739,0.0281699131249869,10.1990881285402,0.00035479257309247,0.00704646038438882,-2.90265980873496,86351,2.15202898535747,11,3,0,1e-07,0.0548399568725596,548399.568725596,19.0648679109849
"294",298,432,432,432,"Q96JJ6","JPH4","JPH4_HUMAN","dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; calcium ion transport into cytosol [GO:0060402]; learning [GO:0007612]; neuromuscular process controlling balance [GO:0050885]; regulation of cytokine production [GO:0001817]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic plasticity [GO:0048167]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}. Note=Localized predominantly on the plasma membrane. The transmembrane domain is anchored in endoplasmic reticulum membrane, while the N-terminal part associates with the plasma membrane (By similarity). {ECO:0000250}.","Junctophilin-4 (JP-4) (Junctophilin-like 1 protein)","GO:0001817; GO:0005790; GO:0005886; GO:0007612; GO:0014701; GO:0016021; GO:0030314; GO:0043198; GO:0048167; GO:0050885; GO:0060314; GO:0060402; GO:2001256",0.0549619380871499,0.0560187182778187,0.0500780621848325,0.157961486906879,0.194997841779958,0.199724803666839,0.130541804601292,0.118957141817246,10.1612644747428,0.0003603212351392,0.00713969854812862,-2.92158873347946,65861,2.1463201245891,3,0,0,0.0549619380871499,0.194997841779958,3.54787055490586,1.82695337344897
"295",299,434,434,434,"P61129","ZC3H6","ZC3H6_HUMAN","metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]",NA,"Zinc finger CCCH domain-containing protein 6","GO:0000981; GO:0046872",0.00051318478453907,1.57172050122742e-05,3.12844664229311e-05,0.207380293725078,0.267883268239552,0.29677703772977,0.257160137746142,0.128766797691729,10.1305310733839,0.00036489134458545,0.00718588753337719,-2.93701712278403,131670,2.14351958423907,4,0,0,3.12844664229311e-05,0.267883268239552,8562.8204303717,13.0638703559039
"296",301,436,436,436,"P78318","IGBP1","IGBP1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16)","GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0042113; GO:0043154; GO:0051721; GO:0060632; GO:0070555",0.0186726028261714,0.00127758844621045,0.00108276249903233,0.100601896279564,0.080005894349566,0.0866083085168419,0.0820610484581858,0.0480415088195643,10.1144369021925,0.00036731288161289,0.00718588753337719,-2.94511369246026,39222,2.14351958423907,12,0,0,0.00127758844621045,0.0866083085168419,67.790460045046,6.08301035624179
"297",302,438,438,438,"O94766","B3GAT3","B3GA3_HUMAN","cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:21763480}; Single-pass type II membrane protein {ECO:0000269|PubMed:21763480}. Golgi apparatus, cis-Golgi network {ECO:0000269|PubMed:21763480, ECO:0000269|PubMed:25893793}.","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)","GO:0000139; GO:0005794; GO:0005801; GO:0005975; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0030203; GO:0030204; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316",0.00010087287244757,0.0130178854633714,3.13982325829858e-05,0.0898362317113622,0.0797503890773849,0.106841459132362,0.0877593077842357,0.0482630394149185,10.1096394407527,0.00036803851304661,0.00718588753337719,-2.94752946522423,37122,2.14351958423907,4,0,0,0.00010087287244757,0.0898362317113622,890.58861447666,9.79861535787369
"298",303,439,439,439,"Q8N1G1","REXO1","REXO1_HUMAN","nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12943681}.","RNA exonuclease 1 homolog (EC 3.1.-.-) (Elongin-A-binding protein 1) (EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1)","GO:0003676; GO:0004527; GO:0005654; GO:0016604",1e-07,7.49098798209603e-06,1e-07,0.0711768311699459,0.0509813001466762,0.0702700589044938,0.0641401664110446,0.032072646868183,10.1051691952815,0.00036871623190201,0.00718588753337719,-2.9497814162104,131510,2.14351958423907,5,2,0,1e-07,0.0702700589044938,702700.589044938,19.4225505823509
"299",304,441,441,441,"Q8TEW0","PARD3","PARD3_HUMAN","adherens junction [GO:0005912]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell cycle [GO:0007049]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Endomembrane system {ECO:0000269|PubMed:20332120}. Cell junction {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cell junction, tight junction {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q99NH2}. Cell membrane {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cytoplasm, cell cortex {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:20332120}. Note=Localized along the cell-cell contact region. Colocalizes with PARD6A and PRKCI at epithelial tight junctions. Colocalizes with the cortical actin that overlays the meiotic spindle during metaphase I and metaphase II. Colocalized with SIRT2 in internode region of myelin sheat (By similarity). Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction. {ECO:0000250}.","Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)","GO:0005546; GO:0005547; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007163; GO:0007179; GO:0007205; GO:0007409; GO:0008356; GO:0010801; GO:0012505; GO:0019903; GO:0022011; GO:0030054; GO:0031643; GO:0032266; GO:0032991; GO:0033269; GO:0042802; GO:0043025; GO:0044295; GO:0060341; GO:0065003; GO:0070830; GO:0090162",1e-07,1.59700826750727e-05,1.13998553537372e-05,0.0962764160145614,0.0684926651977476,0.0764212304814203,0.0803876139185668,0.040202963605293,10.0942950593936,0.00037037121154316,0.00718906478641605,-2.95526324475029,151423,2.1433276025957,6,1,0,1.13998553537372e-05,0.0764212304814203,6703.7017672656,12.7107422528435
"300",305,442,442,442,"Q16555","DPYSL2","DPYL2_HUMAN","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; axon guidance [GO:0007411]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20801876}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:20801876}. Membrane {ECO:0000269|PubMed:20801876}. Note=Tightly but non-covalently associated with membranes.","Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2)","GO:0004157; GO:0005829; GO:0005856; GO:0005886; GO:0006139; GO:0006897; GO:0007010; GO:0007165; GO:0007399; GO:0007411; GO:0007420; GO:0008017; GO:0030516; GO:0042802; GO:0070062",1e-07,0.0001655349178798,4.67960907035e-05,0.010562039923275,0.00867826643907247,0.00744032127187561,0.00882273220854659,0.00448217644046773,10.0669991664333,0.00037456571680252,0.00725403288649237,-2.96904748998481,62294,2.13942047985707,28,1,0,4.67960907035e-05,0.00867826643907247,185.448534452546,7.53487505644876
"301",306,444,444,444,"P35790","CHKA","CHKA_HUMAN","cytosol [GO:0005829]; ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]","SUBCELLULAR LOCATION: Cytoplasm.","Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82)","GO:0004103; GO:0004104; GO:0004305; GO:0005524; GO:0005829; GO:0006580; GO:0006629; GO:0006646; GO:0006656; GO:0006869; GO:0008144; GO:0009636; GO:0019695; GO:0033265; GO:0042803; GO:1904681",0.0146382747518032,1e-07,3.82451870963653e-06,0.0860180047132881,0.0799662068454587,0.0666488252774216,0.0726636125218852,0.0412125393511135,10.0276395842427,0.00038071690427479,0.00733994752385639,-2.98898437752021,52249,2.13430704501323,7,1,0,3.82451870963653e-06,0.0799662068454587,20908.8287747083,14.3518246299875
"302",307,445,445,445,"Q6ICG6","KIAA0930","K0930_HUMAN",NA,NA,"Uncharacterized protein KIAA0930",NA,4.40040972956297e-05,1e-07,1e-07,0.0630927191119879,0.0833869913552639,0.0903611287425669,0.0789322117041743,0.0394808405511857,10.0137502221923,0.00038291703051051,0.00735941939650602,-2.9960369356721,45794,2.13315644691791,5,2,0,1e-07,0.0833869913552639,833869.913552639,19.669462810492
"303",308,446,446,446,"Q9Y4D8","HECTD4","HECD4_HUMAN","cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)","GO:0005737; GO:0006006; GO:0016021; GO:0042593; GO:0061630",3.4464822961495e-06,1e-07,3.26230046803724e-05,0.00082801947939306,0.00104235945482341,0.001167245811335,0.00100048508619165,0.00051229903875466,10.0104229928175,0.00038344638444412,0.00735941939650602,-2.99772772541014,439344,2.13315644691791,68,1,0,3.4464822961495e-06,0.00104235945482341,302.441552068311,8.24051255302644
"304",310,448,448,448,"Q8NCA5","FAM98A","FA98A_HUMAN","tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; lysosome localization [GO:0032418]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]",NA,"Protein FAM98A","GO:0003723; GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029",0.0158137483575938,0.0139591939908278,0.0145367756155441,0.0306133409374978,0.0261110264751209,0.0283402096129119,0.0135849530205216,0.0215623824982494,9.99148332836109,0.00038647675692374,0.00738446660550726,-3.00736207988801,55401,2.13168086916056,5,0,0,0.0145367756155441,0.0283402096129119,1.94955266301338,0.963143126596053
"305",311,449,449,449,"Q02543","RPL18A","RL18A_HUMAN","cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",NA,"60S ribosomal protein L18a (Large ribosomal subunit protein eL20)","GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0042788; GO:0097327",0.00128737600769133,0.00513675885907952,0.00235790825988423,0.0265617363429011,0.0204222744306852,0.0253699034518976,0.0211906236996096,0.0135226595586898,9.98443643258887,0.00038761174718053,0.00738965825359764,-3.01095101875173,20762,2.13137564577414,4,0,0,0.00235790825988423,0.0253699034518976,10.7594955594851,3.4275385360822
"306",312,450,450,450,"P14373","TRIM27","TRI27_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell proliferation [GO:0008283]; innate immune response [GO:0045087]; interferon-gamma secretion [GO:0072643]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 secretion [GO:1900041]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of DNA binding transcription factor activity [GO:0051091]; protein K63-linked ubiquitination [GO:0070534]; protein trimerization [GO:0070206]; retrograde transport, endosome to Golgi [GO:0042147]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17156811}. Cytoplasm {ECO:0000269|PubMed:17156811}. Nucleus, PML body {ECO:0000250}. Early endosome {ECO:0000269|PubMed:1437549, ECO:0000269|PubMed:23452853, ECO:0000269|PubMed:9247190}. Note=Nuclear or cytoplasmic depending on the cell type (By similarity). Colocalized with PML and EIF3S6 in nuclear bodies. Recruited to retromer-containing endosomes via interaction with MAGEL2 (PubMed:23452853). {ECO:0000250, ECO:0000269|PubMed:23452853}.","Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27)","GO:0000122; GO:0001650; GO:0002820; GO:0003676; GO:0003677; GO:0004714; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005887; GO:0006351; GO:0006469; GO:0007283; GO:0008270; GO:0008283; GO:0016020; GO:0016605; GO:0031965; GO:0032720; GO:0032897; GO:0034314; GO:0042147; GO:0042802; GO:0045087; GO:0045814; GO:0046872; GO:0051091; GO:0051127; GO:0061630; GO:0070206; GO:0070534; GO:0072643; GO:0090281; GO:1900041; GO:1902187",0.00064286431715069,0.00305398506058005,0.00100039174975562,0.106313605836216,0.125945365483032,0.0880971592744547,0.105219629822072,0.0541755619535316,9.96666313569853,0.00039049252858263,0.00742779715415599,-3.02001317443474,58490,2.12913996492601,6,0,0,0.00100039174975562,0.106313605836216,106.271973816444,6.73161736738584
"307",313,451,451,451,"Q96IG2","FBXL20","FXL20_HUMAN","cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","GO:0000209; GO:0001662; GO:0004842; GO:0005829; GO:0043687",7.09139218819764e-05,5.39277516230444e-05,7.65169294522795e-05,0.0378781307951595,0.0527368633629577,0.0407253460924497,0.0437129938825365,0.0219236164755874,9.96141778402752,0.00039134772389303,0.00742779715415599,-3.02269047908878,48423,2.12913996492601,10,0,0,7.09139218819764e-05,0.0407253460924497,574.29267782185,9.16564235738854
"308",314,452,452,452,"A6NJT0","UNCX","UNC4_HUMAN","nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.","Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1)","GO:0000981; GO:0001502; GO:0005634; GO:0006351; GO:0007389; GO:0021516; GO:0021889; GO:0035726; GO:0043565; GO:0045595",0.00537803640388344,0.00041241547426931,0.00088714558675478,0.172602957838944,0.238552293738098,0.240964611566987,0.21514742189304,0.109799576768156,9.94302900819252,0.00039436396626968,0.00745689944675607,-3.03208659972721,53690,2.1274417131536,4,0,0,0.00088714558675478,0.238552293738098,268.89869858986,8.07091896267797
"309",315,453,453,453,"O43920","NDUFS5","NDUS5_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}. Mitochondrion intermembrane space {ECO:0000305}.","NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit)","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0032981",0.00734685218676935,0.00891160716657918,0.00634060853738699,0.0310413812669071,0.0293635741719882,0.0376066570263708,0.0251375148581769,0.0201017800593336,9.93951738813029,0.00039494319539191,0.00745689944675607,-3.03388274490761,12518,2.1274417131536,4,0,0,0.00734685218676935,0.0310413812669071,4.22512669069459,2.07899460134666
"310",316,454,454,454,"Q8IUD2","ERC1","RB6I2_HUMAN","cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; cadherin binding [GO:0045296]; leucine zipper domain binding [GO:0043522]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; I-kappaB phosphorylation [GO:0007252]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=In neurons, localized closed to presynaptic membrane. Recruited on Golgi membranes by RAB6A in a GTP-dependent manner (By similarity). {ECO:0000250}.","ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2)","GO:0000139; GO:0005737; GO:0006355; GO:0007252; GO:0007275; GO:0008385; GO:0015031; GO:0017137; GO:0030165; GO:0042147; GO:0042734; GO:0043066; GO:0043522; GO:0045202; GO:0045296; GO:0048786; GO:0051092",1e-07,1e-07,4.64224306069137e-05,0.00562677108957797,0.00431165399195896,0.00620192518342226,0.00536457594478409,0.00269782878259435,9.93285383605083,0.00039604518949872,0.00745689944675607,-3.03729265925954,128086,2.1274417131536,23,2,0,1e-07,0.00562677108957797,56267.7108957797,15.7800196518754
"311",317,455,455,455,"P49458","SRP9","SRP09_HUMAN","cytosol [GO:0005829]; signal recognition particle receptor complex [GO:0005785]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","SUBCELLULAR LOCATION: Cytoplasm.","Signal recognition particle 9 kDa protein (SRP9)","GO:0003723; GO:0005047; GO:0005785; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0008312; GO:0045900",0.0235942118977978,1e-07,1e-07,0.0829612340063471,0.0827310047593028,0.0839871811039124,0.0753616693239215,0.0455456386278933,9.93062420162129,0.00039641475834657,0.00745689944675607,-3.03843408976222,10112,2.1274417131536,3,2,0,1e-07,0.0829612340063471,829612.340063471,19.6620778281058
"312",319,458,458,458,"P09012","SNRPA","SNRPA_HUMAN","nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]","SUBCELLULAR LOCATION: Nucleus.","U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)","GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0035614; GO:0042802; GO:1900363; GO:1990446",0.00270544871014362,0.00144895298349813,0.0007257874877615,0.0180710574367628,0.0147609798082572,0.0136277293775339,0.0138598591470502,0.00855665930065952,9.8951813116321,0.00040234659914933,0.00751347412103049,-3.05661018945209,31280,2.12415920511067,4,0,0,0.00144895298349813,0.0147609798082572,10.1873421542089,3.34870580084661
"313",320,460,460,460,"Q9NP66","HMG20A","HM20A_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.","High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)","GO:0000122; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0033234; GO:0042802; GO:0045665; GO:0046982",0.00013790902181784,0.00019016486000588,0.0273562146959346,0.288384672578201,0.258673165669143,0.206925851150521,0.242099800273369,0.130277996329271,9.86364312630902,0.00040771650082983,0.00758707227631167,-3.07283404947366,40144,2.11992577872046,3,0,0,0.00019016486000588,0.258673165669143,1360.257440103,10.4096640040875
"314",322,463,463,463,"Q02790","FKBP4","FKBP4_HUMAN","axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein-containing complex localization [GO:0031503]; regulation of cellular response to heat [GO:1900034]; steroid hormone receptor complex assembly [GO:0006463]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:2378870}. Mitochondrion {ECO:0000269|PubMed:21730050}. Nucleus {ECO:0000250|UniProtKB:P30416}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9QVC8}. Cell projection, axon {ECO:0000250|UniProtKB:Q9QVC8}. Note=Shuttles from mitochondria to nucleus; co-localizes in mitochondria with the glucocorticoid receptor (PubMed:21730050). Colocalized with MAPT/TAU in the distal part of the primary cortical neurons (By similarity). {ECO:0000250|UniProtKB:Q9QVC8, ECO:0000269|PubMed:21730050}.","Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]","GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0061077; GO:0070062; GO:1900034",0.00067863721545218,0.00052940010167742,0.00031117616548348,0.0144095383898125,0.0131360678589285,0.018316128668485,0.0147808404782043,0.0078968247333065,9.81653874380619,0.00041590112934323,0.00768418622625701,-3.09715409068819,51805,2.11440211855582,28,0,0,0.00052940010167742,0.0144095383898125,27.2186165891458,4.76652183730979
"315",323,464,464,464,"O95758","PTBP3","PTBP3_HUMAN","nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]",NA,"Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)","GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0045595",0.0100718756323954,0.0307616493865374,0.0195689994583763,0.0864984270468938,0.0979948621846413,0.0842223974664859,0.0694377207402373,0.0548530351958883,9.81182454292063,0.00041673126666844,0.00768418622625701,-3.09959391041554,59690,2.11440211855582,9,0,0,0.0195689994583763,0.0864984270468938,4.42017627068149,2.14410390350071
"316",324,466,466,466,"Q9BUN8","DERL1","DERL1_HUMAN","Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; ATPase binding [GO:0051117]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15215855, ECO:0000269|PubMed:15215856, ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16449189}; Multi-pass membrane protein {ECO:0000269|PubMed:15215855, ECO:0000269|PubMed:15215856, ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16449189}.","Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1)","GO:0002020; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0016032; GO:0016567; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0032092; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0045184; GO:0051117; GO:0051260; GO:0055085; GO:0071712; GO:1990381",0.00937353752691873,0.00969442466057331,0.0098150019698545,0.0289472149081443,0.023042820934317,0.0277130555059687,0.0169400423970278,0.0180976759176294,9.74808960509869,0.00042815604396018,0.00784296415068719,-3.13268532638999,28801,2.10551977009692,3,0,0,0.00969442466057331,0.0277130555059687,2.858659123803,1.51533859838154
"317",325,467,467,467,"Q08945","SSRP1","SSRP1_HUMAN","chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10421373, ECO:0000269|PubMed:22002106}. Nucleus, nucleolus {ECO:0000269|PubMed:22002106}. Chromosome {ECO:0000269|PubMed:10421373}. Note=Colocalizes with RNA polymerase II on chromatin. Recruited to actively transcribed loci. {ECO:0000250|UniProtKB:Q05344}.","FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160)","GO:0000981; GO:0003677; GO:0003682; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006281; GO:0006366; GO:0006368; GO:1901796",6.74396345457416e-05,9.13670290943743e-05,0.00011580920979886,0.0051346308498126,0.00467411483019489,0.00357106241443996,0.00436839740700282,0.00227573732798107,9.74766174267784,0.00042823402623748,0.00784296415068719,-3.1329081413763,81075,2.10551977009692,13,0,0,9.13670290943743e-05,0.00467411483019489,51.1575660993303,5.67687572228216
"318",326,470,470,470,"O75179","ANKRD17","ANR17_HUMAN","chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:22328336}. Nucleus {ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984, ECO:0000269|PubMed:22328336}. Note=Detected around the nucleolus. Localized on chromatin in a cell cycle-dependent manner. {ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984}.","Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)","GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006275; GO:0016020; GO:0016032; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246",8.84342053059061e-05,3.36568075038247e-05,3.78764812985217e-05,0.0315782680426006,0.0447694788066796,0.0349567197070823,0.0370481663540848,0.0185774056750785,9.71668989602938,0.00043392541030447,0.00790298194086443,-3.14906090790844,274258,2.1022090104677,13,0,0,3.78764812985217e-05,0.0349567197070823,922.913599908412,9.85005178367167
"319",327,471,471,471,"Q96F63","CCDC97","CCD97_HUMAN","U2 snRNP [GO:0005686]",NA,"Coiled-coil domain-containing protein 97","GO:0005686",1e-07,1e-07,1e-07,0.0667227876104957,0.0950099848106393,0.0927458499521496,0.0848261074577615,0.0424131537288808,9.69843306645088,0.00043732365154875,0.00794796275426184,-3.15860443572291,38947,2.09974417674799,3,3,0,1e-07,0.0927458499521496,927458.499521496,19.8229232021281
"320",328,472,472,472,"Q14344","GNA13","GNA13_HUMAN","brush border membrane [GO:0031526]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; type 1 angiotensin receptor binding [GO:0031702]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G-protein coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10747909}; Lipid-anchor {ECO:0000269|PubMed:10747909}. Melanosome {ECO:0000269|PubMed:17081065}. Cytoplasm {ECO:0000269|PubMed:10747909, ECO:0000269|PubMed:18703424}. Nucleus {ECO:0000269|PubMed:18703424}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Detected in the cytoplasm of Leydig cells and in the seminiferous epithelium, including differentiating cells from the spermatogonia to mature spermatozoa stages (PubMed:18703424). In round spermatids, also present in the nuclei (PubMed:18703424). {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18703424}.","Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)","GO:0001569; GO:0001701; GO:0003924; GO:0005085; GO:0005089; GO:0005525; GO:0005634; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031702; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062",0.00018598020303809,0.00014588741350679,0.00010078704246661,0.0301838645572538,0.0269395355879408,0.0207350455674594,0.0258085970178808,0.0130485167286109,9.66007514385985,0.00044457010870752,0.00805157392837585,-3.17870906943596,44050,2.09411921508631,9,0,0,0.00014588741350679,0.0269395355879408,184.659765639665,7.52872575054392
"321",329,473,473,473,"Q96MY1","NOL4L","NOL4L_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]",NA,"Nucleolar protein 4-like","GO:0005654; GO:0005829",0.00665528508221589,1e-07,1e-07,0.19919920406689,0.228302521915454,0.284954375040503,0.235266871980211,0.119851931017511,9.6583162821591,0.00044490589580861,0.00805157392837585,-3.17963269077372,47215,2.09411921508631,4,2,0,1e-07,0.228302521915454,2283025.21915454,21.1225153655264
"322",330,474,474,474,"Q7L523","RRAGA","RRAGA_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein ubiquitination [GO:0016567]; regulation of macroautophagy [GO:0016241]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Nucleus {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Lysosome {ECO:0000269|PubMed:20381137}. Note=Predominantly cytoplasmic. May shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state (PubMed:8995684, PubMed:9394008). Colocalizes in vivo with adenovirus E3-14.7K mainly to the cytoplasm especially near the nuclear membrane and in discrete foci on or near the plasma membrane (PubMed:8995684). {ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}.","Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1)","GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0007050; GO:0008219; GO:0010507; GO:0016241; GO:0016567; GO:0019048; GO:0031625; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0042803; GO:0045919; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131",1e-07,1e-07,1e-07,0.0292205080352492,0.0258160189202227,0.0369569111716615,0.0306643793757111,0.0153322896878556,9.65262963972049,0.000445993667086,0.00805423162501308,-3.18261993574855,36566,2.09397588503172,3,3,0,1e-07,0.0292205080352492,292205.080352492,18.1566217358624
"323",331,475,475,475,"P02786","TFRC","TFR1_HUMAN","basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; transferrin transmembrane transporter activity [GO:0033570]; virus receptor activity [GO:0001618]; cellular iron ion homeostasis [GO:0006879]; cellular response to drug [GO:0035690]; cellular response to leukemia inhibitory factor [GO:1990830]; iron ion import [GO:0097286]; membrane organization [GO:0061024]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of isotype switching [GO:0045830]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; transferrin transport [GO:0033572]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17081065}; Single-pass type II membrane protein {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. {ECO:0000269|PubMed:17081065}.; SUBCELLULAR LOCATION: Transferrin receptor protein 1, serum form: Secreted {ECO:0000269|PubMed:17081065}.","Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]","GO:0001618; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006879; GO:0009897; GO:0009986; GO:0010008; GO:0016020; GO:0016323; GO:0030316; GO:0030665; GO:0030890; GO:0031410; GO:0031623; GO:0033570; GO:0033572; GO:0035690; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0045780; GO:0045830; GO:0048471; GO:0055037; GO:0061024; GO:0070062; GO:0072562; GO:0097286; GO:1903561; GO:1990712; GO:1990830",1e-07,2.90158389694096e-05,2.52130234151806e-05,0.0621467368266451,0.0462271573620269,0.0451030408345702,0.0511408687202859,0.0255885439809378,9.64184707931018,0.00044806516008701,0.00806665011145164,-3.18828852064182,84871,2.09330678004244,17,1,0,2.52130234151806e-05,0.0462271573620269,1833.46346849437,10.8403558054992
"324",332,476,476,476,"P56159","GFRA1","GFRA1_HUMAN","anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; MAPK cascade [GO:0000165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}.","GDNF family receptor alpha-1 (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1)","GO:0000165; GO:0005088; GO:0005102; GO:0005622; GO:0005886; GO:0007166; GO:0007411; GO:0016167; GO:0019898; GO:0031225; GO:0070062",0.00108856425747171,0.00016035150349422,0.00033890948729386,0.130345565608547,0.109387741198723,0.0896133543011634,0.109252945286725,0.0551557477261156,9.63674951974808,0.00044904857528894,0.00806665011145164,-3.19097041080715,51456,2.09330678004244,8,0,0,0.00033890948729386,0.109387741198723,322.763880327362,8.33433532914564
"325",333,477,477,477,"P55795","HNRNPH2","HNRH2_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm.","Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]","GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016020; GO:0016070; GO:1990904",1e-07,1e-07,1e-07,0.0466198043800248,0.0579924184093518,0.0680831442496612,0.0575650223463459,0.028782611173173,9.63437056886864,0.00044950842326664,0.00806665011145164,-3.19222244930827,49264,2.09330678004244,3,3,0,1e-07,0.0579924184093518,579924.184093518,19.145504777467
"326",334,478,478,478,"O75164","KDM4A","KDM4A_HUMAN","cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959, ECO:0000269|PubMed:16024779}.","Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A)","GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0008270; GO:0010507; GO:0010629; GO:0016032; GO:0016577; GO:0031625; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045892; GO:0051864; GO:0070544",1e-07,1.08922508626597e-05,1e-07,0.11797837926017,0.0813851404489075,0.110236922633089,0.103196450030434,0.0516019224321714,9.61707295227154,0.00045286940874934,0.00810996263367033,-3.2013346415418,120662,2.09098114677875,5,2,0,1e-07,0.110236922633089,1102369.22633089,20.0721760888583
"327",336,480,480,480,"Q15771","RAB30","RAB30_HUMAN","cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]","SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:22188167}. Cytoplasm {ECO:0000269|PubMed:22188167}. Golgi apparatus {ECO:0000269|PubMed:22188167}.","Ras-related protein Rab-30","GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0031985; GO:0043231",1e-07,1e-07,1e-07,0.0958348693214306,0.103203941182711,0.135206334446862,0.111414948317001,0.0557075741585007,9.56649650470233,0.00046287445317397,0.00825459441493582,-3.22806365085215,23058,2.08330426070314,3,3,0,1e-07,0.103203941182711,1032039.41182711,19.9770666352034
"328",337,481,481,481,"Q9C0C2","TNKS1BP1","TB182_HUMAN","CCR4-NOT complex [GO:0030014]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton. Chromosome. Note=Colocalizes with chromosomes during mitosis, and in the cytoplasm with cortical actin.","182 kDa tankyrase-1-binding protein","GO:0000289; GO:0005634; GO:0005720; GO:0005737; GO:0005829; GO:0005856; GO:0005913; GO:0006302; GO:0006977; GO:0007004; GO:0010800; GO:0019899; GO:0030014; GO:0031954; GO:0033138; GO:0044877; GO:0045296; GO:0071479; GO:0071532",0.00020354968821493,0.0004102520931929,0.00037119345111258,0.0345739871870267,0.049557909143751,0.0478934202177487,0.0436801071053353,0.0221683852968411,9.55746789436997,0.00046468882772181,0.00826972217317819,-3.23284868470702,181796,2.08250908061461,41,0,0,0.00037119345111258,0.0478934202177487,129.025498898748,7.01151239883
"329",338,482,482,482,"Q15393","SF3B3","SF3B3_HUMAN","catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; cellular response to calcium ion [GO:0071277]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; RNA splicing, via transesterification reactions [GO:0000375]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10490618, ECO:0000269|PubMed:11564863, ECO:0000269|PubMed:27720643, ECO:0000269|PubMed:28541300, ECO:0000269|PubMed:28781166}.","Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130)","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0030532; GO:0042177; GO:0044877; GO:0071005; GO:0071013; GO:0071277",6.43900700593684e-05,0.0001411778311563,0.00021325175318563,0.011499274564701,0.0117693435789288,0.0158278228872743,0.0128925404588343,0.00658587678088423,9.54870125275159,0.00046645888835505,0.00828400017493622,-3.23749881667129,135577,2.08175990060743,29,0,0,0.0001411778311563,0.0117693435789288,83.3653802621376,6.38137648463218
"330",339,484,484,484,"Q8N9I0","SYT2","SYT2_HUMAN","cell junction [GO:0030054]; chromaffin granule membrane [GO:0042584]; clathrin-coated vesicle membrane [GO:0030665]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; membrane organization [GO:0061024]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; synaptic vesicle endocytosis [GO:0048488]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Note=Synaptic vesicles and chromaffin granules. {ECO:0000250}.","Synaptotagmin-2 (Synaptotagmin II) (SytII)","GO:0005509; GO:0005544; GO:0005886; GO:0006906; GO:0016021; GO:0017158; GO:0019905; GO:0030054; GO:0030276; GO:0030665; GO:0030672; GO:0042584; GO:0043533; GO:0048488; GO:0048791; GO:0061024; GO:1903861",0.0266749933154923,0.00428721421377578,0.00839516997376869,0.227577103455752,0.168788593307442,0.178358540439003,0.17845561989972,0.102346935784205,9.5111311094773,0.00047413867235583,0.00838559304827681,-3.25747141743716,46872,2.0764662176749,4,0,0,0.00839516997376869,0.178358540439003,21.2453757334631,4.40907695343668
"331",340,485,485,485,"O75396","SEC22B","SC22B_HUMAN","endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990668]; vesicle fusion with Golgi apparatus [GO:0048280]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q4KM74}; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:Q4KM74}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000250|UniProtKB:Q4KM74}. Golgi apparatus, cis-Golgi network membrane {ECO:0000250|UniProtKB:Q4KM74}. Golgi apparatus, trans-Golgi network membrane {ECO:0000250|UniProtKB:Q4KM74}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Concentrated most in the intermediate compartment/cis-Golgi network and the cis-Golgi cisternae 1 and 2. Greatly reduced in concentration at the trans end of the Golgi apparatus (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). {ECO:0000250|UniProtKB:Q4KM74, ECO:0000269|PubMed:17081065}.","Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1)","GO:0000139; GO:0000149; GO:0002479; GO:0005484; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0012507; GO:0015031; GO:0016021; GO:0019905; GO:0030133; GO:0030670; GO:0031201; GO:0033116; GO:0042470; GO:0045732; GO:0048208; GO:0048280; GO:1902902; GO:1990668",1.51991906396823e-05,1.54497606487632e-05,0.00015451574044817,0.0119503023186532,0.00867265231346259,0.00884345862433054,0.00976041618823655,0.00494192965803048,9.4948979677535,0.00047750472459251,0.00840207111932935,-3.26612329322753,24593,2.07561364669691,8,0,0,1.54497606487632e-05,0.00884345862433054,572.40101160004,9.16088241150575
"332",341,486,486,486,"P35813","PPM1A","PPM1A_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; cell cycle arrest [GO:0007050]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein dephosphorylation [GO:0006470]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16751101}. Cytoplasm, cytosol {ECO:0000269|PubMed:22781750}. Membrane {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}; Lipid-anchor {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}. Note=Weakly associates at the membrane and N-myristoylation mediates the membrane localization. {ECO:0000250|UniProtKB:P49443}.","Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA)","GO:0000122; GO:0000287; GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006470; GO:0006499; GO:0007050; GO:0010991; GO:0016020; GO:0016055; GO:0016311; GO:0030145; GO:0030177; GO:0030512; GO:0030514; GO:0033192; GO:0035970; GO:0043123; GO:0043124; GO:0045893; GO:0046827; GO:0070412; GO:0071560; GO:1901223",0.00040670908627361,0.00048926557589205,0.00311355113082661,0.0169915600807634,0.0179234439453486,0.0225983942747807,0.0178346241693002,0.0102538206823142,9.4933463811428,0.00047782798457027,0.00840207111932935,-3.26695095555481,42448,2.07561364669691,9,0,0,0.00048926557589205,0.0179234439453486,36.6333640225348,5.19508628394327
"333",342,487,487,487,"Q9Y6I4","USP3","UBP3_HUMAN","cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17980597}. Note=Localizes preferentially with monoubiquitinated H2A to chromatin.","Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3)","GO:0000122; GO:0000278; GO:0000790; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0006511; GO:0008270; GO:0016578; GO:0016579; GO:0031647; GO:0036459; GO:0036464; GO:0042393; GO:0090543; GO:1990841",3.42453050870006e-05,4.35348452132402e-05,1.89135246938989e-05,0.0336155738101011,0.0491295409048055,0.0452315191218572,0.0426266467205899,0.021345554585293,9.49207078493585,0.00047809394476384,0.00840207111932935,-3.26763148850162,58897,2.07561364669691,5,0,0,3.42453050870006e-05,0.0452315191218572,1320.80934910482,10.3672065219122
"334",343,488,488,488,"O96005","CLPTM1","CLPT1_HUMAN","external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Cleft lip and palate transmembrane protein 1","GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081",0.00044639830858009,0.00023164279022412,0.00025670328116627,0.0151078472368873,0.0143769307000269,0.0105222537051686,0.0130240957540375,0.00682362933700889,9.48774804554503,0.00047899657783092,0.00840207111932935,-3.26993829621929,76097,2.07561364669691,7,0,0,0.00025670328116627,0.0143769307000269,56.0060262366291,5.80751016409235
"335",344,489,489,489,"O14979","HNRNPDL","HNRDL_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; interleukin-12-mediated signaling pathway [GO:0035722]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11705999, ECO:0000269|PubMed:12406575}. Cytoplasm {ECO:0000269|PubMed:11705999, ECO:0000269|PubMed:12406575}. Note=Shuttles between the nucleus and the cytoplasm in a TNPO1-dependent manner. {ECO:0000269|PubMed:11705999, ECO:0000269|PubMed:12406575}.","Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)","GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006351; GO:0006355; GO:0006396; GO:0008143; GO:0010468; GO:0034046; GO:0035722",1e-07,0.00122628196830898,1e-07,0.00445919436536989,0.00540736019823919,0.00532098468351578,0.00465368575960529,0.00273567020257231,9.47874366894551,0.00048088348739541,0.00841791953395654,-3.27474650393222,46438,2.07479522994529,9,2,0,1e-07,0.00532098468351578,53209.8468351578,15.6994056302705
"336",346,491,491,491,"Q9NRG7","SDR39U1","D39U1_HUMAN","nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]",NA,"Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1)","GO:0005634; GO:0016491",1.33804664608306e-06,1e-07,1e-07,0.0198913148121081,0.0231665992991693,0.0157393906286566,0.0195985888977626,0.00979980713109667,9.46190441209468,0.00048443669171024,0.00844557653979569,-3.28374957254572,34748,2.07337069783894,4,2,0,1e-07,0.0198913148121081,198913.148121081,17.6017791156268
"337",347,492,492,492,"Q92845","KIFAP3","KIFA3_HUMAN","axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intraciliary transport particle [GO:0030990]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; kinesin binding [GO:0019894]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; signal transduction [GO:0007165]",NA,"Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)","GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0030990; GO:0032391; GO:0035735; GO:0036064; GO:0043066; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:1990075",7.4307694166774e-05,0.0155740512775207,7.96206183668932e-05,0.119161585158222,0.139912327577311,0.167928722457166,0.137091551867548,0.0737884357971254,9.45510339739656,0.0004858808530615,0.00845353679310257,-3.28738984536269,91205,2.07296155278224,13,0,0,7.96206183668932e-05,0.139912327577311,1757.23738959917,10.7790933864598
"338",348,494,494,494,"Q6PI78","TMEM65","TMM65_HUMAN","integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26403541}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion inner membrane {ECO:0000269|PubMed:24765583, ECO:0000269|PubMed:28295037}; Multi-pass membrane protein {ECO:0000255}. Note=Localizes at the intercalated disk in the ventricular tissue (PubMed:26403541). {ECO:0000269|PubMed:26403541}.","Transmembrane protein 65","GO:0003231; GO:0005743; GO:0005886; GO:0014704; GO:0016021; GO:1903779",1e-07,3.64448392627277e-05,3.63106895119942e-05,0.0225769511187198,0.0219988036927718,0.0305250310281386,0.0250093101036185,0.0125289402280675,9.43302318264466,0.00049060591221386,0.0085011874667017,-3.29922478919793,25498,2.07052040673083,5,1,0,3.63106895119942e-05,0.0225769511187198,621.771478926671,9.28024063058564
"339",349,495,495,495,"O00233","PSMD9","PSMD9_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]; bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]; negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]",NA,"26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27)","GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0016579; GO:0032024; GO:0043425; GO:0043687; GO:0045893; GO:0046676; GO:0070682",1e-07,1e-07,0.00025341089431064,0.0419920878245365,0.0437450321012793,0.0587416477930455,0.0480750522748502,0.0241220631021953,9.38372545014681,0.00050135979007244,0.00866997940004059,-3.32573925131053,24682,2.06198193441068,4,2,0,1e-07,0.0437450321012793,437450.321012793,18.7387596612149
"340",350,496,496,496,"Q14686","NCOA6","NCOA6_HUMAN","cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription, initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725]","SUBCELLULAR LOCATION: Nucleus.","Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)","GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019216; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0030520; GO:0035097; GO:0042921; GO:0043231; GO:0045893; GO:0045944; GO:0046965; GO:0046966",0.305483145968422,0.215271911760037,0.242231496742054,0.51863390736529,0.4908836755876,0.517914476293947,0.254815168258775,0.381736435619558,9.35865976730065,0.00050693816097238,0.00874877148774924,-3.33926914770522,219145,2.05805292681192,4,0,0,0.242231496742054,0.517914476293947,2.13809716432319,1.09632741681051
"341",351,497,497,497,"P30876","POLR2B","RPB2_HUMAN","DNA-directed RNA polymerase II, core complex [GO:0005665]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9852112}.","DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)","GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0042795; GO:0046872; GO:0060964",1e-07,2.00240781344121e-05,1e-07,0.0450813399052566,0.0662113842964327,0.061651437774898,0.0576413126328177,0.028827397675787,9.31632119098918,0.0005165340458728,0.00889644151442905,-3.36219732476122,133897,2.05078367197131,31,2,0,1e-07,0.061651437774898,616514.37774898,19.2337750145885
"342",352,498,498,498,"O95402","MED26","MED26_HUMAN","mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Mediator of RNA polymerase II transcription subunit 26 (Activator-recruited cofactor 70 kDa component) (ARC70) (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26) (Transcriptional coactivator CRSP70)","GO:0001104; GO:0003713; GO:0005654; GO:0006357; GO:0006367; GO:0016592",0.053054441267181,0.0887318794389351,0.0558208845999825,0.276043298157601,0.246814387081841,0.319590880432936,0.214947120122093,0.173342628496413,9.27383809539575,0.00052638686410494,0.00901698246648562,-3.38529879706572,65446,2.04493877480938,3,0,0,0.0558208845999825,0.276043298157601,4.94516165653325,2.30601768322237
"343",353,500,500,500,"Q9UPP1","PHF8","PHF8_HUMAN","nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Note=Recruited to H3K4me3 sites on chromatin during interphase. Dissociates from chromatin when cells enter mitosis.","Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8)","GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558",6.36588430852019e-05,4.62734110306814e-05,8.31327982481482e-05,0.0370754849070184,0.0546261147990189,0.0446895237304543,0.0453993527947092,0.0227640314148093,9.27064170891287,0.00052713743592291,0.00901698246648562,-3.38704080053968,117864,2.04493877480938,11,0,0,6.36588430852019e-05,0.0446895237304543,702.015958264293,9.45536001609812
"344",354,502,502,502,"Q6P1Q0","LETMD1","LTMD1_HUMAN","integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:17943721, ECO:0000269|PubMed:18045496}; Single-pass membrane protein {ECO:0000269|PubMed:17943721, ECO:0000269|PubMed:18045496}.","LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2)","GO:0005654; GO:0005739; GO:0005741; GO:0005743; GO:0006875; GO:0016021; GO:0043022",1.2544864007952e-05,7.73242286316744e-06,7.68842490728084e-07,0.0167182824018839,0.0196128158824154,0.0244979601770627,0.0202693374440001,0.010141684098454,9.26358266847896,0.00052879967268408,0.00901698246648562,-3.39088984326224,41790,2.04493877480938,4,0,0,7.73242286316744e-06,0.0196128158824154,2536.43860785717,11.308588526459
"345",355,503,503,503,"Q9H2V7","SPNS1","SPNS1_HUMAN","integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; vesicle [GO:0031982]; sphingolipid transporter activity [GO:0046624]; locomotion [GO:0040011]; sphingosine-1-phosphate signaling pathway [GO:0003376]; transmembrane transport [GO:0055085]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:12815463}; Multi-pass membrane protein {ECO:0000269|PubMed:12815463}. Note=Colocalizes with SDHB.","Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1)","GO:0003376; GO:0005743; GO:0005765; GO:0016021; GO:0031982; GO:0040011; GO:0046624; GO:0055085",0.00547656840820406,1e-07,1e-07,0.071256314124622,0.070853028465765,0.0507612293142132,0.0624646011654654,0.033057890052134,9.24922241295902,0.00053220099556721,0.00904324391692503,-3.39872817205188,56630,2.04367575508759,3,2,0,1e-07,0.070853028465765,708530.28465765,19.4344699939056
"346",356,504,504,504,"O15399","GRIN2D","NMDE4_HUMAN","cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; NMDA glutamate receptor activity [GO:0004972]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; MAPK cascade [GO:0000165]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26875626, ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:9489750}; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein.","Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D)","GO:0000165; GO:0001964; GO:0004970; GO:0004972; GO:0005088; GO:0005234; GO:0005622; GO:0005886; GO:0005887; GO:0007420; GO:0008344; GO:0017146; GO:0022849; GO:0030054; GO:0045211; GO:0048167; GO:0051930; GO:0097553; GO:0098976",0.00017010534516016,0.107039414618739,0.00013193956839854,0.396175287915725,0.350878298947799,0.397662854673981,0.345791660668403,0.208676316844967,9.248164274739,0.00053245267922081,0.00904324391692503,-3.39930617606058,143752,2.04367575508759,3,0,0,0.00017010534516016,0.396175287915725,2328.99964162039,11.1854947022132
"347",358,506,506,506,"P49327","FASN","FAS_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; NADPH binding [GO:0070402]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]; mammary gland development [GO:0030879]; osteoblast differentiation [GO:0001649]; positive regulation of cellular metabolic process [GO:0031325]; regulation of cholesterol biosynthetic process [GO:0045540]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]","GO:0001649; GO:0003723; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004320; GO:0005794; GO:0005829; GO:0005886; GO:0006084; GO:0006631; GO:0006633; GO:0008144; GO:0016020; GO:0016295; GO:0016296; GO:0030879; GO:0031177; GO:0031325; GO:0042470; GO:0042587; GO:0042803; GO:0045296; GO:0045540; GO:0046949; GO:0047117; GO:0047451; GO:0070062; GO:0070402; GO:0071353; GO:0102131; GO:0102132",1.60919571456486e-06,1e-07,1e-07,0.00748062933815925,0.0105534729761339,0.0108952496101384,0.00964251424290566,0.00482186018669102,9.21183528535601,0.00054118265852893,0.0091412511370547,-3.41918709820393,273427,2.03899435954702,80,2,0,1e-07,0.0105534729761339,105534.729761339,16.6873583189548
"348",360,508,508,508,"P29372","MPG","3MG_HUMAN","mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23290262}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:23290262}. Nucleus {ECO:0000269|PubMed:23290262}.","DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)","GO:0003684; GO:0003905; GO:0005654; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822",1e-07,1e-07,0.00489202776428757,0.061903811420039,0.0894177470771672,0.0719221911954514,0.07278384064279,0.0380226629094908,9.20596727303093,0.00054260912773365,0.00914317742795295,-3.42240499318684,32869,2.03890285244765,5,2,0,1e-07,0.0719221911954514,719221.911954514,19.4560774493862
"349",361,509,509,509,"Q9NV06","DCAF13","DCA13_HUMAN","cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:24754225}. Note=In the nucleolus, localizes predominantly in the granular component, but also detected in the fibrillar center and dense fibrillar component. {ECO:0000269|PubMed:24754225}.","DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)","GO:0000462; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006364; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0043687; GO:0080008",0.0337947354167277,1e-07,4.86262030566334e-07,0.147909127887238,0.137673179411423,0.119638241252397,0.123808408957433,0.0731693117049692,9.19507857605739,0.00054526828530849,0.00916993422837081,-3.42838103832781,51402,2.03763377930905,6,1,0,4.86262030566334e-07,0.137673179411423,283125.497689136,18.111082155624
"350",362,510,510,510,"P23443","RPS6KB1","KS6B1_HUMAN","cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to testosterone [GO:0033574]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]","SUBCELLULAR LOCATION: Cell junction, synapse, synaptosome {ECO:0000250}. Mitochondrion outer membrane. Mitochondrion. Note=Colocalizes with URI1 at mitochondrion.; SUBCELLULAR LOCATION: Isoform Alpha I: Nucleus. Cytoplasm.; SUBCELLULAR LOCATION: Isoform Alpha II: Cytoplasm.","Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)","GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009611; GO:0009612; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016301; GO:0016477; GO:0018105; GO:0030054; GO:0030165; GO:0031929; GO:0032496; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048015; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:2001237",0.0128260987765615,0.0210186140444779,0.00696188502602126,0.0855729188507807,0.0675559549633656,0.0706327851560741,0.0609850203743866,0.0440947094695469,9.17393367944739,0.00055047779204034,0.00923939196052022,-3.44000427227151,59140,2.03435660852878,4,0,0,0.0128260987765615,0.0706327851560741,5.50695783546817,2.46125556240311
"351",363,511,511,511,"P05060","CHGB","SCG1_HUMAN","endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; secretory granule [GO:0030141]; hormone activity [GO:0005179]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]","SUBCELLULAR LOCATION: Secreted. Note=Neuroendocrine and endocrine secretory granules.","Secretogranin-1 (Chromogranin-B) (CgB) (Secretogranin I) (SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide]","GO:0005179; GO:0005576; GO:0005788; GO:0030141; GO:0043687; GO:0044267",4.67035195781252e-05,1.55391678166554e-05,0.00063636826841365,0.144339412410622,0.21490280400775,0.181710155719283,0.180084587060616,0.0902751638489107,9.1674058259687,0.00055209834899294,0.00924606266969708,-3.44359748361659,78276,2.0340431672454,6,0,0,4.67035195781252e-05,0.181710155719283,3890.71653187336,11.9258201575562
"352",364,512,512,512,"Q15048","LRRC14","LRC14_HUMAN","cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27426725}.","Leucine-rich repeat-containing protein 14","GO:0005737; GO:0019900; GO:0032088; GO:0034122",0.00092194269649173,0.00085033578333437,0.00401540544760616,0.0511147563549538,0.0726591877921986,0.056262792677742,0.0580830176324874,0.0309707367920544,9.16049722176505,0.00055381978481265,0.00924606266969708,-3.44740279266851,54513,2.0340431672454,9,0,0,0.00092194269649173,0.056262792677742,61.0263445785068,5.93136027179054
"353",365,513,513,513,"P07437","TUBB","TBB5_HUMAN","azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; microtubule [GO:0005874]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; MHC class I protein binding [GO:0042288]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular process [GO:0009987]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoskeleton-dependent intracellular transport [GO:0030705]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based process [GO:0007017]; natural killer cell mediated cytotoxicity [GO:0042267]; neutrophil degranulation [GO:0043312]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:26637975}.","Tubulin beta chain (Tubulin beta-5 chain)","GO:0000086; GO:0003924; GO:0005198; GO:0005200; GO:0005525; GO:0005576; GO:0005634; GO:0005641; GO:0005737; GO:0005856; GO:0005874; GO:0007017; GO:0009987; GO:0010389; GO:0019904; GO:0030705; GO:0031625; GO:0032794; GO:0035578; GO:0036464; GO:0042267; GO:0042288; GO:0043312; GO:0044297; GO:0044877; GO:0045121; GO:0051225; GO:0051301; GO:0070062; GO:0097711",0.00038896447745931,0.00032744470771639,0.00027922030882027,0.0025742867122277,0.00274406418322075,0.00352699098312989,0.00261657079486079,0.00164016189542906,9.15611544607116,0.00055491500461193,0.00924606266969708,-3.44981764878023,49671,2.0340431672454,6,0,0,0.00032744470771639,0.00274406418322075,8.38023678060929,3.0669910073357
"354",366,514,514,514,"Q14669","TRIP12","TRIPC_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:20208519}.","E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12)","GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0045995; GO:0046966; GO:0061630; GO:1901315; GO:2000780",1e-07,8.65365295952867e-05,1e-07,0.0455376472971207,0.0454362066605298,0.0316047457320355,0.0408306210533636,0.0204442227032136,9.15499366041263,0.00055519581918508,0.00924606266969708,-3.45043604775333,220434,2.0340431672454,26,2,0,1e-07,0.0454362066605298,454362.066605298,18.7934828678075
"355",367,515,515,515,"Q2TBE0","CWF19L2","C19L2_HUMAN",NA,NA,"CWF19-like protein 2",NA,9.56435249598279e-05,9.94748622667396e-05,5.71634320424402e-05,0.127468246684804,0.0906461295187527,0.093801023480243,0.103887705954844,0.0520279469171781,9.14794231104569,0.00055696495384885,0.00925751457271105,-3.45432476231378,103787,2.03350559563358,3,0,0,9.56435249598279e-05,0.093801023480243,980.735742640615,9.93772064717759
"356",368,517,517,517,"Q8TEY7","USP33","UBP33_HUMAN","cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]; cysteine-type endopeptidase activity [GO:0004197]; G-protein coupled receptor binding [GO:0001664]; Ral GTPase binding [GO:0017160]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:19118533}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:23486064}. Note=Associates with centrosomes predominantly in S and G2 phases but less in G1 phase (PubMed:23486064). {ECO:0000269|PubMed:23486064}.; SUBCELLULAR LOCATION: Isoform 3: Golgi apparatus {ECO:0000269|PubMed:21801292}.","Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1) (hVDU1)","GO:0001664; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0009267; GO:0010506; GO:0016477; GO:0016579; GO:0017160; GO:0030891; GO:0032091; GO:0032092; GO:0036459; GO:0044297; GO:0048471; GO:0050821; GO:0051298; GO:0070536; GO:0071108",0.0140898770489457,0.0383703620204234,0.00705174594903924,0.144366807505422,0.181764086246432,0.144838273645935,0.13715239412646,0.0884135254026996,9.12064507994828,0.00056387894346811,0.009322163595393,-3.46940431815653,106727,2.03048327986803,8,0,0,0.0140898770489457,0.144838273645935,10.2795981216013,3.36171195870844
"357",370,519,519,519,"O15344","MID1","TRI18_HUMAN","cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; interferon-gamma-mediated signaling pathway [GO:0060333]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10077590}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10077590}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:10077590}. Note=Microtubule-associated. It is associated with microtubules throughout the cell cycle, co-localizing with cytoplasmic fibers in interphase and with the mitotic spindle and midbodies during mitosis and cytokinesis.","E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)","GO:0000226; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007026; GO:0007389; GO:0008017; GO:0008270; GO:0016740; GO:0031625; GO:0032874; GO:0035372; GO:0042802; GO:0042803; GO:0046982; GO:0051219; GO:0060333",1e-07,5.16467041053172e-06,1e-07,0.0119433309648965,0.0177582958352134,0.0164233743000728,0.0153732121432574,0.00768839429509888,9.06940237668601,0.00057714355184455,0.00951897650055763,-3.4978220489789,75251,2.02140974531888,10,2,0,1e-07,0.0164233743000728,164233.743000728,17.3253910440529
"358",371,520,520,520,"Q9NR46","SH3GLB2","SHLB2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11161816}.","Endophilin-B2 (SH3 domain-containing GRB2-like protein B2)","GO:0005654; GO:0005737; GO:0005829; GO:0042802; GO:0045296",1e-07,1e-07,0.00018530655643377,0.0175159153190882,0.0176969802317322,0.0122039599662877,0.0157437829868914,0.00793372701225697,9.06102063972056,0.00057934937465958,0.00952924673172716,-3.50248407753948,43974,2.02094142813228,5,2,0,1e-07,0.0175159153190882,175159.153190882,17.4183068546296
"359",372,521,521,521,"Q8WUU5","GATAD1","GATD1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin assembly [GO:0031497]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21965549}.","GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein)","GO:0000981; GO:0005634; GO:0005654; GO:0008270; GO:0031497; GO:0043565",3.3912938354281e-05,0.00014372858414311,1e-07,0.0358637363565261,0.043805847712022,0.0534215688092395,0.0443044704517634,0.0222114824000475,9.05569599247441,0.0005807560154899,0.00952924673172716,-3.50544773123667,28690,2.02094142813228,3,1,0,3.3912938354281e-05,0.043805847712022,1291.71489814277,10.3350719642728
"360",373,523,523,523,"Q92841","DDX17","DDX17_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12138182, ECO:0000269|PubMed:12595555, ECO:0000269|PubMed:17226766, ECO:0000269|PubMed:17699760, ECO:0000269|PubMed:19995069, ECO:0000269|PubMed:22002106, ECO:0000269|PubMed:24581491, ECO:0000269|PubMed:25126784}. Nucleus, nucleolus {ECO:0000269|PubMed:17226766, ECO:0000269|PubMed:22002106}. Cytoplasm, cytosol {ECO:0000269|PubMed:25126784}. Note=In the course of bunyavirus infection, relocalizes from the nucleus to the cytosol where it binds viral RNA to antagonize replication. {ECO:0000269|PubMed:25126784}.","Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)","GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010501; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:2001014",7.50446087319722e-06,1.17981697286485e-05,2.90557304373414e-06,0.0194924694681757,0.0142567768489755,0.0212619587166789,0.0183296656100615,0.00917223553957928,9.04238472667944,0.00058429082643821,0.00956315387057582,-3.51286353768637,80272,2.01939885639523,21,0,0,7.50446087319722e-06,0.0194924694681757,2597.45100914506,11.3428808231929
"361",374,525,525,525,"Q9UKE5","TNIK","TNIK_HUMAN","apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of JNKK activity [GO:0007256]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microvillus assembly [GO:0030033]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic cell cycle [GO:0007346]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Recycling endosome. Cytoplasm, cytoskeleton. Note=Associated with recycling endosomes and the cytoskeletal fraction upon RAP2A overexpression.","TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1)","GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0007256; GO:0007346; GO:0008349; GO:0016055; GO:0016324; GO:0030033; GO:0031532; GO:0035556; GO:0042981; GO:0046777; GO:0048814; GO:0055037; GO:0070062; GO:0072659",0.0153185816822587,0.0274465320308724,0.0360778574278475,0.164107010709987,0.122136485398351,0.149848558668012,0.119083027878457,0.0858225043195546,9.00988557330851,0.00059303206679706,0.00966924665101505,-3.53101041307278,154943,2.01460736128951,14,0,0,0.0274465320308724,0.149848558668012,5.45965364583982,2.44880943113073
"362",375,528,528,528,"Q96N64","PWWP2A","PWP2A_HUMAN","nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28645917}.","PWWP domain-containing protein 2A","GO:0003682; GO:0005634; GO:0042393",0.00024523616371493,0.00027751016347289,0.00616740105794012,0.0331570877465586,0.0247729655116557,0.0297256347220138,0.0269885135317,0.015724305894226,8.94600788585316,0.00061068369272552,0.0098936399181497,-3.56685060277263,81960,2.0046438999559,4,0,0,0.00027751016347289,0.0297256347220138,107.115481285491,6.7430231960974
"363",376,529,529,529,"Q5VWQ0","RSBN1","RSBN1_HUMAN","nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1)","GO:0005634; GO:0006325; GO:0046872; GO:0051213",0.0227797500778044,0.0124526123110922,0.0421725287180707,0.102051068452256,0.103713978419928,0.112783274637284,0.0803811434675003,0.0659922021027392,8.94126041317323,0.00061202104652947,0.0098936399181497,-3.56952346129218,90072,2.0046438999559,10,0,0,0.0227797500778044,0.103713978419928,4.55290238328744,2.18678652751946
"364",377,530,530,530,"Q9UKB1","FBXW11","FBW1B_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stress-activated MAPK cascade [GO:0051403]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.","F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS)","GO:0000086; GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005813; GO:0005829; GO:0006470; GO:0016055; GO:0016567; GO:0019005; GO:0031146; GO:0031648; GO:0038061; GO:0042753; GO:0043161; GO:0043687; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051403; GO:0061630; GO:0070498; GO:1901223",8.69464755300921e-05,6.62954535884169e-05,7.1391021350949e-05,0.140617473859892,0.168080138912779,0.111762143097377,0.140078374306526,0.0701140648034195,8.93930295806726,0.00061257349960506,0.0098936399181497,-3.57062589247191,62091,2.0046438999559,6,0,0,7.1391021350949e-05,0.140617473859892,1969.68009700596,10.943745619958
"365",378,531,531,531,"Q86Y79","PTRH1","PTH_HUMAN","aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723]",NA,"Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29)","GO:0003723; GO:0004045",0.00012183710639809,0.00010300317883813,0.0102041985337707,0.0976275736276052,0.0684773757655607,0.0927781758869472,0.0828180288203687,0.0448853606831867,8.92821260684013,0.00061571506388684,0.00992565150069938,-3.57687603069002,22937,2.00324097737366,4,0,0,0.00012183710639809,0.0927781758869472,761.493592795976,9.57268808770809
"366",379,532,532,532,"Q96BY9","SARAF","SARAF_HUMAN","endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22464749}; Single-pass type I membrane protein {ECO:0000269|PubMed:22464749}. Note=Translocates to the endoplasmic reticulum-plasma membrane (ER-PM) region in a STIM1-dependent manner following cytosolic Ca(2+) elevation.; SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane; Single-pass type I membrane protein.","Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)","GO:0005783; GO:0006816; GO:0030176; GO:2001256",1e-07,1e-07,1e-07,0.402066389551183,0.466263782876174,0.595220556989952,0.487850143139103,0.243925171569552,8.91290739096886,0.00062008296986098,0.00996018259933446,-3.58551297394209,36975,2.0017326996128,3,3,0,1e-07,0.466263782876174,4662637.82876174,22.1527149417552
"367",380,533,533,533,"P55011","SLC12A2","S12A2_HUMAN","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transport [GO:0015696]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; ion transport [GO:0006811]; positive regulation of cell volume [GO:0045795]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]","SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.","Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1)","GO:0005886; GO:0005887; GO:0006811; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0015696; GO:0016020; GO:0016324; GO:0019901; GO:0030321; GO:0045795; GO:0070062; GO:0070634; GO:1903561",0.0248802046891445,0.0249110144722776,0.012541156581914,0.0931624337235103,0.106517610620521,0.12530860180698,0.0875520901358918,0.0645535036490579,8.91255400823819,0.00062018426699127,0.00996018259933446,-3.58571254980253,131447,2.0017326996128,14,0,0,0.0248802046891445,0.106517610620521,4.28121922433362,2.09802171214339
"368",381,534,534,534,"Q08174","PCDH1","PCDH1_HUMAN","cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell junction. Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Note=Found at cell-cell boundaries and probably at cell-matrix boundaries.","Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42)","GO:0005509; GO:0005634; GO:0005730; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007267; GO:0007399; GO:0030054; GO:0043231",0.00308805132222807,0.00761595897540349,0.00155143598527707,0.077623501766821,0.0999232965598023,0.0700157566111505,0.0784357028849551,0.0433030002034471,8.88791291844193,0.00062729776279431,0.0100395408406095,-3.59964634615631,114743,1.99828614923777,9,0,0,0.00308805132222807,0.077623501766821,25.1367265848466,4.65172488278062
"369",382,537,537,537,"O94805","ACTL6B","ACL6B_HUMAN","nBAF complex [GO:0071565]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000303|PubMed:26601204}.","Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B)","GO:0003713; GO:0005200; GO:0005634; GO:0005730; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0016514; GO:0021510; GO:0071565",1e-07,1e-07,0.00215533757502288,0.0370930913468381,0.0269479732044077,0.0397502761652559,0.0338786010471596,0.0176578130485874,8.86254154770043,0.0006347265221398,0.0101178007998449,-3.6140293339527,46877,1.99491387527137,5,2,0,1e-07,0.0370930913468381,370930.913468381,18.5007909818276
"370",383,538,538,538,"Q8N6N2","TTC9B","TTC9B_HUMAN",NA,NA,"Tetratricopeptide repeat protein 9B (TPR repeat protein 9B)",NA,0.00627607402266998,0.0089632447400748,0.00988989634817424,0.0970020886856584,0.0879736516518293,0.0671072795508259,0.0756512682591315,0.0462020391665388,8.80135675845706,0.00065308835188486,0.0103911455244134,-3.64886720543583,25932,1.9833365729906,3,0,0,0.0089632447400748,0.0879736516518293,9.81493356512935,3.29497850247669
"371",384,540,540,540,"O95782","AP2A1","AP2A1_HUMAN","AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=AP-2 appears to be excluded from internalizing CCVs and to disengage from sites of endocytosis seconds before internalization of the nascent CCV. {ECO:0000250}.","AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)","GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0008022; GO:0010976; GO:0016020; GO:0016323; GO:0016324; GO:0019886; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0044877; GO:0045334; GO:0048013; GO:0048260; GO:0050690; GO:0050750; GO:0060071; GO:0061024; GO:0072583; GO:1900126",1e-07,1e-07,1e-07,0.00253336887521881,0.00382935042480425,0.0034760445752203,0.00327948795841445,0.00163984397920723,8.77295614797143,0.00066183178033725,0.0104912593327535,-3.66511187572398,107546,1.97917237754151,20,3,0,1e-07,0.0034760445752203,34760.445752203,15.0851589622878
"372",386,542,542,542,"Q9BYV9","BACH2","BACH2_HUMAN","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0001206]; import into nucleus [GO:0051170]; protein ubiquitination [GO:0016567]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17018862}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978, ECO:0000269|PubMed:17018862}. Note=Nucleocytoplasmic shuttling is controlled by phosphorylation. {ECO:0000269|PubMed:17018862}.","Transcription regulator protein BACH2 (BTB and CNC homolog 2)","GO:0000980; GO:0000981; GO:0001206; GO:0003700; GO:0005634; GO:0005829; GO:0006366; GO:0016567; GO:0031463; GO:0051170",0.0075793632058428,0.00011185778111509,6.48942922698347e-05,0.159705330984688,0.118137216287793,0.112398176539859,0.127494869511038,0.0663328065152614,8.75358947416933,0.00066787608547784,0.0105480060732294,-3.67621627261929,92537,1.97682962882464,12,0,0,0.00011185778111509,0.118137216287793,1056.13766972762,10.0445821898961
"373",387,544,544,544,"Q9C0D0","PHACTR1","PHAR1_HUMAN","cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Nucleus {ECO:0000250}. Note=Enriched at synapses (By similarity). Cytoplasmic in resting cells, and is imported into the nucleus upon serum stimulation. Interaction with actin prevents nuclear import (By similarity). {ECO:0000250}.","Phosphatase and actin regulator 1","GO:0003779; GO:0004864; GO:0005634; GO:0005829; GO:0008157; GO:0030054; GO:0031032; GO:0031532; GO:0043149; GO:0045202; GO:0048870",0.0025913699411814,3.83329714692081e-05,1.75864881178154e-05,0.0242779561940471,0.0174710951301691,0.0185107246505088,0.0192041621913189,0.0104845108959156,8.72746199665251,0.00067613764517317,0.0106390135392161,-3.69123199316286,66308,1.97309863842593,5,0,0,3.83329714692081e-05,0.0185107246505088,482.893027621874,8.91555982270346
"374",388,545,545,545,"P61006","RAB8A","RAB8A_HUMAN","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; post-translational protein modification [GO:0043687]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:12221131}; Lipid-anchor {ECO:0000305|PubMed:12221131}; Cytoplasmic side {ECO:0000305|PubMed:12221131}. Golgi apparatus {ECO:0000269|PubMed:15837803}. Recycling endosome membrane {ECO:0000269|PubMed:19864458}. Cell projection, cilium {ECO:0000269|PubMed:21844891}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle, phagosome membrane {ECO:0000250|UniProtKB:Q92930}; Lipid-anchor {ECO:0000250|UniProtKB:Q92930}; Cytoplasmic side {ECO:0000250|UniProtKB:Q92930}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000250|UniProtKB:P55258}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:P55258}. Midbody {ECO:0000269|PubMed:22159412}. Note=Colocalizes with OPTN at the Golgi complex and in vesicular structures close to the plasma membrane (PubMed:15837803). In the GDP-bound form, present in the perinuclear region (PubMed:12221131). Shows a polarized distribution to distal regions of cell protrusions in the GTP-bound form (PubMed:12221131). Colocalizes with PARD3, PRKCI, EXOC5, OCLN, PODXL and RAB11A in apical membrane initiation sites (AMIS) during the generation of apical surface and lumenogenesis (PubMed:20890297). Localizes to tubular recycling endosome (PubMed:19864458). Recruited to phagosomes containing S.aureus or M.tuberculosis (PubMed:21255211). {ECO:0000269|PubMed:12221131, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:19864458, ECO:0000269|PubMed:20890297, ECO:0000269|PubMed:21255211}.","Ras-related protein Rab-8A (Oncogene c-mel)","GO:0000139; GO:0003924; GO:0005525; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017137; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030496; GO:0030667; GO:0030670; GO:0031489; GO:0032588; GO:0032869; GO:0036064; GO:0043025; GO:0043197; GO:0043687; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060271; GO:0070062; GO:0072659; GO:0097546; GO:0097730; GO:0098969",1e-07,1e-07,1e-07,0.0671619271565547,0.0441209391324358,0.0567309553240505,0.056004507204347,0.0280023536021735,8.72360714034453,0.0006773671003356,0.0106390135392161,-3.69345081534938,23668,1.97309863842593,4,3,0,1e-07,0.0567309553240505,567309.553240505,19.1137766329929
"375",389,546,546,546,"Q96C86","DCPS","DCPS_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Predominantly localized in the nucleus. Nucleocytoplasmic shuttling protein that can transiently enter the cytoplasm in mammalian cells in a XPO1/CRM1-dependent manner.","m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS)","GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0036245; GO:0043069; GO:0043928; GO:0045292; GO:0050072",1e-07,1e-07,1e-07,0.00095213952383643,0.00140034714470505,0.00137381566020469,0.00124200077624872,0.00062110038812436,8.70554734075367,0.00068316352631377,0.0107104025370804,-3.70385755242604,38609,1.97019420644662,4,3,0,1e-07,0.00137381566020469,13738.1566020469,13.7459008146005
"376",390,547,547,547,"Q9P291","ARMCX1","ARMX1_HUMAN","integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q9CX83}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q9CX83}; Single-pass membrane protein {ECO:0000255}.","Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1) (Protein ALEX1)","GO:0005741; GO:0016021",1e-07,3.00141505403925e-05,0.00188172394572541,0.21420814046284,0.205684026596452,0.143282838180066,0.187087722381031,0.0941811405559373,8.67958673231429,0.00069160229825241,0.0108228805722864,-3.71885083775925,49180,1.96565713385502,6,1,0,3.00141505403925e-05,0.205684026596452,6852.90181108561,12.7424993007617
"377",391,549,549,549,"Q9UHG3","PCYOX1","PCYOX_HUMAN","extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]; prenylcysteine metabolic process [GO:0030329]","SUBCELLULAR LOCATION: Lysosome.","Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase)","GO:0001735; GO:0005764; GO:0005774; GO:0005886; GO:0008555; GO:0030327; GO:0030328; GO:0030329; GO:0034361; GO:0070062",1.3315208450831e-05,8.40083426637238e-06,0.00028308480035278,0.0132981848721349,0.0189788953844671,0.0137186759735251,0.0152303184623524,0.00771675951219951,8.63556900485754,0.00070620365167671,0.0109904942916482,-3.74436445843697,56640,1.95898277497342,22,0,0,1.3315208450831e-05,0.0137186759735251,1030.30125470315,10.0088505202453
"378",392,550,550,550,"Q5VUA4","ZNF318","ZN318_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9853615}.","Zinc finger protein 318 (Endocrine regulatory protein)","GO:0003676; GO:0005654; GO:0005829; GO:0006351; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0051321",1e-07,4.97145777675471e-06,1e-07,0.134711420666332,0.113404384894993,0.0881179889285457,0.112076207677365,0.0560398276579413,8.63545299644298,0.000706242628133,0.0109904942916482,-3.74443185239261,251112,1.95898277497342,16,2,0,1e-07,0.113404384894993,1134043.84894993,20.1130449939426
"379",393,551,551,551,"O00451","GFRA2","GFRA2_HUMAN","anchored component of membrane [GO:0031225]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}.","GDNF family receptor alpha-2 (GDNF receptor alpha-2) (GDNFR-alpha-2) (GFR-alpha-2) (GDNF receptor beta) (GDNFR-beta) (Neurturin receptor alpha) (NRTNR-alpha) (NTNR-alpha) (RET ligand 2) (TGF-beta-related neurotrophic factor receptor 2)","GO:0000165; GO:0005088; GO:0005622; GO:0005886; GO:0007169; GO:0007411; GO:0016167; GO:0019898; GO:0031225; GO:0033141",1e-07,1e-07,1e-07,0.100890697376988,0.139532605869429,0.0972418125182948,0.112554938588237,0.0562775692941186,8.63186662312146,0.0007074488732124,0.0109904942916482,-3.7465157189259,51544,1.95898277497342,7,3,0,1e-07,0.100890697376988,1008906.97376988,19.944361726258
"380",394,552,552,552,"Q9HCM2","PLXNA4","PLXA4_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Plexin-A4","GO:0002116; GO:0005886; GO:0016021; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:1902287",1.78136778146526e-05,1e-07,1e-07,0.00036586839330761,0.00030043190613004,0.00040366158452487,0.00035064940204929,0.00018132926029619,8.62380859534221,0.00071016830946306,0.0110127549438476,-3.75120066008505,212455,1.95810402460263,20,2,0,1e-07,0.00036586839330761,3658.6839330761,11.8371090739715
"381",395,553,553,553,"Q6IEE7","TMEM132E","T132E_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Transmembrane protein 132E","GO:0016021",0.00519156589455286,0.00257359130156002,0.00595723861151061,0.0844447098911802,0.126542400891779,0.106401804618784,0.10122217319804,0.0551852185348944,8.60933485567169,0.00071508506097968,0.0110689477793601,-3.75962549737529,107094,1.95589366144622,6,0,0,0.00519156589455286,0.106401804618784,20.495127439377,4.35720905561319
"382",396,554,554,554,"Q9C0I3","CCSER1","CCSE1_HUMAN",NA,NA,"Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1)",NA,0.402060563659314,0.40018366600985,0.296862977149747,1.21606864046409,0.988075396669772,1.28506242940393,0.796699753239627,0.76471894555945,8.5904003206522,0.00072158006842954,0.0111493238010052,-3.77066591910386,99510,1.95275147148554,5,0,0,0.40018366600985,1.21606864046409,3.03877630136498,1.60349047519258
"383",397,555,555,555,"P48449","LSS","ERG7_HUMAN","endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; lanosterol synthase activity [GO:0000250]; cholesterol biosynthetic process [GO:0006695]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:15525992}; Peripheral membrane protein {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:15525992}.","Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)","GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0031647; GO:0045540",1e-07,1e-07,1e-07,0.0276100589483375,0.0180584777234077,0.0227875618313029,0.0228185995010161,0.011409399750508,8.58633143545585,0.00072298518494743,0.0111509066363064,-3.7730412468104,83309,1.95268982040618,19,3,0,1e-07,0.0227875618313029,227875.618313029,17.7978870452857
"384",398,556,556,556,"Q684P5","RAP1GAP2","RPGP2_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15632203}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:15632203}.","Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4)","GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0010977; GO:0031965; GO:0043005; GO:0048471; GO:0051056",0.0001313782771069,0.00013230172597983,0.00036920113493788,0.063344162064624,0.0432555752095819,0.0469778147615712,0.0509815569659175,0.0257017388623003,8.5726307187034,0.00072774111104072,0.0112007223096043,-3.7810467998289,80056,1.95075396974407,7,0,0,0.00013230172597983,0.0469778147615712,355.080891149774,8.47200391288989
"385",399,558,558,558,"Q14671","PUM1","PUM1_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:26724866}. Cytoplasm, P-body {ECO:0000305|PubMed:20818387}. Cytoplasmic granule {ECO:0000269|PubMed:25340845}. Note=Recruited to cytoplasmic stress granules upon viral infection. {ECO:0000269|PubMed:25340845}.","Pumilio homolog 1 (HsPUM) (Pumilio-1)","GO:0000932; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0016607; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637",0.00107501666793635,0.00090436597663427,0.00044521645710093,0.0656032212166869,0.0830079359274812,0.0551269425643681,0.0671045002022883,0.0343604498017013,8.56100702382427,0.00073180602196779,0.0112262715914773,-3.7878476418298,126473,1.9497644553238,9,0,0,0.00090436597663427,0.0656032212166869,72.5405675485923,6.18071612771053
"386",400,559,559,559,"P51149","RAB7A","RAB7A_HUMAN","alveolar lamellar body [GO:0097208]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; retromer complex binding [GO:1905394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intracellular transport [GO:1902583]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, phagosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:21255211}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Late endosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lysosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Melanosome membrane {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lipid droplet {ECO:0000250|UniProtKB:P51150}. Endosome membrane {ECO:0000269|PubMed:22431521}. Note=Colocalizes with OSBPL1A at the late endosome (PubMed:16176980). Found in the ruffled border (a late endosomal-like compartment in the plasma membrane) of bone-resorbing osteoclasts. Recruited to phagosomes containing S.aureus or Mycobacterium (PubMed:21255211). Lipid droplet localization is increased upon ADRB2 stimulation (By similarity). {ECO:0000250|UniProtKB:P51150, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:21255211}.","Ras-related protein Rab-7a","GO:0000045; GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0019886; GO:0022615; GO:0030667; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0034045; GO:0042147; GO:0043312; GO:0045022; GO:0045335; GO:0045453; GO:0045732; GO:0048365; GO:0048524; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:0097208; GO:1902583; GO:1903542; GO:1903543; GO:1905366; GO:1905394",1e-07,4.64074349419732e-05,2.29701447799555e-05,0.00730349098953866,0.00702461417424698,0.00485707741933758,0.00637190166780043,0.00320911002714086,8.54370749962906,0.00073790728440622,0.0112996178077233,-3.79798453827718,23490,1.94693624561427,13,1,0,2.29701447799555e-05,0.00702461417424698,305.814971631214,8.25651522750477
"387",401,566,566,566,"P0CK96","SLC35E2B","S352B_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Solute carrier family 35 member E2B","GO:0016021",0.254018421523396,0.278771809029365,0.229409245896164,0.764496552224936,0.603853555144891,0.637867843822255,0.414672824914385,0.461402904606835,8.45154634158511,0.00077147810572298,0.0116675840724183,-3.85229682629317,43777,1.93301906106155,3,0,0,0.254018421523396,0.637867843822255,2.51110860384393,1.32832442559819
"388",402,568,568,568,"O00743","PPP6C","PPP6_HUMAN","cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:29053956}. Cytoplasm {ECO:0000269|PubMed:16769727, ECO:0000269|PubMed:17568194}.","Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]","GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208",1e-07,0.00523573000281798,1e-07,0.0557805135987535,0.0819155244154644,0.0811966514079919,0.071218919806464,0.0373547699041713,8.42633992795663,0.00078098268295277,0.0117697390247812,-3.8672428980706,35144,1.9292331668383,7,2,0,1e-07,0.0811966514079919,811966.514079919,19.6310607055825
"389",403,570,570,570,"P30040","ERP29","ERP29_HUMAN","cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]","SUBCELLULAR LOCATION: Endoplasmic reticulum lumen. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)","GO:0000187; GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0030133; GO:0042470; GO:0042803; GO:0043335; GO:0050709; GO:0051087; GO:1902235",1e-07,1e-07,1e-07,0.0325736917473133,0.0219618718426711,0.0329157136359152,0.0291503257419666,0.0145752628709833,8.41178474190201,0.00078653611375089,0.011811840585452,-3.87589140026103,28993,1.92768242297734,7,3,0,1e-07,0.0325736917473133,325736.917473133,18.3133477116319
"390",404,571,571,571,"Q92520","FAM3C","FAM3C_HUMAN","extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]; cytokine activity [GO:0005125]; multicellular organism development [GO:0007275]; platelet degranulation [GO:0002576]","SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Cytoplasmic vesicle {ECO:0000269|PubMed:16959614}. Note=Cytoplasmic in some cancer cells.","Protein FAM3C (Interleukin-like EMT inducer)","GO:0002576; GO:0005125; GO:0005576; GO:0005794; GO:0007275; GO:0031089; GO:0070062",1e-07,2.81938415374101e-05,0.00093390970439699,0.112346107471052,0.169047247157704,0.128851084364309,0.13642741181571,0.0685344404231665,8.40580908381023,0.00078883003505446,0.0118255430824276,-3.87944589541043,24680,1.92717890536515,5,1,0,2.81938415374101e-05,0.128851084364309,4570.18544966063,12.1580369930258
"391",405,572,572,572,"Q8NB37","GATD1","GALD1_HUMAN","extracellular exosome [GO:0070062]","SUBCELLULAR LOCATION: Secreted {ECO:0000305}.","Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1)","GO:0070062",0.0249494149635747,0.00911521626633463,0.0181930580477262,0.122929611924159,0.1552526167588,0.111269297708967,0.112397945704764,0.0736182026115937,8.37072899221372,0.00080246240494735,0.0120088779481632,-3.9003577589871,23298,1.92049756909051,4,0,0,0.0181930580477262,0.122929611924159,6.75695155820838,2.75637251221862
"392",406,573,573,573,"Q96DE0","NUDT16","NUD16_HUMAN","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; IDP phosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:21337011}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q6TEC1}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q6TEC1}. Cytoplasm {ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011}. Note=Localized predominantly in the cytoplasm (PubMed:21070968). Localized in nucleolus, and in a minor proportion in distinct foci in the nucleoplasm (By similarity). {ECO:0000250|UniProtKB:Q6TEC1, ECO:0000269|PubMed:21070968}.","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase)","GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0008284; GO:0016077; GO:0030145; GO:0030515; GO:0034656; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0090068; GO:0097383; GO:0098519; GO:1901639; GO:1901640; GO:1901641; GO:1990003; GO:2000233; GO:2000781",1e-07,1e-07,1e-07,0.0741251342408562,0.0547768419457624,0.0498814071679424,0.059594361118187,0.0297972805590935,8.3544168310874,0.00080889930092558,0.0120680333103465,-3.91010813811055,21273,1.91836349974997,4,3,0,1e-07,0.0547768419457624,547768.419457624,19.0632065670496
"393",407,574,574,574,"Q10469","MGAT2","MGAT2_HUMAN","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type II membrane protein.","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009311; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0030246",0.102001144431393,0.132607223631445,0.110129531347937,0.263082178803123,0.229824853028931,0.282218330458366,0.143462487626549,0.186643876950199,8.34653938121528,0.00081203035731157,0.0120680333103465,-3.91482280641975,51550,1.91836349974997,4,0,0,0.110129531347937,0.263082178803123,2.38884317024792,1.2563121426463
"394",408,575,575,575,"Q9H857","NT5DC2","NT5D2_HUMAN","5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]",NA,"5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)","GO:0008253; GO:0046872",0.0003023898238355,0.00033268358918251,0.00074489347109395,0.0568272948010899,0.0374461874831222,0.0544783390445358,0.0491239514815453,0.0250219647021433,8.34452437744222,0.00081283363679658,0.0120680333103465,-3.91602942140933,60719,1.91836349974997,10,0,0,0.00033268358918251,0.0544783390445358,163.754212158175,7.35538820654117
"395",410,577,577,577,"Q1L5Z9","LONRF2","LONF2_HUMAN","intracellular [GO:0005622]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]",NA,"LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192)","GO:0000209; GO:0005622; GO:0031624; GO:0032436; GO:0046872; GO:0061630",0.00016125774836465,0.0001048193420994,0.0153737619287478,0.0835180037808985,0.0762312220779201,0.0604983825107179,0.0682025897834416,0.0393145745647914,8.34294384129981,0.00081346439486798,0.0120680333103465,-3.91697605072972,83654,1.91836349974997,8,0,0,0.00016125774836465,0.0762312220779201,472.729049307693,8.88486971113398
"396",411,578,578,578,"P24666","ACP1","PPAC_HUMAN","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; sarcolemma [GO:0042383]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]","SUBCELLULAR LOCATION: Cytoplasm.","Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1)","GO:0003993; GO:0004726; GO:0005737; GO:0005829; GO:0009898; GO:0042383; GO:0070062",0.00312098367556444,0.0104105615443324,0.0062262711219916,0.0369673556407813,0.0377401512903472,0.0485497170291307,0.034499802539457,0.023835840050358,8.33650330987084,0.0008160408573034,0.0120763125114942,-3.92083511230038,18042,1.9180656568065,6,0,0,0.0062262711219916,0.0377401512903472,6.06143718301095,2.59965990112017
"397",412,579,579,579,"Q9BSV6","TSEN34","SEN34_HUMAN","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15109492}. Nucleus, nucleolus {ECO:0000269|PubMed:15109492}. Note=May be transiently localized in the nucleolus.","tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34)","GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0016829",0.00287028846383489,0.00572209051316637,0.00754586944486633,0.226268021375421,0.153335899043062,0.227250378744931,0.196905350247182,0.103832091264214,8.33450063115714,0.00081684403553214,0.0120763125114942,-3.9220356215779,33652,1.9180656568065,4,0,0,0.00572209051316637,0.226268021375421,39.542894481446,5.30534657296488
"398",413,580,580,580,"Q9NSI2","FAM207A","F207A_HUMAN",NA,NA,"Protein FAM207A",NA,2.60251999323581e-05,1e-07,0.00589178636310079,0.10656393797177,0.0937968528488926,0.139973751540037,0.111472210265889,0.0577087423206221,8.31776197176042,0.00082359497540866,0.0121551258439624,-3.93207961576563,25456,1.91524054047712,3,1,0,2.60251999323581e-05,0.10656393797177,4094.64435426969,11.9995224347913
"399",414,581,581,581,"Q9NWU5","MRPL22","RM22_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503}.","39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22) (39S ribosomal protein L25, mitochondrial) (L25mt) (MRP-L25) (Mitochondrial large ribosomal subunit protein uL22m)","GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0070125; GO:0070126",1e-07,1e-07,1e-07,0.0082325910885466,0.00860995505453776,0.012007734073409,0.00961666007216444,0.00480843003608222,8.30982746432167,0.00082681885580134,0.0121817029357307,-3.93684693482155,23641,1.91429199545568,5,3,0,1e-07,0.00860995505453776,86099.5505453776,16.3937180860723
"400",415,583,583,583,"Q9UKR5","ERG28","ERG28_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; protein binding, bridging [GO:0030674]; ergosterol biosynthetic process [GO:0006696]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Probable ergosterol biosynthetic protein 28","GO:0005789; GO:0006696; GO:0016021; GO:0030133; GO:0030674",1e-07,1e-07,1e-07,0.0245369607440576,0.0362629713929818,0.0374113793823736,0.0327370038398044,0.0163686019199022,8.25763800817883,0.00084841217136825,0.0124569608694892,-3.96830457391213,15864,1.90458789977983,3,3,0,1e-07,0.0362629713929818,362629.713929818,18.4681376189972
"401",416,584,584,584,"Q9UGL1","KDM5B","KDM5B_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]; uterus morphogenesis [GO:0061038]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:10336460, ECO:0000269|PubMed:12237901}.","Lysine-specific demethylase 5B (EC 1.14.11.-) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1)","GO:0000981; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864",4.86375926875197e-05,1.68295428394588e-05,0.00011440229959022,0.191604562265367,0.147906176135446,0.125188748535025,0.15483987250024,0.0774798927284925,8.24383415539942,0.00085423816929715,0.0125210252212049,-3.97665426990004,175658,1.90236010964931,20,0,0,4.86375926875197e-05,0.147906176135446,3040.98471907715,11.5703228515185
"402",417,585,585,585,"Q92529","SHC3","SHC3_HUMAN","cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor tyrosine kinase binding [GO:0030971]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; synaptic transmission, glutamatergic [GO:0035249]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]",NA,"SHC-transforming protein 3 (Neuronal Shc) (N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3) (SH2 domain protein C3)","GO:0000165; GO:0001784; GO:0005088; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007265; GO:0007411; GO:0007417; GO:0007611; GO:0030971; GO:0035249",0.00374783246514437,0.00185584339350508,0.0179490448035019,0.127835739274307,0.104749818241563,0.0884872124832326,0.099173349778984,0.0574375817768758,8.23592282486534,0.00085759920016641,0.0125488019716658,-3.98144524149771,64056,1.9013977340977,6,0,0,0.00374783246514437,0.104749818241563,27.9494399004647,4.80474746701062
"403",418,586,586,586,"Q9H8M7","MINDY3","MINY3_HUMAN","nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; apoptotic process [GO:0006915]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12054670}.","Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP)","GO:0005654; GO:0006915; GO:0016807; GO:0031965; GO:0036459; GO:1990380",1e-07,1e-07,1e-07,0.0667724389010974,0.0427883341602243,0.0596056076935224,0.056388693584948,0.028194446792474,8.23144737851298,0.00085950768377889,0.0125552658244836,-3.98415729335001,49725,1.9011740878189,7,3,0,1e-07,0.0596056076935224,596056.076935224,19.1850885402092
"404",419,587,587,587,"P18433","PTPRA","PTPRA_HUMAN","extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)","GO:0000165; GO:0004725; GO:0005001; GO:0005088; GO:0005622; GO:0005886; GO:0005887; GO:0007411; GO:0008286; GO:0043235; GO:0070062",3.66553879362555e-05,4.91205513769418e-05,4.36303924881515e-05,0.115715805867786,0.122722367811087,0.0795660331372793,0.105958266828117,0.0530222688579924,8.2221685985588,0.00086348100851754,0.0125918184547022,-3.9897842303589,90719,1.8999115464756,14,0,0,4.36303924881515e-05,0.115715805867786,2652.18347277555,11.3729648663372
"405",420,588,588,588,"P53677","AP3M2","AP3M2_HUMAN","AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]","SUBCELLULAR LOCATION: Golgi apparatus. Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Component of the coat surrounding the cytoplasmic face of coated vesicles located at the Golgi complex. {ECO:0000250}.","AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B)","GO:0005794; GO:0006886; GO:0008089; GO:0030119; GO:0030131; GO:0030659; GO:0048490; GO:1904115",1e-07,1e-07,1e-07,0.0336037765226226,0.0515799233873733,0.0494074845635455,0.0448636281578472,0.0224319140789236,8.21747773391022,0.00086549824073847,0.0125997703073491,-3.99263104232506,46977,1.89963737195863,4,3,0,1e-07,0.0494074845635455,494074.845635455,18.9143700815261
"406",421,589,589,589,"Q13310","PABPC4","PABP4_HUMAN","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.","Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP)","GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904",0.00011053923820697,2.44677624900385e-05,1.89584361833852e-05,0.00198751371320991,0.00307193884999978,0.00263856429929618,0.00251468380854182,0.00130866371656438,8.20906268297282,0.00086913142902146,0.012631180021093,-3.99774159048377,70783,1.89855607519999,6,0,0,2.44677624900385e-05,0.00263856429929618,107.838397580098,6.75272715390322
"407",422,590,590,590,"Q96RE7","NACC1","NACC1_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell proliferation [GO:0008284]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Distribution in the cytoplasm is dependent on phosphorylation. {ECO:0000250}.","Nucleus accumbens-associated protein 1 (NAC-1) (BTB/POZ domain-containing protein 14B)","GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0008284; GO:0016604; GO:0030054; GO:0043231; GO:0045892; GO:0051260",1e-07,1e-07,1e-07,0.0478112034184021,0.0647274084894991,0.0749408104570147,0.0624930407883053,0.0312466203941526,8.19664253232605,0.00087452787606955,0.0126880654561956,-4.00529290604937,57258,1.89660458954797,7,3,0,1e-07,0.0647274084894991,647274.084894991,19.3040172178563
"408",423,592,592,592,"Q9BZM4","ULBP3","ULBP3_HUMAN","anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of immune response [GO:0050776]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9BZM6}; Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q9BZM6}.","UL16-binding protein 3 (ALCAN-gamma) (NKG2D ligand 3) (N2DL-3) (NKG2DL3) (Retinoic acid early transcript 1N)","GO:0005886; GO:0016032; GO:0030101; GO:0042267; GO:0046658; GO:0046703; GO:0050776",7.29910265726392e-05,5.95026342930634e-05,0.00641451308710511,0.0974673760244383,0.0724941014177929,0.0665063000536124,0.0766402569159577,0.0405024640406357,8.18589300249375,0.00087923148400258,0.0126914060539401,-4.01183663160381,27949,1.89649026067595,4,0,0,7.29910265726392e-05,0.0724941014177929,993.191969229919,9.95592878596627
"409",424,593,593,593,"Q9Y5B8","NME7","NDK7_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleobase-containing small molecule interconversion [GO:0015949]; UTP biosynthetic process [GO:0006228]",NA,"Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-H7)","GO:0004550; GO:0005524; GO:0005813; GO:0005829; GO:0006183; GO:0006228; GO:0006241; GO:0015949; GO:0046872",8.70934257420817e-05,0.0001176810891599,0.00058106958332042,0.0379686933958333,0.0265668439493337,0.0411909388289253,0.0349802106919566,0.0177520533787191,8.17612550507834,0.00088353217685749,0.0126914060539401,-4.01778910462443,42492,1.89649026067595,4,0,0,0.0001176810891599,0.0379686933958333,322.64056754474,8.33378403842331
"410",425,594,594,594,"Q9Y4F5","CEP170B","C170B_HUMAN","cytoplasm [GO:0005737]; microtubule [GO:0005874]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q498L0}.","Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B)","GO:0005737; GO:0005874",0.0205625766330038,0.0504965470521625,0.0104845842116169,0.160724282279476,0.142097162839594,0.184485311042468,0.135254349421585,0.0948084106763869,8.17337600759326,0.00088474742440793,0.0126914060539401,-4.01946582091424,171688,1.89649026067595,16,0,0,0.0205625766330038,0.160724282279476,7.81634933928984,2.96649494770527
"411",426,595,595,595,"Q96C03","MIEF2","MID49_HUMAN","integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein targeting to membrane [GO:0090314]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:21508961}; Single-pass membrane protein {ECO:0000269|PubMed:21508961}. Note=Colocalizes with DNM1L at mitochondrial membrane. Forms foci and rings around mitochondria.","Mitochondrial dynamics protein MID49 (Mitochondrial dynamics protein of 49 kDa) (Mitochondrial elongation factor 2) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein)","GO:0005739; GO:0005741; GO:0007005; GO:0016021; GO:0032464; GO:0090141; GO:0090314",0.00020264223039474,2.70781403202466e-05,3.58313938607977e-05,0.128944037833699,0.148665287764949,0.196481002563694,0.157941592132589,0.079059313321153,8.17334851627249,0.00088475958556063,0.0126914060539401,-4.01948258835186,49269,1.89649026067595,3,0,0,3.58313938607977e-05,0.148665287764949,4149.02329344213,12.0185560414713
"412",427,598,598,598,"Q5T5Y3","CAMSAP1","CAMP1_HUMAN","cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19508979}. Note=Associates with the minus-end of microtubules (PubMed:24486153, PubMed:24706919). In contrast to CAMSAP2 and CAMSAP3, does not form stretches of decorated microtubule minus-ends (PubMed:24486153, PubMed:24706919). {ECO:0000269|PubMed:19508979, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919}.","Calmodulin-regulated spectrin-associated protein 1","GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031175; GO:0051011",1.67610038920795e-05,8.84502024696222e-07,0.00019516566402955,0.0447034177394658,0.065114651027244,0.0694617961398063,0.0596890179121899,0.0299154460127437,8.11454854715162,0.00091124382411454,0.0130438915291312,-4.05545959479039,177972,1.88459282137295,30,0,0,1.67610038920795e-05,0.065114651027244,3884.88967883447,11.9236579149403
"413",429,600,600,600,"P46926","GNPDA1","GNPI1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glucosamine-6-phosphate deaminase activity [GO:0004342]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine metabolic process [GO:0006044]; single fertilization [GO:0007338]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin)","GO:0004342; GO:0005737; GO:0005829; GO:0005975; GO:0006043; GO:0006044; GO:0006091; GO:0007338; GO:0070062",0.00011062425107875,0.00010122712785289,0.00010252902960122,0.0131085302377386,0.020473072613807,0.0164932465421713,0.0165868229950613,0.00839820496704163,8.08592224802963,0.00092448717637517,0.0131893503829524,-4.07305758578368,32669,1.87977659429797,6,0,0,0.00010252902960122,0.0164932465421713,160.864163118687,7.32969915194854
"414",430,602,602,602,"Q9NZI8","IGF2BP1","IF2B1_HUMAN","CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; regulation of cytokine biosynthetic process [GO:0042035]; regulation of mRNA stability [GO:0043488]; regulation of mRNA stability involved in response to stress [GO:0010610]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Cell projection, lamellipodium. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Cell projection, growth cone. Cell projection, filopodium {ECO:0000250}. Cell projection, axon {ECO:0000250}. Note=In the nucleus, located in discrete foci, coinciding with the sites of ACTB transcription (By similarity). In the cytoplasm, localizes in cytoplasmic mRNP granules. Colocalizes with microtubules in growth cone filopodia and along neurites in neuronal cells (By similarity). Cytoplasmic colocalization with ACTB mRNA is partially lost at the cell periphery, suggesting release of the transcript. In neuronal processes, exhibits fast retrograde and anterograde movements, when associated with ACTB mRNA; this motility is lost when the association is inhibited (By similarity). In hippocampal neurons, predominantly located within dendrites, particularly at dendritic branching points in young cells, compared to axons (By similarity). In axons, predominantly found in axonal branches and their growth cones (By similarity). In motile cells, such as migrating fibroblasts, localizes to leading edges where it colocalizes with microtubules and microfilaments and to retracting tails (By similarity). Dendritic levels are regulated by neuronal activity and glutaminergic signals: they are increased by KCl-induced depolarization, which induces rapid efflux from the cell body into dendrites, and decreased by the NMDA receptor agonist (By similarity). In motile cells, transported towards the leading edge into the cortical region of the lamellipodia where it is connected to microfilaments (By similarity). In response to cellular stress, such as oxidative stress or heat shock, recruited to stress granules, but not to processing bodies. {ECO:0000250}.","Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IMP1) (Coding region determinant-binding protein) (CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1) (ZBP-1)","GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0010494; GO:0010610; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0042035; GO:0043197; GO:0043488; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150; GO:1990904",5.53208721794722e-05,7.74566537039209e-05,5.15846284786689e-05,0.00069818498348859,0.0006539459299559,0.00092760194513006,0.00069845690140416,0.0004106825021561,8.05539035303307,0.0009388717612311,0.0133500702261433,-4.09188731805397,63481,1.87451644974912,21,0,0,5.53208721794722e-05,0.00069818498348859,12.620643095133,3.65771352077998
"415",431,603,603,603,"Q969T9","WBP2","WBP2_HUMAN","cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription coactivator activity [GO:0001105]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21642474}. Nucleus {ECO:0000269|PubMed:21642474}. Note=Translocates from cytoplasm to nucleus when phosphorylated. {ECO:0000269|PubMed:21642474}.","WW domain-binding protein 2 (WBP-2)","GO:0000790; GO:0000979; GO:0001105; GO:0003713; GO:0005634; GO:0005737; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045184; GO:0045815; GO:0045944; GO:0050847; GO:0071391; GO:0071442",0.00023778161383741,0.00152309798631523,9.59047490936674e-05,0.00523744632825543,0.00491439244392144,0.00635386169825864,0.0048829720403964,0.00306041413661364,8.04072809165163,0.00094587660831145,0.0134160843716802,-4.10095209996206,28087,1.87237421918254,3,0,0,0.00023778161383741,0.00523744632825543,22.02628808734,4.46115448465189
"416",432,604,604,604,"Q9H4L4","SENP3","SENP3_HUMAN","cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protein desumoylation [GO:0016926]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19680224}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19015314, ECO:0000269|PubMed:19680224}. Cytoplasm {ECO:0000250|UniProtKB:Q9EP97}. Note=Redistributes between the nucleolus and the nucleoplasm in response to mild oxidative stress (PubMed:19680224). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (By similarity). {ECO:0000250|UniProtKB:Q9EP97, ECO:0000269|PubMed:19680224}.","Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3)","GO:0004175; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008234; GO:0016926; GO:0071339",0.00587899532767547,0.00121073997257914,0.00066352796166637,0.0684767104112957,0.105831646248046,0.087023519273619,0.0845262042236799,0.0448475231991469,8.03911957788725,0.00094664894398304,0.0134160843716802,-4.10194742636783,65010,1.87237421918254,9,0,0,0.00121073997257914,0.087023519273619,71.8763080797935,6.16744440173516
"417",433,605,605,605,"Q9Y4X5","ARIH1","ARI1_HUMAN","Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11278816, ECO:0000269|PubMed:21590270, ECO:0000269|PubMed:23059369}. Nucleus {ECO:0000269|PubMed:23059369}. Nucleus, Cajal body {ECO:0000269|PubMed:23059369}. Note=Mainly cytoplasmic (PubMed:11278816). Present in Lewy body (PubMed:21590270). {ECO:0000269|PubMed:11278816, ECO:0000269|PubMed:21590270}.","E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1)","GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019787; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413",2.54110525371874e-05,5.57829818807471e-06,4.69378310387196e-05,0.0852785988179429,0.0751738788222962,0.114647952384989,0.0916741676144881,0.0458630595344987,8.03468139694789,0.00094878394990718,0.0134241167127364,-4.10469461633233,64118,1.87211428063061,9,0,0,2.54110525371874e-05,0.0852785988179429,3355.9648382586,11.7125118848452
"418",434,607,607,607,"Q9NYB0","TERF2IP","TE2IP_HUMAN","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q91VL8}. Cytoplasm {ECO:0000250|UniProtKB:Q91VL8}. Chromosome {ECO:0000250|UniProtKB:Q91VL8}. Chromosome, telomere {ECO:0000250|UniProtKB:Q91VL8}. Note=Associates with chromosomes, both at telomeres and in extratelomeric sites. Also exists as a cytoplasmic form, where it associates with the IKK complex. {ECO:0000250|UniProtKB:Q91VL8}.","Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1)","GO:0000228; GO:0000723; GO:0000781; GO:0000783; GO:0000784; GO:0001933; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0007004; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0031848; GO:0032204; GO:0032205; GO:0033138; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224; GO:1901985",3.99495553226072e-05,3.29248487676805e-05,3.0160023258021e-05,0.0252686613868986,0.0281135944126096,0.0382845807154782,0.030521267362546,0.0152949784903891,8.01569958215968,0.00095798176316167,0.0135095945513409,-4.11645917241903,44260,1.86935768478683,15,0,0,3.29248487676805e-05,0.0281135944126096,853.871633882987,9.7378753895032
"419",435,608,608,608,"Q14108","SCARB2","SCRB2_HUMAN","cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; action potential [GO:0001508]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; phagocytosis, engulfment [GO:0006911]; positive regulation of neuron projection development [GO:0010976]; production of molecular mediator involved in inflammatory response [GO:0002532]; protein targeting to lysosome [GO:0006622]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of lysosome organization [GO:1905671]","SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18022370, ECO:0000269|PubMed:7509809}; Multi-pass membrane protein {ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18022370, ECO:0000269|PubMed:7509809}.","Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)","GO:0000139; GO:0001508; GO:0001618; GO:0002532; GO:0004888; GO:0005044; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006631; GO:0006911; GO:0009986; GO:0010008; GO:0010976; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0031664; GO:0031902; GO:0043202; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671",1e-07,1e-07,1.47727419415309e-05,0.0290591194981067,0.0388766377802955,0.0253805273198135,0.0311004372854247,0.0155552095566929,8.01103788851099,0.0009602572375583,0.0135194111077288,-4.11935212481489,54290,1.86904222542352,11,2,0,1e-07,0.0290591194981067,290591.194981067,18.1486314638852
"420",436,609,609,609,"P46821","MAP1B","MAP1B_HUMAN","apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; axon extension [GO:0048675]; cellular process [GO:0009987]; dendrite development [GO:0016358]; establishment of monopolar cell polarity [GO:0061162]; microtubule bundle formation [GO:0001578]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:18195017}. Cytoplasm {ECO:0000269|PubMed:18195017}. Cell junction, synapse {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Note=Colocalizes with DAPK1 in the microtubules and cortical actin fibers. {ECO:0000250}.","Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1]","GO:0001578; GO:0001750; GO:0001764; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0008017; GO:0009987; GO:0014069; GO:0016358; GO:0030054; GO:0030424; GO:0030425; GO:0032387; GO:0036477; GO:0043025; GO:0043197; GO:0045773; GO:0047497; GO:0048675; GO:0061162; GO:0097440; GO:0097441; GO:0097457",1e-07,1e-07,1e-07,0.0014136531788139,0.00212518932254609,0.00217316519251122,0.00190390256462374,0.00095205128231187,7.9895467880753,0.00097083313787002,0.0136308033739181,-4.1327081240972,270634,1.86547854691092,90,3,0,1e-07,0.00212518932254609,21251.8932254609,14.3753037490501
"421",437,610,610,610,"P37235","HPCAL1","HPCL1_HUMAN","membrane [GO:0016020]; calcium ion binding [GO:0005509]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.","Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3)","GO:0005509; GO:0016020",5.48348943939647e-05,0.00163961814126098,5.99965747261366e-05,0.0330104414375966,0.0512089473494434,0.0482069416063998,0.0435572935943529,0.0223634633339702,7.98844593428937,0.00097137868875148,0.0136308033739181,-4.13339311274086,22313,1.86547854691092,6,0,0,5.99965747261366e-05,0.0482069416063998,803.494896607809,9.65014505043678
"422",439,614,614,614,"Q92805","GOLGA1","GOGA1_HUMAN","acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:10209123, ECO:0000269|PubMed:10209125, ECO:0000269|PubMed:9324025}; Peripheral membrane protein {ECO:0000305}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:29084197}. Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250|UniProtKB:Q9CW79}.","Golgin subfamily A member 1 (Golgin-97)","GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471",0.014429516860441,0.0283474054899514,0.0859065743397234,0.208253698930973,0.212664274325903,0.225840546244124,0.172691674270295,0.129240336031853,7.96139608248032,0.00098490200377176,0.0137308813555152,-4.15025040409624,88184,1.862301585447,5,0,0,0.0283474054899514,0.212664274325903,7.50207190570891,2.90728909098026
"423",440,615,615,615,"Q15858","SCN9A","SCN9A_HUMAN","cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; behavioral response to pain [GO:0048266]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15385606, ECO:0000269|PubMed:17167479, ECO:0000269|PubMed:19369487, ECO:0000269|PubMed:24311784, ECO:0000269|PubMed:25240195, ECO:0000269|PubMed:26680203, ECO:0000269|PubMed:7720699}; Multi-pass membrane protein {ECO:0000250|UniProtKB:D0E0C2}. Cell projection {ECO:0000250|UniProtKB:O08562}. Note=In neurite terminals. {ECO:0000250|UniProtKB:O08562}.","Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)","GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006954; GO:0009636; GO:0009791; GO:0019228; GO:0019233; GO:0031402; GO:0034765; GO:0035725; GO:0042995; GO:0048266; GO:0086010",0.00022729988732831,0.00012385231192915,0.0153711754679634,0.0809636026111301,0.0595303529553277,0.0644274742726521,0.0630663673906297,0.0367739595843885,7.95294769687342,0.00098917266469803,0.0137602303243654,-4.15552562994776,226372,1.86137429664093,9,0,0,0.00022729988732831,0.0644274742726521,283.447013678426,8.14693525916483
"424",441,616,616,616,"Q7Z4K8","TRIM46","TRI46_HUMAN","axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]; zinc ion binding [GO:0008270]; anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of cellular protein localization [GO:1903827]","SUBCELLULAR LOCATION: Cell projection, axon {ECO:0000250|UniProtKB:Q7TNM2}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q7TNM2}. Note=Microtubule-associated. Localizes to the proximal part of the axon. {ECO:0000250|UniProtKB:Q7TNM2}.","Tripartite motif-containing protein 46 (Gene Y protein) (GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)","GO:0001578; GO:0001764; GO:0005856; GO:0007409; GO:0008270; GO:0030517; GO:0043194; GO:0044304; GO:0048490; GO:0099612; GO:1901953; GO:1903827; GO:1904115; GO:1990769",2.92357192225913e-05,2.55360427156958e-05,7.95748412680683e-05,0.0404996719631887,0.0366268925575518,0.0555290045309803,0.0441737408161715,0.0221316526091545,7.95087830678,0.00099022218222068,0.0137602303243654,-4.15681851586587,83424,1.86137429664093,20,0,0,2.92357192225913e-05,0.0404996719631887,1385.28050754754,10.4359624240212
"425",442,617,617,617,"Q9Y580","RBM7","RBM7_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21855801}. Note=Excluded from the nucleolus. {ECO:0000269|PubMed:21855801}.","RNA-binding protein 7 (RNA-binding motif protein 7)","GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0051321",0.00011612259534837,8.95448483487561e-05,0.0213000867933512,0.059432153615046,0.0665540066664114,0.0664180240268108,0.0569661433570732,0.0356516564242194,7.93738307500501,0.00099709985784259,0.0138333464880593,-4.16525709315873,30504,1.85907274501801,4,0,0,0.00011612259534837,0.0664180240268108,571.964688074319,9.15978227049757
"426",444,620,620,620,"Q9H3R0","KDM4C","KDM4C_HUMAN","nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537}.","Lysine-specific demethylase 4C (EC 1.14.11.-) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C)","GO:0000790; GO:0001825; GO:0003682; GO:0005654; GO:0005721; GO:0006351; GO:0006357; GO:0008270; GO:0008284; GO:0010628; GO:0019899; GO:0032452; GO:0032454; GO:0033169; GO:0045666; GO:0050681; GO:0051864; GO:0070544; GO:1900113; GO:2000036; GO:2000736",0.0479469618163423,4.68965016367735e-05,4.51998120923601e-05,0.166040571087712,0.168563724598198,0.138930152484555,0.141831796680131,0.0869289177167561,7.92411242027683,0.00100391995738461,0.0138605723148585,-4.17356745243924,119982,1.85821883696423,5,0,0,4.68965016367735e-05,0.166040571087712,3540.57478260836,11.7897678734182
"427",445,621,621,621,"Q96T58","SPEN","MINT_HUMAN","extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA polymerase II transcription factor binding [GO:0001085]; transcriptional repressor activity, RNA polymerase II transcription factor binding [GO:0001191]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11331609}. Note=Associates with chromatin.","Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog)","GO:0000122; GO:0000398; GO:0001085; GO:0001191; GO:0003676; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0007219; GO:0016032; GO:0017053; GO:0045892; GO:0050769; GO:0070062",7.12267946596494e-05,9.4862880164765e-05,0.00010076708411429,0.061240286575193,0.0915134731435147,0.0955900219989967,0.0826923083195886,0.0414351064127738,7.91927130804577,0.00100642206730945,0.0138727421838468,-4.17660207781225,402248,1.85783768473761,33,0,0,9.4862880164765e-05,0.0915134731435147,964.692121771626,9.9139247743688
"428",446,622,622,622,"Q8NF37","LPCAT1","PCAT1_HUMAN","azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; neutrophil degranulation [GO:0043312]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:21498505}; Single-pass type II membrane protein {ECO:0000269|PubMed:21498505}. Golgi apparatus membrane {ECO:0000269|PubMed:21498505}; Single-pass type II membrane protein {ECO:0000269|PubMed:21498505}. Lipid droplet {ECO:0000269|PubMed:21498505}. Note=May adopt a monotopic topology when embedded in the lipid monolayer of the lipid droplet, with both termini exposed to the cytoplasm. {ECO:0000269|PubMed:21498505}.","Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3)","GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0006656; GO:0008654; GO:0016020; GO:0016021; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0043312; GO:0045732; GO:0047144; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0060041; GO:2001246",0.00023340985232279,0.00016981678065912,0.00023106145056382,0.0228314052251135,0.0358528584891041,0.0334169567676219,0.0304889774660979,0.0154559180942309,7.91484619998216,0.00100871582069161,0.013882005506624,-4.1793773478518,59151,1.8575477876605,11,0,0,0.00023106145056382,0.0334169567676219,144.623677753603,7.17615995908474
"429",447,623,623,623,"Q96FE5","LINGO1","LIGO1_HUMAN","extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; axonogenesis [GO:0007409]; negative regulation of axonogenesis [GO:0050771]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9D1T0}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q9D1T0}.","Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A)","GO:0005154; GO:0005615; GO:0005886; GO:0007165; GO:0007409; GO:0016021; GO:0050771",1e-07,1e-07,1e-07,0.0438105340724855,0.0314428662843747,0.0501132711626849,0.041788790506515,0.0208944952532575,7.90711512025694,0.00101273853719117,0.0139149949893362,-4.18422925154915,69876,1.85651694571542,10,3,0,1e-07,0.0438105340724855,438105.340724855,18.7409182763844
"430",448,624,624,624,"Q92759","GTF2H4","TF2H4_HUMAN","core TFIIH complex portion of holo TFIIH complex [GO:0000438]; holo TFIIH complex [GO:0005675]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; 7-methylguanosine mRNA capping [GO:0006370]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Nucleus.","General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)","GO:0000438; GO:0003690; GO:0003700; GO:0004003; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006296; GO:0006361; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0016607; GO:0033683; GO:0070816; GO:0070911",0.00017002160523441,0.0001555825329702,0.00020497082685749,0.0104694813787157,0.0165807500449061,0.0138696034360773,0.0134630866315457,0.00690840163746021,7.90036149933003,0.00101626866644444,0.013941121449943,-4.18847110065624,52186,1.85570228937056,6,0,0,0.00017002160523441,0.0138696034360773,81.5755351618706,6.3500646417812
"431",449,625,625,625,"Q9UBI9","HECA","HDC_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323]",NA,"Headcase protein homolog (hHDC)","GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930",7.20395133730241e-05,0.00027796172257744,2.64078092979973e-05,0.0386087871810214,0.0428582405134894,0.0587468377418997,0.0466124854637207,0.0234317124136098,7.89123373086778,0.00102106363604854,0.0139844875593207,-4.19420913790021,58837,1.85435344307413,5,0,0,7.20395133730241e-05,0.0428582405134894,594.926846487251,9.21656847214757
"432",450,626,626,626,"P36873","PPP1CC","PP1G_HUMAN","cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11739654}. Nucleus. Nucleus, nucleolus {ECO:0000269|PubMed:11739654, ECO:0000269|PubMed:20926688}. Nucleus, nucleoplasm {ECO:0000269|PubMed:11739654}. Nucleus speckle {ECO:0000269|PubMed:11739654}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:12529430}. Cleavage furrow {ECO:0000269|PubMed:12529430}. Midbody {ECO:0000269|PubMed:12529430}. Mitochondrion {ECO:0000269|PubMed:17936702}. Note=Colocalizes with SPZ1 in the nucleus (By similarity). Colocalizes with URI1 at mitochondrion (PubMed:17936702). Rapidly exchanges between the nucleolar, nucleoplasmic and cytoplasmic compartments (PubMed:11739654). Highly mobile in cells and can be relocalized through interaction with targeting subunits (PubMed:17965019). In the presence of PPP1R8 relocalizes from the nucleolus to nuclear speckles (PubMed:11739654). Shows a dynamic targeting to specific sites throughout the cell cycle (PubMed:12529430). Highly concentrated in nucleoli of interphase cells and localizes at kinetochores early in mitosis (PubMed:12529430). Relocalization to chromosome-containing regions occurs at the transition from early to late anaphase (PubMed:12529430). Also accumulates at the cleavage furrow and midbody by telophase (PubMed:12529430). {ECO:0000250|UniProtKB:P63087, ECO:0000269|PubMed:11739654, ECO:0000269|PubMed:12529430, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:17965019}.","Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)","GO:0000164; GO:0000777; GO:0003723; GO:0004721; GO:0004722; GO:0005521; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005925; GO:0005977; GO:0006470; GO:0007049; GO:0008022; GO:0008157; GO:0016607; GO:0016791; GO:0019901; GO:0019904; GO:0030182; GO:0030496; GO:0032154; GO:0032922; GO:0032991; GO:0042752; GO:0043153; GO:0043197; GO:0044877; GO:0046822; GO:0046872; GO:0047485; GO:0051301; GO:0060252; GO:0072357",1e-07,1e-07,1e-07,0.0560178801942903,0.0554873845802809,0.0363135110251767,0.0492728252665826,0.0246365126332913,7.88788588567177,0.0010228292250768,0.0139856451711594,-4.19631516009759,36984,1.8543174944114,3,3,0,1e-07,0.0554873845802809,554873.845802809,19.0818002770297
"433",451,627,627,627,"Q9UHV9","PFDN2","PFD2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17936702}. Cytoplasm {ECO:0000269|PubMed:17936702}. Mitochondrion {ECO:0000269|PubMed:17936702}.","Prefoldin subunit 2","GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495",1e-07,1e-07,1e-07,0.0249833408769902,0.0157020423280364,0.0224360392451507,0.0210403741500591,0.0105202870750295,7.88488342379406,0.00102441583204637,0.0139856451711594,-4.19820457469586,16648,1.8543174944114,4,3,0,1e-07,0.0224360392451507,224360.392451507,17.7754584861355
"434",452,628,628,628,"Q9ULJ6","ZMIZ1","ZMIZ1_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]","SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:14609956}. Cytoplasm {ECO:0000269|PubMed:14609956}.","Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)","GO:0001570; GO:0001701; GO:0003007; GO:0005654; GO:0005737; GO:0006351; GO:0007296; GO:0007569; GO:0008270; GO:0016607; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0048146; GO:0048589; GO:0048844",0.0140619241085673,0.0374207020784961,0.0281242265826822,0.166538550368964,0.153959828711851,0.215802600235149,0.152231375515406,0.102651305347618,7.87625298554127,0.00102899319563371,0.0140257671251983,-4.20363909912907,115483,1.85307337612317,5,0,0,0.0281242265826822,0.166538550368964,5.92153351770789,2.56597084340351
"435",453,629,629,629,"O14682","ENC1","ENC1_HUMAN","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuronal cell body [GO:0043025]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:19424503}. Cytoplasm {ECO:0000269|PubMed:19424503}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19424503}.","Ectoderm-neural cortex protein 1 (ENC-1) (Kelch-like protein 37) (Nuclear matrix protein NRP/B) (p53-induced gene 10 protein)","GO:0000790; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005856; GO:0007275; GO:0007399; GO:0010499; GO:0010976; GO:0016363; GO:0016567; GO:0017148; GO:0031463; GO:0043025",1e-07,1e-07,1e-07,0.0534860767273173,0.0338155205711032,0.0499771362160094,0.0457594778381433,0.0228798389190716,7.83843521727487,0.00104934717641426,0.0142804639588332,-4.22751392664749,66130,1.84525768251167,7,3,0,1e-07,0.0499771362160094,499771.362160094,18.9309087090881
"436",455,632,632,632,"P10645","CHGA","CMGA_HUMAN","chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mast cell granule [GO:0042629]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; antimicrobial humoral response [GO:0019730]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell cytokine production [GO:0032762]; mast cell degranulation [GO:0043303]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cAMP metabolic process [GO:0030816]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle lumen {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000250}. Secreted. Note=Associated with the secretory granule membrane through direct interaction to SCG3 that in turn binds to cholesterol-enriched lipid rafts in intragranular conditions. {ECO:0000250}.; SUBCELLULAR LOCATION: Serpinin: Secreted {ECO:0000250|UniProtKB:P26339}. Cytoplasmic vesicle, secretory vesicle {ECO:0000250|UniProtKB:P26339}. Note=Pyroglutaminated serpinin localizes to secretory vesicle. {ECO:0000250|UniProtKB:P26339}.","Chromogranin-A (CgA) (Pituitary secretory protein I) (SP-I) [Cleaved into: Vasostatin-1 (Vasostatin I); Vasostatin-2 (Vasostatin II); EA-92; ES-43; Pancreastatin; SS-18; WA-8; WE-14; LF-19; Catestatin (SL21); AL-11; GV-19; GR-44; ER-37; GE-25; Serpinin-RRG; Serpinin; p-Glu serpinin precursor]","GO:0002026; GO:0002551; GO:0005576; GO:0005615; GO:0006996; GO:0008217; GO:0019730; GO:0030141; GO:0030658; GO:0030816; GO:0031640; GO:0032762; GO:0033604; GO:0042583; GO:0042629; GO:0043303; GO:0045087; GO:0045576; GO:0048471; GO:0050829; GO:0050830; GO:0050832; GO:0060452; GO:0086030; GO:0097756; GO:1900738; GO:1901215; GO:1901899; GO:2000707",1e-07,3.84968376936786e-06,1.40100422466715e-06,0.0310140149734364,0.0269256184027184,0.0193381226792597,0.0257574684558068,0.0128805177905681,7.81298375927935,0.00106332206394088,0.0144019570685663,-4.24363817385917,50688,1.8415784880209,5,1,0,1.40100422466715e-06,0.0269256184027184,19218.7988648752,14.2302305530265
"437",456,634,634,634,"Q9P1Z2","CALCOCO1","CACO1_HUMAN","cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; transcription regulatory region DNA binding [GO:0044212]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between nucleus and cytoplasm. {ECO:0000250}.","Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3)","GO:0000790; GO:0000980; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005829; GO:0006351; GO:0007165; GO:0008013; GO:0008022; GO:0010628; GO:0016055; GO:0030374; GO:0030518; GO:0043231; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0070016",0.00202249216638446,0.00409062981314504,0.00632190002334347,0.0557881517122662,0.0715795554880881,0.0473756247642608,0.0541027699872474,0.0311963923279147,7.79435824249639,0.0010736928718417,0.0144965472917429,-4.25546691259066,77336,1.83873542333054,6,0,0,0.00409062981314504,0.0557881517122662,13.6380347918537,3.76956386532646
"438",457,635,635,635,"A6NNY8","USP27X","UBP27_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; positive regulation of apoptotic process [GO:0043065]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q8CEG8}. Nucleus {ECO:0000250|UniProtKB:Q8CEG8}.","Ubiquitin carboxyl-terminal hydrolase 27 (EC 3.4.19.12) (Deubiquitinating enzyme 27) (Ubiquitin carboxyl-terminal hydrolase 22-like) (Ubiquitin thioesterase 27) (Ubiquitin-specific-processing protease 27) (X-linked ubiquitin carboxyl-terminal hydrolase 27)","GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0043065; GO:0050821; GO:0061578; GO:0070536; GO:0071108; GO:1990380",0.0262266138423385,0.0210724818146263,0.0218668282647095,0.0619408461807498,0.048933042662856,0.0526033183808509,0.0314370944342608,0.0387738551910218,7.7841783963664,0.00107941317546783,0.01455082957796,-4.26194232410449,49630,1.83711224579423,5,0,0,0.0218668282647095,0.0526033183808509,2.4056217821835,1.26640983625445
"439",459,638,638,638,"Q8IW70","TMEM151B","T151B_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Transmembrane protein 151B (Transmembrane protein 193)","GO:0016021",1e-07,1e-07,1e-07,0.0544825759702502,0.0458914443185562,0.0720036462219814,0.0574591221702626,0.0287296610851313,7.75948100706106,0.00109344633825338,0.0146646257673595,-4.27768293340587,61506,1.83372901548224,3,3,0,1e-07,0.0544825759702502,544825.759702502,19.0554353909228
"440",460,639,639,639,"Q53EL6","PDCD4","PDCD4_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q61823}. Cytoplasm {ECO:0000250|UniProtKB:Q61823}. Note=Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133). {ECO:0000269|PubMed:16357133}.","Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a)","GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007569; GO:0030509; GO:0035722; GO:0043066; GO:0043508; GO:0045786; GO:0045892; GO:0050729; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353",6.99592645450877e-07,1.51680688189322e-05,1e-07,0.0321965242082322,0.0280767773245566,0.0435562426308131,0.0346045255007125,0.0173075853041777,7.75728045015243,0.00109470746090452,0.0146646257673595,-4.27908754023281,51735,1.83372901548224,6,1,0,6.99592645450877e-07,0.0321965242082322,46021.8162920824,15.4900303014833
"441",461,640,640,640,"O95405","ZFYVE9","ZFYV9_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; serine-type peptidase activity [GO:0008236]; endocytosis [GO:0006897]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cytoplasm. Early endosome membrane.","Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation)","GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008236; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872",0.00031697913213448,0.00022793299402732,0.00028187130328065,0.168833431658514,0.111862862874018,0.119425713375845,0.133098408159645,0.0668247985563033,7.7310111926775,0.00110989990737144,0.014844911261093,-4.29588181105441,156403,1.82842239415637,7,0,0,0.00028187130328065,0.119425713375845,423.688796929203,8.7268611716076
"442",462,641,641,641,"Q14202","ZMYM3","ZMYM3_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Zinc finger MYM-type protein 3 (Zinc finger protein 261)","GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0007010; GO:0007275; GO:0008270; GO:0022604",4.10738776026946e-06,1.44915348058863e-06,0.00115456636021851,0.0412917136433818,0.0618771568996461,0.0652917045298031,0.0557668173904573,0.0282701163290484,7.70918581573701,0.00112271806680864,0.0149872746738128,-4.30987266520841,152379,1.82427733324458,11,0,0,4.10738776026946e-06,0.0618771568996461,15064.8442540976,13.8788981374468
"443",463,642,642,642,"Q14847","LASP1","LASP1_HUMAN","cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; ion transmembrane transporter activity [GO:0015075]; metal ion binding [GO:0046872]; SH3/SH2 adaptor activity [GO:0005070]; ion transport [GO:0006811]","SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated with the F-actin rich cortical cytoskeleton. {ECO:0000250}.","LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50)","GO:0005070; GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0045296; GO:0046872; GO:0051015",1e-07,1.57738038963705e-05,0.00018223377783313,0.00061744613421573,0.00055497945742231,0.00067839601174599,0.00055090467388484,0.00034148819751892,7.70694279572194,0.00112404560053596,0.0149872746738128,-4.31131246304838,29717,1.82427733324458,8,1,0,1.57738038963705e-05,0.00061744613421573,39.1437688887335,5.29071076488667
"444",464,643,643,643,"Q9BTU6","PI4K2A","P4K2A_HUMAN","cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; growing cell tip [GO:0035838]; host cell presynaptic membrane [GO:0044231]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; basophil degranulation [GO:0002561]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:16443754, ECO:0000269|PubMed:22535966}; Lipid-anchor {ECO:0000269|PubMed:22535966}. Membrane raft {ECO:0000269|PubMed:11279162}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q2TBE6}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:Q2TBE6}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:Q2TBE6}. Mitochondrion {ECO:0000250|UniProtKB:Q2TBE6}. Endosome {ECO:0000269|PubMed:16443754, ECO:0000269|PubMed:23146885}. Cytoplasmic vesicle {ECO:0000269|PubMed:16443754}. Membrane {ECO:0000269|PubMed:24675427}; Lipid-anchor {ECO:0000269|PubMed:24675427}. Cell membrane {ECO:0000269|PubMed:11279162, ECO:0000269|PubMed:16443754}. Note=Localized in neuronal cell body. Transported from neuronal cell body to neuron projections in a BLOC-1- and AP-3-complexes-dependent manner. Enriched in neurite tips and neuron projections in a BLOC-1- and AP-3-complexes-dependent manner (By similarity). Found in subdomains of the plasma membrane termed non-caveolar membrane rafts. {ECO:0000250|UniProtKB:Q2TBE6, ECO:0000250|UniProtKB:Q99M64}.","Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha)","GO:0000287; GO:0002561; GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005829; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0030054; GO:0030425; GO:0030672; GO:0031224; GO:0031410; GO:0031901; GO:0032991; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0044231; GO:0045121; GO:0046854",0.0004469895455725,2.46117252626173e-05,4.74135452571612e-05,0.0236535467998966,0.0302488648196283,0.0190309175274879,0.0241381047769735,0.0122420573271842,7.68750399080693,0.00113563095444915,0.015075902392767,-4.32380545937605,54022,1.82171668300407,17,0,0,4.74135452571612e-05,0.0236535467998966,498.877413017835,8.96254154169307
"445",465,644,644,644,"Q15386","UBE3C","UBE3C_HUMAN","cytoplasm [GO:0005737]; intracellular [GO:0005622]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2)","GO:0000209; GO:0000502; GO:0004842; GO:0005622; GO:0005634; GO:0005737; GO:0061630",1e-07,1e-07,1e-07,0.0360876850865655,0.0435615687993898,0.0269689604033622,0.0355393047631058,0.0177697523815529,7.68601050517758,0.00113652706275736,0.015075902392767,-4.32476642687522,123923,1.82171668300407,14,3,0,1e-07,0.0360876850865655,360876.850865655,18.4611470762132
"446",467,646,646,646,"O00203","AP3B1","AP3B1_HUMAN","AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; positive regulation of NK T cell differentiation [GO:0051138]; protein targeting to lysosome [GO:0006622]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, clathrin-coated vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus {ECO:0000250}. Note=Component of the coat surrounding the cytoplasmic face of coated vesicles located at the Golgi complex. {ECO:0000250}.","AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)","GO:0005765; GO:0005794; GO:0006622; GO:0006886; GO:0007596; GO:0008089; GO:0016020; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0032438; GO:0048007; GO:0048490; GO:0051138; GO:1904115",4.60066922392611e-05,0.00911480775391832,7.92822105076009e-05,0.0394224429029721,0.0300140488661812,0.0408881378026875,0.0336948443050586,0.0199274543714177,7.68225794806196,0.00113878244405065,0.015075902392767,-4.32718168221133,121320,1.82171668300407,6,0,0,7.92822105076009e-05,0.0394224429029721,497.241974593943,8.9578042761541
"447",468,647,647,647,"Q719H9","KCTD1","KCTD1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18358072}.","BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1)","GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008134; GO:0042802; GO:0045892; GO:0051260",0.0550905731255052,0.0814253700099528,0.0507403315054204,0.215253745692319,0.198551198497174,0.164942892857512,0.130497187468709,0.127667351947981,7.68106812294181,0.00113949869721031,0.015075902392767,-4.32794770125155,29405,1.82171668300407,3,0,0,0.0550905731255052,0.198551198497174,3.60408663828642,1.84963369237337
"448",469,651,651,651,"Q9Y2S7","POLDIP2","PDIP2_HUMAN","mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mitochondrion morphogenesis [GO:0070584]; negative regulation of macroautophagy [GO:0016242]; positive regulation of mitotic cell cycle [GO:0045931]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38)","GO:0003677; GO:0005634; GO:0005739; GO:0016242; GO:0042645; GO:0045931; GO:0070584",0.0006288614276513,0.00063263985879365,0.00068330195673352,0.0441217908327555,0.0713674492607328,0.0596853045247633,0.0577432471250244,0.0295198913102383,7.59207742432595,0.00119466045684847,0.0157085921822165,-4.38553297968299,42033,1.8038627350677,10,0,0,0.00063263985879365,0.0596853045247633,94.3432565860999,6.55984749625866
"449",470,653,653,653,"Q8IUZ0","LRRC49","LRC49_HUMAN","cytoplasm [GO:0005737]; microtubule [GO:0005874]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4)","GO:0005737; GO:0005874",0.00798804729170793,1e-07,1e-07,0.0548621996227978,0.0788388935937844,0.055746150232698,0.0604863320525241,0.032905915123498,7.57214053414261,0.00120746126223117,0.0158282823961697,-4.39851371499799,78894,1.80056620998523,8,2,0,1e-07,0.055746150232698,557461.50232698,19.0885126519905
"450",471,654,654,654,"Q13315","ATM","ATM_HUMAN","cytoplasmic vesicle [GO:0031410]; DNA repair complex [GO:1990391]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to X-ray [GO:0071481]; determination of adult lifespan [GO:0008340]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; immunoglobulin production [GO:0002377]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic spindle assembly checkpoint [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction involved in mitotic G2 DNA damage checkpoint [GO:0072434]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}. Cytoplasmic vesicle {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}. Note=Primarily nuclear. Found also in endocytic vesicles in association with beta-adaptin. {ECO:0000269|PubMed:9050866, ECO:0000269|PubMed:9150358}.","Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)","GO:0000723; GO:0000724; GO:0000729; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0002377; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0006260; GO:0006281; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007050; GO:0007094; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0016303; GO:0016572; GO:0018105; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042981; GO:0043065; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0046777; GO:0046983; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0071044; GO:0071480; GO:0071481; GO:0071500; GO:0072434; GO:0090399; GO:0097694; GO:0097695; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391",0.00010375200204922,9.52229046937641e-05,0.00010577792315013,0.0004302188428205,0.00037952274155556,0.00034196217346763,0.00028231697598352,0.0002427427646228,7.56299534712924,0.00121338894297951,0.0158816656756952,-4.40447790739574,350687,1.79910395053444,31,0,0,0.00010375200204922,0.00037952274155556,3.65797993349096,1.87104716094434
"451",472,655,655,655,"A5PKW4","PSD","PSD1_HUMAN","cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23603394}. Cell projection, ruffle membrane {ECO:0000269|PubMed:23603394}. Cleavage furrow {ECO:0000269|PubMed:23603394}. Note=Distributed uniformly on the plasma membrane, as well as throughout the cytoplasm during metaphase. Subsequently concentrated at patches in the equatorial region at the onset of cytokinesis, and becomes distributed in the equatorial region concurrent with cleavage furrow ingression. In later cytokinesis phases, fades away from the cleavage furrow and becomes uniformly distributed throughout the plasma membrane. {ECO:0000269|PubMed:23603394}.","PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)","GO:0005086; GO:0005543; GO:0007165; GO:0014069; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999",8.76905540618645e-05,0.00010757292199619,0.0580128807069345,0.328392319298403,0.226384365691748,0.310921213546522,0.269163251451226,0.153984340453277,7.55999447627173,0.0012153417509857,0.0158829395243322,-4.40643632901664,109543,1.79906911771151,5,0,0,0.00010757292199619,0.310921213546522,2890.3297203132,11.4970183651829
"452",473,656,656,656,"Q9Y376","CAB39","CAB39_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine/threonine protein kinase complex [GO:1902554]; kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein heterooligomerization [GO:0051291]; signal transduction by protein phosphorylation [GO:0023014]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Calcium-binding protein 39 (MO25alpha) (Protein Mo25)","GO:0004674; GO:0005576; GO:0005829; GO:0007050; GO:0010800; GO:0018105; GO:0019900; GO:0023014; GO:0030295; GO:0034774; GO:0035556; GO:0043312; GO:0043539; GO:0051291; GO:0070062; GO:0071476; GO:0071902; GO:1901017; GO:1901380; GO:1902554; GO:1904813",0.00243626511391096,0.00010372558479511,7.14970073260723e-05,0.0542479457781612,0.0471147197237172,0.0337286347203515,0.0441599375053993,0.0229504646547104,7.5546947975921,0.00121879985899897,0.0159038518186451,-4.40989662668566,39869,1.79849767939071,8,0,0,0.00010372558479511,0.0471147197237172,454.224671924321,8.82726226018803
"453",474,657,657,657,"P28799","GRN","GRN_HUMAN","azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Secreted.","Granulins (Proepithelin) (PEPI) [Cleaved into: Acrogranin (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Progranulin); Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Granulin B); Granulin-4 (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)]","GO:0003723; GO:0005125; GO:0005576; GO:0005764; GO:0005768; GO:0005783; GO:0007165; GO:0008083; GO:0035578; GO:0043312; GO:0070062",0.551887537690189,0.518765937877066,0.536235375328771,0.790923630105,0.696387495019105,0.759929885332589,0.213450719853556,0.64235497689212,7.5274632789044,0.00123675893618858,0.0161136324106153,-4.42770976193162,63544,1.7928065478449,3,0,0,0.536235375328771,0.759929885332589,1.41715731616302,0.502999918206951
"454",475,658,658,658,"O15042","U2SURP","SR140_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20858735}.","U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)","GO:0000398; GO:0003723; GO:0005634; GO:0005654",0.00033904553581932,0.0010724370843871,0.00028954598340411,0.0740366369027301,0.0634408084547121,0.0454665474379232,0.0604143213972516,0.0307741702331627,7.51407700296008,0.00124570522893307,0.0162055269903755,-4.43648651617514,118292,1.79033684150368,21,0,0,0.00033904553581932,0.0634408084547121,187.115893743902,7.5477882969993
"455",476,659,659,659,"Q9BRJ6","C7orf50","CG050_HUMAN","RNA binding [GO:0003723]",NA,"Uncharacterized protein C7orf50","GO:0003723",1e-07,1e-07,1e-07,0.0160585590314612,0.0160468103679556,0.0102045160922267,0.0141031951638812,0.00705169758194058,7.50593117047683,0.00125118781308305,0.0162521512594703,-4.44183392759192,22083,1.78908914432941,5,3,0,1e-07,0.0160468103679556,160468.103679556,17.291927035109
"456",477,660,660,660,"Q96LT9","RNPC3","RBM40_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; developmental process [GO:0032502]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14974681}.","RNA-binding protein 40 (RNA-binding motif protein 40) (RNA-binding region-containing protein 3) (U11/U12 small nuclear ribonucleoprotein 65 kDa protein) (U11/U12 snRNP 65 kDa protein) (U11/U12-65K)","GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0008380; GO:0030626; GO:0032502; GO:0097157",0.00022802940260665,0.0081378001437576,0.00016882642168365,0.034214675007085,0.0370002487988693,0.0264725624441483,0.0297176100940182,0.0177036903696917,7.49558283561214,0.00125819523760819,0.0163184109604941,-4.44863437841043,58575,1.78732213385963,4,0,0,0.00022802940260665,0.034214675007085,150.045014440989,7.22925157295115
"457",478,661,661,661,"Q9H3K2","GHITM","GHITM_HUMAN","extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:18417609}; Multi-pass membrane protein {ECO:0000269|PubMed:18417609}.","Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5)","GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062",8.3222951229239e-05,8.61809069664106e-05,6.75353417456324e-05,0.0167743587154706,0.0109924036210781,0.0176338579594428,0.0150545603653501,0.0076062599159888,7.48985385697044,0.00126209519432692,0.016330105387847,-4.45240266404037,37205,1.78701101249464,3,0,0,8.3222951229239e-05,0.0167743587154706,201.559287044091,7.6550604481003
"458",479,662,662,662,"Q6PIJ6","FBXO38","FBX38_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of neuron projection development [GO:0010976]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.","F-box only protein 38 (Modulator of KLF7 activity homolog) (MoKA)","GO:0005634; GO:0005737; GO:0010976",0.00013686737279733,0.00014437582586565,0.000111416895283,0.076083706716304,0.0813625574528972,0.116324770539595,0.0911261248716166,0.0456939491337903,7.48865618990178,0.00126291235592929,0.016330105387847,-4.45319075233571,133944,1.78701101249464,11,0,0,0.00013686737279733,0.0813625574528972,594.462769248716,9.2154426476814
"459",480,663,663,663,"Q8TAE8","GADD45GIP1","G45IP_HUMAN","mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; mitotic cell cycle arrest [GO:0071850]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22453275, ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}. Nucleus {ECO:0000269|PubMed:12482659}. Note=Using N-terminally tagged constructs, has been found in the nucleus (PubMed:12482659). C-terminally tagged constructs are targeted exclusively to mitochondria (PubMed:22453275). This discrepancy may be explained by masking of a potential N-terminal mitochondrial targeting signal by the tag (PubMed:22453275). {ECO:0000269|PubMed:12482659, ECO:0000269|PubMed:22453275}.","Growth arrest and DNA damage-inducible proteins-interacting protein 1 (39S ribosomal protein L59, mitochondrial) (MRP-L59) (CKII beta-associating protein) (CR6-interacting factor 1) (CRIF1) (Mitochondrial large ribosomal subunit protein mL64) (Papillomavirus L2-interacting nuclear protein 1) (PLINP) (PLINP-1) (p53-responsive gene 6 protein)","GO:0005634; GO:0005739; GO:0005759; GO:0005761; GO:0016032; GO:0070125; GO:0070126; GO:0071850",1e-07,1e-07,1e-07,0.0354049421814157,0.0339022208865146,0.0220549972599737,0.0304539534426347,0.0152270767213173,7.48449274669679,0.00126575806695805,0.0163422157664569,-4.45593122021683,25384,1.78668905980447,5,3,0,1e-07,0.0339022208865146,339022.208865146,18.3710202598047
"460",481,664,664,664,"O60347","TBC1D12","TBC12_HUMAN","autophagosome [GO:0005776]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of autophagosome assembly [GO:2000785]; regulation of vesicle fusion [GO:0031338]",NA,"TBC1 domain family member 12","GO:0005096; GO:0005776; GO:0006886; GO:0017137; GO:0031338; GO:0055037; GO:0090630; GO:2000785",0.252426387968267,0.211223447520629,0.366348689851049,0.656431508769678,0.646096055168851,0.74783811804623,0.406789052214938,0.480060701220784,7.46456713779911,0.00127948579793529,0.0164945759492863,-4.46906480193625,85626,1.78265884503239,5,0,0,0.252426387968267,0.656431508769678,2.60048687481991,1.37878175638056
"461",482,665,665,665,"Q8WXG6","MADD","MADD_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; protein kinase activator activity [GO:0030295]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; activation of MAPK activity [GO:0000187]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:8988362}. Cytoplasm {ECO:0000269|PubMed:8988362}.","MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor)","GO:0000187; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0010803; GO:0016021; GO:0017112; GO:0030295; GO:0032483; GO:0042981; GO:0051726; GO:0097194; GO:1902041; GO:2001236",1e-07,1e-07,1e-07,0.00026187176287188,0.00023465211866737,0.00020872188400695,0.00023498192184873,0.00011759096092436,7.44919197856396,0.00129020254653549,0.0165846684869263,-4.47921958459519,183303,1.78029320522605,21,3,0,1e-07,0.00023465211866737,2346.5211866737,11.19630777114
"462",483,666,666,666,"Q9GZN1","ACTR6","ARP6_HUMAN","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Nucleus {ECO:0000269|PubMed:16487625}. Note=Colocalizes with HP1 family proteins at pericentric heterochromatin.","Actin-related protein 6 (hArp6) (hARPX)","GO:0005634; GO:0005737; GO:0005856; GO:0006338",0.00732572189036105,0.0145045504667491,0.0243007893817298,0.15854493982948,0.111674193410069,0.115738427634473,0.113275499711728,0.072014770435477,7.448982646471,0.00129034920704356,0.0165846684869263,-4.47935796527503,45810,1.78029320522605,4,0,0,0.0145045504667491,0.115738427634473,7.97945637128135,2.9962904610877
"463",484,667,667,667,"Q9NRF8","CTPS2","PYRG2_HUMAN","cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine nucleotide metabolic process [GO:0006220]",NA,"CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2)","GO:0003883; GO:0005524; GO:0005829; GO:0006220; GO:0006541; GO:0015949; GO:0044210",0.00037326408321447,0.00011098045220962,0.00013572261248365,0.0281980190772102,0.0253612477190229,0.0173069893992246,0.0234154296825166,0.0119143705572276,7.44545372278507,0.0012928246700036,0.016591572976358,-4.48169129011232,65678,1.78011243841392,10,0,0,0.00013572261248365,0.0253612477190229,186.860886737485,7.5458208090708
"464",486,669,669,669,"Q9Y2B0","CNPY2","CNPY2_HUMAN","endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; enzyme linked receptor protein signaling pathway [GO:0007167]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]; tissue development [GO:0009888]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000255|PROSITE-ProRule:PRU10138}.","Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)","GO:0005783; GO:0005887; GO:0007167; GO:0009888; GO:0010629; GO:0010988; GO:0045716",0.00027366365865498,1e-07,1e-07,0.0362553925470519,0.0224060969952731,0.034096141034599,0.0308279223060897,0.0155052490392632,7.43370454227084,0.00130110823918339,0.0166473915311219,-4.48946667682747,20652,1.7786538061449,6,2,0,1e-07,0.034096141034599,340961.41034599,18.3792489402175
"465",487,670,670,670,"Q9NR31","SAR1A","SAR1A_HUMAN","COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; cargo loading into COPII-coated vesicle [GO:0090110]; intracellular protein transport [GO:0006886]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250}. Golgi apparatus {ECO:0000250}.","GTP-binding protein SAR1a (COPII-associated small GTPase)","GO:0000139; GO:0005525; GO:0005783; GO:0006886; GO:0030127; GO:0090110",0.0306441735058947,0.045823781409848,0.0416304830309388,0.134123164246901,0.100292902375318,0.128371592715312,0.0815630737969499,0.0801476828807022,7.43102217556979,0.00130300844928174,0.0166473915311219,-4.49124329073343,22367,1.7786538061449,5,0,0,0.0416304830309388,0.128371592715312,3.08359604234977,1.62461378150772
"466",488,671,671,671,"Q96P16","RPRD1A","RPR1A_HUMAN","DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription by RNA polymerase II [GO:0042795]",NA,"Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein)","GO:0005654; GO:0016591; GO:0042795; GO:0042802; GO:0070940",1e-07,1e-07,1e-07,0.121186857142475,0.0780599799760958,0.125512729713158,0.10825308894391,0.0541266444719549,7.41504159150317,0.00131439950793301,0.0167489005836812,-4.50183910349396,35720,1.77601369526063,7,3,0,1e-07,0.121186857142475,1211868.57142475,20.2088018146407
"467",489,672,672,672,"Q9NYQ7","CELSR3","CELR3_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.","Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2)","GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:1904938",0.00029917241644901,0.00032728111383891,0.00024587141360904,0.0494368161092676,0.0321883462604042,0.0518143039890841,0.0441890471382863,0.0223852985504421,7.41438940219016,0.00131486696170955,0.0167489005836812,-4.50227194747932,358185,1.77601369526063,31,0,0,0.00029917241644901,0.0494368161092676,165.245234490705,7.36846485620807
"468",490,673,673,673,"Q9BWU0","SLC4A1AP","NADAP_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15764369}. Cytoplasm {ECO:0000269|PubMed:15764369}. Note=Mainly nuclear. Small amounts are found in the cytoplasm.","Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)","GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231",0.0201911608491479,0.00061324430349739,0.00124383270597654,0.115370496499269,0.0859584644879205,0.0826431417983759,0.0873079549756479,0.0510033901073645,7.41071902719189,0.00131750146407085,0.0167575223364733,-4.50470850330329,88814,1.7757901930531,5,0,0,0.00124383270597654,0.0859584644879205,69.1077377808891,6.11077534867217
"469",491,674,674,674,"O75390","CS","CISY_HUMAN","extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; tricarboxylic acid cycle [GO:0006099]","SUBCELLULAR LOCATION: Mitochondrion matrix.","Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)","GO:0003723; GO:0004108; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0070062",2.10129780703334e-05,3.50238005326614e-06,1.41420016203052e-05,0.00489358139515253,0.00307320977072683,0.00482440274211541,0.00425084551608362,0.00213830854462311,7.39658066573214,0.00132770985993823,0.0168538780231516,-4.51410381408851,51712,1.77330015353,13,0,0,1.41420016203052e-05,0.00482440274211541,341.14002187558,8.41422020879629
"470",493,678,678,678,"Q9Y2Q5","LAMTOR2","LTOR2_HUMAN","endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; activation of MAPKK activity [GO:0000186]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of macroautophagy [GO:0016241]","SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Lysosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.","Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (MAPBP-interacting protein) (Roadblock domain-containing protein 3)","GO:0000165; GO:0000186; GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0005886; GO:0007050; GO:0010008; GO:0016241; GO:0032008; GO:0032947; GO:0034613; GO:0035579; GO:0043312; GO:0070821; GO:0071230; GO:0071986",0.00565525578078249,0.00074810144319005,0.00146077296807758,0.08377142244861,0.067333959289041,0.0524652298594111,0.0652354938016707,0.0352391236315187,7.38170724283666,0.00133855311130978,0.0168997265970674,-4.52400416206081,13508,1.77212032132393,3,0,0,0.00146077296807758,0.067333959289041,46.0947462477037,5.52653042050257
"471",494,679,679,679,"Q8N158","GPC2","GPC2_HUMAN","anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuron differentiation [GO:0030182]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; smoothened signaling pathway [GO:0007224]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.; SUBCELLULAR LOCATION: Secreted glypican-2: Secreted, extracellular space {ECO:0000250}.","Glypican-2 [Cleaved into: Secreted glypican-2]","GO:0001523; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0007224; GO:0009966; GO:0030182; GO:0043202; GO:0043395; GO:0046658",0.00014424352208074,2.65922863606958e-05,8.55327468534331e-06,0.0373470395626918,0.0346473862100232,0.0534859201317709,0.0417669856071197,0.0209432891646021,7.36830667958657,0.00134841503059399,0.0169991644504927,-4.53293870745506,62830,1.76957242470751,18,0,0,2.65922863606958e-05,0.0373470395626918,1404.43130974597,10.4557703491319
"472",495,681,681,681,"Q8NAF0","ZNF579","ZN579_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Zinc finger protein 579","GO:0000981; GO:0003677; GO:0003723; GO:0005634; GO:0006351; GO:0046872",0.00040351355272381,0.00676568898598047,0.00022058951639382,0.0197439188256542,0.0239351074773435,0.0267986930074679,0.0210293090851225,0.0129779185609273,7.34400955719654,0.00136652263437267,0.0171768483850662,-4.549173710307,60509,1.76505651771867,5,0,0,0.00040351355272381,0.0239351074773435,59.3167374819903,5.89036734426466
"473",496,682,682,682,"Q16799","RTN1","RTN1_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuron differentiation [GO:0030182]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.","Reticulon-1 (Neuroendocrine-specific protein)","GO:0005783; GO:0005789; GO:0030176; GO:0030182",1e-07,2.81966696359325e-05,2.86054607908048e-05,0.0145971736973128,0.0233546538191043,0.0172058740771678,0.0183669331543861,0.00920243395400194,7.34066805260127,0.00136903600309415,0.0171832084845834,-4.55141003770599,83618,1.76489574056008,12,1,0,2.81966696359325e-05,0.0172058740771678,610.209443147905,9.25316069594045
"474",497,683,683,683,"Q9UEU0","VTI1B","VTI1B_HUMAN","cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; cell proliferation [GO:0008283]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; membrane fusion [GO:0061025]; platelet degranulation [GO:0002576]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000269|PubMed:18033301}; Single-pass type IV membrane protein {ECO:0000255}. Late endosome membrane {ECO:0000269|PubMed:18033301, ECO:0000269|PubMed:23217709}; Single-pass type IV membrane protein {ECO:0000269|PubMed:23217709}. Lysosome membrane {ECO:0000269|PubMed:18033301, ECO:0000269|PubMed:23217709}. Cytoplasmic granule {ECO:0000269|PubMed:23217709}. Recycling endosome membrane {ECO:0000269|PubMed:18033301}; Single-pass type IV membrane protein {ECO:0000255}.","Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1)","GO:0000149; GO:0002576; GO:0005484; GO:0005576; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0006904; GO:0008021; GO:0008283; GO:0012507; GO:0016021; GO:0016192; GO:0019869; GO:0031093; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0042147; GO:0043025; GO:0043231; GO:0048280; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:1903076",1e-07,1e-07,6.99897198460362e-06,0.00040442127132038,0.00053029281008945,0.00035174216978606,0.00042641909307043,0.00021560920386341,7.32695252148293,0.00137941149220496,0.0172880854659948,-4.56059835607745,26688,1.76225309912585,8,2,0,1e-07,0.00040442127132038,4044.2127132038,11.9816431652397
"475",498,684,684,684,"Q00839","HNRNPU","HNRPU_HUMAN","catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II core binding [GO:0000993]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10671544, ECO:0000269|PubMed:11003645, ECO:0000269|PubMed:1324173, ECO:0000269|PubMed:14608463, ECO:0000269|PubMed:15563465, ECO:0000269|PubMed:19617346, ECO:0000269|PubMed:21242313, ECO:0000269|PubMed:8174554, ECO:0000269|PubMed:9353307, ECO:0000269|PubMed:9405365}. Nucleus matrix {ECO:0000269|PubMed:1324173, ECO:0000269|PubMed:14608463, ECO:0000269|PubMed:8174554}. Chromosome {ECO:0000269|PubMed:11003645, ECO:0000269|PubMed:14608463, ECO:0000269|PubMed:15563465}. Nucleus speckle {ECO:0000269|PubMed:9353307}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:25986610}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:21242313}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:21242313, ECO:0000269|PubMed:25986610}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:21242313}. Midbody {ECO:0000269|PubMed:25986610}. Cytoplasm {ECO:0000269|PubMed:19029303}. Cell surface {ECO:0000269|PubMed:7993898}. Cytoplasmic granule {ECO:0000269|PubMed:17289661}. Note=Localizes at inactive X chromosome (Xi) regions (PubMed:11003645, PubMed:14608463, PubMed:15563465). Localizes in the nucleus during interphase (PubMed:21242313). At metaphase, localizes with mitotic spindle microtubules (MTs) (PubMed:21242313). At anaphase, localizes in the mitotic spindle midzone (PubMed:21242313). Localizes in spindle MTs proximal to spindle poles in a TPX2- and AURKA-dependent manner (PubMed:21242313). The Ser-59 phosphorylated form localizes to centrosomes during prophase and metaphase, to mitotic spindles in anaphase and to the midbody during cytokinesis (PubMed:25986610). Colocalizes with SMARCA4 in the nucleus (By similarity). Colocalizes with CBX5 in the nucleus (PubMed:19617346). Colocalizes with NR3C1 in nuclear speckles (PubMed:9353307). Localized in cytoplasmic ribonucleoprotein (RNP) granules containing untranslated mRNAs (PubMed:17289661). {ECO:0000250|UniProtKB:Q8VEK3, ECO:0000269|PubMed:11003645, ECO:0000269|PubMed:14608463, ECO:0000269|PubMed:15563465, ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:19617346, ECO:0000269|PubMed:21242313, ECO:0000269|PubMed:25986610, ECO:0000269|PubMed:9353307}.","Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120)","GO:0000122; GO:0000228; GO:0000381; GO:0000398; GO:0000776; GO:0000777; GO:0000922; GO:0000993; GO:0001047; GO:0001097; GO:0001649; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003714; GO:0003723; GO:0003725; GO:0003727; GO:0003730; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006325; GO:0006351; GO:0006396; GO:0007049; GO:0007346; GO:0008143; GO:0009048; GO:0009986; GO:0016020; GO:0016070; GO:0016363; GO:0016607; GO:0017069; GO:0017130; GO:0030496; GO:0031490; GO:0032211; GO:0032922; GO:0032991; GO:0033673; GO:0034046; GO:0034244; GO:0036002; GO:0036464; GO:0042802; GO:0043021; GO:0044877; GO:0045944; GO:0048255; GO:0051301; GO:0051457; GO:0055013; GO:0070034; GO:0070934; GO:0070937; GO:0071013; GO:0071385; GO:0072686; GO:0090336; GO:0098577; GO:0099122; GO:1901673; GO:1902275; GO:1902425; GO:1902889; GO:1990023; GO:1990280; GO:1990498; GO:1990830; GO:1990837; GO:1990841; GO:1990845; GO:1990904; GO:2000373; GO:2000648; GO:2000737",1e-07,1e-07,3.73910104933151e-06,0.00103712122552799,0.0017066801984295,0.00151202040163661,0.00141729424151492,0.00070996015444057,7.31849958571015,0.00138585362111588,0.0173434312818011,-4.56626845053378,90584,1.76086497610256,28,2,0,1e-07,0.00151202040163661,15120.2040163661,13.8841899854718
"476",499,685,685,685,"P38646","HSPA9","GRP75_HUMAN","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; interleukin-12-mediated signaling pathway [GO:0035722]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; regulation of erythrocyte differentiation [GO:0045646]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22002106, ECO:0000269|PubMed:26702583}. Nucleus, nucleolus {ECO:0000269|PubMed:22002106}.","Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)","GO:0003723; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005925; GO:0006457; GO:0006611; GO:0016226; GO:0030218; GO:0031625; GO:0035722; GO:0042645; GO:0043066; GO:0043209; GO:0045646; GO:0045647; GO:0051082; GO:0070062; GO:1902037",1e-07,1e-07,1e-07,0.00261498474270847,0.00383868539326872,0.00252347756729067,0.00299228256775595,0.00149624128387798,7.30615572188006,0.00139532699889247,0.0174364950518533,-4.57455853896466,73680,1.75854080911776,28,3,0,1e-07,0.00261498474270847,26149.8474270847,14.6745149085521
"477",500,686,686,686,"Q7Z5J4","RAI1","RAI1_HUMAN","mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; enhancer binding [GO:0035326]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; skeletal system development [GO:0001501]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=In neurons, localized to neurites. {ECO:0000250}.","Retinoic acid-induced protein 1","GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0032922; GO:0035326; GO:0040015; GO:0045893; GO:0045944; GO:0046872",0.0001598666040249,0.00026010276244765,0.00072784185971857,0.0325418286295284,0.046896125690833,0.0305108122759411,0.0362669851233705,0.0185160963037489,7.29316826302433,0.00140537952145325,0.0175365141452475,-4.5832937364491,203352,1.75605673012258,12,0,0,0.00026010276244765,0.0325418286295284,125.111430279707,6.96706979106533
"478",501,687,687,687,"Q9H3P2","NELFA","NELFA_HUMAN","cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11150502}.","Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein)","GO:0005654; GO:0005829; GO:0006355; GO:0006366; GO:0006368; GO:0007275; GO:0016604; GO:0032021",1e-07,1e-07,1e-07,0.0629906920053485,0.0611906861709808,0.0930018582048359,0.0723943121270551,0.0361972560635275,7.28100159993588,0.00141487678909455,0.0176145484484095,-4.59148888391604,57277,1.7541284855442,7,3,0,1e-07,0.0629906920053485,629906.920053485,19.2647791349568
"479",502,688,688,688,"Q9Y4C5","CHST2","CHST2_HUMAN","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:12855678, ECO:0000269|PubMed:22260995}; Single-pass type II membrane protein {ECO:0000269|PubMed:12855678, ECO:0000269|PubMed:22260995}.","Carbohydrate sulfotransferase 2 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2) (GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1) (GlcNAc6ST-1) (Gn6ST-1)","GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0006954; GO:0007275; GO:0008146; GO:0016021; GO:0018146; GO:0031228",0.00026668324016109,0.00031045855801068,0.00024263453908305,0.00112543001104464,0.00111435188207232,0.00081879082901245,0.00074626546162486,0.00064639150989737,7.27988953503411,0.0014157487537974,0.0176145484484095,-4.59223852227135,57857,1.7541284855442,4,0,0,0.00026668324016109,0.00111435188207232,4.17855985775183,2.06300580257502
"480",503,690,690,690,"Q13425","SNTB2","SNTB2_HUMAN","cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]","SUBCELLULAR LOCATION: Membrane. Cytoplasmic vesicle, secretory vesicle membrane; Peripheral membrane protein. Cell junction {ECO:0000250}. Cytoplasm, cytoskeleton. Note=Membrane-associated. In muscle, it is exclusively localized at the neuromuscular junction (By similarity). In insulinoma cell line, it is enriched in secretory granules. {ECO:0000250}.","Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL)","GO:0003723; GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005874; GO:0005925; GO:0016010; GO:0016020; GO:0030658; GO:0032991; GO:0045202",1e-07,5.4287358201276e-06,1e-07,0.00728193899303296,0.0102201963002372,0.0121695700973871,0.00988869221827904,0.00494622235441289,7.22157573223435,0.00146240255507939,0.018142269378956,-4.63168449983053,57950,1.74130838887938,8,2,0,1e-07,0.0102201963002372,102201.963002372,16.641063380953
"481",504,691,691,691,"O94812","BAIAP3","BAIP3_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28626000}. Recycling endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Late endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Cell membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Note=Rapidly recruited to the plasma membrane and to Golgi structures in response to increased intracellular calcium concentration. {ECO:0000269|PubMed:28626000}.","BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3)","GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005783; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502",1e-07,1e-07,1e-07,0.183148293274714,0.134942957800462,0.113159431962175,0.143750127679117,0.0718751638395584,7.21315746689332,0.00146929109790392,0.018201348477652,-4.63740127417011,131901,1.73989643538258,4,3,0,1e-07,0.134942957800462,1349429.57800462,20.3639182589007
"482",505,694,694,694,"Q6UWE0","LRSAM1","LRSM1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:27615052}. Note=Displays a punctuate distribution and localizes to a submembranal ring (PubMed:15256501). Localizes to intracellular bacterial pathogens (PubMed:23245322). {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322}.","E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL)","GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0006914; GO:0007165; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786",4.88684245254313e-05,1e-07,1e-07,0.00064680518727823,0.0010115341139599,0.0007495359785913,0.000786268951768,0.00040949061739247,7.18576605074068,0.00149197993046025,0.0184025190270025,-4.65604174456955,83594,1.73512272456397,21,2,0,1e-07,0.0007495359785913,7495.359785913,12.8717820155229
"483",506,695,695,695,"Q9HAR2","ADGRL3","AGRL3_HUMAN","axon [GO:0030424]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G-protein coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26235030}; Multi-pass membrane protein {ECO:0000305}. Cell projection, axon {ECO:0000250|UniProtKB:Q80TS3}. Cell junction {ECO:0000250|UniProtKB:Q80TS3}.","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007416; GO:0016021; GO:0030246; GO:0030424; GO:0031987; GO:0042220; GO:0051965; GO:0098742",1e-07,1e-07,0.00025169650284645,0.0596309834595408,0.0999407919536294,0.0840818386965279,0.0811339058689506,0.0406509184354241,7.18025977906195,0.00149659219708277,0.0184150028591092,-4.6597961431062,161812,1.7348282093806,20,2,0,1e-07,0.0840818386965279,840818.386965279,19.6814346928492
"484",508,699,699,699,"Q10471","GALNT2","GALT2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]","SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane {ECO:0000269|PubMed:9394011}; Single-pass type II membrane protein {ECO:0000269|PubMed:9394011}. Secreted {ECO:0000269|PubMed:9394011}. Note=Resides preferentially in the trans and medial parts of the Golgi stack. A secreted form also exists.","Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]","GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471",0.0107360089164569,0.0361714623015637,0.00901863933816956,0.0929319304902098,0.097858950108813,0.121340340056079,0.0854017033663038,0.0613428885352153,7.14340906175549,0.00152791027979077,0.0187108898354921,-4.68498529608878,64733,1.72790555822663,13,0,0,0.0107360089164569,0.097858950108813,9.11502131474649,3.18824602989503
"485",509,700,700,700,"Q9UM19","HPCAL4","HPCL4_HUMAN","intracellular [GO:0005622]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]",NA,"Hippocalcin-like protein 4 (HLP4)","GO:0005246; GO:0005509; GO:0005622; GO:0007165; GO:0007417; GO:0008022; GO:0019904",0.800601468909728,0.194906604892603,0.389708536211981,1.67201837653728,1.98220533740135,1.85688517964338,1.3752974278559,1.14938758393272,7.13638041182768,0.00153397386809836,0.0187583090156028,-4.68980216069781,22202,1.72680631405357,3,0,0,0.389708536211981,1.85688517964338,4.7648049942466,2.25241717119917
"486",510,701,701,701,"P51812","RPS6KA3","KS6A3_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.","Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)","GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0018105; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944",1e-07,1e-07,1e-07,0.0874582332822072,0.0572463535242875,0.0957126528580771,0.0801389798881906,0.0400695899440953,7.11208282846128,0.00155516199124753,0.0189902805207972,-4.70648464632144,83736,1.72146861990045,7,3,0,1e-07,0.0874582332822072,874582.332822072,19.7382346796963
"487",511,702,702,702,"P07949","RET","RET_HUMAN","axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to drug [GO:0042493]; response to pain [GO:0048265]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19823924, ECO:0000269|PubMed:28953886}; Single-pass type I membrane protein {ECO:0000269|PubMed:19823924}. Endosome membrane {ECO:0000269|PubMed:19823924}; Single-pass type I membrane protein {ECO:0000269|PubMed:19823924}.","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","GO:0000165; GO:0000187; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005088; GO:0005509; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007411; GO:0007497; GO:0010008; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042493; GO:0042551; GO:0043025; GO:0043231; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241",8.78842440824109e-05,0.00010222148390783,0.00011015102561347,0.0778068684881716,0.0740465988997817,0.114655666904666,0.0887362925130053,0.0444682318410372,7.10706210456119,0.0015595844628447,0.0190171552734339,-4.70993781770676,124319,1.72085444751687,6,0,0,0.00010222148390783,0.0778068684881716,761.159645836561,9.57205526650131
"488",512,703,703,703,"Q9Y5I4","PCDHAC2","PCDC2_HUMAN","integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Protocadherin alpha-C2 (PCDH-alpha-C2)","GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399",9.40089875626644e-05,8.00074178827619e-05,7.07294703593635e-05,0.0991876993303676,0.128978787411806,0.0775687731618991,0.101830171342756,0.0509966676299796,7.08975597579951,0.00157494612400685,0.0191771533733977,-4.72185646623528,109450,1.71721585837371,4,0,0,8.00074178827619e-05,0.0991876993303676,1239.73128936259,10.2758117363111
"489",513,705,705,705,"P37837","TALDO1","TALDO_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Transaldolase (EC 2.2.1.2)","GO:0004801; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005975; GO:0005999; GO:0006002; GO:0006098; GO:0009052; GO:0035722; GO:0048029; GO:0070062",3.81228343709338e-05,0.00027202690506752,2.36112791108692e-05,0.00118123472714211,0.00165688305408493,0.00183081677159448,0.0014450578447574,0.00083378259522847,7.06770787778299,0.00159478438504904,0.0193636231716593,-4.73707642762011,37540,1.71301337759391,8,0,0,3.81228343709338e-05,0.00165688305408493,43.4616964196187,5.44167258253141
"490",514,706,706,706,"P61962","DCAF7","DCAF7_HUMAN","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Overexpression of DIAHP1 or active RHOA causes translocation from the nucleus to cytoplasm.","DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)","GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0016363; GO:0016567; GO:0016604; GO:0032991; GO:0043687; GO:0080008",0.0022221466539435,3.74663434551686e-05,3.95278164205606e-05,0.020203048678026,0.0148903140087729,0.0241980726422043,0.0189974315050613,0.0102650960238037,7.05871861766796,0.00160295978728697,0.0194150740665059,-4.74329324600525,38926,1.7118609483261,8,0,0,3.95278164205606e-05,0.020203048678026,511.109656629484,8.99748903887035
"491",515,707,707,707,"Q0VG06","FAAP100","FP100_HUMAN","cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17396147}.","Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa)","GO:0003677; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:0045111",0.0105879020579164,0.0191101280534991,0.00531993735628875,0.0432661138104935,0.048794933885657,0.0565501283335256,0.0378644028539907,0.0306048572495634,7.05806292933509,0.00160355810339015,0.0194150740665059,-4.74374696933373,93433,1.7118609483261,8,0,0,0.0105879020579164,0.048794933885657,4.6085554644108,2.20431461379737
"492",516,708,708,708,"Q86XP3","DDX42","DDX42_HUMAN","Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; RNA secondary structure unwinding [GO:0010501]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus speckle. Nucleus, Cajal body. Note=Isoform 2 is present in Cajal bodies (CBs) and nuclear speckles.","ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125)","GO:0000398; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008104; GO:0010501; GO:0015030; GO:0016020; GO:0016607; GO:0042981",0.00360091780634711,0.00024970971401124,0.00011984519080852,0.065231971776669,0.0677812440750854,0.0417200056434521,0.0569209162613466,0.0297839490343956,7.05396397455771,0.00160730456321761,0.0194329478264728,-4.74658416836401,102975,1.71146131532066,19,0,0,0.00024970971401124,0.065231971776669,261.231214151856,8.02918348256851
"493",517,709,709,709,"A6NHL2","TUBAL3","TBAL3_HUMAN","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.","Tubulin alpha chain-like 3","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017",1e-07,0.00020501902651402,1e-07,0.0248638155561973,0.031455587342513,0.0187111480115576,0.0249417772945846,0.0125392949894637,7.03165043188609,0.00162788689026482,0.0196450023202476,-4.76205341897654,49909,1.70674791555817,4,2,0,1e-07,0.0248638155561973,248638.155561973,17.9236881811898
"494",518,711,711,711,"Q9P107","GMIP","GMIP_HUMAN","cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056]",NA,"GEM-interacting protein (GMIP)","GO:0005096; GO:0005622; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872; GO:0051056",0.0122401363349091,0.0334751315732065,0.0244793008408893,0.0656943916514322,0.0643439387212681,0.0653704644360625,0.0417380753532526,0.0442672272596279,7.022151371841,0.00163674612366948,0.0197054104340517,-4.76865132262581,106683,1.70541451500353,12,0,0,0.0244793008408893,0.0653704644360625,2.67043837816112,1.41707659363013
"495",521,716,716,716,"Q9NUJ3","TCP11L1","T11L1_HUMAN","microtubule [GO:0005874]",NA,"T-complex protein 11-like protein 1","GO:0005874",3.99091489778511e-05,6.73449226573282e-05,6.86025645874792e-05,0.0583373473005057,0.0389262439606386,0.0661596210549546,0.0544157852266254,0.0272665114920536,6.97458291384037,0.00168200243165281,0.0201088558867989,-4.8018047154668,57035,1.6966126383135,10,0,0,6.73449226573282e-05,0.0583373473005057,866.247149727147,9.75863489003321
"496",522,718,718,718,"Q9NZN8","CNOT2","CNOT2_HUMAN","CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription cofactor activity [GO:0001104]; RNA polymerase II transcription corepressor binding [GO:0001226]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; transcription, DNA-templated [GO:0006351]; trophectodermal cell differentiation [GO:0001829]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21299754}. Nucleus {ECO:0000305|PubMed:21299754}.","CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2)","GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001104; GO:0001226; GO:0001829; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006351; GO:0006357; GO:0006977; GO:0010606; GO:0016020; GO:0017148; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036",1e-07,1e-07,1e-07,0.0489495197228345,0.0548450470579069,0.0786226439480764,0.0608056369096059,0.030402918454803,6.95647709641743,0.00169962695360335,0.0202629620095329,-4.81447356442972,59738,1.69329706981631,10,3,0,1e-07,0.0548450470579069,548450.470579069,19.0650018141603
"497",523,719,719,719,"O14497","ARID1A","ARI1A_HUMAN","nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; ligand-dependent nuclear receptor binding [GO:0016922]; nucleosome binding [GO:0031491]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; ATP-dependent chromatin remodeling [GO:0043044]; cardiac chamber development [GO:0003205]; cardiac muscle cell differentiation [GO:0055007]; cellular response to calcium ion [GO:0071277]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; embryo implantation [GO:0007566]; forebrain development [GO:0030900]; formation of primary germ layer [GO:0001704]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; maintenance of chromatin silencing [GO:0006344]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; nucleosome disassembly [GO:0006337]; nucleosome mobilization [GO:0042766]; optic cup formation involved in camera-type eye development [GO:0003408]; placenta blood vessel development [GO:0060674]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:26614907}.","AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)","GO:0000122; GO:0000790; GO:0000981; GO:0001704; GO:0001843; GO:0003205; GO:0003408; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006344; GO:0006351; GO:0006357; GO:0007566; GO:0016514; GO:0016922; GO:0019827; GO:0030520; GO:0030521; GO:0030900; GO:0031491; GO:0042766; GO:0042921; GO:0043044; GO:0045893; GO:0048096; GO:0055007; GO:0060674; GO:0071277; GO:0071564; GO:0071565; GO:1901998",1.38445862592402e-05,1.92225563214066e-05,1.11875132693822e-05,0.031407216043611,0.0307309506693222,0.0474060785638101,0.0364999968736311,0.0182647499887655,6.95009863701019,0.00170588926939521,0.0203093353908525,-4.8189432183549,242045,1.69230428835334,33,0,0,1.38445862592402e-05,0.031407216043611,2268.55577014077,11.1475584119798
"498",525,723,723,723,"Q58EX2","SDK2","SDK2_HUMAN","cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell-cell junction organization [GO:0045216]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8AV57}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q8AV57}. Cell junction, synapse {ECO:0000250|UniProtKB:Q6V4S5}.","Protein sidekick-2","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0030054; GO:0045202; GO:0045216; GO:0060219",0.00010882048251223,6.97015342769977e-05,0.00010247813478431,0.022111032877084,0.0300419622095611,0.0181558727598685,0.02334262256498,0.0117649779996812,6.93053725468956,0.00172527010648546,0.0204264344557615,-4.83267212026923,239396,1.68980743519472,16,0,0,0.00010247813478431,0.022111032877084,215.763420398137,7.75330648702223
"499",526,724,724,724,"Q9HA65","TBC1D17","TBC17_HUMAN","autophagosome [GO:0005776]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of vesicle fusion [GO:0031338]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, autophagosome {ECO:0000269|PubMed:24752605}.","TBC1 domain family member 17","GO:0005096; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0012505; GO:0017137; GO:0031338; GO:0042147; GO:0055037; GO:0090630",0.00013006517653756,0.0003113492760995,0.00124620600068953,0.0278538317408667,0.0372360553209011,0.0468963066998523,0.0367661911027645,0.0189456357024911,6.92581612299566,0.00172998768134913,0.0204539980004814,-4.83599043538873,72728,1.68922179084273,6,0,0,0.0003113492760995,0.0372360553209011,119.595766488955,6.90202251097053
"500",527,725,725,725,"P22304","IDS","IDS_HUMAN","lysosomal lumen [GO:0043202]; iduronate-2-sulfatase activity [GO:0004423]; metal ion binding [GO:0046872]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]","SUBCELLULAR LOCATION: Lysosome.","Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]","GO:0004423; GO:0006027; GO:0030207; GO:0043202; GO:0046872",0.00877446229900439,0.00689334921357717,0.00350461182543436,0.0451908527710832,0.0347276869368067,0.0307401957432796,0.0304954373710512,0.0216385264648642,6.91400986092462,0.00174185383914785,0.0205610534898992,-4.84429691253487,61873,1.68695463709268,4,0,0,0.00689334921357717,0.0347276869368067,5.03785400403144,2.33280931367363
"501",528,726,726,726,"P56945","BCAR1","BCAR1_HUMAN","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epidermal growth factor receptor signaling pathway [GO:0007173]; G-protein coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000269|PubMed:12832404}. Cytoplasm {ECO:0000269|PubMed:12832404}. Note=Unphosphorylated form localizes in the cytoplasm and can move to the membrane upon tyrosine phosphorylation. {ECO:0000250}.","Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)","GO:0001558; GO:0001726; GO:0005737; GO:0005829; GO:0005925; GO:0007015; GO:0007155; GO:0007173; GO:0007186; GO:0007229; GO:0008283; GO:0008286; GO:0010595; GO:0015629; GO:0016477; GO:0017124; GO:0019901; GO:0030027; GO:0030335; GO:0035729; GO:0042981; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050852; GO:0050853; GO:0051301; GO:0060326",0.0016676807712344,0.00033037426977443,0.00067119608028927,0.173083377097145,0.159181523322011,0.102418749432535,0.144004799576798,0.0728921501621649,6.91203698236906,0.00174384635907323,0.0205610534898992,-4.84568611614555,93372,1.68695463709268,14,0,0,0.00067119608028927,0.159181523322011,237.160984690804,7.88972288168756
"502",529,727,727,727,"O95071","UBR5","UBR5_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus, translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus.","E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)","GO:0000209; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0008283; GO:0010628; GO:0016020; GO:0032991; GO:0033160; GO:0034450; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000780",6.52810960475094e-05,9.80347016418348e-05,0.0072888899992658,0.0589486172421977,0.0843476953293021,0.0547910335843467,0.0635450467862971,0.0342565919921336,6.90785773793447,0.00174807636630646,0.0205825772979137,-4.84863002700009,309352,1.68650024491951,23,0,0,9.80347016418348e-05,0.0589486172421977,601.303581843537,9.23194974217619
"503",530,728,728,728,"Q9NPH2","ISYNA1","INO1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; inositol phosphate metabolic process [GO:0043647]; phospholipid biosynthetic process [GO:0008654]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Inositol-3-phosphate synthase 1 (IPS 1) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase) (hIPS) (Myo-inositol 1-phosphate synthase A1) (hINO1)","GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0008654; GO:0043647",1e-07,1e-07,2.69127051379248e-05,0.0435229922578784,0.0716433023783369,0.051494532153759,0.0555445713616122,0.0277813232491854,6.88774880968096,0.00176860472685951,0.0207956819531833,-4.86281581064847,61068,1.68202683323854,8,2,0,1e-07,0.051494532153759,514945.32153759,18.9740597251123
"504",531,730,730,730,"Q6ZSY5","PPP1R3F","PPR3F_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycogen binding [GO:2001069]; protein phosphatase binding [GO:0019903]; regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of glycogen biosynthetic process [GO:0005979]","SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.","Protein phosphatase 1 regulatory subunit 3F (R3F)","GO:0005979; GO:0016020; GO:0016021; GO:0019903; GO:2000465; GO:2001069",0.00023967531623851,0.00020592131311598,0.00052942098300931,0.0449292171820385,0.0264483458889967,0.0356252804904702,0.0353426086497139,0.0179963101956449,6.872435757032,0.00178443386866157,0.0209239652943359,-4.87364153311593,82798,1.67935600898923,6,0,0,0.00023967531623851,0.0356252804904702,148.639755856286,7.21567622695497
"505",532,732,732,732,"Q9Y216","MTMR7","MTMR7_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16787938}.","Myotubularin-related protein 7 (EC 3.1.3.-)","GO:0004438; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0016020; GO:0046855; GO:0046856; GO:0052629",0.0057738503024179,0.0113845519775463,0.014763361977164,0.126053802346261,0.0866271001931826,0.0863226552913831,0.0890272645245661,0.0551542203479925,6.86744029893914,0.00178963488603231,0.0209279707984106,-4.87717747133048,75833,1.67927287934293,12,0,0,0.0113845519775463,0.0866271001931826,7.6091795587597,2.92774090703784
"506",533,733,733,733,"O95989","NUDT3","NUDT3_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; cell-cell signaling [GO:0007267]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diadenosine polyphosphate catabolic process [GO:0015961]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; inositol phosphate metabolic process [GO:0043647]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3)","GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0007267; GO:0008486; GO:0015961; GO:0034431; GO:0034432; GO:0043647; GO:0050072; GO:0052840; GO:0052841; GO:0052842; GO:0052843; GO:0052844; GO:0052845; GO:0052846; GO:0052847; GO:0052848; GO:0071544; GO:1901907; GO:1901909; GO:1901911",1e-07,1e-07,1e-07,0.0545647569708081,0.0345893445002838,0.0366191480530449,0.0419243165080456,0.0209622582540228,6.85343522215953,0.00180431476482681,0.0210708518238984,-4.88710212344172,19471,1.67631790696709,3,3,0,1e-07,0.0366191480530449,366191.480530449,18.4822387015648
"507",534,734,734,734,"P35052","GPC1","GPC1_HUMAN","anchored component of plasma membrane [GO:0046658]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; fibroblast growth factor binding [GO:0017134]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; axon guidance [GO:0007411]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; leukocyte migration [GO:0050900]; myelin assembly [GO:0032288]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; retinoid metabolic process [GO:0001523]; Schwann cell differentiation [GO:0014037]","SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor; Extracellular side. Endosome. Note=S-nitrosylated form recycled in endosomes. Localizes to CAV1-containing vesicles close to the cell surface. Cleavage of heparan sulfate side chains takes place mainly in late endosomes. Associates with both forms of PRNP in lipid rafts. Colocalizes with APP in perinuclear compartments and with CP in intracellular compartments. Associates with fibrillar APP amyloid-beta peptides in lipid rafts in Alzheimer disease brains.; SUBCELLULAR LOCATION: Secreted glypican-1: Secreted, extracellular space.","Glypican-1 [Cleaved into: Secreted glypican-1]","GO:0001523; GO:0005507; GO:0005576; GO:0005615; GO:0005654; GO:0005768; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0006024; GO:0006027; GO:0007411; GO:0014037; GO:0017134; GO:0030200; GO:0031012; GO:0032288; GO:0040037; GO:0043202; GO:0043236; GO:0043395; GO:0045121; GO:0046658; GO:0050900; GO:0062023; GO:0070062; GO:2001016",6.05012157521244e-05,6.67186722456929e-05,7.00747145708892e-05,0.0224835709244438,0.038732642120965,0.0322052083681769,0.0310747089370057,0.0156031193360257,6.8299235467024,0.00182928968634342,0.0213334056064029,-4.90380159833797,61680,1.67093980943536,7,0,0,6.67186722456929e-05,0.0322052083681769,482.701577896822,8.91498773257174
"508",535,735,735,735,"Q9UN75","PCDHA12","PCDAC_HUMAN","integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Protocadherin alpha-12 (PCDH-alpha-12)","GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399",1e-07,1e-07,1e-07,0.0884105289775182,0.0944855565926961,0.140344962276549,0.107746915948921,0.0538735579744605,6.8199088354959,0.00184005508999444,0.0214147120549281,-4.91092919226089,101652,1.66928776080963,3,3,0,1e-07,0.0944855565926961,944855.565926961,19.8497342849911
"509",536,737,737,737,"Q5VU43","PDE4DIP","MYOME_HUMAN","centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; protein-containing complex scaffold activity [GO:0032947]; astral microtubule organization [GO:0030953]; cellular protein-containing complex assembly [GO:0034622]; positive regulation of microtubule nucleation [GO:0090063]; regulation of Golgi organization [GO:1903358]","SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:27666745}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q9WUJ3}.; SUBCELLULAR LOCATION: Isoform 13: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:29162697}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:29162697}. Golgi apparatus {ECO:0000269|PubMed:25217626}. Note=Associated with the microtubule network at the growing distal tip of microtubules (PubMed:29162697). Targeting to the Golgi apparatus requires AKAP9 (PubMed:25217626). {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:29162697}.","Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein)","GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0019899; GO:0030016; GO:0030953; GO:0032947; GO:0034622; GO:0090063; GO:1903358",6.64535292886437e-05,0.00010634125388374,9.46874233013357e-05,0.0264173960957982,0.01851405588656,0.0162144227969506,0.0202927975242783,0.0102355594976304,6.81417192415417,0.00184625670581488,0.0214436328382298,-4.91501614039379,265103,1.66870163745195,16,0,0,9.46874233013357e-05,0.01851405588656,195.528141341859,7.61123245179623
"510",537,741,741,741,"Q9Y2H9","MAST1","MAST1_HUMAN","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes with syntrophins at the cell membrane. {ECO:0000250}.","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","GO:0000287; GO:0004674; GO:0005524; GO:0005622; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0018105; GO:0035556",0.00026030525018983,0.00020598199201442,0.00015267542225446,0.00097860657156832,0.00095335879601724,0.00068895855037617,0.00066732041783433,0.00053998109707007,6.7958350034363,0.00186624995016183,0.0215553317552582,-4.92809845759584,170677,1.66644528858976,19,0,0,0.00020598199201442,0.00095335879601724,4.62835991968899,2.21050105851633
"511",538,742,742,742,"Q8N2K0","ABHD12","ABD12_HUMAN","AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.","Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12)","GO:0002084; GO:0004622; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0052651",9.08575774364466e-05,0.00012612314900031,0.00010365343655635,0.0569647616218027,0.033003349912057,0.0497527836490828,0.0464667536733165,0.0233402548909893,6.79321762652492,0.00186912514959939,0.0215553317552582,-4.92996819031687,45097,1.66644528858976,6,0,0,0.00010365343655635,0.0497527836490828,479.991646220386,8.90686548714748
"512",539,743,743,743,"Q96FW1","OTUB1","OTUB1_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1)","GO:0002250; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0070062; GO:0071108; GO:0071347; GO:1901315; GO:2000780",0.00011031939397896,6.63662096158731e-05,0.00023356679856743,0.00807685690208232,0.0135362717260867,0.0101039501153464,0.010435608780451,0.00535455519094628,6.79152928799986,0.00187098265118655,0.0215553317552582,-4.93117457809507,31284,1.66644528858976,10,0,0,0.00011031939397896,0.0101039501153464,91.5881582641164,6.517089174454
"513",540,744,744,744,"P78509","RELN","RELN_HUMAN","cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000250}.","Reelin (EC 3.4.21.-)","GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969",0.0189778541169099,0.00950415374611199,0.0238481466324389,0.0543601343740053,0.0570218838584713,0.0708494078629816,0.0433004238666658,0.0390935967651531,6.78436431601325,0.00187889050731865,0.0216173423960318,-4.93629701571526,388388,1.66519769861963,5,0,0,0.0189778541169099,0.0570218838584713,3.0046539248957,1.5871988313394
"514",541,745,745,745,"Q14964","RAB39A","RB39A_HUMAN","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle, phagosome membrane {ECO:0000269|PubMed:24349490}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Lysosome {ECO:0000269|PubMed:24349490}. Note=Recruited to phagosomes containing S.aureus or M.tuberculosis.","Ras-related protein Rab-39A (Rab-39)","GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0006914; GO:0015031; GO:0030670; GO:0045335; GO:0090383; GO:0090385",0.0293542886029441,0.0297512090062351,0.0256993222166159,0.0980421148420346,0.0952475573479535,0.0697544721312297,0.0594131081651409,0.0579748273578355,6.78068423089414,0.00188296793186694,0.0216351751634645,-4.93892975426442,25007,1.6648395843008,7,0,0,0.0293542886029441,0.0952475573479535,3.24475781499268,1.69811080113718
"515",542,747,747,747,"P07741","APRT","APT_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; grooming behavior [GO:0007625]; lactation [GO:0007595]; neutrophil degranulation [GO:0043312]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]","SUBCELLULAR LOCATION: Cytoplasm.","Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)","GO:0002055; GO:0003999; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0006166; GO:0006168; GO:0007595; GO:0007625; GO:0016208; GO:0032869; GO:0034774; GO:0043101; GO:0043312; GO:0044209; GO:0070062",1e-07,1e-07,1e-07,0.0214221957521224,0.0157997938186822,0.0271969087893911,0.0214728661200652,0.0107365330600326,6.77158172191562,0.00189309949565478,0.0216912095752778,-4.94544679306112,19608,1.66371622958001,4,3,0,1e-07,0.0214221957521224,214221.957521224,17.7087468368006
"516",543,748,748,748,"O95996","APC2","APCL_HUMAN","actin filament [GO:0005884]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; beta-catenin binding [GO:0008013]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423}. Golgi apparatus {ECO:0000269|PubMed:11691822}. Cytoplasm {ECO:0000269|PubMed:11691822}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:10646860}. Note=Associated with actin filaments (PubMed:11691822, PubMed:25753423). Associated with microtubule network (PubMed:10644998, PubMed:11691822, PubMed:25753423). {ECO:0000269|PubMed:10644998, ECO:0000269|PubMed:11691822, ECO:0000269|PubMed:25753423}.","Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like)","GO:0000226; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0030496; GO:0031258; GO:0045171; GO:0048471; GO:0090090; GO:0090630",2.08344806939585e-05,2.62015796975108e-05,3.3566917245238e-05,0.0747103064577469,0.128627640212742,0.101384222241358,0.101547188644737,0.0508004619815807,6.76948125478539,0.00189544681802661,0.0216912095752778,-4.94695167547725,243949,1.66371622958001,20,0,0,2.62015796975108e-05,0.101384222241358,3869.39350267456,11.9178917375294
"517",544,749,749,749,"Q9Y5L0","TNPO3","TNPO3_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; signaling receptor activity [GO:0038023]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10713112}. Nucleus {ECO:0000269|PubMed:10713112}.","Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR)","GO:0005737; GO:0008139; GO:0008565; GO:0031965; GO:0038023; GO:0042802; GO:0043231",0.00023930242249982,0.00031923576610979,0.00053172405339228,0.00560405355059458,0.00573322627211327,0.00853623189640696,0.00626108315903764,0.00349396232685278,6.76022744710524,0.00190583035429888,0.0217809183348444,-4.95358618596013,104203,1.66192381331543,21,0,0,0.00031923576610979,0.00573322627211327,17.9592228714797,4.16665301825599
"518",545,750,750,750,"Q13895","BYSL","BYST_HUMAN","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; female pregnancy [GO:0007565]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; trophectodermal cell differentiation [GO:0001829]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17381424}. Nucleus, nucleolus {ECO:0000269|PubMed:17381424}. Note=Associated with 40S ribosomal subunits.","Bystin","GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007155; GO:0007565; GO:0008283; GO:0016020; GO:0043231; GO:0045177",2.63102129302489e-05,6.93716872172458e-05,8.20939472372235e-05,0.121699643991922,0.107525456254096,0.0702846742386347,0.0997773328790893,0.0499479250553395,6.75250946117358,0.00191454344330301,0.021851322499565,-4.9591253425461,49601,1.66052227325272,6,0,0,6.93716872172458e-05,0.107525456254096,1549.99050141835,10.5980436591302
"519",546,751,751,751,"Q96PE2","ARHGEF17","ARHGH_HUMAN","cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]",NA,"Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4)","GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0035023; GO:0043065; GO:0051056",0.0344751670669864,0.00020204952328075,0.00012421419795168,0.132889268918402,0.0966073249998845,0.109722738886093,0.101472634005387,0.0623367939320997,6.74986773004308,0.00191753688810921,0.0218563458884352,-4.96102250216496,221673,1.6604224450003,10,0,0,0.00020204952328075,0.109722738886093,543.048739261968,9.08493787718922
"520",547,752,752,752,"O14733","MAP2K7","MP2K7_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; magnesium ion binding [GO:0000287]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}.","Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)","GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007257; GO:0007346; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0032212; GO:0034612; GO:0042981; GO:0051403; GO:0051973; GO:1904355",0.00090947421508126,0.00186670947157635,0.00225962938908916,0.223691856218095,0.15098075330908,0.26178723892218,0.21047467845787,0.106915943587517,6.71853646999251,0.00195347660716359,0.0221918360648567,-4.98357000047275,47485,1.65380676447154,7,0,0,0.00186670947157635,0.223691856218095,119.832175078213,6.90487151520915
"521",548,755,755,755,"Q6ZTW0","TPGS1","TPGS1_HUMAN","axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium axoneme. Cytoplasm, cytoskeleton, flagellum axoneme. Cytoplasm, cytoskeleton, cilium basal body. Cytoplasm, cytoskeleton, flagellum basal body. Cell projection, axon. Cell projection, dendrite. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Associated with microtubules from neurites, centrosomes, basal bodies and axonemes. {ECO:0000250}.","Tubulin polyglutamylase complex subunit 1 (PGs1)","GO:0005737; GO:0005813; GO:0005874; GO:0007268; GO:0007275; GO:0007288; GO:0008017; GO:0018095; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0051648; GO:0070740",0.0131461839748582,0.0262686517466988,0.027835664839659,0.0750301783919019,0.0596106788188553,0.0792111176332397,0.0488671580942603,0.0468504125675355,6.70342027742237,0.00197110853338847,0.0223479325110004,-4.99447942500592,31275,1.65076264884509,6,0,0,0.0262686517466988,0.0750301783919019,2.85626301324471,1.51412883316006
"522",549,756,756,756,"Q6ZT07","TBC1D9","TBCD9_HUMAN","endomembrane system [GO:0012505]; intracellular [GO:0005622]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of vesicle fusion [GO:0031338]",NA,"TBC1 domain family member 9 (TBC1 domain family member 9A)","GO:0005096; GO:0005509; GO:0005622; GO:0006886; GO:0012505; GO:0017137; GO:0031338; GO:0090630",2.79546199010969e-06,3.67031723705617e-07,3.19244808952018e-05,0.117588713982451,0.183099487350041,0.204320138049859,0.168324417469247,0.0841739043928267,6.69106872583859,0.00198565931624017,0.0224589790929196,-5.00340867587296,143229,1.64860998914262,8,0,0,2.79546199010969e-06,0.183099487350041,65498.8291730829,15.9991814974776
"523",550,757,757,757,"P51665","PSMD7","PSMD7_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; protein homodimerization activity [GO:0042803]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]",NA,"26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40)","GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0016579; GO:0034774; GO:0042803; GO:0043161; GO:0043312; GO:0043687; GO:0070062; GO:1904813",1e-07,1e-07,1e-07,0.00025893741044276,0.00034320653481019,0.00040946594083123,0.00033710329536139,0.00016865164768069,6.69065380847524,0.0019861503707173,0.0224589790929196,-5.00370886610896,37025,1.64860998914262,11,3,0,1e-07,0.00034320653481019,3432.0653481019,11.7448613073378
"524",551,758,758,758,"Q9Y6K1","DNMT3A","DNM3A_HUMAN","chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; aging [GO:0007568]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; hepatocyte apoptotic process [GO:0097284]; methylation-dependent chromatin silencing [GO:0006346]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; regulation of gene expression by genetic imprinting [GO:0006349]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to vitamin A [GO:0033189]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12145218}. Cytoplasm {ECO:0000269|PubMed:12145218}. Note=Accumulates in the major satellite repeats at pericentric heterochromatin. {ECO:0000250}.","DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA)","GO:0000122; GO:0000278; GO:0000775; GO:0000791; GO:0000981; GO:0001741; GO:0003677; GO:0003682; GO:0003886; GO:0005634; GO:0005654; GO:0005720; GO:0005737; GO:0006306; GO:0006346; GO:0006349; GO:0007283; GO:0007568; GO:0009008; GO:0010212; GO:0010288; GO:0010942; GO:0016363; GO:0030182; GO:0032355; GO:0033189; GO:0042220; GO:0042802; GO:0043045; GO:0043046; GO:0045814; GO:0046872; GO:0071230; GO:0071361; GO:0071456; GO:0097284",0.00023066126258341,0.00022732075605782,0.00010741889612844,0.00843797595112836,0.00986055539292971,0.013902082900024,0.0105450711097708,0.00546100252647529,6.68238937201134,0.00199596211037091,0.0225401525920514,-5.00969133607528,101858,1.64704314819845,16,0,0,0.00022732075605782,0.00986055539292971,43.3772769540747,5.43886758431622
"525",552,759,759,759,"P16949","STMN1","STMN1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17)","GO:0000281; GO:0005622; GO:0005737; GO:0005829; GO:0005874; GO:0007019; GO:0007052; GO:0007165; GO:0007409; GO:0007420; GO:0009615; GO:0015631; GO:0016020; GO:0031110; GO:0031115; GO:0031175; GO:0035024; GO:0035556; GO:0043005; GO:0048012; GO:0051272; GO:0051497; GO:0061436; GO:0070062; GO:0070495; GO:1905098",0.00105623495775059,0.00160550093190265,0.00090458068229631,0.00956473786957002,0.0154735389496891,0.0148008145337206,0.0120909249270101,0.00723423465415489,6.67349722453532,0.00200658488168056,0.0226003139123957,-5.01613500766635,17303,1.64588552857497,8,0,0,0.00105623495775059,0.0148008145337206,14.0128050346309,3.80867387324612
"526",553,760,760,760,"Q9BQG0","MYBBP1A","MBB1A_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; core promoter binding [GO:0001047]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression, epigenetic [GO:0045815]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12429849}. Nucleus {ECO:0000269|PubMed:12429849}. Nucleus, nucleolus {ECO:0000269|PubMed:12429849}. Note=Shuttles between the nucleus and cytoplasm. Nuclear import may be mediated by KPNA2, while export appears to depend partially on XPO1/CRM1 (By similarity). Predominantly nucleolar. {ECO:0000250|UniProtKB:Q7TPV4}.","Myb-binding protein 1A","GO:0001047; GO:0001649; GO:0003714; GO:0003723; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006351; GO:0006355; GO:0008134; GO:0016020; GO:0022904; GO:0032922; GO:0042149; GO:0042564; GO:0043231; GO:0043565; GO:0045815; GO:0045892; GO:0071158; GO:0072332; GO:2000210",2.19008798822761e-06,1e-07,1e-07,0.00140339091829647,0.00215381443580605,0.00244210606548003,0.00199897377719811,0.00100028358459513,6.67073996536305,0.00200989270075024,0.0226003139123957,-5.01813448494812,148855,1.64588552857497,15,2,0,1e-07,0.00215381443580605,21538.1443580605,14.3946063378463
"527",554,762,762,762,"Q70CQ3","USP30","UBP30_HUMAN","integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:18287522, ECO:0000269|PubMed:24896179}.","Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30)","GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006511; GO:0008053; GO:0016021; GO:0016579; GO:0035871; GO:0036459; GO:0044313; GO:1901525",0.00016319245314391,0.00019966240002176,0.00018465583334655,0.00048677703368181,0.00043909252147881,0.00057042643090029,0.00031626176651623,0.00034063444542885,6.66911072461567,0.00201185037397728,0.0226003139123957,-5.01931627882593,58503,1.64588552857497,4,0,0,0.00018465583334655,0.00048677703368181,2.63613136319533,1.39842226424141
"528",555,763,763,763,"O15126","SCAMP1","SCAM1_HUMAN","clathrin-coated vesicle [GO:0030136]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; zymogen granule membrane [GO:0042589]; neutrophil degranulation [GO:0043312]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:15840657}; Multi-pass membrane protein {ECO:0000269|PubMed:15840657}. Recycling endosome membrane {ECO:0000269|PubMed:15840657}; Multi-pass membrane protein {ECO:0000269|PubMed:15840657}.","Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)","GO:0005802; GO:0005886; GO:0006892; GO:0015031; GO:0016021; GO:0030136; GO:0030672; GO:0035579; GO:0042589; GO:0043312; GO:0055038",0.00016998374771405,0.00248265935072932,0.00022806583646733,0.0231286388302921,0.0380783747508579,0.0377307455489349,0.0320190167317247,0.0169697446774993,6.66477033642977,0.00201707703287776,0.0226293308013547,-5.02246580427273,37920,1.64532828889,4,0,0,0.00022806583646733,0.0377307455489349,165.437954817664,7.37014644572002
"529",556,765,765,765,"Q6PCB5","RSBN1L","RSBNL_HUMAN","nucleus [GO:0005634]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Round spermatid basic protein 1-like protein","GO:0005634",0.0165323136885287,0.00473541430918576,0.00952500693222176,0.0733711494382819,0.0548170450620629,0.0509522764396575,0.0494492453366887,0.0349888676449897,6.6454716890699,0.00204051683587034,0.0228119908525378,-5.03648999698019,94870,1.6418368112362,3,0,0,0.00952500693222176,0.0548170450620629,5.75506615923024,2.52483251342175
"530",557,766,766,766,"P15586","GNS","GNS_HUMAN","azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]","SUBCELLULAR LOCATION: Lysosome.","N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)","GO:0005576; GO:0006027; GO:0008449; GO:0008484; GO:0035578; GO:0042340; GO:0043202; GO:0043312; GO:0046872; GO:0070062; GO:1904813",1e-07,1e-07,1e-07,0.0208056279105185,0.0319291031682068,0.0364171580411837,0.029717196373303,0.0148586981866515,6.64478791223827,0.00204135338703784,0.0228119908525378,-5.03698750708313,62082,1.6418368112362,11,3,0,1e-07,0.0319291031682068,319291.031682068,18.2845125051728
"531",558,767,767,767,"A1L020","MEX3A","MEX3A_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17267406}. Nucleus {ECO:0000269|PubMed:17267406}. Cytoplasm, P-body {ECO:0000269|PubMed:17267406}. Note=Predominantly expressed in the cytoplasm and shuttles between the cytoplasm and the nucleus through the CRM1 export pathway.","RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4)","GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872",1.42456411352409e-05,8.33554979669808e-05,8.68072050233907e-05,0.12314125370692,0.071431141436825,0.115798874318752,0.103395620372791,0.0517592796344372,6.64188705532344,0.00204490700672278,0.0228219087060587,-5.03909861368859,54173,1.6416480362612,9,0,0,8.33554979669808e-05,0.115798874318752,1389.21699399628,10.4400562487845
"532",559,768,768,768,"P22314","UBA1","UBA1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1376922}. Mitochondrion {ECO:0000269|PubMed:1376922}. Nucleus {ECO:0000269|PubMed:1376922, ECO:0000269|PubMed:22456334}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus {ECO:0000269|PubMed:7528747, ECO:0000269|PubMed:9099746}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:7528747}.","Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)","GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0070062",2.35750532147389e-05,3.42866839381519e-05,4.56405975312719e-05,0.00467540577276735,0.00402061534463265,0.00267912790651826,0.00375721556307804,0.00191310855976707,6.62702981813821,0.00206322563551694,0.0229894427582133,-5.04992290478786,117849,1.63847155548,35,0,0,3.42866839381519e-05,0.00402061534463265,117.264631128669,6.87362412906018
"533",560,769,769,769,"O43173","ST8SIA3","SIA8C_HUMAN","Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.","Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII)","GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743",0.00683481255161206,0.010868676782687,0.00826537297972456,0.104472453333139,0.0635194959720678,0.0858103284706707,0.0759444718206179,0.0466285233483168,6.62394872237739,0.00206704945379175,0.0229894427582133,-5.0521701433942,43970,1.63847155548,4,0,0,0.00826537297972456,0.0858103284706707,10.381906379926,3.3759994781145
"534",561,770,770,770,"P38606","ATP6V1A","VATA_HUMAN","apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]",NA,"V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)","GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0005902; GO:0006879; GO:0008286; GO:0015991; GO:0016241; GO:0016324; GO:0016469; GO:0033180; GO:0033572; GO:0034220; GO:0036295; GO:0043209; GO:0046034; GO:0046961; GO:0070062",6.08247966076147e-05,5.16535715940891e-05,5.67864427895499e-05,0.0562396161580704,0.0336285696381532,0.0569494403077936,0.0488827870976753,0.0244978151525014,6.62320352743629,0.00206797557521312,0.0229894427582133,-5.05271379026617,68304,1.63847155548,33,0,0,5.67864427895499e-05,0.0562396161580704,990.370472165231,9.95182449110413
"535",562,771,771,771,"Q9P2K6","KLHL42","KLH42_HUMAN","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of microtubule-based process [GO:0032886]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19261606}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19261606}. Note=Predominantly in mitotic cells. Localized diffusely in the cytoplasm during the interphase. During metaphase is localized throughout the cell and more widely dispersed than the microtubules. In anaphase cells is localized between the two sets of separated chromosomes as well as at the spindle poles. During telophase is localized arround the nuclei of the two daughter cells. Not detected at the midbody region during cytokinesis.","Kelch-like protein 42 (Cullin-3-binding protein 9) (Ctb9) (Kelch domain-containing protein 5)","GO:0000209; GO:0005819; GO:0005829; GO:0007049; GO:0031463; GO:0032886; GO:0043161; GO:0043687; GO:0051301",1e-07,1e-07,1e-07,0.0449813877629259,0.0270476818765941,0.0461323193239138,0.0393870296544779,0.019693614827239,6.61436345519844,0.00207900044981325,0.0230753597730406,-5.05916678000865,56868,1.63685151906789,10,3,0,1e-07,0.0449813877629259,449813.877629259,18.7789686461752
"536",563,772,772,772,"Q8N1I0","DOCK4","DOCK4_HUMAN","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12628187}. Cell projection {ECO:0000269|PubMed:20679435}. Cytoplasm, cytosol {ECO:0000305|PubMed:20679435}. Note=Colocalizes with EPHA2, RhoG and CTTN/cortactin at the tip of protrusions in migrating cells. {ECO:0000269|PubMed:20679435}.","Dedicator of cytokinesis protein 4","GO:0005085; GO:0005096; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030971; GO:0032420; GO:0032421; GO:0048365; GO:0060326; GO:1904694; GO:1904754",1e-07,1e-07,1.65538274431001e-05,0.00029120821090694,0.00026819516325695,0.00020504406634868,0.00024923120435649,0.00013020021132594,6.61268998966038,0.00208109553093311,0.0230753597730406,-5.060389156962,225206,1.63685151906789,23,2,0,1e-07,0.00026819516325695,2681.9516325695,11.3890675039771
"537",564,774,774,774,"P61160","ACTR2","ARP2_HUMAN","actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; membrane [GO:0016020]; podosome core [GO:0061825]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; associative learning [GO:0008306]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to trichostatin A [GO:0035984]; cilium assembly [GO:0060271]; cytosolic transport [GO:0016482]; ephrin receptor signaling pathway [GO:0048013]; establishment or maintenance of cell polarity [GO:0007163]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of dendritic spine morphogenesis [GO:0061003]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; spindle localization [GO:0051653]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:9000076}. Cell projection {ECO:0000269|PubMed:9000076}.","Actin-related protein 2 (Actin-like protein 2)","GO:0003779; GO:0005200; GO:0005524; GO:0005576; GO:0005737; GO:0005829; GO:0005885; GO:0005925; GO:0007163; GO:0008306; GO:0008356; GO:0014069; GO:0015629; GO:0016020; GO:0016344; GO:0016482; GO:0030027; GO:0030478; GO:0033206; GO:0034314; GO:0035578; GO:0035902; GO:0035984; GO:0038096; GO:0043312; GO:0045471; GO:0048013; GO:0051653; GO:0060271; GO:0061003; GO:0061024; GO:0061825; GO:0070062; GO:0071346; GO:0071437; GO:1904813",1e-07,1e-07,1e-07,0.0128447861106572,0.012044898562776,0.00741989189683625,0.0107697588567565,0.00538497942837825,6.60812176283005,0.00208682774183301,0.0230791285143289,-5.06372729488338,44761,1.63678059450087,19,3,0,1e-07,0.012044898562776,120448.98562776,16.878062718275
"538",565,775,775,775,"Q9NUM4","TMEM106B","T106B_HUMAN","endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; dendrite morphogenesis [GO:0048813]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of dendrite development [GO:1900006]","SUBCELLULAR LOCATION: Late endosome membrane; Single-pass type II membrane protein. Lysosome membrane; Single-pass type II membrane protein. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.","Transmembrane protein 106B","GO:0005764; GO:0005765; GO:0005768; GO:0007040; GO:0007041; GO:0016021; GO:0031902; GO:0032418; GO:0048813; GO:1900006",0.0261166645231321,0.049471929470666,0.0518948197653879,0.160661763154745,0.171274897589561,0.228793749640143,0.144415665541755,0.114702304023939,6.5998887264715,0.00209720701994589,0.0231639897944991,-5.06974820085131,31127,1.6351866350784,4,0,0,0.049471929470666,0.171274897589561,3.46206221229186,1.79163164976479
"539",566,776,776,776,"Q92604","LPGAT1","LGAT1_HUMAN","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15485873}; Multi-pass membrane protein {ECO:0000269|PubMed:15485873}.","Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-)","GO:0003841; GO:0005737; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0036148; GO:0045723; GO:0047144",1e-07,1e-07,1e-07,0.0301247506646064,0.0323152938178369,0.048593583188036,0.0370111092234931,0.0185056546117465,6.59203537825078,0.00210716606646889,0.0232439968156877,-5.07549717956225,43089,1.63368919272945,9,3,0,1e-07,0.0323152938178369,323152.938178369,18.3018575834164
"540",567,777,777,777,"Q8TAD8","SNIP1","SNIP1_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10887155}.","Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1)","GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007249; GO:0035196",1e-07,1e-07,1e-07,0.0601984404668211,0.104239794879791,0.078734458204035,0.0810574645168825,0.0405288322584412,6.5879596113279,0.00211235727798141,0.0232712719427553,-5.07848302440976,45778,1.63317987874063,4,3,0,1e-07,0.078734458204035,787344.58204035,19.5866356451136
"541",569,780,780,780,"Q9ULU8","CADPS","CAPS1_HUMAN","cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; catecholamine secretion [GO:0050432]; exocytosis [GO:0006887]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein transport [GO:0015031]; synaptic vesicle priming [GO:0016082]; vesicle organization [GO:0016050]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Membrane-associated to vesicles. Strongly enriched in synaptic fractions. Preferentially binds to DCVs but not to SVs. Binds phosphoinosides, with a strong selectivity for PtdIns(4,5)P2 over PtdIns(3,4,5)P3. Probably localizes to different vesicles compared to CADPS2 (By similarity). {ECO:0000250}.","Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1)","GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016050; GO:0016082; GO:0019901; GO:0030054; GO:0030659; GO:0046872; GO:0050432; GO:0098793; GO:0099525",2.81561991047886e-05,2.12572126126583e-05,0.00022173959569045,0.00581230888759622,0.00582014203525045,0.00902791507240575,0.00679640432928151,0.00348858650044339,6.57242804519153,0.00213228227400035,0.0234004311095423,-5.08987510401565,152786,1.63077614144581,34,0,0,2.81561991047886e-05,0.00582014203525045,206.709080781454,7.69145795788306
"542",570,781,781,781,"Q6ZN54","DEF8","DEFI8_HUMAN","intracellular [GO:0005622]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]",NA,"Differentially expressed in FDCP 8 homolog (DEF-8)","GO:0005622; GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029",0.102644429714164,0.118895681223177,0.17717959065577,0.270908779334295,0.301522787597106,0.310638037647411,0.1614499676619,0.213631551028654,6.53860613392719,0.00217646620569573,0.0238547384388674,-5.11475920072172,58710,1.62242534100735,4,0,0,0.118895681223177,0.301522787597106,2.53602809198025,1.34257072652469
"543",571,783,783,783,"O75427","LRCH4","LRCH4_HUMAN","basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; PML body [GO:0016605]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; nervous system development [GO:0007399]; signal transduction [GO:0007165]",NA,"Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein)","GO:0005737; GO:0007165; GO:0007399; GO:0016323; GO:0016605; GO:0045199",0.00016291958465149,3.7356449989106e-05,6.99373263296805e-05,0.0545473049659188,0.0402567507215032,0.0705673659737471,0.0550337361000663,0.0276069391703566,6.52254470467546,0.00219783708161742,0.0240274398705557,-5.1266130775161,73450,1.61929250091156,5,0,0,6.99373263296805e-05,0.0545473049659188,779.945528783671,9.60722955977808
"544",572,784,784,784,"Q93050","ATP6V0A1","VPP1_HUMAN","cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; neutrophil degranulation [GO:0043312]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; transferrin transport [GO:0033572]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane; Multi-pass membrane protein. Melanosome. Note=Coated vesicle. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)","GO:0000220; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008286; GO:0010008; GO:0015986; GO:0015991; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030667; GO:0030670; GO:0033572; GO:0034220; GO:0042470; GO:0043231; GO:0043312; GO:0046961; GO:0051117; GO:0070062; GO:0070072; GO:0101003; GO:1901998",1e-07,2.45705478095027e-05,1e-07,0.0224279365031095,0.0278153364054226,0.0384577625943505,0.0295587549850243,0.014787634341782,6.51223842921161,0.00221168445525815,0.0241479833380226,-5.13423201242255,96413,1.6171191324793,15,2,0,1e-07,0.0278153364054226,278153.364054226,18.0855210284375
"545",573,785,785,785,"O75093","SLIT1","SLIT1_HUMAN","extracellular space [GO:0005615]; intracellular [GO:0005622]; calcium ion binding [GO:0005509]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]","SUBCELLULAR LOCATION: Secreted {ECO:0000250}.","Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)","GO:0005509; GO:0005615; GO:0005622; GO:0007097; GO:0007411; GO:0008045; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964",1e-07,1e-07,1e-07,0.189539376688885,0.164167485489166,0.106637827666061,0.153448129948037,0.0767241649740186,6.49226769491842,0.00223881934306606,0.0244131128364911,-5.14902344814594,167926,1.61237684157748,13,3,0,1e-07,0.164167485489166,1641674.85489166,20.6467369889581
"546",574,786,786,786,"P12955","PEPD","PEPD_HUMAN","extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]",NA,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","GO:0004177; GO:0004181; GO:0005634; GO:0005654; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009",0.0173510617300656,4.93587033596149e-05,6.29415749281031e-05,0.0502209408544574,0.0433500687049506,0.0420505228597719,0.0393860568036089,0.0255141490712555,6.48926005272083,0.00224294083059678,0.0244269383077715,-5.15125428658093,54548,1.61213096443745,7,0,0,6.29415749281031e-05,0.0433500687049506,688.735049201875,9.42780528632397
"547",575,787,787,787,"Q99447","PCYT2","PCY2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]",NA,"Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)","GO:0004306; GO:0005789; GO:0006646; GO:0008654",0.0328909363827383,0.044633127830701,0.0302413549160341,0.0782339882736386,0.0908560614389158,0.0719217405695337,0.0444154570508716,0.0581295349019269,6.48266640474576,0.00225200860856971,0.0244945281948625,-5.15614789728865,43835,1.61093092135732,9,0,0,0.0328909363827383,0.0782339882736386,2.37858805122669,1.25010543237072
"548",576,788,788,788,"Q3KQU3","MAP7D1","MA7D1_HUMAN","cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; microtubule cytoskeleton organization [GO:0000226]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15561729}.","MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1)","GO:0000226; GO:0005198; GO:0005819; GO:0005829; GO:0015630",4.18447845834548e-05,9.5935435053477e-06,1e-07,0.00059344546891758,0.000915693108214,0.0010202080530401,0.00082593610069429,0.00043014749304341,6.48024467758913,0.00225535019918682,0.0244997432805066,-5.15794624920691,92820,1.61083846634745,15,1,0,9.5935435053477e-06,0.000915693108214,95.4488930710084,6.57665656155558
"549",577,790,790,790,"Q9Y2X7","GIT1","GIT1_HUMAN","cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; regulation of cytokinesis [GO:0032465]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11896197}. Note=Cycles between at least 3 distinct intracellular compartments, including focal adhesions, cytoplasmic complexes and membrane protrusions. During cell migration, when cells detach, moves from the adhesions into the cytoplasmic complexes towards the leading edge, while, when cells adhere, it is found in vinculin-containing adhesions. Recruitment to adhesions may be mediated by active tyrosine-phosphorylated paxillin.","ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1)","GO:0005096; GO:0005829; GO:0005925; GO:0008277; GO:0016020; GO:0032465; GO:0044877; GO:0046872; GO:0048013",0.00011317116937819,2.83217637220016e-05,0.00013180937701012,0.0325790969115775,0.0250244692069185,0.0435976296154306,0.0336426311412721,0.0169124163406728,6.47309386199752,0.00226525231969468,0.0245450124766917,-5.163259572014,84341,1.610036742804,13,0,0,0.00011317116937819,0.0325790969115775,287.874527501843,8.16929632785083
"550",579,794,794,794,"P50542","PEX5","PEX5_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; negative regulation of protein homotetramerization [GO:1901094]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13).","Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","GO:0000268; GO:0005052; GO:0005622; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016567; GO:0019899; GO:0031267; GO:0032991; GO:0045046; GO:0047485; GO:0051262; GO:1901094",0.00224713364208029,0.00013571884492697,0.00021560190382077,0.0453094618252202,0.0727216619255195,0.0479286264596938,0.0544537652732018,0.0280930341002102,6.44924223656316,0.00229866442298304,0.0247815711092378,-5.18101680748104,70865,1.60587116355951,19,0,0,0.00021560190382077,0.0479286264596938,222.301499246207,7.79637386799916
"551",580,795,795,795,"O95376","ARIH2","ARI2_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism development [GO:0007275]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16118314}. Cytoplasm {ECO:0000269|PubMed:19340006}.","E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein)","GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0007275; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955",0.00022247799050823,0.00061654863652685,0.00044644839621406,0.0327908150180692,0.0534266038266509,0.0575310174443915,0.0474876537552875,0.0241723185520601,6.4361029422376,0.0023173256566169,0.0249513303404285,-5.19082165342525,57819,1.60290629396426,9,0,0,0.00044644839621406,0.0534266038266509,119.670278311481,6.90292107424481
"552",581,796,796,796,"P52429","DGKE","DGKE_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phospholipid biosynthetic process [GO:0008654]; platelet activation [GO:0030168]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Membrane {ECO:0000269|PubMed:23542698}. Cytoplasm {ECO:0000269|PubMed:23542698}.","Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon)","GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0008654; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046834; GO:0046872",0.00093064258334656,0.00102620305102573,0.00693110953213715,0.021673411098146,0.0330055993940126,0.0258633708985348,0.0238848087413947,0.0149050560928671,6.42420275762159,0.00233438578530615,0.0251034451284179,-5.19971587828334,63927,1.60026667303731,8,0,0,0.00102620305102573,0.0258633708985348,25.2029760315791,4.65552219577512
"553",582,797,797,797,"Q75T13","PGAP1","PGAP1_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphoric ester hydrolase activity [GO:0042578]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; forebrain regionalization [GO:0021871]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1)","GO:0004518; GO:0005783; GO:0005789; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0015798; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0042578",9.03343179254244e-05,9.09679863606311e-05,5.71142383713598e-05,0.0161683568140208,0.0155445015192329,0.0249722367173262,0.0188155595026408,0.00948725193220621,6.41347492320283,0.00234989591630698,0.0252385307949658,-5.20774534627655,105383,1.5979359301811,16,0,0,9.03343179254244e-05,0.0161683568140208,178.983548947241,7.4836831798177
"554",584,800,800,800,"P06576","ATP5F1B","ATPB_HUMAN","cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrion organization [GO:0007005]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P00829}; Peripheral membrane protein {ECO:0000250|UniProtKB:P00829}; Matrix side {ECO:0000250|UniProtKB:P00829}.","ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) (ATP synthase F1 subunit beta)","GO:0001525; GO:0001649; GO:0005215; GO:0005524; GO:0005634; GO:0005739; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0007005; GO:0009986; GO:0016020; GO:0022857; GO:0031966; GO:0042288; GO:0042407; GO:0042645; GO:0042776; GO:0043209; GO:0043532; GO:0043536; GO:0045259; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:1902600",1e-07,1e-07,1e-07,0.0138847963175603,0.017171500250255,0.00958457135895354,0.0135468559755896,0.00677352798779482,6.39840506325706,0.00237189528804787,0.0253740804394335,-5.21904309628912,56560,1.59560968769218,21,3,0,1e-07,0.0138847963175603,138847.963175603,17.0831464881941
"555",585,801,801,801,"Q9NVT9","ARMC1","ARMC1_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; metal ion transport [GO:0030001]",NA,"Armadillo repeat-containing protein 1","GO:0005634; GO:0005737; GO:0030001; GO:0046872",1.4197278325208e-05,9.16071563279791e-05,2.82018284578141e-05,0.0226665528095015,0.023906700612538,0.0367350165898524,0.027724754582927,0.0139070460458338,6.39671797931294,0.00237437364859652,0.0253740804394335,-5.22030923018419,31281,1.59560968769218,7,0,0,2.82018284578141e-05,0.023906700612538,847.700376885102,9.7274106182827
"556",587,806,806,806,"Q8N9T8","KRI1","KRI1_HUMAN","90S preribosome [GO:0030686]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]",NA,"Protein KRI1 homolog","GO:0000447; GO:0003723; GO:0005730; GO:0030686",1e-07,1e-07,0.00674093368037705,0.0234302116513821,0.0225988348086897,0.0168779290544533,0.0187219472780494,0.0116080181991504,6.37301149796427,0.00240953319305375,0.0255900795689083,-5.23812926441934,82598,1.59192836373047,6,2,0,1e-07,0.0225988348086897,225988.348086897,17.785888863933
"557",588,808,808,808,"O60716","CTNND1","CTND1_HUMAN","cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; entry of bacterium into host cell [GO:0035635]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:17047063}. Nucleus {ECO:0000269|PubMed:11896187, ECO:0000269|PubMed:17115030}. Cell membrane {ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:17047063}. Note=Interaction with GLIS2 promotes nuclear translocation (By similarity). Detected at cell-cell contacts (PubMed:15240885, PubMed:17047063). NANOS1 induces its translocation from sites of cell-cell contact to the cytoplasm (PubMed:17047063). CDH1 enhances cell membrane localization (PubMed:15240885). Isoforms 4A and 1AB are excluded from the nucleus (PubMed:11896187). {ECO:0000250|UniProtKB:P30999, ECO:0000269|PubMed:11896187, ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:17047063}.; SUBCELLULAR LOCATION: Isoform 1A: Nucleus {ECO:0000269|PubMed:11896187}.; SUBCELLULAR LOCATION: Isoform 2A: Nucleus {ECO:0000269|PubMed:11896187}.; SUBCELLULAR LOCATION: Isoform 3A: Nucleus {ECO:0000269|PubMed:11896187}.","Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas))","GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005915; GO:0006351; GO:0006355; GO:0007155; GO:0007420; GO:0016055; GO:0019901; GO:0030027; GO:0030426; GO:0030496; GO:0034332; GO:0035635; GO:0043197; GO:0045296; GO:0070062; GO:0090090; GO:0098609",7.23186604949885e-05,0.00010461444779676,7.04763131904804e-05,0.05190750994933,0.0300793649751652,0.0517718955623283,0.0445037870217804,0.0223343633180509,6.36614338014784,0.00241983713169306,0.0256358983258572,-5.2433020043544,108170,1.59115145953323,27,0,0,7.23186604949885e-05,0.0517718955623283,715.885709275768,9.48358547024974
"558",589,810,810,810,"Q9BRK5","SDF4","CAB45_HUMAN","bleb [GO:0032059]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium ion regulated exocytosis [GO:0017156]; cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; response to ethanol [GO:0045471]; UV protection [GO:0009650]; zymogen granule exocytosis [GO:0070625]","SUBCELLULAR LOCATION: Isoform 1: Golgi apparatus lumen {ECO:0000250|UniProtKB:Q61112}.; SUBCELLULAR LOCATION: Isoform 5: Cytoplasm {ECO:0000269|PubMed:17442889}. Cell membrane {ECO:0000269|PubMed:17442889}. Cell projection, bleb. Note=Isoform 5 colocalizes with STX3 and STXBP1 isoform 2 at the plasma membrane and cell surface blebs. {ECO:0000269|PubMed:17442889}.","45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4)","GO:0005509; GO:0005737; GO:0005770; GO:0005794; GO:0005796; GO:0005886; GO:0009650; GO:0016020; GO:0017156; GO:0021549; GO:0032059; GO:0042802; GO:0045444; GO:0045471; GO:0070062; GO:0070625",0.00046287166004256,0.00039313449840665,0.00017886627569151,0.00128878705068752,0.00180035281578062,0.00194232267174381,0.00133219670135707,0.00101105582872545,6.34078891124929,0.00245834083608514,0.0259795031566529,-5.26243689865279,41807,1.58536915882062,3,0,0,0.00039313449840665,0.00180035281578062,4.5794831618119,2.19518478566597
"559",590,811,811,811,"Q15067","ACOX1","ACOX1_HUMAN","cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; protein targeting to peroxisome [GO:0006625]; regulation of lipid metabolic process [GO:0019216]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]","SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:P07872}.","Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX)","GO:0000038; GO:0003995; GO:0003997; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0005886; GO:0006091; GO:0006625; GO:0006629; GO:0006693; GO:0007283; GO:0016020; GO:0016401; GO:0016559; GO:0019216; GO:0019395; GO:0030165; GO:0033539; GO:0033540; GO:0036109; GO:0042632; GO:0043231; GO:0047485; GO:0050660; GO:0055088; GO:0071949",9.36408603173253e-05,0.00430368344250786,2.37179812619406e-05,0.031063271712447,0.0436311539515356,0.0266127692021249,0.0322953841940068,0.0176213728583658,6.3362766234287,0.00246527088912269,0.0260206150565847,-5.26584876943753,74424,1.58468244211249,12,0,0,9.36408603173253e-05,0.031063271712447,331.727747985029,8.3738558838605
"560",591,812,812,812,"Q96AY4","TTC28","TTC28_HUMAN","cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250}. Midbody {ECO:0000250}. Note=At interphase, localizes to centrosomes. At prometaphase and metaphase, associated with spindle microtubules and spindle poles. At anaphase, accumulates in the spindle midzone. At telophase, condensed on central spindles. During cytokinesis, condensed on the midbody where it colocalizes with AURKB (By similarity). {ECO:0000250}.","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301",2.51163523852662e-05,1.4340321884367e-05,3.05940364919342e-05,0.00044284734853374,0.00036638865660256,0.00027917860565751,0.00033945463334408,0.00019307755359256,6.33205425115237,0.00247177714029852,0.0260571580307332,-5.26904320145509,270884,1.58407295312366,46,0,0,2.51163523852662e-05,0.00036638865660256,14.5876539308905,3.86667597441284
"561",592,813,813,813,"Q06210","GFPT1","GFPT1_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; IRE1-mediated unfolded protein response [GO:0036498]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]",NA,"Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1)","GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0036498; GO:0070062; GO:0097367",0.0104624255363257,0.00020348232648984,0.00031266594948721,0.106747115477001,0.0647629631498562,0.108553280683914,0.0896949284994898,0.0485069888538458,6.32939539893464,0.00247588484389888,0.0260617269327132,-5.27105563489481,78806,1.58399680993967,12,0,0,0.00031266594948721,0.106747115477001,341.409468002743,8.41535925766352
"562",593,814,814,814,"O14522","PTPRT","PTPRT_HUMAN","cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)","GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0045294; GO:0045295; GO:0045296; GO:0070097",0.00059891588966614,5.06331194754731e-05,8.55811407224879e-05,0.140295471879333,0.0986106553896924,0.0814599950604267,0.106543664059863,0.0535168754132194,6.3278347725652,0.00247829973402203,0.0260617269327132,-5.27223715991527,162134,1.58399680993967,21,0,0,8.55811407224879e-05,0.0986106553896924,1152.24749935801,10.1702349213601
"563",594,815,815,815,"O94985","CLSTN1","CSTN1_HUMAN","cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17332754}; Single-pass type I membrane protein {ECO:0000269|PubMed:17332754}. Golgi apparatus membrane {ECO:0000269|PubMed:17332754}. Cell projection {ECO:0000269|PubMed:17332754}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Nucleus {ECO:0000269|PubMed:17332754}. Note=Neurite tips. Localized in the postsynaptic membrane of both excitatory and inhibitory synapses (By similarity). The AlcICD fragment is translocated to the nucleus upon interaction with APBB1. {ECO:0000250}.","Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]","GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0030054; GO:0042988; GO:0042995; GO:0045211; GO:0050806; GO:0051965",0.0073028986921557,0.0145606749398158,0.0170814271663615,0.272979754205754,0.159975295768374,0.207461015287464,0.200490354821086,0.113226844343321,6.32492743347992,0.00248280612464551,0.0260770802784853,-5.27443888567964,109793,1.58374103602013,3,0,0,0.0145606749398158,0.207461015287464,14.248035626437,3.83269112382441
"564",595,817,817,817,"Q8N8R5","C2orf69","CB069_HUMAN","extracellular region [GO:0005576]","SUBCELLULAR LOCATION: Secreted {ECO:0000305}.","UPF0565 protein C2orf69","GO:0005576",8.41066734596107e-05,0.00011926102820501,6.6214069944205e-05,0.0393847838645126,0.0240745856218084,0.0256452186222542,0.0296116687789888,0.0148956949800307,6.31829235159721,0.0024931277851097,0.0261213878097173,-5.27946668345184,43448,1.58300375304433,6,0,0,8.41066734596107e-05,0.0256452186222542,304.913005917056,8.25225387889529
"565",596,818,818,818,"Q15819","UBE2V2","UB2V2_HUMAN","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; cell proliferation [GO:0008283]; DNA double-strand break processing [GO:0000729]; double-strand break repair via nonhomologous end joining [GO:0006303]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA repair [GO:0006282]",NA,"Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein)","GO:0000209; GO:0000729; GO:0005634; GO:0005654; GO:0005737; GO:0006282; GO:0006301; GO:0006303; GO:0008283; GO:0010976; GO:0016567; GO:0031372; GO:0031625; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0061630; GO:0061631; GO:0070062; GO:0070534",0.0045597431976651,0.00399910858319574,0.00334376577199245,0.0305972211253223,0.02885099176376,0.0448173794837094,0.0307876582733128,0.0193613683209408,6.30269477317137,0.002517597212296,0.0263322755107812,-5.29130266336702,16363,1.57951160959598,6,0,0,0.00399910858319574,0.0305972211253223,7.65101034112749,2.93565027301949
"566",597,819,819,819,"Q9P2R3","ANKFY1","ANFY1_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10940552}. Endosome membrane {ECO:0000269|PubMed:10940552}; Peripheral membrane protein {ECO:0000269|PubMed:10940552}. Early endosome {ECO:0000269|PubMed:15328530}. Note=Also associated with endosomal membranes. Localizes to macropinosomes. {ECO:0000269|PubMed:15328530}.","Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)","GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0017137; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981",0.00025405500957897,0.00012282415791858,0.00010264782663239,0.0149293804157741,0.0141461402811627,0.0230057136725026,0.0172005691251031,0.00876012689392822,6.30154774049743,0.00251940813590302,0.0263322755107812,-5.29217400130571,128399,1.57951160959598,24,0,0,0.00012282415791858,0.0149293804157741,121.550846908071,6.9254161351843
"567",598,820,820,820,"O95394","PGM3","AGM1_HUMAN","cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]",NA,"Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3)","GO:0000287; GO:0004610; GO:0004614; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097",0.00139718043381509,0.00224031939335966,0.0103708092146124,0.0544298152309556,0.061916650289217,0.0377522496376517,0.0466968020386791,0.0280178373666019,6.29777438946324,0.00252537661237057,0.026332996700535,-5.29504130990362,59852,1.57949971527863,9,0,0,0.00224031939335966,0.0544298152309556,24.2955604420898,4.60262080734659
"568",599,822,822,822,"Q3YEC7","RABL6","RABL6_HUMAN","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]","SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:17962191}. Note=Predominantly cytoplasmic (PubMed:17962191).; SUBCELLULAR LOCATION: Isoform 3: Nucleus {ECO:0000269|PubMed:17962191}. Note=Predominantly nuclear (PubMed:17962191).","Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1)","GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829",1e-07,0.00449934626112361,1e-07,0.0130953149049639,0.0189480567467283,0.0145456105491832,0.0140298119799173,0.00851475474366651,6.29567420355565,0.00252870599157007,0.026332996700535,-5.29663780580615,79549,1.57949971527863,17,2,0,1e-07,0.0145456105491832,145456.105491832,17.1502243289907
"569",600,823,823,823,"Q9BWD1","ACAT2","THIC_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]","SUBCELLULAR LOCATION: Cytoplasm.","Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)","GO:0003985; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0006695; GO:0070062",1e-07,1e-07,1e-07,0.00654153784593561,0.00826633551143324,0.00457565536319828,0.00646107624018904,0.00323063812009452,6.28571853441586,0.00254456105437315,0.0264651278313921,-5.30421162540432,41351,1.57732600394613,10,3,0,1e-07,0.00654153784593561,65415.3784593561,15.9973422173974
"570",601,824,824,824,"Q9BXJ3","C1QTNF4","C1QT4_HUMAN","extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469]","SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:21658842}.","Complement C1q tumor necrosis factor-related protein 4","GO:0005125; GO:0005615; GO:0032755; GO:0070105; GO:1901224; GO:1904469; GO:2000778",0.0344533747721693,0.0242175321442969,0.0285747244956755,0.153927876958054,0.111780235074789,0.104950774374102,0.094471084998268,0.0763174196365145,6.2838328250249,0.0025475777258256,0.0264651278313921,-5.30564727293607,35256,1.57732600394613,6,0,0,0.0285747244956755,0.111780235074789,3.91185696616973,1.96785362029778
"571",603,826,826,826,"O15498","YKT6","YKT6_HUMAN","apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; ER to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]","SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasmic vesicle membrane; Lipid-anchor; Cytoplasmic side. Golgi apparatus membrane; Lipid-anchor; Cytoplasmic side. Note=Probably cycles through vesicles between Golgi and endosomes.","Synaptobrevin homolog YKT6 (EC 2.3.1.-)","GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0006906; GO:0015031; GO:0019706; GO:0030133; GO:0030659; GO:0031201; GO:0033116; GO:0042147; GO:0043025; GO:0045296; GO:0097440; GO:0097441",1e-07,6.37126762556843e-06,1e-07,0.0189932339432308,0.0340054570918334,0.0257691331892897,0.0262537509855761,0.0131290659153299,6.27592084646063,0.00256028227803312,0.0265212406551837,-5.3116746758501,22418,1.57640616363463,6,2,0,1e-07,0.0257691331892897,257691.331892897,17.9752844837125
"572",604,827,827,827,"Q9BXB4","OSBPL11","OSB11_HUMAN","Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]","SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000269|PubMed:20599956}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:20599956}. Note=Localizes at the Golgi-late endosome interface.","Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)","GO:0005654; GO:0005794; GO:0006869; GO:0008289; GO:0010890; GO:0031902; GO:0045444",0.00119967006539726,0.00235064540346926,0.00487840850732246,0.0537483698536193,0.0861673660722218,0.0568672246167925,0.0627847455221482,0.0342019474198038,6.27436797110241,0.00256278479095708,0.0265212406551837,-5.31285838386686,83643,1.57640616363463,16,0,0,0.00235064540346926,0.0568672246167925,24.1921748524314,4.59646856688306
"573",605,828,828,828,"P48426","PIP4K2A","PI42A_HUMAN","autophagosome [GO:0005776]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; megakaryocyte development [GO:0035855]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Nucleus {ECO:0000269|PubMed:20583997}. Cytoplasm {ECO:0000269|PubMed:20583997}. Note=May translocate from the cytosol to the cell membrane upon activation of tyrosine phosphorylation. May translocate from the inner to the outer segments of the rod photoreceptor cells in response to light (By similarity). Localization to the nucleus is modulated by the interaction with PIP4K2B. {ECO:0000250}.","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha)","GO:0005524; GO:0005654; GO:0005776; GO:0005829; GO:0005886; GO:0006644; GO:0006661; GO:0010506; GO:0014066; GO:0016308; GO:0016309; GO:0035855; GO:0052811; GO:2000786",0.00509868841495001,0.00336522462510224,0.00491183792252861,0.0411087115114866,0.0281727244875068,0.0474543516042045,0.0344533455468723,0.0216852564276298,6.27169761964035,0.00256709508962026,0.0265212406551837,-5.3148944588117,46225,1.57640616363463,4,0,0,0.00491183792252861,0.0411087115114866,8.36931351560637,3.06510929204121
"574",606,829,829,829,"Q96FK6","WDR89","WDR89_HUMAN",NA,NA,"WD repeat-containing protein 89",NA,0.00010437472400452,7.44548528732083e-05,8.93827690533369e-05,0.0268632093034255,0.0149195780490088,0.0210028262331036,0.0208391337465356,0.0105089709885782,6.27084658336572,0.00256847061952655,0.0265212406551837,-5.31554349850943,43215,1.57640616363463,6,0,0,8.93827690533369e-05,0.0210028262331036,234.976231499057,7.87637102131955
"575",607,831,831,831,"Q9H2Y7","ZNF106","ZN106_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.","Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474)","GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0017124; GO:0046872",0.00033518542583703,0.522414086279962,0.00013941237379791,1.22237661138587,1.23551664092919,1.21804027837651,1.05101494887066,0.69980370246186,6.26251673309137,0.00258198141388635,0.0265965835172889,-5.32189996296987,208883,1.57517414738711,3,0,0,0.00033518542583703,1.22237661138587,3646.86683000412,11.8324418034476
"576",609,833,833,833,"Q6SZW1","SARM1","SARM1_HUMAN","axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to glucose [GO:0009749]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm. Cell projection, axon {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Mitochondrion. Note=Associated with microtubules. {ECO:0000250}.","Sterile alpha and TIR motif-containing protein 1 (Sterile alpha and Armadillo repeat protein) (Sterile alpha motif domain-containing protein 2) (MyD88-5) (SAM domain-containing protein 2) (Tir-1 homolog)","GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0007165; GO:0009749; GO:0030054; GO:0030424; GO:0030425; GO:0031315; GO:0034128; GO:0042981; GO:0045087; GO:0045202; GO:0048814; GO:1901214",2.24778680028579e-05,3.50109202121093e-05,4.1092136836819e-05,0.0129187484264244,0.0143363808666831,0.0079252707964109,0.0116939397214888,0.00587983016909502,6.23989842984547,0.00261910436974442,0.026914205768322,-5.33919413267449,79388,1.57001843158392,25,0,0,3.50109202121093e-05,0.0129187484264244,368.991970166958,8.52744561113802
"577",610,835,835,835,"O75592","MYCBP2","MYCB2_HUMAN","intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26304119, ECO:0000269|PubMed:9689053}. Cell projection, axon {ECO:0000250|UniProtKB:Q7TPH6}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q7TPH6}. Note=Localizes to axon shafts and associates with microtubule cytoskeleton (By similarity). Translocates to the nucleus following interaction with sumoylated RANGAP1 (PubMed:26304119). {ECO:0000250|UniProtKB:Q7TPH6, ECO:0000269|PubMed:26304119}.","E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.-) (Myc-binding protein 2) (Protein associated with Myc)","GO:0005634; GO:0006351; GO:0006355; GO:0016020; GO:0016567; GO:0016740; GO:0043231; GO:0046872",0.0001071212492353,4.42176908590653e-06,1.53727896693009e-05,0.0295441541500133,0.0238144337351162,0.0162031801945014,0.0231449507572135,0.0116147806479369,6.21485354239516,0.0026609672335208,0.0272788976274708,-5.35840235786191,513636,1.56417318401482,70,0,0,1.53727896693009e-05,0.0238144337351162,1549.12896405999,10.5972415372886
"578",611,836,836,836,"P49902","NT5C2","5NTC_HUMAN","cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; drug metabolic process [GO:0017144]; IMP metabolic process [GO:0046040]; purine nucleotide catabolic process [GO:0006195]","SUBCELLULAR LOCATION: Cytoplasm.","Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)","GO:0000166; GO:0005829; GO:0006195; GO:0008253; GO:0017144; GO:0046040; GO:0046085; GO:0046872; GO:0050146",0.00031742790053196,0.00107196783345335,0.00014423662047133,0.00544579850160667,0.00460611828580812,0.00744237399853363,0.00532021947716393,0.00317132052340084,6.21285127912596,0.00266434890738942,0.0272808931187242,-5.35994066865068,64970,1.56414141590029,13,0,0,0.00031742790053196,0.00544579850160667,17.1560171380032,4.10064275715439
"579",612,837,837,837,"Q00610","CLTC","CLH1_HUMAN","clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; transferrin transport [GO:0033572]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}; Cytoplasmic side {ECO:0000269|PubMed:17081065}. Membrane, coated pit {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}; Cytoplasmic side {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15858577, ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:23918938}. Note=Cytoplasmic face of coated pits and vesicles. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. In complex with TACC3 and CKAP5 (forming the TACC3/ch-TOG/clathrin complex) localized to inter-microtubule bridges in mitotic spindles. {ECO:0000269|PubMed:25596274}.","Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)","GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019886; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032802; GO:0032991; GO:0033572; GO:0034383; GO:0036020; GO:0042147; GO:0042470; GO:0043231; GO:0045056; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060071; GO:0060236; GO:0061024; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498",1e-07,1e-07,1e-07,0.00093366901704433,0.00098957431000866,0.00055887674325418,0.00082727335676906,0.00041373667838453,6.20799628358291,0.00267257027163981,0.0273323793610953,-5.36367233946376,191615,1.56332256009603,55,3,0,1e-07,0.00093366901704433,9336.6901704433,13.1886954940229
"580",613,838,838,838,"Q8N9F7","GDPD1","GDPD1_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18991142}. Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000255}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:18991142}. Note=Concentrated at the perinuclear region and the cell periphery (PubMed:18991142). {ECO:0000269|PubMed:18991142}.","Lysophospholipase D GDPD1 (EC 3.1.4.39) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","GO:0004622; GO:0006644; GO:0016020; GO:0016021; GO:0046872; GO:0047391; GO:0048471; GO:0070291",1e-07,1e-07,1e-07,0.00027718690060084,0.0004318950519456,0.00029948412130393,0.00033608869128346,0.00016814434564173,6.19653379985821,0.00269210287184905,0.0274992847052838,-5.37249194943305,36167,1.5606786026275,13,3,0,1e-07,0.00029948412130393,2994.8412130393,11.5482637977818
"581",614,839,839,839,"Q6VAB6","KSR2","KSR2_HUMAN","cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; calcium-mediated signaling [GO:0019722]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.","Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1)","GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0019722; GO:0043410; GO:0046872",0.00014799850572494,0.00015038488296896,0.00015491894511915,0.0884549746656563,0.101023015998592,0.0552660067234752,0.0814302316846367,0.040866216620256,6.19052453843157,0.00270241200367355,0.0275716886191247,-5.37712087745659,107632,1.55953663485504,9,0,0,0.00015038488296896,0.0884549746656563,588.190600806025,9.20013992014237
"582",616,841,841,841,"Q9HCM7","FBRSL1","FBSL_HUMAN","RNA binding [GO:0003723]",NA,"Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9)","GO:0003723",7.99204208731302e-05,6.75203519163649e-05,0.00011656626383708,0.0688515493789031,0.0581389298923774,0.10052091975229,0.0757491306623148,0.0379625676766996,6.17740573308319,0.00272508445716662,0.027730409915705,-5.38723874943881,110907,1.55704371055871,5,0,0,7.99204208731302e-05,0.0688515493789031,861.501336288026,9.75070922401324
"583",617,842,842,842,"P07384","CAPN1","CAN1_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; endopeptidase activity [GO:0004175]; cornification [GO:0070268]; mammary gland involution [GO:0060056]; neutrophil degranulation [GO:0043312]; positive regulation of cell proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21531719, ECO:0000269|PubMed:8769305}. Cell membrane {ECO:0000269|PubMed:8769305}. Note=Translocates to the plasma membrane upon Ca(2+) binding. In granular keratinocytes and in lower corneocytes, colocalizes with FLG and FLG2 (PubMed:21531719). {ECO:0000269|PubMed:21531719}.","Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)","GO:0004175; GO:0004198; GO:0005509; GO:0005576; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008284; GO:0016020; GO:0016241; GO:0032801; GO:0043312; GO:0050790; GO:0060056; GO:0070062; GO:0070268; GO:0097264; GO:1904813; GO:2000310",1e-07,1e-07,6.21131692949998e-06,0.00033221913880636,0.00057917546035748,0.00051741088863982,0.00047413139029139,0.00023920280078886,6.17590800476273,0.0027276875174093,0.027730409915705,-5.38839496109561,81890,1.55704371055871,17,2,0,1e-07,0.00051741088863982,5174.1088863982,12.337094699762
"584",618,843,843,843,"P61019","RAB2A","RAB2A_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; post-translational protein modification [GO:0043687]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:17081065}; Lipid-anchor {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Endoplasmic reticulum membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Golgi apparatus membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","Ras-related protein Rab-2A","GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0015031; GO:0019003; GO:0033116; GO:0042470; GO:0043687; GO:0070062",1e-07,1e-07,1e-07,0.00374033828461534,0.00369128458363204,0.00210920373640107,0.00318017553488282,0.00159018776744141,6.15054123212437,0.0027722358871394,0.0281175717395143,-5.40801153518784,23546,1.55102218812112,7,3,0,1e-07,0.00369128458363204,36912.8458363204,15.1718353475767
"585",619,844,844,844,"Q9UQB3","CTNND2","CTND2_HUMAN","adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; beta-catenin binding [GO:0008013]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35927}. Cell junction, adherens junction {ECO:0000250|UniProtKB:O35927}. Cell projection, dendrite {ECO:0000250|UniProtKB:O35116}. Perikaryon {ECO:0000269|PubMed:22022388}.","Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin)","GO:0005634; GO:0005737; GO:0005912; GO:0006351; GO:0006355; GO:0007155; GO:0007165; GO:0008013; GO:0016055; GO:0030425; GO:0043204; GO:0050808; GO:0060828; GO:0060997; GO:0098609",0.00023339908750242,0.00102213866171935,0.00034551998058705,0.064201596242618,0.0725941754501176,0.0397948564766481,0.0583298568131916,0.0296986143165321,6.15048251767405,0.00277234001730725,0.0281175717395143,-5.40805701476365,132656,1.55102218812112,28,0,0,0.00034551998058705,0.064201596242618,185.811530012063,7.53769621665738
"586",620,845,845,845,"C9J069","AJM1","AJM1_HUMAN","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]","SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250|UniProtKB:A0A1C3NSL9}. Cell projection, cilium {ECO:0000250|UniProtKB:A0A1C3NSL9}. Cell junction, adherens junction {ECO:0000250|UniProtKB:A0A1C3NSL9}.","Apical junction component 1 homolog","GO:0005912; GO:0005929; GO:0016324",0.0179320663448659,0.0263615531611601,0.0674456104777579,0.150593905136675,0.155020518856832,0.201162399970415,0.13167919799338,0.103086008991284,6.13893013314141,0.00279292064607274,0.0282750963495431,-5.417012092087,106650,1.54859590650848,12,0,0,0.0263615531611601,0.155020518856832,5.88055331600234,2.55595190824123
"587",621,846,846,846,"P11137","MAP2","MTAP2_HUMAN","apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}. Cell projection, dendrite {ECO:0000250|UniProtKB:P20357}.","Microtubule-associated protein 2 (MAP-2)","GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005516; GO:0005730; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0008017; GO:0014069; GO:0016358; GO:0021954; GO:0030010; GO:0030425; GO:0030517; GO:0031113; GO:0031115; GO:0031175; GO:0032839; GO:0034399; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0043203; GO:0044294; GO:0044307; GO:0048813; GO:0071310; GO:0097441; GO:0097442; GO:0150001; GO:0150002; GO:0150014; GO:1901953; GO:1902513; GO:1902737; GO:1903744; GO:1903827; GO:1904527; GO:1990635; GO:1990769; GO:2000575",1.3210746917957e-05,1.90228292892339e-05,2.78813154854801e-05,0.00131035831543906,0.00117226006445787,0.00072939260394879,0.00105063203071768,0.00054535431258973,6.13634528012493,0.00279755087037199,0.0282750963495431,-5.41901763020779,199526,1.54859590650848,81,0,0,1.90228292892339e-05,0.00117226006445787,61.6238545083995,5.94541701917043
"588",622,847,847,847,"P61086","UBE2K","UBE2K_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61085}.","Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase)","GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0010800; GO:0010994; GO:0016567; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0070059; GO:0070936",0.00343597270792946,0.00166141375650061,0.00338035632524764,0.0469175791667879,0.052831487706058,0.0779774164688299,0.056416246850666,0.0310340376885589,6.13621686258937,0.00279778114580176,0.0282750963495431,-5.41911728442927,22407,1.54859590650848,6,0,0,0.00338035632524764,0.052831487706058,15.6289700323789,3.96615080104706
"589",623,849,849,849,"Q9HCN4","GPN1","GPN1_HUMAN","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11058119, ECO:0000269|PubMed:20855544}. Nucleus {ECO:0000269|PubMed:20855544}. Note=Shuttles between the nucleus and the cytoplasm. {ECO:0000269|PubMed:20855544}.","GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)","GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829",1e-07,1e-07,1e-07,0.0183677783399109,0.0284298912409498,0.0169984524613487,0.0212652740140698,0.0106327370070349,6.1221798009593,0.00282309102851256,0.0284636739741667,-5.43002028898051,41740,1.54570904368508,4,3,0,1e-07,0.0183677783399109,183677.783399109,17.4868176114019
"590",624,850,850,850,"Q12972","PPP1R8","PP1R8_HUMAN","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ribonuclease E activity [GO:0008995]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; negative regulation of protein dephosphorylation [GO:0035308]; regulation of transcription, DNA-templated [GO:0006355]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Nucleus speckle. Note=Primarily, but not exclusively, nuclear.; SUBCELLULAR LOCATION: Isoform Gamma: Cytoplasm. Note=Found mainly in the cytoplasm.","Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) [Includes: Activator of RNA decay (EC 3.1.4.-) (ARD-1)]","GO:0003677; GO:0003723; GO:0003729; GO:0004519; GO:0004865; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006351; GO:0006355; GO:0006397; GO:0006401; GO:0008283; GO:0008380; GO:0008995; GO:0016607; GO:0035308",0.0078695692481433,0.0133124448839986,0.0246318929944329,0.0553053057482514,0.0708290862322343,0.0526569203192203,0.044325801724377,0.0374342032377135,6.11887938701852,0.00282908211877164,0.0284905211019826,-5.43258670108566,38479,1.54529960728401,9,0,0,0.0133124448839986,0.0553053057482514,4.15440636413284,2.05464234060378
"591",625,852,852,852,"Q9Y4K4","MAP4K5","M4K5_HUMAN","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9038372}.","Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5)","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007257; GO:0007346; GO:0008349; GO:0035556; GO:0042981",1e-07,1e-07,1e-07,0.0321507260203038,0.0594543537331574,0.0512624884718569,0.0476224227417727,0.0238113113708864,6.10848206732652,0.00284805678150015,0.0286142794009874,-5.44067887696781,95024,1.54341718654103,18,3,0,1e-07,0.0512624884718569,512624.884718569,18.9675439885495
"592",626,853,853,853,"P20337","RAB3B","RAB3B_HUMAN","anchored component of synaptic vesicle membrane [GO:0098993]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; peptidyl-cysteine methylation [GO:0018125]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of vesicle size [GO:0097494]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Golgi apparatus {ECO:0000250|UniProtKB:Q9CZT8}. Note=Colocalizes with GAS8/DRC4 in the Golgi apparatus. {ECO:0000250|UniProtKB:Q9CZT8}.","Ras-related protein Rab-3B","GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0015031; GO:0017157; GO:0018125; GO:0019003; GO:0019882; GO:0030141; GO:0030742; GO:0031489; GO:0031982; GO:0048471; GO:0051586; GO:0070062; GO:0097494; GO:0098993",1e-07,0.00348099340464817,1e-07,0.00770159958468834,0.00871754491522737,0.00819522887787972,0.00704439332438242,0.0046825944637406,6.10562453821367,0.00285329861436341,0.0286333366224511,-5.44290478981215,24758,1.54312804100091,5,2,0,1e-07,0.00819522887787972,81952.2887787972,16.3224966212929
"593",627,854,854,854,"Q9P0I2","EMC3","EMC3_HUMAN","ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:22119785}; Multi-pass membrane protein {ECO:0000269|PubMed:22119785}.","ER membrane protein complex subunit 3 (Transmembrane protein 111)","GO:0016021; GO:0034975; GO:0072546",1e-07,1e-07,1e-07,0.056205698265719,0.0506972960359829,0.0305331023732204,0.0458119322249741,0.022906066112487,6.0916770548754,0.00287905203360007,0.0288579454421741,-5.45378124680336,29952,1.53973459198435,4,3,0,1e-07,0.0506972960359829,506972.960359829,18.951549276902
"594",628,855,855,855,"P05067","APP","A4_HUMAN","amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; intracellular [GO:0005622]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588]; acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; receptor activator activity [GO:0030546]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]; activation of MAPK activity [GO:0000187]; activation of MAPKKK activity [GO:0000185]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular process [GO:0009987]; cellular protein metabolic process [GO:0044267]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; cholesterol metabolic process [GO:0008203]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G-protein coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; platelet degranulation [GO:0002576]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cAMP metabolic process [GO:0030816]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G-protein coupled receptor internalization [GO:1904022]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of response to calcium ion [GO:1905945]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; tumor necrosis factor production [GO:0032640]; visual learning [GO:0008542]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. Membrane, clathrin-coated pit. Note=Cell surface protein that rapidly becomes internalized via clathrin-coated pits. During maturation, the immature APP (N-glycosylated in the endoplasmic reticulum) moves to the Golgi complex where complete maturation occurs (O-glycosylated and sulfated). After alpha-secretase cleavage, soluble APP is released into the extracellular space and the C-terminal is internalized to endosomes and lysosomes. Some APP accumulates in secretory transport vesicles leaving the late Golgi compartment and returns to the cell surface. Gamma-CTF(59) peptide is located to both the cytoplasm and nuclei of neurons. It can be translocated to the nucleus through association with APBB1 (Fe65). Amyloid-beta protein 42 associates with FRPL1 at the cell surface and the complex is then rapidly internalized. APP sorts to the basolateral surface in epithelial cells. During neuronal differentiation, the Thr-743 phosphorylated form is located mainly in growth cones, moderately in neurites and sparingly in the cell body. Casein kinase phosphorylation can occur either at the cell surface or within a post-Golgi compartment. Associates with GPC1 in perinuclear compartments. Colocalizes with SORL1 in a vesicular pattern in cytoplasm and perinuclear regions.","Amyloid-beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]","GO:0000122; GO:0000185; GO:0000187; GO:0001774; GO:0001878; GO:0001934; GO:0001967; GO:0002265; GO:0002576; GO:0003677; GO:0004867; GO:0005102; GO:0005109; GO:0005158; GO:0005178; GO:0005576; GO:0005615; GO:0005622; GO:0005641; GO:0005737; GO:0005768; GO:0005769; GO:0005788; GO:0005790; GO:0005791; GO:0005794; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005905; GO:0005911; GO:0006378; GO:0006417; GO:0006468; GO:0006878; GO:0006897; GO:0006979; GO:0007155; GO:0007176; GO:0007186; GO:0007193; GO:0007204; GO:0007219; GO:0007409; GO:0007611; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008088; GO:0008201; GO:0008203; GO:0008285; GO:0008306; GO:0008344; GO:0008542; GO:0009986; GO:0009987; GO:0010288; GO:0010468; GO:0010628; GO:0010629; GO:0010739; GO:0010800; GO:0010823; GO:0010971; GO:0014005; GO:0016020; GO:0016021; GO:0016199; GO:0016322; GO:0016358; GO:0016504; GO:0019722; GO:0019731; GO:0019732; GO:0019899; GO:0030111; GO:0030134; GO:0030198; GO:0030424; GO:0030546; GO:0030549; GO:0030816; GO:0030900; GO:0031093; GO:0031175; GO:0031594; GO:0031904; GO:0032092; GO:0032588; GO:0032640; GO:0032930; GO:0032991; GO:0033130; GO:0033138; GO:0034121; GO:0034185; GO:0034363; GO:0034364; GO:0035235; GO:0035253; GO:0040014; GO:0042056; GO:0042157; GO:0042327; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043198; GO:0043235; GO:0043280; GO:0043395; GO:0043410; GO:0043687; GO:0044267; GO:0044304; GO:0045087; GO:0045121; GO:0045177; GO:0045202; GO:0045429; GO:0045665; GO:0045666; GO:0045745; GO:0045931; GO:0045944; GO:0046330; GO:0046875; GO:0046914; GO:0046982; GO:0046983; GO:0048143; GO:0048169; GO:0048471; GO:0048669; GO:0050730; GO:0050750; GO:0050803; GO:0050808; GO:0050829; GO:0050830; GO:0050867; GO:0050885; GO:0051044; GO:0051087; GO:0051091; GO:0051092; GO:0051124; GO:0051233; GO:0051247; GO:0051260; GO:0051262; GO:0051402; GO:0051425; GO:0051563; GO:0051897; GO:0061098; GO:0061844; GO:0061890; GO:0061903; GO:0070062; GO:0070206; GO:0070374; GO:0070381; GO:0070851; GO:0071320; GO:0071874; GO:0090026; GO:0090090; GO:0090647; GO:0097449; GO:0097645; GO:0098815; GO:0106003; GO:0150003; GO:1900122; GO:1900181; GO:1900272; GO:1900273; GO:1901215; GO:1901216; GO:1901224; GO:1902004; GO:1902949; GO:1902950; GO:1903048; GO:1903223; GO:1903980; GO:1904022; GO:1904399; GO:1904591; GO:1904646; GO:1905893; GO:1905896; GO:1905898; GO:1905906; GO:1905908; GO:1905945; GO:1990000; GO:1990090; GO:1990535; GO:1990761; GO:1990777; GO:1990812; GO:2000310; GO:2000406; GO:2000463",1e-07,1e-07,6.09646046172902e-05,0.00033681605760461,0.00030623519906633,0.00023512215706412,0.00027233626970592,0.00015655633639206,6.0872990824204,0.00288719372873268,0.0289057056350313,-5.45719932363757,86943,1.53901642432866,16,2,0,1e-07,0.00030623519906633,3062.3519906633,11.5804244022479
"595",629,856,856,856,"Q7L775","EPM2AIP1","EPMIP_HUMAN","cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:12782127}.","EPM2A-interacting protein 1 (Laforin-interacting protein)","GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0005783; GO:0032868; GO:0042802; GO:0045725; GO:2000467",1e-07,0.00190982198334158,1e-07,0.0451410960311513,0.08112989170343,0.059748347855274,0.0613697712021712,0.0313215595955328,6.08213975683441,0.00289682430514171,0.0289682430514171,-5.46122993678093,70370,1.53807784432725,9,2,0,1e-07,0.059748347855274,597483.47855274,19.188539295079
"596",630,857,857,857,"Q8WXF1","PSPC1","PSPC1_HUMAN","cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; core promoter binding [GO:0001047]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus matrix {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus speckle. Note=In punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles. Colocalizes with NONO and SFPQ in paraspeckles and perinucleolar caps in an RNA-dependent manner. May cycle between paraspeckles and nucleolus. In telophase, when daughter nuclei form, localizes to perinucleolar caps.","Paraspeckle component 1 (Paraspeckle protein 1)","GO:0000398; GO:0000976; GO:0000981; GO:0001047; GO:0001650; GO:0002218; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006355; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045087; GO:0045892; GO:0048511",8.76043047146617e-05,0.00012158694865849,0.00019783253655668,0.0115277798617532,0.0196659949251568,0.0209333774895264,0.0172400428288355,0.00875569601106105,6.06986284093119,0.00291989761254542,0.0291642844500534,-5.47083190582163,58744,1.53514867458132,8,0,0,0.00012158694865849,0.0196659949251568,161.744291983131,7.33757098964051
"597",631,858,858,858,"P21579","SYT1","SYT1_HUMAN","axon [GO:0030424]; cell junction [GO:0030054]; chromaffin granule membrane [GO:0042584]; clathrin-coated vesicle membrane [GO:0030665]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; dense core granule [GO:0031045]; excitatory synapse [GO:0060076]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; 1-phosphatidylinositol binding [GO:0005545]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; fast, calcium ion-dependent exocytosis of neurotransmitter [GO:0098746]; glutamate secretion [GO:0014047]; membrane organization [GO:0061024]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of vesicle fusion [GO:0031340]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of regulated secretory pathway [GO:1903305]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic vesicle endocytosis [GO:0048488]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000250|UniProtKB:P21707}; Single-pass membrane protein {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:P21707}; Single-pass membrane protein {ECO:0000250|UniProtKB:P21707}. Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane {ECO:0000250|UniProtKB:P21707}; Single-pass membrane protein {ECO:0000250|UniProtKB:P21707}. Cytoplasm {ECO:0000250|UniProtKB:P21707}. Note=Synaptic vesicles and chromaffin granules. {ECO:0000250|UniProtKB:P21707}.","Synaptotagmin-1 (Synaptotagmin I) (SytI) (p65)","GO:0000149; GO:0001786; GO:0005509; GO:0005513; GO:0005516; GO:0005544; GO:0005545; GO:0005546; GO:0005794; GO:0005829; GO:0005886; GO:0006906; GO:0007268; GO:0007269; GO:0007420; GO:0008021; GO:0008022; GO:0014047; GO:0014059; GO:0017075; GO:0017157; GO:0017158; GO:0030054; GO:0030276; GO:0030285; GO:0030348; GO:0030424; GO:0030665; GO:0030672; GO:0031045; GO:0031201; GO:0031340; GO:0042584; GO:0042734; GO:0042802; GO:0043005; GO:0044306; GO:0045956; GO:0046982; GO:0048278; GO:0048306; GO:0048488; GO:0048791; GO:0050750; GO:0050806; GO:0051260; GO:0051291; GO:0051966; GO:0060076; GO:0060201; GO:0060203; GO:0061024; GO:0061202; GO:0070083; GO:0071277; GO:0098746; GO:1903305; GO:1903861",3.63853757200362e-05,0.00021945601271744,5.80520126899785e-05,0.0254454595927198,0.0327665394250821,0.045633990525827,0.0345106987141671,0.0173599804907927,6.06809281352275,0.00292324253015722,0.0291642844500534,-5.47221753875249,47573,1.53514867458132,11,0,0,5.80520126899785e-05,0.0327665394250821,564.434166995533,9.1406615112731
"598",632,859,859,859,"Q6ZW49","PAXIP1","PAXI1_HUMAN","chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; vasculogenesis [GO:0001570]","SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000250|UniProtKB:Q6NZQ4}. Chromosome {ECO:0000269|PubMed:15456759, ECO:0000269|PubMed:17690115}. Note=Localizes to DNA damage foci upon ionizing radiation. {ECO:0000269|PubMed:15456759, ECO:0000269|PubMed:17690115}.","PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)","GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0006351; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022",0.00019117076555043,0.00016819196169694,0.00051830915140403,0.154110388321908,0.0830708515900555,0.132973332903252,0.123092300312188,0.0618387074489779,6.06448427555379,0.00293007615780858,0.0291984306296175,-5.47504340540069,121341,1.53464049057944,6,0,0,0.00019117076555043,0.132973332903252,695.573575386317,9.44205931594533
"599",633,860,860,860,"O60231","DHX16","DHX16_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20423332, ECO:0000269|PubMed:20841358, ECO:0000269|PubMed:25296192}. Nucleus, nucleoplasm {ECO:0000269|PubMed:20423332}.","Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16)","GO:0000398; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887",4.29132145127235e-05,2.21903618048442e-05,0.00098944000750158,0.0506088895758702,0.0277597304408082,0.0469361509338203,0.0414167424555598,0.0210598857557196,6.0601696906446,0.00293827224949049,0.0292460586693472,-5.47842392640898,119264,1.53393265311981,14,0,0,4.29132145127235e-05,0.0469361509338203,1093.74586515545,10.0950618475901
"600",634,861,861,861,"O60503","ADCY9","ADCY9_HUMAN","axon [GO:0030424]; dendrite [GO:0030425]; guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to glucagon stimulus [GO:0071377]; cGMP biosynthetic process [GO:0006182]; G-protein coupled receptor signaling pathway [GO:0007186]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10987815, ECO:0000269|PubMed:9628827}; Multi-pass membrane protein {ECO:0000305}.","Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (ACIX) (Adenylyl cyclase 9) (AC9)","GO:0003091; GO:0004016; GO:0004383; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0006182; GO:0007165; GO:0007186; GO:0007189; GO:0007193; GO:0008074; GO:0016021; GO:0030424; GO:0030425; GO:0046872; GO:0071377; GO:0071880",0.0175911426429617,0.00831664373920742,0.0088693036569797,0.0331781765571313,0.0316475597659914,0.0403099473326295,0.0234528645388678,0.0233187956158168,6.05594191082781,0.00294633037322998,0.0292922044074897,-5.48173827987532,150701,1.53324794392153,15,0,0,0.0088693036569797,0.0331781765571313,3.74078708321388,1.90334185342333
"601",635,862,862,862,"Q8NEY1","NAV1","NAV1_HUMAN","axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule bundle formation [GO:0001578]; neuron migration [GO:0001764]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associates with a subset of microtubule plus ends. Enriched in neuronal growth cones (By similarity). {ECO:0000250}.","Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1)","GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0043194",0.00024684328305591,0.00037582096286843,0.00028156498416616,0.0331904923075517,0.031060775915611,0.0517914351483737,0.0383794913804819,0.0194911554336045,6.0482488601045,0.00296106200377716,0.0294045136337964,-5.48777391140983,202472,1.53158599966291,41,0,0,0.00028156498416616,0.0331904923075517,117.878621895559,6.88115828907794
"602",636,863,863,863,"Q155Q3","DIXDC1","DIXC1_HUMAN","cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:16814745, ECO:0000269|PubMed:19375513, ECO:0000269|PubMed:20085589}. Note=Colocalizes with gamma-tubulin at the centrosome, both during interphase and mitosis.; SUBCELLULAR LOCATION: Isoform 1: Cell junction, focal adhesion. Note=Associated with actin stress fiber at the filament ends.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.","Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1)","GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0090263",0.161823050913622,0.217982301640034,0.177003181764454,0.342525618734634,0.383997145769579,0.450196670327677,0.206636966837927,0.288921328191667,6.02979494225989,0.00299676484942245,0.0297245737092192,-5.50227678408311,77478,1.52688436503766,4,0,0,0.177003181764454,0.383997145769579,2.16943640188672,1.11732029344781
"603",637,864,864,864,"Q15126","PMVK","PMVK_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; regulation of cholesterol biosynthetic process [GO:0045540]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10191291, ECO:0000269|PubMed:27052676}.","Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2)","GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0045540; GO:0070062; GO:0070723",1e-07,1e-07,0.00019012467848525,0.0409365166336296,0.0317221431819027,0.0571740004950427,0.0432141118773632,0.0216704974981767,6.02655764413204,0.00300308164794941,0.0297527533639432,-5.50482457327215,21995,1.52647283781993,4,2,0,1e-07,0.0409365166336296,409365.166336296,18.6430288203449
"604",638,865,865,865,"Q06587","RING1","RING1_HUMAN","cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin-protein transferase activator activity [GO:0097027]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}. Nucleus speckle {ECO:0000269|PubMed:21282530}.","E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein)","GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0009952; GO:0016607; GO:0016740; GO:0031519; GO:0035102; GO:0035518; GO:0045892; GO:0046872; GO:0048593; GO:0070317; GO:0097027",1e-07,1e-07,1e-07,0.0423295396981308,0.0791544970103375,0.0682738605555006,0.063252532421323,0.0316263662106615,6.00859229662642,0.00303843088695306,0.0300681715518129,-5.51898312335418,42429,1.52189298058262,5,3,0,1e-07,0.0682738605555006,682738.605555006,19.380973806025
"605",639,867,867,867,"Q96PQ0","SORCS2","SORC2_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; neuropeptide signaling pathway [GO:0007218]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","VPS10 domain-containing receptor SorCS2","GO:0007218; GO:0008188; GO:0016020; GO:0016021",3.54944285222211e-06,1e-07,8.30518892963208e-07,0.00030993027281628,0.00047836070887679,0.00031044926645015,0.00036475342879934,0.0001838700349814,5.99965388471945,0.00305620589858822,0.0301743050656461,-5.52603993163292,128152,1.52036272320677,11,1,0,8.30518892963208e-07,0.00031044926645015,373.801570416415,8.54612881992579
"606",640,868,868,868,"Q9NRL3","STRN4","STRN4_HUMAN","cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Note=CTTNBP2-binding may regulate dendritic spine distribution. {ECO:0000250}.","Striatin-4 (Zinedin)","GO:0005516; GO:0005737; GO:0016020; GO:0032991; GO:0043197; GO:0044877; GO:0051721; GO:0070016",1e-07,1e-07,1e-07,0.0338549447871342,0.0528827521816905,0.0634719687844025,0.0500697885844091,0.0250349942922045,5.99595880316847,0.00306359071055363,0.0302123692192846,-5.52895958601744,80596,1.51981521651697,9,3,0,1e-07,0.0528827521816905,528827.521816905,19.0124377355403
"607",641,869,869,869,"Q8WVM0","TFB1M","TFB1M_HUMAN","mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; mitochondrion organization [GO:0007005]; regulation of transcription, DNA-templated [GO:0006355]; rRNA modification [GO:0000154]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11809803}.","Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (h-mtTFB) (h-mtTFB1) (hTFB1M) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)","GO:0000154; GO:0000179; GO:0003677; GO:0003723; GO:0005759; GO:0006351; GO:0006355; GO:0007005; GO:0042645",0.00628186913618512,0.0129427266558801,0.00755619307652735,0.256002242777047,0.154275016956933,0.16843501698556,0.183977162616983,0.100915510931356,5.98830608791333,0.00307895382754718,0.0303289352863105,-5.53501084961236,39543,1.51814283556459,4,0,0,0.00755619307652735,0.16843501698556,22.2909890310755,4.47838872398269
"608",642,872,872,872,"P62829","RPL23","RL23_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; ribosomal protein import into nucleus [GO:0006610]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",NA,"60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14)","GO:0000122; GO:0000184; GO:0001223; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006610; GO:0006614; GO:0008284; GO:0010628; GO:0016020; GO:0022625; GO:0031625; GO:0032986; GO:0032991; GO:0045944; GO:0050821; GO:0070062; GO:0070180; GO:0071157; GO:0071158; GO:0072717; GO:1901798; GO:1904667; GO:1990948; GO:2000059",0.0223246208663971,1e-07,1e-07,0.204369937746962,0.11619668061087,0.189137857983871,0.162459885158435,0.0886715495346834,5.97569346537613,0.00310447805095954,0.0304751515094193,-5.54499734996645,14865,1.51605412657779,6,2,0,1e-07,0.189137857983871,1891378.57983871,20.8510067325012
"609",643,875,875,875,"Q96KA5","CLPTM1L","CLP1L_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein) (Cisplatin resistance-related protein 9) (CRR9p)","GO:0006915; GO:0016020; GO:0016021",1e-07,1e-07,1e-07,0.0193374442809132,0.0360554870057877,0.0327238842556366,0.0293721718474459,0.0146861859237229,5.96551446807123,0.00312526415225101,0.0305740127351642,-5.5530690092095,62229,1.51464755785972,6,3,0,1e-07,0.0327238842556366,327238.842556366,18.3199844777211
"610",644,876,876,876,"P35249","RFC4","RFC4_HUMAN","Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37)","GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006271; GO:0006281; GO:0006283; GO:0006296; GO:0006297; GO:0019899; GO:0019985; GO:0031390; GO:0032201; GO:0033683; GO:0042276; GO:0042769; GO:0070987; GO:1900264",1e-07,0.00010669331209102,1.4197710570056e-05,0.405213270500753,0.445452430728847,0.238742153346003,0.363095621184314,0.181588140933044,5.95444432129879,0.00314806144059691,0.0307618789172483,-5.56185959300946,39682,1.51198714161209,4,1,0,1.4197710570056e-05,0.405213270500753,28540.74736214,14.8007354929734
"611",645,877,877,877,"Q9H9T3","ELP3","ELP3_HUMAN","cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; histone acetyltransferase complex [GO:0000123]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; central nervous system development [GO:0007417]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19185337}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.","Elongator complex protein 3 (hELP3) (EC 2.3.1.48)","GO:0000123; GO:0001764; GO:0005730; GO:0005737; GO:0006357; GO:0006368; GO:0007417; GO:0008023; GO:0008607; GO:0010484; GO:0010485; GO:0030335; GO:0033588; GO:0043966; GO:0043967; GO:0046872; GO:0051536",1e-07,1e-07,1e-07,0.0343945766340414,0.0536959979708135,0.0315541320040729,0.0398814688696426,0.0199408344348213,5.94921668264596,0.00315889686452718,0.030802696818132,-5.566015208985,62259,1.51141125876055,8,3,0,1e-07,0.0343945766340414,343945.766340414,18.3918215719221
"612",647,879,879,879,"Q96EC8","YIPF6","YIPF6_HUMAN","cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; intestinal epithelial cell development [GO:0060576]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:27999994}; Multi-pass membrane protein {ECO:0000305}. Note=Evenly distributed between cis- and trans-Golgi apparatus (PubMed:27999994). Mainly localizes within medial-/trans-Golgi and trans-Golgi network (TGN), while less so within cis-Golgi (PubMed:28286305). {ECO:0000269|PubMed:27999994, ECO:0000269|PubMed:28286305}.","Protein YIPF6 (YIP1 family member 6)","GO:0000138; GO:0000139; GO:0005783; GO:0005797; GO:0005801; GO:0005802; GO:0016021; GO:0030134; GO:0042802; GO:0060576",0.0775947655838868,0.0904911717901545,0.119079360395128,0.283479518885988,0.387876788831584,0.441673569345728,0.275288193098043,0.233365862472078,5.94722643608106,0.00316303393728248,0.030802696818132,-5.56759807080713,26256,1.51141125876055,4,0,0,0.0904911717901545,0.387876788831584,4.28634949861247,2.09974948868875
"613",648,880,880,880,"Q8WUA2","PPIL4","PPIL4_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)","GO:0003723; GO:0003755; GO:0005654; GO:0005829; GO:1901407",0.00085831096030517,0.0017246256272741,0.00183145918009797,0.0922120132603393,0.133863943240513,0.0757216987044294,0.0991277531458683,0.0510353418288266,5.94441580738296,0.00316888748349471,0.0308121182035381,-5.56983409677711,57225,1.51127844473769,7,0,0,0.0017246256272741,0.0922120132603393,53.4678435725713,5.7405995870364
"614",649,881,881,881,"P98170","XIAP","XIAP_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=TLE3 promotes its nuclear localization.","E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)","GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046872; GO:0050727; GO:0055070; GO:0061630; GO:0070424; GO:0090263; GO:1902530; GO:1990001",3.02604547833533e-05,2.83347632325365e-05,3.61592756769194e-05,0.0694223948536676,0.0959059045923364,0.128552251792961,0.0979285989150908,0.0489958842887764,5.94212730289096,0.00317366330800674,0.0308121182035381,-5.57165535252541,56685,1.51127844473769,4,0,0,3.02604547833533e-05,0.0959059045923364,3169.34776026881,11.6299702544134
"615",650,882,882,882,"Q15208","STK38","STK38_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; cellular protein modification process [GO:0006464]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm.","Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1)","GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006468; GO:0018105; GO:0031435; GO:0035556; GO:0043407; GO:0045296",0.00088534250532602,0.00067121581042852,0.001040030836854,0.0683036957524842,0.0425170237544996,0.0793799881560208,0.062534706170132,0.0321328828026022,5.94158321617221,0.00317480002985054,0.0308121182035381,-5.572088432692,54190,1.51127844473769,8,0,0,0.00088534250532602,0.0683036957524842,77.1494594934555,6.26958414424536
"616",652,884,884,884,"Q15102","PAFAH1B3","PA1B3_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Cytoplasm.","Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma)","GO:0003847; GO:0004623; GO:0005737; GO:0005829; GO:0006629; GO:0007283; GO:0007399; GO:0007420; GO:0016020; GO:0016042; GO:0042802; GO:0046982; GO:0047179",0.00034553229831997,0.0001146923281731,0.00011748793049724,0.0118824084557724,0.0199202203881823,0.0126670992682509,0.0146306718517384,0.00750790677819931,5.93041598851017,0.00319824005904506,0.0309693833771785,-5.58098414294534,25734,1.50906744167437,13,0,0,0.00011748793049724,0.0126670992682509,107.816174943591,6.75242982204309
"617",653,885,885,885,"Q2V2M9","FHOD3","FHOD3_HUMAN","striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:21149568}. Note=Main part of the protein localizes to actin fibers and the remaining part displays filamentous staining. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, myofibril, sarcomere, Z line. Note=Threonine phosphorylation in isoform 4-specific sequence TDTDEEEEVE is required for targeting to myofibrils in cardiomyocytes.","FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2)","GO:0003779; GO:0005865; GO:0030018; GO:0030837; GO:0045214; GO:0051639; GO:0055003",5.24782420904601e-05,0.00019713122060114,0.00010455275060668,0.195241054539151,0.165929668667638,0.292138012399554,0.217651524464348,0.108943816303274,5.92207680756467,0.00321588059648121,0.0310712860620131,-5.58763560342259,158613,1.50764077062412,14,0,0,0.00010455275060668,0.195241054539151,1867.39280799636,10.8668097165331
"618",654,889,889,889,"P23193","TCEA1","TCEA1_HUMAN","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Nucleus.","Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o)","GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006283; GO:0006355; GO:0006366; GO:0006368; GO:0008270; GO:1901919",0.00010130540721014,0.0403691091391233,0.00010142832059854,0.092201488434518,0.100352953978277,0.121597086133209,0.0911932285596907,0.059120561902156,5.90314913455037,0.00325635835413604,0.0313548115988802,-5.60275979957449,33970,1.50369580441861,7,0,0,0.00010142832059854,0.100352953978277,989.397767665706,9.95040683418611
"619",655,890,890,890,"Q8WU20","FRS2","FRS2_HUMAN","cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; anterior/posterior axis specification, embryo [GO:0008595]; axon guidance [GO:0007411]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G-protein coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; MAPK cascade [GO:0000165]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; neurotrophin TRK receptor signaling pathway [GO:0048011]; optic placode formation involved in camera-type eye formation [GO:0046619]; organ induction [GO:0001759]; positive regulation of protein kinase B signaling [GO:0051897]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]","SUBCELLULAR LOCATION: Endomembrane system. Note=Cytoplasmic, membrane-bound.","Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1) (SNT-1)","GO:0000165; GO:0000186; GO:0000187; GO:0001702; GO:0001759; GO:0003281; GO:0005068; GO:0005088; GO:0005104; GO:0005168; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005913; GO:0007185; GO:0007186; GO:0007405; GO:0007411; GO:0008543; GO:0008595; GO:0016020; GO:0016303; GO:0019211; GO:0030900; GO:0042981; GO:0046619; GO:0046934; GO:0048011; GO:0050678; GO:0051897; GO:0060527; GO:0070307; GO:0070372; GO:2000726",3.2778851061239e-05,2.63747650582132e-05,2.58903219327747e-05,0.00045557333687439,0.00048633455956217,0.00073600518939125,0.00053095638259186,0.00029382617064667,5.89792507796022,0.00326763854989748,0.0314280741428342,-5.60694075539755,57029,1.50268223096988,3,0,0,2.63747650582132e-05,0.00048633455956217,18.4393892604827,4.20471896727801
"620",656,891,891,891,"Q9C0J8","WDR33","WDR33_HUMAN","collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11162572, ECO:0000269|PubMed:19217410}.","pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein WDC146)","GO:0000398; GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006369; GO:0006378; GO:0006379; GO:0006406; GO:0007283; GO:0031124",0.0107892458113894,0.0393743211778271,0.00558501314996976,0.084233708466966,0.0837918791616457,0.106015155206877,0.072764054232101,0.0549648871624459,5.89319575961661,0.00327789123499215,0.0314835142697193,-5.61072824956951,145891,1.50191679655557,13,0,0,0.0107892458113894,0.084233708466966,7.80719152566223,2.96480366223634
"621",658,893,893,893,"Q9Y4H2","IRS2","IRS2_HUMAN","cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 14-3-3 protein binding [GO:0071889]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; interleukin-7-mediated signaling pathway [GO:0038111]; lipid homeostasis [GO:0055088]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of kinase activity [GO:0033673]; negative regulation of plasma membrane long-chain fatty acid transport [GO:0010748]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of lipid metabolic process [GO:0019216]; response to glucose [GO:0009749]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}.","Insulin receptor substrate 2 (IRS-2)","GO:0000165; GO:0002053; GO:0002903; GO:0005088; GO:0005158; GO:0005829; GO:0005886; GO:0006006; GO:0007165; GO:0007411; GO:0007420; GO:0008283; GO:0008284; GO:0008286; GO:0009749; GO:0010748; GO:0010907; GO:0016303; GO:0019216; GO:0019901; GO:0019903; GO:0019904; GO:0030335; GO:0030879; GO:0030890; GO:0032000; GO:0032024; GO:0032869; GO:0032991; GO:0033673; GO:0038111; GO:0043548; GO:0045725; GO:0046326; GO:0046934; GO:0048015; GO:0051897; GO:0055088; GO:0071333; GO:0071889",0.0286779623423622,0.0385501730881235,0.0144721895978598,0.155430430781229,0.120691084011141,0.196310886873329,0.130244025545785,0.0923554544490074,5.8901858317917,0.00328443671061441,0.0314835142697193,-5.61313999655822,137334,1.50191679655557,15,0,0,0.0286779623423622,0.155430430781229,5.41985615734044,2.43825456304679
"622",660,896,896,896,"Q8N568","DCLK2","DCLK2_HUMAN","cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pyramidal neuron development [GO:0021860]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Note=Colocalizes with microtubules. {ECO:0000250}.","Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)","GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005874; GO:0015630; GO:0018105; GO:0018107; GO:0021766; GO:0021860; GO:0030182; GO:0035556; GO:1900181",9.81904363904066e-06,4.16856236551179e-05,1e-07,0.0259692452554137,0.0343032192434884,0.0477797960734352,0.0360002186350144,0.0180173108732719,5.87855588022135,0.00330987648355101,0.0316211414053534,-5.62246768950709,83606,1.50002245770868,13,1,0,9.81904363904066e-06,0.0343032192434884,3493.53974832114,11.7704738395247
"623",661,898,898,898,"Q6NUM9","RETSAT","RETST_HUMAN","endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; all-trans-retinol 13,14-reductase activity [GO:0051786]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]; retinol metabolic process [GO:0042572]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q64FW2}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q64FW2}.","All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)","GO:0005640; GO:0005789; GO:0016020; GO:0016491; GO:0031965; GO:0042572; GO:0051786; GO:0055114",0.00036468323647933,0.00024675310272191,0.00067091874023668,0.0762012686232557,0.0484247695586197,0.0917780748388395,0.0717072526470923,0.0362810780166921,5.86793766146744,0.0033333114504992,0.0317411891994223,-5.63099648462702,66820,1.49837680621784,5,0,0,0.00036468323647933,0.0762012686232557,208.951936916285,7.70702732180938
"624",662,899,899,899,"Q8WX77","IGFBPL1","IBPL1_HUMAN","extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558]","SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15845387}.","Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4) (IGFBP-rP4)","GO:0001558; GO:0005520; GO:0005615; GO:0071228",0.0316586847430109,0.0168482077241722,0.0218814467256893,0.0607101710322474,0.0838801367111374,0.065896018598749,0.0466993290497538,0.0468124442558344,5.867822605064,0.00333356648250942,0.0317411891994223,-5.63108896627736,29005,1.49837680621784,4,0,0,0.0218814467256893,0.065896018598749,3.01150190957829,1.5904831737269
"625",663,901,901,901,"Q96S55","WRNIP1","WRIP1_HUMAN","membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; innate immune response [GO:0045087]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18842586}. Cytoplasm {ECO:0000269|PubMed:29053956}. Note=Colocalizes with WRN in granular structures in the nucleus. {ECO:0000269|PubMed:18842586, ECO:0000269|PubMed:29053956}.","ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1)","GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006260; GO:0016020; GO:0016887; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471",0.00033238318972098,0.00042024309462495,0.0016231156265449,0.0504842855264751,0.0533668731476442,0.0848271449292826,0.0621008538975037,0.0318423409190488,5.85433233253243,0.00336363298399595,0.0319309045894443,-5.64194215242823,72133,1.49578877790154,5,0,0,0.00042024309462495,0.0533668731476442,126.990482009638,6.98857656022039
"626",664,902,902,902,"Q658Y4","FAM91A1","F91A1_HUMAN","trans-Golgi network [GO:0005802]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:29084197}. Note=Recruitment to the TGN requires the presence of GOLGA1, GOLGA4 and TBC1D23. {ECO:0000269|PubMed:29084197}.","Protein FAM91A1","GO:0005802",1.86004701927316e-05,1e-07,1e-07,0.0318136094421096,0.0455260251243846,0.0249691944341706,0.034096676176824,0.0170546049118096,5.85386439595705,0.00336468176865406,0.0319309045894443,-5.64231896507811,93909,1.49578877790154,9,2,0,1e-07,0.0318136094421096,318136.094421096,18.2792845378836
"627",665,903,903,903,"O95182","NDUFA7","NDUA7_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial translation [GO:0032543]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}; Matrix side {ECO:0000305}.","NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a)","GO:0003735; GO:0005739; GO:0005743; GO:0005747; GO:0005761; GO:0006120; GO:0008137; GO:0032543; GO:0032981",0.00208565204749819,0.00056605935716623,0.0002575585610279,0.00536219834121432,0.00428792729286153,0.0044137031898674,0.00371818628608364,0.0028288497982726,5.8492164320697,0.00337512072551204,0.0319944999007565,-5.64606307554048,12551,1.49492467380679,5,0,0,0.00056605935716623,0.0044137031898674,7.79724446560339,2.96296436779852
"628",666,906,906,906,"P30044","PRDX5","PRDX5_HUMAN","cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]","SUBCELLULAR LOCATION: Isoform Mitochondrial: Mitochondrion {ECO:0000269|PubMed:10521424, ECO:0000269|PubMed:10751410}.; SUBCELLULAR LOCATION: Isoform Cytoplasmic+peroxisomal: Cytoplasm {ECO:0000269|PubMed:10514471, ECO:0000269|PubMed:10751410}. Peroxisome matrix {ECO:0000269|PubMed:10514471, ECO:0000269|PubMed:10521424, ECO:0000269|PubMed:10751410}. Note=Imported into peroxisomes via peroxisomal targeting signal 1 receptor PEX5. {ECO:0000269|PubMed:10514471}.","Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)","GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057",1e-07,1e-07,1e-07,0.0001768483864497,0.00021976232943356,0.00026974547501489,0.00022201873029938,0.00011110936514969,5.83931709451643,0.00339748461874603,0.0320998546760111,-5.65404507025255,22086,1.49349693374931,9,3,0,1e-07,0.00021976232943356,2197.6232943356,11.1017283925276
"629",667,907,907,907,"Q92953","KCNB2","KCNB2_HUMAN","dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q63099}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q63099}. Perikaryon {ECO:0000250|UniProtKB:Q63099}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q63099}. Note=Localized uniformly throughout cell bodies and dendrites. Colocalizes with KCNB1 to high-density somatodendritic clusters on cortical pyramidal neurons. {ECO:0000250|UniProtKB:Q63099}.","Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2)","GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659",0.0262362889211872,0.0243296260942002,0.0266185829418709,0.103940301198023,0.0783698622361862,0.0694975364032994,0.0582077339600833,0.0548320329657944,5.83590465063727,0.00340523525606616,0.0321099556679556,-5.65679901191724,102563,1.49336029403411,7,0,0,0.0262362889211872,0.0783698622361862,2.98707879272127,1.57873529334639
"630",668,908,908,908,"O95155","UBE4B","UBE4B_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ES00}. Nucleus {ECO:0000250|UniProtKB:Q9ES00}.","Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)","GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0043161; GO:0051117; GO:0051865",1.39958115160364e-05,1e-07,1e-07,0.0439098459320561,0.0742391965026973,0.0462511487785071,0.0547953318005815,0.0274023978374628,5.83554382407489,0.0034060560451523,0.0321099556679556,-5.65709028247507,146185,1.49336029403411,21,2,0,1e-07,0.0462511487785071,462511.487785071,18.8191296739354
"631",669,909,909,909,"Q9BVL2","NUP58","NUP58_HUMAN","nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of protein import into nucleus [GO:0042306]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P70581}. Nucleus membrane {ECO:0000250|UniProtKB:P70581}; Peripheral membrane protein {ECO:0000250|UniProtKB:P70581}; Cytoplasmic side {ECO:0000250|UniProtKB:P70581}. Nucleus membrane {ECO:0000250|UniProtKB:P70581}; Peripheral membrane protein {ECO:0000250|UniProtKB:P70581}; Nucleoplasmic side {ECO:0000250|UniProtKB:P70581}. Note=Biased towards cytoplasmic side. Central region of the nuclear pore complex, within the transporter. {ECO:0000250|UniProtKB:P70581}.","Nucleoporin p58/p45 (58 kDa nucleoporin) (Nucleoporin-like protein 1)","GO:0005635; GO:0005643; GO:0006406; GO:0006606; GO:0008139; GO:0016032; GO:0017056; GO:0031965; GO:0042306; GO:0051260; GO:0051290; GO:0070208",0.00191624253737533,0.00095747912926054,0.00359422928786663,0.00822453922637488,0.00718603694254288,0.00998760778316269,0.00631007766585932,0.00531102248443049,5.82543491062103,0.0034291487514081,0.0322920938526439,-5.66525619647045,60897,1.49090379396807,5,0,0,0.00191624253737533,0.00822453922637488,4.29201370179372,2.10165468175107
"632",671,912,912,912,"Q9BXQ6","TMEM121B","T121B_HUMAN",NA,NA,"Transmembrane protein 121B (Cat eye syndrome critical region protein 6)",NA,8.86721403533699e-05,0.00014967258341301,0.00011581844582868,0.115764165083528,0.0625729384924443,0.0826075498872474,0.0868634967645417,0.0435498027721359,5.81112219524448,0.00346216906021383,0.0324957973195509,-5.67683670933206,58425,1.48817280268112,4,0,0,0.00011581844582868,0.0826075498872474,713.250374723915,9.47826478953782
"633",674,916,916,916,"P07858","CTSB","CATB_HUMAN","endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]","SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:16733801}. Melanosome. Secreted, extracellular space {ECO:0000250}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","GO:0004197; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0008233; GO:0008234; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0070062; GO:0097067; GO:1904813",1e-07,6.10251918503103e-07,1e-07,0.0173849799018229,0.0130801135371057,0.0242807465883629,0.0182483432584577,0.00912444171320167,5.80429748562862,0.00347804931570751,0.0325022949153453,-5.6823664014711,37822,1.48808597336316,7,2,0,1e-07,0.0173849799018229,173849.799018229,17.4074818736532
"634",675,918,918,918,"Q15560","TCEA2","TCEA2_HUMAN","transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]","SUBCELLULAR LOCATION: Nucleus.","Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l)","GO:0003677; GO:0006354; GO:0008023; GO:0008270; GO:0032784; GO:0045944",6.94206743659341e-05,4.41748533559028e-05,0.0779097645307859,0.214312682530142,0.215725407970683,0.302862433085249,0.218292387842522,0.13515398060743,5.7887436072902,0.00351457135668815,0.0327624438836626,-5.69498767388916,33601,1.48462370991521,5,0,0,6.94206743659341e-05,0.215725407970683,3107.50954151697,11.6015431056995
"635",676,920,920,920,"Q9P265","DIP2B","DIP2B_HUMAN","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; metabolic process [GO:0008152]",NA,"Disco-interacting protein 2 homolog B (DIP2 homolog B)","GO:0003824; GO:0005634; GO:0005737; GO:0008152; GO:0016020; GO:0070062",5.95578011091898e-05,5.12188609905673e-05,1.54218520936471e-05,0.0145850506206741,0.0220569652189994,0.0123879566433229,0.016301257989601,0.00819269516619829,5.77961443626074,0.00353622337534884,0.0329022522749848,-5.70240778908465,171492,1.48277437204644,32,0,0,5.12188609905673e-05,0.0145850506206741,284.759370642001,8.15359950758628
"636",678,924,924,924,"P19086","GNAZ","GNAZ_HUMAN","cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; heterotrimeric G-protein complex [GO:0005834]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein coupled receptor binding [GO:0001664]; G-protein coupled serotonin receptor binding [GO:0031821]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; G-protein coupled receptor signaling pathway [GO:0007186]; protein folding [GO:0006457]","SUBCELLULAR LOCATION: Membrane; Lipid-anchor.","Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha)","GO:0001664; GO:0003924; GO:0005525; GO:0005635; GO:0005783; GO:0005829; GO:0005834; GO:0005886; GO:0006457; GO:0007186; GO:0007188; GO:0007193; GO:0030425; GO:0031683; GO:0031821; GO:0044297; GO:0046872",0.00139910087846692,0.00255518187247284,0.00221003450151514,0.0179047045171175,0.0213551017287416,0.0306694502094181,0.0212549797342741,0.012682262284622,5.76171545119725,0.00357914473473697,0.0331459574155601,-5.71698221769291,40924,1.47956943194018,13,0,0,0.00221003450151514,0.0213551017287416,9.66279110760539,3.27243997327265
"637",679,926,926,926,"Q9Y5Z7","HCFC2","HCFC2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription coactivator activity [GO:0003713]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10196288}. Nucleus {ECO:0000269|PubMed:10196288}.","Host cell factor 2 (HCF-2) (C2 factor)","GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0016032; GO:0071339",0.101082960685835,0.11012596641154,0.111083550193788,0.171292708622608,0.153109725888822,0.191991461261991,0.0647004728274194,0.139781062177431,5.75014420480764,0.00360722741451895,0.0333291173387146,-5.72642279778157,86779,1.47717618768965,3,0,0,0.11012596641154,0.171292708622608,1.55542524805175,0.637309062274137
"638",680,927,927,927,"Q12931","TRAP1","TRAP1_HUMAN","membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; response to stress [GO:0006950]; translational attenuation [GO:0009386]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:23564345}. Mitochondrion inner membrane {ECO:0000269|PubMed:23564345}. Mitochondrion matrix {ECO:0000269|PubMed:23564345}.","Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)","GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006950; GO:0009386; GO:0016020; GO:0019901; GO:0051082; GO:0061077; GO:1901856; GO:1903427; GO:1903751",1e-07,1e-07,1e-07,0.00458802966836988,0.00245801511990024,0.00327695206431816,0.00344089895086276,0.00172054947543138,5.74927136577712,0.00360935651553604,0.0333291173387146,-5.72713550996651,80110,1.47717618768965,17,3,0,1e-07,0.00327695206431816,32769.5206431816,15.0000669486534
"639",681,928,928,928,"Q9P2S2","NRXN2","NRX2A_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha)","GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793",0.00032730805896553,0.00011722938713364,0.00026843055994615,0.132805410795084,0.0689780469770109,0.115617875460654,0.105562788408901,0.0530190502064658,5.7442885397877,0.00362154014415228,0.0333714309803393,-5.7312058056142,184982,1.47662517022442,14,0,0,0.00026843055994615,0.115617875460654,430.718005743639,8.75059982506585
"640",682,929,929,929,"Q6P2Q9","PRPF8","PRP8_HUMAN","catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]","SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}.","Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)","GO:0000244; GO:0000375; GO:0000386; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157",5.96960361465019e-05,2.41380846850428e-05,9.4973848444224e-05,0.0003481053876932,0.00057089426672681,0.00049395682351648,0.00041138283622024,0.00026529407453537,5.74414554634761,0.00362189051347955,0.0333714309803393,-5.73132265201858,273600,1.47662517022442,74,0,0,5.96960361465019e-05,0.00049395682351648,8.27453304109246,3.04867789822695
"641",683,930,930,930,"P00441","SOD1","SODC_HUMAN","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; interleukin-12-mediated signaling pathway [GO:0035722]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; platelet degranulation [GO:0002576]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19741096}. Mitochondrion {ECO:0000269|PubMed:19741096}. Nucleus {ECO:0000269|PubMed:22496122}. Note=Predominantly cytoplasmic; the pathogenic variants ALS1 Arg-86 and Ala-94 gradually aggregates and accumulates in mitochondria. {ECO:0000269|PubMed:19741096}.","Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)","GO:0000187; GO:0000303; GO:0001541; GO:0001819; GO:0001890; GO:0001895; GO:0001975; GO:0002262; GO:0002576; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005764; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0033081; GO:0034465; GO:0034599; GO:0035722; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043085; GO:0043087; GO:0043209; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046620; GO:0046688; GO:0046716; GO:0048365; GO:0048538; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115",0.00580631485448716,0.00164802318401953,0.00142623785297585,0.0105177694052297,0.0109914102998194,0.0116664978473232,0.00809836722029659,0.00700937557397581,5.7426186095614,0.00362563444062098,0.0333714309803393,-5.73257052060531,15936,1.47662517022442,6,0,0,0.00164802318401953,0.0109914102998194,6.66945125918152,2.73756806602388
"642",684,931,931,931,"Q9H6T3","RPAP3","RPAP3_HUMAN","cytosol [GO:0005829]; R2TP complex [GO:0097255]",NA,"RNA polymerase II-associated protein 3","GO:0005829; GO:0097255",0.00468130587555167,0.00930745959742742,0.0218214239454779,0.0727398438322721,0.117889176824026,0.122939664264313,0.0925861651673846,0.0582298123898446,5.73220748247263,0.00365128666183825,0.0335714434214129,-5.74108568040749,75719,1.47402998563676,19,0,0,0.00930745959742742,0.117889176824026,12.6660960050378,3.66290001462389
"643",685,932,932,932,"O75153","CLUH","CLU_HUMAN","cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03013}. Cytoplasmic granule {ECO:0000269|PubMed:25349259}. Note=A fraction colocalizes with tyrosinated tubulin and can be detected close to mitochondria. {ECO:0000269|PubMed:25349259}.","Clustered mitochondria protein homolog","GO:0003729; GO:0005737; GO:0007005; GO:0048312",4.0125944231316e-05,6.46193552296321e-05,4.55535048471411e-05,0.0226702947076782,0.0131525287766582,0.0252530973905332,0.0203085406901872,0.0102043699465296,5.72693977463362,0.00366434938924889,0.0336553978240027,-5.74539861577975,146670,1.47294527149416,17,0,0,4.55535048471411e-05,0.0226702947076782,497.663018109154,8.95902537250423
"644",686,934,934,934,"P56211","ARPP19","ARP19_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of glucose import [GO:0046326]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","cAMP-regulated phosphoprotein 19 (ARPP-19)","GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0015459; GO:0019212; GO:0019888; GO:0035308; GO:0045722; GO:0046326; GO:0051301; GO:0051721",0.00051281634772493,0.0130923474149059,0.00056488509492229,0.0647534218090836,0.0603602870810274,0.0981746777807896,0.0697061126044492,0.039576405921409,5.71661388335952,0.00369011940590291,0.0338161372297412,-5.7538617830772,12323,1.47087600275893,3,0,0,0.00056488509492229,0.0647534218090836,114.631138954005,6.8408551877289
"645",687,935,935,935,"Q86SK9","SCD5","SCD5_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty-acyl-CoA biosynthetic process [GO:0046949]; monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15907797}; Multi-pass membrane protein {ECO:0000269|PubMed:15907797}.","Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2)","GO:0004768; GO:0005789; GO:0006636; GO:0016021; GO:0016491; GO:0046872; GO:0046949; GO:1903966",0.0646584117457819,0.0286375868221267,0.0484952249807735,0.166051498505488,0.124343585951351,0.129067588541627,0.0925571498165943,0.0935423160911912,5.71518529334987,0.00369370190535141,0.0338161372297412,-5.75503358821581,37610,1.47087600275893,4,0,0,0.0484952249807735,0.129067588541627,2.66144942296478,1.41221215017052
"646",689,937,937,937,"Q17R31","TATDN3","TATD3_HUMAN","nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Putative deoxyribonuclease TATDN3 (EC 3.1.21.-)","GO:0004518; GO:0005634; GO:0046872",5.47318429621862e-05,3.84471829115201e-05,2.75049310076084e-05,0.0349501464079636,0.0277917551206287,0.0511349973859373,0.0379187383192161,0.0189995971452351,5.6983807816489,0.00373615975761542,0.0341318330044696,-5.76883442362681,30333,1.46684038789041,4,0,0,3.84471829115201e-05,0.0349501464079636,909.043101763675,9.82820489038388
"647",690,938,938,938,"Q9NPZ5","B3GAT2","B3GA2_HUMAN","Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; protein glycosylation [GO:0006486]","SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type II membrane protein.","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)","GO:0000139; GO:0005975; GO:0006486; GO:0015018; GO:0016021; GO:0030203; GO:0030204; GO:0046872; GO:0050650",2.47809962434634e-05,2.20330505715254e-05,1.28393215257828e-05,0.0403120114479629,0.0781941513581762,0.0623160783612639,0.0602541959330208,0.030146982422624,5.69234667780967,0.00375154900824856,0.0342358843396671,-5.77379758606126,36919,1.46551844948566,4,0,0,2.20330505715254e-05,0.0623160783612639,2828.30006489426,11.4657194738228
"648",691,939,939,939,"Q9P0J1","PDP1","PDP1_HUMAN","mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]","SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.","[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)","GO:0004722; GO:0004741; GO:0005759; GO:0010510; GO:0035970; GO:0046872",0.00545087741279117,0.00273173142773936,0.00581187726968736,0.0397848682399331,0.0626208696730706,0.0727869684403725,0.0537327400810528,0.0315311987439323,5.68540123330789,0.00376935737896671,0.0343617669477689,-5.77951533046119,61054,1.4639245120138,11,0,0,0.00545087741279117,0.0626208696730706,11.4882183052077,3.52208316427657
"649",692,940,940,940,"Q9BTC8","MTA3","MTA3_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:12705869}.","Metastasis-associated protein MTA3","GO:0000981; GO:0003682; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010971; GO:0043231; GO:0043565; GO:0044877; GO:0045892",0.00488575272681713,0.0156334443588655,0.00254086705065628,0.0701498823015467,0.094515411798559,0.1244948205793,0.0887000168476889,0.0520366964692907,5.67263312616254,0.00380236230314995,0.0346257673563443,-5.790040455027,67504,1.46060059323628,3,0,0,0.00488575272681713,0.094515411798559,19.3451075163462,4.2738968419093
"650",694,942,942,942,"Q96SB4","SRPK1","SRPK1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus. Nucleus matrix. Microsome. Note=Shuttles between the nucleus and the cytoplasm. Inhibition of the Hsp90 ATPase activity, osmotic stress and interaction with HHV-1 ICP27 protein can induce its translocation to the nucleus. KAT5/TIP60 inhibits its nuclear translocation.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Nucleus matrix. Microsome. Note=Mainly localized in the microsomal fraction and the cytoplasm, and to a lesser extent in the nuclear matrix.","SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)","GO:0000245; GO:0000287; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016032; GO:0016363; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684",0.027060392133547,0.00021091978394305,0.00032749974236098,0.1832650035233,0.245641230765971,0.335121741684941,0.245476388104787,0.13193779793901,5.6645785890182,0.0038233624013798,0.0347287659073121,-5.79668936017254,74325,1.45931064914438,10,0,0,0.00032749974236098,0.245641230765971,750.050149643226,9.55084324968029
"651",696,945,945,945,"O43301","HSPA12A","HS12A_HUMAN","extracellular exosome [GO:0070062]; ATP binding [GO:0005524]",NA,"Heat shock 70 kDa protein 12A","GO:0005524; GO:0070062",0.00012653028035575,0.00012320176373781,0.0002374670338069,0.00132485071839204,0.00135682416916739,0.00080734931100365,0.00100060837355421,0.00066270387941059,5.63446253309379,0.00390313284357914,0.0353553620540078,-5.82161380811917,74978,1.45154471103624,27,0,0,0.00012653028035575,0.00132485071839204,10.4706218516794,3.38827522155846
"652",697,946,946,946,"P52272","HNRNPM","HNRPM_HUMAN","catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; paraspeckles [GO:0042382]; spliceosomal complex [GO:0005681]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|Ref.5}.","Heterogeneous nuclear ribonucleoprotein M (hnRNP M)","GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005730; GO:0005887; GO:0008543; GO:0016020; GO:0016070; GO:0016363; GO:0019904; GO:0031012; GO:0042382; GO:0070062; GO:0071013",0.00029714877603701,5.01408076009809e-06,1e-07,0.00407095651022222,0.0026847045102203,0.00511674615598316,0.00385671477320952,0.0020291116722038,5.6223503499253,0.00393578074550052,0.0356134071685882,-5.83166662377408,77516,1.4483864749713,43,1,0,5.01408076009809e-06,0.00407095651022222,811.904854548569,9.66516686064136
"653",698,947,947,947,"P51148","RAB5C","RAB5C_HUMAN","azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; neutrophil degranulation [GO:0043312]; plasma membrane to endosome transport [GO:0048227]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Early endosome membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.","Ras-related protein Rab-5C (L1880) (RAB5L)","GO:0003924; GO:0005525; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0015031; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0035577; GO:0042470; GO:0043312; GO:0048227; GO:0070062",0.00018122473617955,0.00011981620570278,0.00018752650905641,0.0663149066404825,0.0355818089557997,0.0670714392255998,0.0561598624569811,0.0282427870454701,5.61776330946916,0.00394823090662849,0.0356883385013093,-5.83547805447229,23483,1.44747367049516,6,0,0,0.00018122473617955,0.0663149066404825,365.926352210442,8.51540950497167
"654",699,948,948,948,"P19784","CSNK2A2","CSK22_HUMAN","acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chromosome separation [GO:1905818]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; Wnt signaling pathway [GO:0016055]",NA,"Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1)","GO:0000785; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0006915; GO:0007049; GO:0007283; GO:0016055; GO:0021987; GO:0047485; GO:0097421; GO:1901796; GO:1903146; GO:1903955; GO:1905818",9.67292185266669e-05,7.68620436854539e-05,0.00367495499631603,0.022219976171941,0.0155544481284589,0.0281203750970548,0.0206820843796422,0.0116238909426638,5.61512643203674,0.00395540944266924,0.0357155114232581,-5.83767014034807,41213,1.44714312667597,11,0,0,9.67292185266669e-05,0.022219976171941,229.713177780044,7.84368981084668
"655",700,949,949,949,"Q9UHQ9","CYB5R1","NB5R1_HUMAN","endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; oxidoreductase activity [GO:0016491]; bicarbonate transport [GO:0015701]; platelet degranulation [GO:0002576]; sterol biosynthetic process [GO:0016126]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)","GO:0002576; GO:0004128; GO:0005739; GO:0005789; GO:0005886; GO:0015701; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0031092; GO:0070062",1e-07,1e-07,1e-07,0.00171406606339088,0.00177082141982533,0.00093202609886871,0.00147220452736164,0.00073620226368082,5.61246008711807,0.0039626842213247,0.035743495189188,-5.83988751841257,34095,1.44680298212811,11,3,0,1e-07,0.00171406606339088,17140.6606339088,14.0651350943031
"656",701,950,950,950,"P60660","MYL6","MYL6_HUMAN","brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin-dependent ATPase activity [GO:0030898]; calcium ion binding [GO:0005509]; motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519]",NA,"Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)","GO:0003774; GO:0005509; GO:0005829; GO:0005903; GO:0006936; GO:0007519; GO:0008307; GO:0016020; GO:0016459; GO:0016461; GO:0030049; GO:0030898; GO:0031982; GO:0070062",0.0157271704027454,0.016879020997055,0.00784317220821445,0.0396908280298013,0.053943378404444,0.0619382630586818,0.0383743686283041,0.0326703055168237,5.60883469613566,0.00397260155276896,0.0357779174761263,-5.84290373935598,16930,1.44638494199526,3,0,0,0.0157271704027454,0.053943378404444,3.42994811037511,1.77818675089641
"657",703,952,952,952,"Q9UPN6","SCAF8","SCAF8_HUMAN","nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus. Nucleus matrix. Note=Detected in granular nuclear foci which correspond to sites of active transcription. {ECO:0000250}.","Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8)","GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016363; GO:0043175",0.00195357993984359,0.00145930398782693,0.00696563229924617,0.0835819814233372,0.160835361249219,0.135814978114055,0.123284601519898,0.0651018061689214,5.60430806439479,0.00398502632441392,0.0358317493035537,-5.84667184509417,140519,1.44573198908938,10,0,0,0.00195357993984359,0.135814978114055,69.5210753059477,6.11937849186362
"658",704,953,953,953,"Q8WU79","SMAP2","SMAP2_HUMAN","cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]","SUBCELLULAR LOCATION: Cytoplasm. Note=Detected in multiple foci throughout the cytoplasm and in juxtanuclear structures. {ECO:0000250}.","Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like)","GO:0005096; GO:0005737; GO:0046872",1e-07,0.00232343195386989,1e-07,0.108624948750699,0.0763102194762533,0.0578751644472265,0.0801622335734363,0.0408556607713414,5.60042017133457,0.0039957353249434,0.0358903403793447,-5.84991008956819,46786,1.44502242285455,5,2,0,1e-07,0.0763102194762533,763102.194762533,19.5415167503752
"659",705,954,954,954,"O75054","IGSF3","IGSF3_HUMAN","cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166]; lacrimal gland development [GO:0032808]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3)","GO:0005886; GO:0007166; GO:0009986; GO:0016021; GO:0032808",1e-07,1e-07,4.26462552343417e-06,0.00667043473035089,0.00345597564705379,0.00628768663665725,0.00546987746284617,0.00273642693993089,5.59642392284261,0.00400677899619705,0.0359326673661751,-5.85324036149298,135196,1.44451054290073,17,2,0,1e-07,0.00628768663665725,62876.8663665725,15.9402416984491
"660",706,955,955,955,"Q01804","OTUD4","OTUD4_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; Lys63-specific deubiquitinase activity [GO:0061578]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of DNA demethylation [GO:1901537]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein K48-linked deubiquitination [GO:1903093]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25944111}. Nucleus {ECO:0000269|PubMed:25944111}. Note=Primarily cytoplasmic. {ECO:0000269|PubMed:25944111}.","OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1)","GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0032947; GO:0034122; GO:0045087; GO:0061578; GO:0070536; GO:0071108; GO:1901537; GO:1903093; GO:2000660",0.370152078086173,0.295049680428247,0.392658785178731,0.533224598940874,0.507879043846005,0.565775664657631,0.183006254583787,0.444123308522943,5.59567846622946,0.00400884314657678,0.0359326673661751,-5.85386178699512,124045,1.44451054290073,5,0,0,0.370152078086173,0.533224598940874,1.44055546492633,0.526625208872428
"661",708,957,957,957,"Q9Y6G5","COMMD10","COMDA_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21778237}. Nucleus {ECO:0000269|PubMed:21778237}.","COMM domain-containing protein 10","GO:0005634; GO:0005737; GO:0006351; GO:0006355",3.30750450870424e-05,0.00573925838131132,8.97745587278094e-05,0.0408374785867189,0.030106436465602,0.0232146566357961,0.0294321545676636,0.0166701132788739,5.58750432843222,0.00403156150742163,0.036060780045485,-5.86068000946511,22966,1.44296488311041,3,0,0,8.97745587278094e-05,0.030106436465602,335.355994974954,8.38954958232489
"662",709,958,958,958,"P49116","NR2C2","NR2C2_HUMAN","nucleoplasm [GO:0005654]; DNA binding transcription factor activity [GO:0003700]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407, ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:15302918}.","Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)","GO:0000977; GO:0000978; GO:0000981; GO:0001077; GO:0001228; GO:0003700; GO:0003707; GO:0003713; GO:0005654; GO:0006355; GO:0006367; GO:0007283; GO:0007399; GO:0008270; GO:0030154; GO:0038023; GO:0043565; GO:0045944; GO:0046982",0.00010211080816044,8.74057753430097e-05,0.00492338181220878,0.108715778651056,0.148487837770443,0.206431962202501,0.152840893409429,0.0781247461699521,5.58098448617022,0.0040497935195488,0.036153460270058,-5.86612376847064,65414,1.44185012978649,10,0,0,0.00010211080816044,0.148487837770443,1454.18335674255,10.5059934735795
"663",710,959,959,959,"O76070","SNCG","SYUG_HUMAN","axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:11746666}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:11746666}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:11746666}. Note=Associated with centrosomes in several interphase cells. In mitotic cells, localized to the poles of the spindle.","Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR)","GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0030424; GO:0043025; GO:0046928; GO:0048471; GO:0050808; GO:0070062",1e-07,1e-07,1e-07,0.00113708857981309,0.00070061830418738,0.00137246690627287,0.00106995793009112,0.00053507896504555,5.58077886229668,0.00405037014006842,0.036153460270058,-5.86629553296754,13331,1.44185012978649,6,3,0,1e-07,0.00113708857981309,11370.8857981309,13.4730570248784
"664",711,961,961,961,"Q9NR80","ARHGEF4","ARHG4_HUMAN","cytosol [GO:0005829]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; filopodium assembly [GO:0046847]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]","SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Cell projection, ruffle membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Note=Associated with membrane ruffles. {ECO:0000305}.","Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1)","GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0019904; GO:0030032; GO:0030676; GO:0032587; GO:0035023; GO:0035556; GO:0043065; GO:0046847; GO:0051056",0.00691448775059121,0.00011568924298718,7.42519996695581e-05,0.0452741136236636,0.061989967866096,0.0839565606928021,0.0613720710631046,0.0330541785293016,5.57167805743,0.00407599055863517,0.0363064299499658,-5.87390254145097,79067,1.4400164536279,3,0,0,0.00011568924298718,0.061989967866096,535.831735652081,9.06563621983893
"665",712,962,962,962,"Q9NYJ8","TAB2","TAB2_HUMAN","cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; activation of MAPK activity [GO:0000187]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of autophagy [GO:0010507]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase activity [GO:0045860]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10882101}; Peripheral membrane protein {ECO:0000269|PubMed:10882101}. Cytoplasm, cytosol {ECO:0000269|PubMed:10882101}. Note=Following IL1 stimulation, translocation occurs from the membrane to cytosol.","TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2)","GO:0000187; GO:0002223; GO:0002755; GO:0005654; GO:0005829; GO:0005886; GO:0007249; GO:0007254; GO:0007507; GO:0010008; GO:0010507; GO:0038095; GO:0043123; GO:0045860; GO:0046872; GO:0050852; GO:0051092; GO:0070423; GO:0070498; GO:0070530",7.93076047454645e-05,1e-07,1e-07,0.0385141106056219,0.0749777067081205,0.0696995253979738,0.0610372783689902,0.0305451417194103,5.56655570990183,0.00409049688582175,0.0363977685474368,-5.87818824718111,76494,1.43892524100042,8,2,0,1e-07,0.0696995253979738,696995.253979738,19.4107893068817
"666",713,963,963,963,"P31930","UQCRC1","QCR1_HUMAN","cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; protein processing [GO:0016485]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]","SUBCELLULAR LOCATION: Mitochondrion inner membrane.","Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)","GO:0004222; GO:0005739; GO:0005743; GO:0005746; GO:0005750; GO:0005829; GO:0006119; GO:0006122; GO:0008121; GO:0008270; GO:0009060; GO:0014823; GO:0016485; GO:0031625; GO:0043209; GO:0043279; GO:0044877; GO:0055114",0.00210245141739718,0.00203665324816618,0.00232571081074674,0.0193486754580882,0.0215319795985134,0.0119846355410914,0.015466825040461,0.00988835101233385,5.55381472092973,0.00412684994727008,0.0366831106424007,-5.88886117039068,52646,1.43553384427928,10,0,0,0.00210245141739718,0.0193486754580882,9.20291203781618,3.2020904391876
"667",714,966,966,966,"Q96NI6","LRFN5","LRFN5_HUMAN","cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000305}.","Leucine-rich repeat and fibronectin type-III domain-containing protein 5","GO:0005615; GO:0009986; GO:0016021",3.76886337854598e-05,3.03095130328369e-05,3.00888951171137e-05,0.095323748122413,0.0489560512975652,0.0702888886449007,0.0714902003409811,0.0357777958511357,5.5359707735593,0.00417842033126023,0.0370261677387035,-5.90383987267132,79445,1.4314912357243,8,0,0,3.03095130328369e-05,0.0702888886449007,2319.03721345674,11.1793102556761
"668",715,967,967,967,"Q15554","TERF2","TERF2_HUMAN","chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; telomeric DNA binding [GO:0042162]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of beta-galactosidase activity [GO:1903770]; negative regulation of cellular senescence [GO:2000773]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of gene expression [GO:0010629]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomere single strand break repair [GO:1903824]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; RNA-dependent DNA biosynthetic process [GO:0006278]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:20655466}. Chromosome, telomere {ECO:0000269|PubMed:20655466}. Note=Colocalizes with telomeric DNA in interphase cells and is located at chromosome ends during metaphase.","Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein)","GO:0000723; GO:0000781; GO:0000783; GO:0000784; GO:0000981; GO:0003691; GO:0005634; GO:0005654; GO:0006278; GO:0007049; GO:0008022; GO:0010628; GO:0010629; GO:0016233; GO:0016604; GO:0019899; GO:0031627; GO:0031848; GO:0032204; GO:0032205; GO:0032208; GO:0032210; GO:0032211; GO:0032214; GO:0042162; GO:0042803; GO:0044877; GO:0051000; GO:0061820; GO:0070187; GO:0070198; GO:0090398; GO:0098505; GO:1903770; GO:1903824; GO:1904354; GO:1904357; GO:1904430; GO:1905778; GO:1905839; GO:2000773",1e-07,9.88827531984268e-06,1e-07,0.00025844647503765,0.00030255844384553,0.00018120522621812,0.00024404062326048,0.00012538307007019,5.52015555836705,0.00422477847065694,0.0373982458209136,-5.9171460480781,59594,1.42714876807129,6,2,0,1e-07,0.00025844647503765,2584.4647503765,11.3356498101019
"669",717,969,969,969,"Q6RFH5","WDR74","WDR74_HUMAN","nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.","WD repeat-containing protein 74 (NOP seven-associated protein 1)","GO:0005634; GO:0005730; GO:0030687; GO:0042273",1e-07,1e-07,1e-07,0.0739756378500165,0.0646732619641227,0.0372078476455147,0.0586188158198846,0.0293095079099423,5.51075364501785,0.00425263171806521,0.0375671078499879,-5.92506997617809,42441,1.42519223834463,4,3,0,1e-07,0.0646732619641227,646732.619641227,19.3028098527332
"670",718,970,970,970,"Q9C0C4","SEMA4C","SEM4C_HUMAN","cell junction [GO:0030054]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]; cell migration in hindbrain [GO:0021535]; cerebellum development [GO:0021549]; muscle cell differentiation [GO:0042692]; negative chemotaxis [GO:0050919]; neural tube closure [GO:0001843]; positive regulation of stress-activated MAPK cascade [GO:0032874]; semaphorin-plexin signaling pathway [GO:0071526]","SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Semaphorin-4C","GO:0001843; GO:0005615; GO:0014069; GO:0016020; GO:0016021; GO:0021535; GO:0021549; GO:0030054; GO:0030672; GO:0032874; GO:0042692; GO:0045211; GO:0050919; GO:0071526",4.99550009407122e-06,1e-07,1e-07,0.0184825369690223,0.0103755813004694,0.0115101296572037,0.0134543508088671,0.00672890723779825,5.50782367070261,0.00426135701189939,0.0376053773421225,-5.92754143422317,92623,1.42475004914062,13,2,0,1e-07,0.0115101296572037,115101.296572037,16.8125445594058
"671",720,975,975,975,"Q9UPT6","MAPK8IP3","JIP3_HUMAN","cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)","GO:0000139; GO:0005078; GO:0005737; GO:0007257; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0046328",4.70469095925061e-05,3.22597658787548e-05,5.47894976986461e-05,0.00219490234380934,0.00414267667945983,0.00417561473254345,0.00345969919421424,0.00177454832149709,5.47655751194822,0.00435582317089642,0.0382418936849983,-5.95397635599372,147457,1.41746061020916,19,0,0,4.70469095925061e-05,0.00414267667945983,88.0541722153775,6.46031945887377
"672",721,976,976,976,"Q86UA1","PRPF39","PRP39_HUMAN","commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Pre-mRNA-processing factor 39 (PRP39 homolog)","GO:0000243; GO:0000395; GO:0005685; GO:0071004",9.36910712640634e-05,0.00011283105509805,0.00015388540319132,0.0345107675306828,0.0398331885580124,0.0627333701004267,0.0455723062198562,0.0229062889531126,5.46160042197379,0.00440190580617917,0.0386068787918993,-5.9666622870066,78430,1.41333530788768,10,0,0,0.00011283105509805,0.0398331885580124,353.033910064897,8.46366295551717
"673",723,978,978,978,"Q14C86","GAPVD1","GAPD1_HUMAN","cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:16410077}; Peripheral membrane protein {ECO:0000269|PubMed:16410077}. Endosome {ECO:0000269|PubMed:16410077}. Note=Recruited to the plasma membrane by TRIP10/CIP4 in response to insulin.","GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)","GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0006897; GO:0007165; GO:0016020; GO:0017112; GO:0032794; GO:0045296; GO:0051223; GO:0061024",4.9589082790259e-06,1e-07,1.63645801990839e-05,0.00170748321252509,0.00092669665162532,0.00181904590588352,0.00147726742718527,0.00074577487641867,5.43102033375802,0.00449796517265742,0.0393422482286144,-5.9926799600856,164980,1.40514082577452,27,1,0,4.9589082790259e-06,0.00170748321252509,344.326435668719,8.42763313787419
"674",724,979,979,979,"O95486","SEC24A","SC24A_HUMAN","COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cargo loading into COPII-coated vesicle [GO:0090110]; cholesterol homeostasis [GO:0042632]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045714]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, COPII-coated vesicle membrane {ECO:0000305|PubMed:17499046}; Peripheral membrane protein {ECO:0000305|PubMed:17499046}; Cytoplasmic side {ECO:0000305|PubMed:17499046}. Endoplasmic reticulum membrane {ECO:0000305|PubMed:17499046}; Peripheral membrane protein {ECO:0000305|PubMed:17499046}; Cytoplasmic side {ECO:0000305|PubMed:17499046}. Cytoplasm, cytosol {ECO:0000305|PubMed:17499046}.","Protein transport protein Sec24A (SEC24-related protein A)","GO:0000139; GO:0002474; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0030127; GO:0042632; GO:0045714; GO:0048208; GO:0050714; GO:0090110",1e-07,1e-07,1e-07,0.0432046422282795,0.049992049571523,0.0248208105400294,0.0393390674466106,0.0196696337233053,5.42871736974506,0.00450530111704596,0.0393422482286144,-5.99464375275536,119749,1.40514082577452,17,3,0,1e-07,0.0432046422282795,432046.422282795,18.7208268090455
"675",726,981,981,981,"Q02878","RPL6","RL6_HUMAN","cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:25957688}. Cytoplasm {ECO:0000305|PubMed:23636399, ECO:0000305|PubMed:25901680}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:Q2YGT9}. Note=Detected on cytosolic polysomes (PubMed:25957688). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:Q2YGT9, ECO:0000269|PubMed:25957688}.","60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)","GO:0000027; GO:0000184; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005791; GO:0005829; GO:0005925; GO:0006355; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0036464; GO:0042788; GO:0045296",6.23470118312978e-05,1e-07,1e-07,0.00870703483129377,0.0172221794551953,0.0161526020616571,0.014006423112105,0.00702406055999626,5.42645321320192,0.0045125275028652,0.0393422482286144,-5.99657505851845,32728,1.40514082577452,9,2,0,1e-07,0.0161526020616571,161526.020616571,17.3014070653042
"676",727,982,982,982,"Q9NVS2","MRPS18A","RT18A_HUMAN","cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein S18a, mitochondrial (MRP-S18-a) (Mrps18a) (S18mt-a) (39S ribosomal protein S18-3, mitochondrial) (MRP-S18-3) (Mitochondrial large ribosomal subunit protein bS18a) (Mitochondrial large ribosomal subunit protein mL66)","GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0022627; GO:0032543; GO:0070125; GO:0070126",0.00011778593584728,0.00019268277022718,0.00027202117880563,0.0121216080796004,0.0198767550726628,0.0113394469952389,0.014251773420874,0.00732005000539702,5.42611606711729,0.00451360474817254,0.0393422482286144,-5.99686269252743,22184,1.40514082577452,4,0,0,0.00019268277022718,0.0121216080796004,62.9096626818713,5.97520972141282
"677",728,984,984,984,"Q9NWQ8","PAG1","PHAG1_HUMAN","integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10790433, ECO:0000269|PubMed:18070987}; Single-pass type III membrane protein {ECO:0000269|PubMed:10790433, ECO:0000269|PubMed:18070987}. Note=Present in lipid rafts.","Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp)","GO:0002250; GO:0005068; GO:0005070; GO:0005622; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0035556; GO:0042169; GO:0045121; GO:0050852; GO:0050863; GO:0050868",1e-07,1e-07,0.0162204713773674,0.0656985153088418,0.11501252198529,0.119921429801761,0.0948039319061753,0.0528088564122101,5.42314450570316,0.00452311286201039,0.0393422482286144,-5.99939843680615,46981,1.40514082577452,6,2,0,1e-07,0.11501252198529,1150125.2198529,20.1333595124296
"678",729,985,985,985,"Q15070","OXA1L","OXA1L_HUMAN","integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain [GO:0005746]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; negative regulation of ATPase activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; oxidation-reduction process [GO:0055114]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:17936786}; Multi-pass membrane protein {ECO:0000269|PubMed:17936786}.","Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein)","GO:0005739; GO:0005746; GO:0005759; GO:0009060; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032981; GO:0032991; GO:0033615; GO:0042803; GO:0051262; GO:0051354; GO:0055114; GO:0065003; GO:0070125; GO:0070126; GO:0097177",1e-07,1e-07,0.00043531543355581,0.534443812980209,1.02964111222644,1.03319235265836,0.865613920810486,0.432952132216428,5.42173617779169,0.00452762752218665,0.0393422482286144,-6.0006005769511,48548,1.40514082577452,4,2,0,1e-07,1.02964111222644,10296411.1222644,23.2956382289638
"679",730,986,986,986,"Q9H1Z4","WDR13","WDR13_HUMAN","microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12659815}.","WD repeat-containing protein 13","GO:0005654; GO:0005815; GO:0005886; GO:1904691; GO:1990841",0.00015772774249152,0.00030442217351976,0.00144971647561124,0.0609294210980572,0.0314669148251938,0.0591792833813357,0.0498879176376547,0.0255812476160349,5.4195918381346,0.00453451203939081,0.0393422482286144,-6.00243141875674,53696,1.40514082577452,5,0,0,0.00030442217351976,0.0591792833813357,194.398728243409,7.60287497063751
"680",731,987,987,987,"P46379","BAG6","BAG6_HUMAN","BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; embryo development [GO:0009790]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of cell proliferation [GO:0042127]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Nucleus {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Secreted, exosome {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}. Note=Normally localized in cytosol and nucleus, it can also be released extracellularly, in exosomes, by tumor and myeloid dendritic cells (PubMed:18055229, PubMed:18852879). Cytoplasmic retention is due to interaction with GET4 (PubMed:29042515). {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879, ECO:0000269|PubMed:29042515}.","Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe)","GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0009790; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0032435; GO:0042127; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381",0.00016111071642759,0.00845759005491993,7.57106147350154e-05,0.0705624484212969,0.079939016115113,0.0420307079496277,0.061279253699985,0.0335377639786867,5.41903299879848,0.00453630829458439,0.0393422482286144,-6.00290864554882,119409,1.40514082577452,20,0,0,0.00016111071642759,0.0705624484212969,437.974890720635,8.77470435167606
"681",733,991,991,991,"Q6IA86","ELP2","ELP2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; histone acetyltransferase complex [GO:0000123]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of JAK-STAT cascade [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus.","Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)","GO:0000123; GO:0002098; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0008023; GO:0019901; GO:0033588; GO:0046425",0.00010141896667716,7.33269934017036e-05,3.06636457947452e-05,0.0862983500806867,0.0519095108290593,0.0490961803918095,0.0623662105652273,0.0312515751512382,5.41091408436086,0.00456250156301907,0.0393455524846906,-6.00984601258703,92500,1.40510435200938,10,0,0,7.33269934017036e-05,0.0519095108290593,707.918167934229,9.4674387908475
"682",734,992,992,992,"O15164","TRIM24","TIF1A_HUMAN","cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; ligand-dependent nuclear receptor binding [GO:0016922]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21164480}. Cytoplasm {ECO:0000269|PubMed:21164480}. Note=Colocalizes with sites of active transcription. Detected both in nucleus and cytoplasm in some breast cancer samples. Predominantly nuclear.","Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)","GO:0002039; GO:0003682; GO:0003713; GO:0004713; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796",0.052723433850583,0.0469550421926775,0.0783737971201093,0.211522415231642,0.156275654280398,0.245981022663743,0.145242273004137,0.131971894223192,5.41056456877286,0.00456363325703975,0.0393455524846906,-6.01014483686831,116831,1.40510435200938,10,0,0,0.052723433850583,0.211522415231642,4.01192410629193,2.00429431469589
"683",735,993,993,993,"Q8NCM8","DYNC2H1","DYHC2_HUMAN","apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium axoneme {ECO:0000250|UniProtKB:Q9JJ79}. Cell membrane {ECO:0000250|UniProtKB:Q45VK7}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q45VK7}. Cytoplasm {ECO:0000250|UniProtKB:Q9JJ79}. Note=Localizes to the apical cytoplasm (By similarity). According to PubMed:8666668, it localizes to Golgi apparatus, cytoplasmic vesicle and endoplasmic reticulum (PubMed:8666668). {ECO:0000250|UniProtKB:Q9JJ79, ECO:0000269|PubMed:8666668}.","Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11) (hDHC11) (Dynein heavy chain isotype 1B)","GO:0003774; GO:0003777; GO:0005524; GO:0005794; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007030; GO:0007368; GO:0009953; GO:0016485; GO:0016887; GO:0021522; GO:0030326; GO:0030900; GO:0031514; GO:0035721; GO:0035735; GO:0045177; GO:0045503; GO:0045505; GO:0045880; GO:0051959; GO:0060271; GO:0060976; GO:0061512; GO:0070062; GO:0097542; GO:1905515",0.00010648924413131,9.59865473562446e-05,0.00039119731639073,0.00123748080388293,0.00220676978594303,0.00194463594554755,0.00159840447583174,0.00099709327387529,5.41002820776954,0.00456537059433008,0.0393455524846906,-6.01060343572101,492622,1.40510435200938,42,0,0,0.00010648924413131,0.00194463594554755,18.2613367332165,4.1907204696179
"684",737,998,998,998,"P49641","MAN2A2","MA2A2_HUMAN","Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.","Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)","GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872",1e-07,1e-07,1e-07,0.0623776014735468,0.109317310645881,0.12639560939644,0.0993634071719559,0.0496818035859779,5.38697045959792,0.00464081659367476,0.0397905031351596,-6.03035026277374,130539,1.4002205693371,5,3,0,1e-07,0.109317310645881,1093173.10645881,20.0600904424796
"685",739,1001,1001,1001,"Q5RI15","COX20","COX20_HUMAN","integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial respiratory chain complex IV assembly [GO:0033617]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:23125284, ECO:0000269|PubMed:29154948}; Multi-pass membrane protein {ECO:0000255}.","Cytochrome c oxidase assembly protein COX20, mitochondrial","GO:0005739; GO:0005743; GO:0009060; GO:0016021; GO:0033617",1e-07,7.2064409239438e-05,1e-07,0.0419954259984407,0.0250216809556757,0.0239298099699112,0.0302915508382627,0.0151698635555445,5.37415368289326,0.00468340312295847,0.0400498808516728,-6.04135377238682,13291,1.39739877160316,3,2,0,1e-07,0.0250216809556757,250216.809556757,17.9328191874
"686",740,1002,1002,1002,"P11171","EPB41","41_HUMAN","cell cortex region [GO:0099738]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12427749}. Cytoplasm, cell cortex {ECO:0000269|PubMed:12427749, ECO:0000269|PubMed:23870127}. Nucleus {ECO:0000269|PubMed:12427749}.","Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1)","GO:0003779; GO:0005200; GO:0005516; GO:0005545; GO:0005634; GO:0005829; GO:0005886; GO:0007049; GO:0008022; GO:0008360; GO:0009898; GO:0014069; GO:0014731; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030866; GO:0031032; GO:0032092; GO:0032991; GO:0047485; GO:0051219; GO:0051301; GO:0065003; GO:0099738; GO:1904778",1e-07,2.73750214090065e-07,1e-07,0.0001746380978344,0.00015893457418555,0.00014081251678814,0.00015797047953133,7.91431565036995e-05,5.37090289167076,0.00469427932398164,0.0401028253625577,-6.04414774450616,97017,1.39682502897226,18,2,0,1e-07,0.00015893457418555,1589.3457418555,10.634217283359
"687",741,1003,1003,1003,"P31629","HIVEP2","ZEP2_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus.","Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2)","GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006366; GO:0007165; GO:0007275; GO:0043565; GO:0044212; GO:0046872",0.0649997574651163,0.00018291984114595,0.00021938873338897,0.150478777784975,0.186103301332713,0.136021119961599,0.135733711013212,0.0896675441864897,5.36940330232599,0.00469930676625354,0.0401044445151424,-6.04543702523849,269053,1.39680749467558,8,0,0,0.00021938873338897,0.150478777784975,685.900207638195,9.42185488218133
"688",742,1005,1005,1005,"Q9NZC7","WWOX","WWOX_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; coenzyme binding [GO:0050662]; cofactor binding [GO:0048037]; enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription coactivator activity [GO:0001105]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; oxidation-reduction process [GO:0055114]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; steroid metabolic process [GO:0008202]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14695174, ECO:0000269|PubMed:15070730, ECO:0000269|PubMed:16219768, ECO:0000269|PubMed:19366691, ECO:0000269|PubMed:19465938}. Nucleus {ECO:0000269|PubMed:14695174, ECO:0000269|PubMed:15064722, ECO:0000269|PubMed:16219768, ECO:0000269|PubMed:19366691}. Mitochondrion {ECO:0000269|PubMed:14695174}. Golgi apparatus {ECO:0000305}. Note=Partially localizes to the mitochondria (PubMed:14695174). Translocates to the nucleus upon genotoxic stress or TNF stimulation (By similarity). Translocates to the nucleus in response to TGFB1 (PubMed:19366691). Isoform 5 and isoform 6 may localize in the nucleus. {ECO:0000250, ECO:0000269|PubMed:14695174, ECO:0000269|PubMed:19366691}.","WW domain-containing oxidoreductase (EC 1.1.1.-) (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1)","GO:0000122; GO:0001105; GO:0001649; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0008202; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0046983; GO:0048037; GO:0048705; GO:0050662; GO:0055114; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241",0.142103033482039,0.204750449249369,0.0963131846483868,0.41662544234881,0.590939756555674,0.65982772447059,0.408075418665094,0.351759931792478,5.36646740219676,0.00470916829703522,0.0401044445151424,-6.04796195433887,46677,1.39680749467558,5,0,0,0.142103033482039,0.590939756555674,4.1585302021745,2.05607370992381
"689",743,1007,1007,1007,"Q8NBJ4","GOLM1","GOLM1_HUMAN","endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; cellular protein metabolic process [GO:0044267]; nucleus organization [GO:0006997]; post-translational protein modification [GO:0043687]; regulation of lipid metabolic process [GO:0019216]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane {ECO:0000269|PubMed:10831838, ECO:0000269|PubMed:12191016}; Single-pass type II membrane protein {ECO:0000269|PubMed:10831838, ECO:0000269|PubMed:12191016}. Note=Early Golgi. Cycles via the cell surface and endosomes upon lumenal pH disruption.","Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2)","GO:0005615; GO:0005788; GO:0005794; GO:0005887; GO:0006997; GO:0019216; GO:0043687; GO:0044267",0.00451897088832053,0.00775333338288522,0.0430880167102177,0.105875189198114,0.0808338774694377,0.0908907269814999,0.0740798242225428,0.0554933524384126,5.36177801554628,0.0047249714491767,0.0401646033812835,-6.05199703521398,45333,1.39615651726451,8,0,0,0.00775333338288522,0.0908907269814999,11.7227936028306,3.55124450736843
"690",744,1008,1008,1008,"Q9Y5F9","PCDHGB6","PCDGI_HUMAN","integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Protocadherin gamma-B6 (PCDH-gamma-B6)","GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399",0.0001125534559238,0.00013956725093485,0.00019775989371224,0.0316718171026721,0.0391232303243792,0.0597480359959333,0.0433644009408046,0.0218321606705926,5.35842973624763,0.00473629418687295,0.0402209109520164,-6.05487972939298,101043,1.39554809741521,8,0,0,0.00013956725093485,0.0391232303243792,280.318126654525,8.13092122843355
"691",746,1010,1010,1010,"P00387","CYB5R3","NB5R3_HUMAN","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; L-ascorbic acid metabolic process [GO:0019852]; neutrophil degranulation [GO:0043312]","SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane; Lipid-anchor; Cytoplasmic side. Mitochondrion outer membrane; Lipid-anchor; Cytoplasmic side.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Note=Produces the soluble form found in erythrocytes.","NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]","GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0008015; GO:0016020; GO:0016208; GO:0016491; GO:0019852; GO:0035578; GO:0043312; GO:0043531; GO:0050660; GO:0051287; GO:0071949",1e-07,0.00497729562062485,1e-07,0.0189214729656424,0.0322599848721722,0.0217080071354956,0.0226373231175618,0.0129778267656558,5.35291821387275,0.00475500352932264,0.040299831892081,-6.059627764015,34235,1.39469676548405,8,2,0,1e-07,0.0217080071354956,217080.071354956,17.7278677624486
"692",747,1013,1013,1013,"Q9Y250","LZTS1","LZTS1_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; microtubule binding [GO:0008017]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Associated with the plasma membrane and with microtubules. Detected in dendritic spines, especially in the postsynaptic density (By similarity). {ECO:0000250}.","Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1)","GO:0003677; GO:0003700; GO:0005737; GO:0006351; GO:0008017; GO:0014069; GO:0016242; GO:0030054; GO:0043197; GO:0044772; GO:0045211",0.00021225532229142,9.4417445187661e-05,7.75913621283836e-05,0.049002725998286,0.0984821094932028,0.0735038111824472,0.0735347941814429,0.0368954851339239,5.34175295736143,0.00479317849192187,0.0405030680067633,-6.06925742162468,66613,1.39251207881144,13,0,0,9.4417445187661e-05,0.0735038111824472,778.498200585214,9.60454989444861
"693",748,1015,1015,1015,"O14531","DPYSL4","DPYL4_HUMAN","cytosol [GO:0005829]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4)","GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485",1e-07,7.08465743672147e-05,1e-07,0.00247796849933515,0.00439889535909724,0.00502478255953533,0.00394353328120017,0.00199544883205582,5.33391549539835,0.00482019602000651,0.040633917461685,-6.07602584339213,61878,1.39111130590449,22,2,0,1e-07,0.00439889535909724,43988.9535909724,15.4248536623826
"694",749,1016,1016,1016,"Q5JTZ9","AARS2","SYAM_HUMAN","mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; mitochondrial respiratory chain complex assembly [GO:0033108]; tRNA modification [GO:0006400]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|PubMed:21549344}.","Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","GO:0000049; GO:0004813; GO:0005524; GO:0005739; GO:0006400; GO:0016597; GO:0033108; GO:0046872; GO:0070143",0.00802880710254353,0.00431287726582918,0.00896182821895019,0.0298513464665873,0.0408006082254253,0.0521054872476168,0.0338179764507688,0.0240101590878254,5.3331327962934,0.00482290422208785,0.040633917461685,-6.07670218390829,107340,1.39111130590449,18,0,0,0.00802880710254353,0.0408006082254253,5.08177711885738,2.34533310176465
"695",751,1018,1018,1018,"O95573","ACSL3","ACSL3_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import [GO:0044539]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Peroxisome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}.","Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3)","GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0035338; GO:0042998; GO:0044539; GO:0048471; GO:0051047; GO:0102391; GO:2001247",0.00025200323728799,0.00017939854981539,0.00043164130558411,0.00560331333170699,0.00525728344568157,0.002940567781026,0.00431270715524236,0.00244403460851701,5.32883721753806,0.00483779993378056,0.0406793393253061,-6.08041535246416,80420,1.39062610908518,15,0,0,0.00025200323728799,0.00525728344568157,20.8619678947756,4.3828033475737
"696",752,1019,1019,1019,"Q9BY67","CADM1","CADM1_HUMAN","basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; multicellular organism development [GO:0007275]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11279526, ECO:0000269|PubMed:22438059}; Single-pass type I membrane protein {ECO:0000269|PubMed:11279526}. Cell junction, synapse {ECO:0000250|UniProtKB:Q8R5M8}. Note=Localized to the basolateral plasma membrane of epithelial cells in gall bladder. {ECO:0000250|UniProtKB:Q8R5M8}.","Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1)","GO:0002376; GO:0005102; GO:0005886; GO:0005887; GO:0005911; GO:0005913; GO:0006915; GO:0007156; GO:0007157; GO:0007275; GO:0007283; GO:0008037; GO:0016323; GO:0030154; GO:0030165; GO:0034332; GO:0042271; GO:0042803; GO:0045202; GO:0045954; GO:0050715; GO:0050839; GO:0051606",1e-07,1e-07,0.00017277196546699,0.106411238253028,0.0542558414945523,0.105912612563037,0.0888022401150502,0.0444587773793474,5.32528654335578,0.00485015438617814,0.0407432007317811,-6.08348627825196,48509,1.3899448563975,6,2,0,1e-07,0.105912612563037,1059126.12563037,20.014442971673
"697",753,1020,1020,1020,"Q9ULP9","TBC1D24","TBC24_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; neuron projection development [GO:0031175]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20727515}. Note=Partially expressed at the plasma membrane.","TBC1 domain family member 24","GO:0005096; GO:0005737; GO:0005886; GO:0030054; GO:0031175; GO:0031594; GO:0043195",7.15869373540763e-05,8.76224016150518e-05,0.00013915000974147,0.0256308486120147,0.0237984853382112,0.0127555602986758,0.0206288449667303,0.010413875599602,5.32261037400229,0.00485949113971147,0.0407756638917421,-6.08580185430434,62919,1.38959895923501,17,0,0,8.76224016150518e-05,0.0237984853382112,271.602751117964,8.08535428277468
"698",754,1021,1021,1021,"Q9C0E8","LNPK","LNP_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum tubular network maintenance [GO:0071788]; limb development [GO:0060173]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22729086, ECO:0000269|PubMed:24223779, ECO:0000269|PubMed:25404289, ECO:0000269|PubMed:25548161, ECO:0000269|PubMed:27619977}; Multi-pass membrane protein {ECO:0000269|PubMed:22729086, ECO:0000269|PubMed:24223779}; Cytoplasmic side {ECO:0000269|PubMed:24223779, ECO:0000269|PubMed:25548161}. Note=Localizes at endoplasmic reticulum (ER) three-way tubular junctions, which represent crossing-points at which the tubules build a polygonal network (PubMed:22729086, PubMed:24223779, PubMed:25404289, PubMed:25548161, PubMed:27619977). {ECO:0000269|PubMed:22729086, ECO:0000269|PubMed:24223779, ECO:0000269|PubMed:25404289, ECO:0000269|PubMed:25548161, ECO:0000269|PubMed:27619977}.","Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark)","GO:0005654; GO:0005783; GO:0005789; GO:0007596; GO:0016021; GO:0030176; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0046872; GO:0060173; GO:0071788; GO:0098826; GO:1903373",6.23861879512741e-05,5.23117540808609e-05,3.23866351962926e-05,0.00842746138264502,0.0166195957830071,0.0162861744681038,0.0137287156855092,0.00691338603516407,5.32118914193679,0.00486445840308316,0.0407756638917421,-6.08703193470183,47740,1.38959895923501,7,0,0,5.23117540808609e-05,0.0162861744681038,311.329160229065,8.2822969010104
"699",755,1023,1023,1023,"Q2M389","WASHC4","WASC4_HUMAN","early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:23676666}.","WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)","GO:0005654; GO:0005768; GO:0005769; GO:0007032; GO:0015031; GO:0016197; GO:0071203",0.00017890308445905,0.00038673240350113,0.00029688201844672,0.00395405805622359,0.00743597950973018,0.00750894064657869,0.00601215356870852,0.00329358261982323,5.30967120789721,0.00490494038348869,0.0410423164053404,-6.09700966684998,136403,1.3867681358673,19,0,0,0.00029688201844672,0.00743597950973018,25.0469177912325,4.64656117491896
"700",756,1024,1024,1024,"P61201","COPS2","CSN2_HUMAN","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription corepressor activity [GO:0003714]; cell proliferation [GO:0008283]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9535219}. Nucleus {ECO:0000269|PubMed:10207062}.","COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15)","GO:0000122; GO:0000338; GO:0000715; GO:0003714; GO:0005654; GO:0005737; GO:0005829; GO:0006283; GO:0006366; GO:0007165; GO:0008180; GO:0008283; GO:0022008; GO:0030182; GO:0035914; GO:0043687; GO:0045892; GO:1903507",1e-07,1e-07,1e-07,0.00030019089599572,0.00017497686358248,0.00029649335250466,0.00025712037069429,0.00012866018534714,5.30617933797501,0.00491729326584213,0.041105498394149,-6.10003773996332,51597,1.38610008171217,15,3,0,1e-07,0.00029649335250466,2964.9335250466,11.5337840440166
"701",757,1025,1025,1025,"P51452","DUSP3","DUS3_HUMAN","cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of mitotic cell cycle [GO:0045931]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10224087}.","Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR)","GO:0000188; GO:0001701; GO:0001772; GO:0004725; GO:0005634; GO:0005654; GO:0005829; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0033549; GO:0035335; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0070373",7.35266326187312e-05,4.46806533563821e-05,0.00051284787570778,0.047550747701411,0.0527299323126607,0.0259765491533364,0.0418753913352417,0.0211480473881818,5.30293630298776,0.00492879942509067,0.0411614859305133,-6.10285134040456,20478,1.38550895558662,7,0,0,7.35266326187312e-05,0.047550747701411,646.714612213823,9.33698539754765
"702",758,1026,1026,1026,"O94829","IPO13","IPO13_HUMAN","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus.","Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13)","GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0008565; GO:0031965",0.0256867191589329,0.0200164382095578,0.0262690821231372,0.0611644842030003,0.0994470869481763,0.0884443833599037,0.0590279050064841,0.0535046990004514,5.30156383543823,0.00493367864474842,0.0411620752427353,-6.10404244984338,108195,1.38550273780297,10,0,0,0.0256867191589329,0.0884443833599037,3.44319501500627,1.78374789430163
"703",759,1027,1027,1027,"P25098","GRK2","ARBK1_HUMAN","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G-protein coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G-protein coupled receptor protein signaling pathway [GO:0002029]; G-protein coupled acetylcholine receptor signaling pathway [GO:0007213]; G-protein coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P21146}. Cell membrane {ECO:0000250|UniProtKB:P21146}.","Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2)","GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0033605; GO:0045988; GO:0046718; GO:0047696; GO:0060048",1e-07,7.78062206051174e-06,1.56852505103648e-05,0.0264830748775224,0.0273708173649726,0.0137229069665633,0.0225177444454958,0.0112667275136049,5.29942755157112,0.0049412848599763,0.0411853927959076,-6.10589689533754,79574,1.38525678768001,6,1,0,7.78062206051174e-06,0.0264830748775224,3403.7220509565,11.7328975155523
"704",760,1028,1028,1028,"Q9UGJ1","TUBGCP4","GCP4_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307]; protein-containing complex assembly [GO:0065003]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.","Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76)","GO:0000922; GO:0000923; GO:0000930; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008274; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051298; GO:0051321; GO:0051415; GO:0055037; GO:0065003; GO:0090307",9.20326511317099e-05,9.89249334835859e-05,6.38765647298608e-05,0.0449533301192245,0.0923914386071007,0.0796617245007808,0.0722505530259203,0.0362102212294085,5.28847805472252,0.0049804927468469,0.0414555726484385,-6.115410454413,76089,1.38241708133098,9,0,0,9.20326511317099e-05,0.0796617245007808,865.581111933581,9.75752520786613
"705",761,1029,1029,1029,"Q8N8U2","CDYL2","CDYL2_HUMAN","nucleus [GO:0005634]; catalytic activity [GO:0003824]; methylated histone binding [GO:0035064]; metabolic process [GO:0008152]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Chromodomain Y-like protein 2 (CDY-like 2)","GO:0003824; GO:0005634; GO:0008152; GO:0035064",0.0135553175649459,0.00680431547907983,0.0313482116397883,0.0544206228191929,0.0633754277926232,0.0546014974500374,0.0402299011260131,0.0373508987909446,5.28767417275315,0.00498338601112654,0.0414555726484385,-6.11610948283496,56500,1.38241708133098,4,0,0,0.0135553175649459,0.0546014974500374,4.02805003928769,2.01008160563461
"706",762,1031,1031,1031,"P78310","CXADR","CXAR_HUMAN","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle fiber development [GO:0048739]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; leukocyte migration [GO:0050900]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; regulation of immune response [GO:0050776]; transepithelial transport [GO:0070633]","SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000269|PubMed:15533241}; Single-pass type I membrane protein {ECO:0000255}. Basolateral cell membrane {ECO:0000269|PubMed:11316797, ECO:0000269|PubMed:12021372, ECO:0000269|PubMed:12297051, ECO:0000269|PubMed:15364909}; Single-pass type I membrane protein {ECO:0000255}. Cell junction, tight junction {ECO:0000269|PubMed:11734628, ECO:0000269|PubMed:12297051}. Cell junction, adherens junction {ECO:0000269|PubMed:12297051}. Note=In epithelial cells localizes to the apical junction complex composed of tight and adherens junctions (PubMed:12297051). In airway epithelial cells localized to basolateral membrane but not to apical surface (PubMed:11316797). {ECO:0000269|PubMed:11316797, ECO:0000269|PubMed:12297051}.; SUBCELLULAR LOCATION: Isoform 3: Secreted {ECO:0000269|PubMed:14978041}.; SUBCELLULAR LOCATION: Isoform 4: Secreted {ECO:0000269|PubMed:14978041}.; SUBCELLULAR LOCATION: Isoform 5: Secreted {ECO:0000269|PubMed:14978041}.","Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR)","GO:0001618; GO:0001669; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0005913; GO:0005923; GO:0007005; GO:0007157; GO:0007507; GO:0008013; GO:0008354; GO:0010669; GO:0014704; GO:0016323; GO:0016327; GO:0030054; GO:0030165; GO:0030175; GO:0030426; GO:0030593; GO:0031532; GO:0031594; GO:0032991; GO:0034109; GO:0042802; GO:0043005; GO:0044297; GO:0045121; GO:0045216; GO:0046629; GO:0048739; GO:0050776; GO:0050839; GO:0050900; GO:0051607; GO:0070633; GO:0071253; GO:0086067; GO:0086072; GO:0086082; GO:0098904",0.00020696652879347,0.00036775821120269,0.00023181190472409,0.00408682410185837,0.00212818958557994,0.00359185174641293,0.00300010959637699,0.00176890034642858,5.26871704855513,0.00505220494116583,0.0419465318102614,-6.13261656380107,40030,1.3773039413414,17,0,0,0.00023181190472409,0.00359185174641293,15.4946819952498,3.95370124099678
"707",765,1036,1036,1036,"P78417","GSTO1","GSTO1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; toxin catabolic process [GO:0009407]; xenobiotic catabolic process [GO:0042178]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:11511179}.","Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)","GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0009407; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687",0.00035157875913636,0.00043569958804915,0.0006568070496802,0.0118028865667448,0.0079641637260553,0.00632837248665517,0.00821711246086316,0.00458991802938683,5.24604738295593,0.0051360090729471,0.0424287671243231,-6.1524134972628,27566,1.37233958758013,6,0,0,0.00043569958804915,0.0079641637260553,18.279025146007,4.19211722575796
"708",766,1037,1037,1037,"O60264","SMARCA5","SMCA5_HUMAN","chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; chromatin silencing at rDNA [GO:0000183]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:12434153}.","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)","GO:0000183; GO:0000793; GO:0000981; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0006334; GO:0006338; GO:0006352; GO:0006357; GO:0016584; GO:0016589; GO:0016887; GO:0031213; GO:0031491; GO:0034080; GO:0043044; GO:0045815; GO:0045893; GO:1990830",0.00018744627977503,0.00040392202389471,0.00041850679964351,0.00161101996486656,0.00289045460743857,0.0027294589671584,0.00207368614538342,0.00137346810712947,5.24497169019197,0.00514002704531811,0.0424287671243231,-6.15335442752061,121905,1.37233958758013,19,0,0,0.00040392202389471,0.0027294589671584,6.75739079746215,2.7564662923341
"709",767,1038,1038,1038,"Q9P0J0","NDUFA13","NDUAD_HUMAN","cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein import into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:12628925, ECO:0000269|PubMed:15059901, ECO:0000269|PubMed:15367666}; Single-pass membrane protein {ECO:0000255}; Matrix side. Nucleus {ECO:0000269|PubMed:12628925}. Note=Localizes mainly in the mitochondrion (PubMed:12628925). May be translocated into the nucleus upon IFN/RA treatment. {ECO:0000269|PubMed:12628925, ECO:0000269|PubMed:15059901}.","NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)","GO:0003954; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005746; GO:0005747; GO:0008137; GO:0010952; GO:0016021; GO:0030308; GO:0031966; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243",0.00366897750790274,0.00983206055214396,0.00455808113138671,0.0216191591938077,0.0239709726582741,0.0331223619479351,0.0202177915361945,0.0161286021652417,5.24266480549087,0.00514865657709999,0.04245905616568,-6.15537278093382,16698,1.3720296641171,8,0,0,0.00455808113138671,0.0239709726582741,5.25900526280922,2.3947899405579
"710",768,1039,1039,1039,"Q8WWM7","ATXN2L","ATX2L_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; stress granule assembly [GO:0034063]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:11784712}; Peripheral membrane protein {ECO:0000269|PubMed:11784712}. Cytoplasm {ECO:0000269|PubMed:23209657}. Nucleus speckle {ECO:0000269|PubMed:23209657}. Cytoplasmic granule {ECO:0000269|PubMed:23209657}. Note=Predominantly cytoplasmic but is also detected in nuclear speckles (PubMed:23209657). Component of cytoplasmic stress granules (PubMed:23209657). Inhibition of methylation alters nuclear localization (PubMed:25748791). Methylation does not seem to be required for localization to stress granules under stress conditions (PubMed:25748791). {ECO:0000269|PubMed:23209657, ECO:0000269|PubMed:25748791}.","Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein)","GO:0003723; GO:0005829; GO:0010494; GO:0010603; GO:0016020; GO:0016607; GO:0034063; GO:0045296",1.9343232930865e-05,4.1879780736025e-05,4.22274234363754e-05,0.00049111304131559,0.00081875805573732,0.00096590966219053,0.00072411010738006,0.00039653853272445,5.23688092294575,0.00517036952811486,0.0425730541385784,-6.1604360982849,113374,1.37086519295292,17,0,0,4.1879780736025e-05,0.00081875805573732,19.5501991975097,4.28911140215377
"711",769,1040,1040,1040,"O43405","COCH","COCH_HUMAN","extracellular matrix [GO:0031012]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:12843317, ECO:0000269|PubMed:22610276}.","Cochlin (COCH-5B2)","GO:0005518; GO:0007605; GO:0008360; GO:0031012; GO:0042742; GO:0045089",1e-07,1e-07,1.28919077911007e-06,0.145506547990608,0.224581713308893,0.298443763319312,0.222843511809345,0.111422252301599,5.23633433432068,0.00517242713833196,0.0425730541385784,-6.16091480275713,59483,1.37086519295292,3,2,0,1e-07,0.224581713308893,2245817.13308893,21.0988090295977
"712",771,1042,1042,1042,"Q6ZSZ5","ARHGEF18","ARHGI_HUMAN","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15558029}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:15558029}. Apical cell membrane {ECO:0000269|PubMed:22006950}.","Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF)","GO:0005085; GO:0005089; GO:0005829; GO:0005856; GO:0005886; GO:0007179; GO:0007186; GO:0007264; GO:0008360; GO:0016324; GO:0030036; GO:0030054; GO:0035023; GO:0043065; GO:0045177; GO:0051056; GO:0070062",0.00038512294341787,3.81280405941873e-05,8.65186959129404e-05,0.0364783409476583,0.0184946498654864,0.0366411621257646,0.0303681277529948,0.0153539871031391,5.23171708616738,0.00518984794686131,0.0426344514636591,-6.16496005997149,130780,1.3702393202927,10,0,0,8.65186959129404e-05,0.0364783409476583,421.623795443758,8.71981248132278
"713",772,1044,1044,1044,"Q96FJ0","STAMBPL1","STALP_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein deubiquitination [GO:0016579]",NA,"AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1)","GO:0005829; GO:0008237; GO:0016020; GO:0016579; GO:0046872; GO:0061578",1e-07,1e-07,1e-07,0.0848232385790723,0.0861917876975271,0.0429842165610366,0.0713329809458787,0.0356665904729394,5.2197449788275,0.00523534838523543,0.0429258449977158,-6.17546116496098,49783,1.36728114697117,5,3,0,1e-07,0.0848232385790723,848232.385790723,19.6941000409926
"714",773,1046,1046,1046,"O75037","KIF21B","KI21B_HUMAN","cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q9QXL1}. Cell projection, axon {ECO:0000250|UniProtKB:Q9QXL1}. Cytoplasmic vesicle {ECO:0000250|UniProtKB:F1M5N7}.","Kinesin-like protein KIF21B","GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410",1e-07,5.81501478609296e-05,1e-07,0.0155425519715523,0.00768585263684927,0.0150062846608851,0.0127254463738086,0.00638217323619128,5.20973913010798,0.00527374452129008,0.0431579857574026,-6.18425104647146,182662,1.36493883263738,40,2,0,1e-07,0.0150062846608851,150062.846608851,17.1952073051727
"715",774,1047,1047,1047,"Q9UJX6","ANAPC2","ANC2_HUMAN","anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]",NA,"Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2)","GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0070979; GO:0090129",5.8030550108317e-05,0.00011762541504253,0.00011674861466868,0.0306156897876927,0.0154104912054614,0.0306461460004077,0.0254599741379141,0.0128274552622302,5.2068552975495,0.00528487367350521,0.0432077541979031,-6.18678669556489,93828,1.36443830635263,6,0,0,0.00011674861466868,0.0306156897876927,262.236000611885,8.03472194680262
"716",775,1049,1049,1049,"Q6L8Q7","PDE12","PDE12_HUMAN","mitochondrial matrix [GO:0005759]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]","SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:21245038, ECO:0000269|PubMed:21666256, ECO:0000269|PubMed:22285541}.","2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)","GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503",1e-07,6.62712574602149e-07,8.41892988307405e-06,0.0217362973716286,0.0170838708854832,0.0104467411367948,0.0164192425838163,0.00821268183939405,5.20065853208985,0.00530888365952109,0.0433213004056249,-6.19223873622073,67352,1.36329851533133,9,1,0,6.62712574602149e-07,0.0170838708854832,25778.7033779151,14.6538920801266
"717",776,1050,1050,1050,"O60701","UGDH","UGDH_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-glucose metabolic process [GO:0006011]; UDP-glucuronate biosynthetic process [GO:0006065]",NA,"UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)","GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0006011; GO:0006024; GO:0006065; GO:0009055; GO:0051287; GO:0070062",0.00061229310860305,0.0106437285663619,0.00043992042589626,0.0285106087748495,0.0479641301694973,0.0349864242343206,0.033255073692602,0.0205261842132548,5.19673462835193,0.00532415506741566,0.0434045403591219,-6.19569350387041,55024,1.36246483846501,9,0,0,0.00061229310860305,0.0349864242343206,57.1399934814591,5.83642896657874
"718",777,1051,1051,1051,"Q15631","TSN","TSN_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; DNA recombination [GO:0006310]; RNA metabolic process [GO:0016070]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11801738}. Nucleus {ECO:0000269|PubMed:11801738}.","Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)","GO:0003677; GO:0003697; GO:0003729; GO:0004519; GO:0005634; GO:0005829; GO:0006310; GO:0016070; GO:0042802; GO:0043565",0.00075441843699905,0.00175885965850061,0.00154233673257976,0.0483099246307775,0.0239724608304068,0.0376656822051934,0.0352974842794327,0.0190006137490762,5.19456499609198,0.00533262172392298,0.043432199768583,-6.19760455014993,26183,1.36218817378851,6,0,0,0.00154233673257976,0.0376656822051934,24.4211795061073,4.61006097688824
"719",779,1054,1054,1054,"Q9BXS5","AP1M1","AP1M1_HUMAN","clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690]","SUBCELLULAR LOCATION: Golgi apparatus. Cytoplasmic vesicle, clathrin-coated vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Note=Component of the coat surrounding the cytoplasmic face of coated vesicles located at the Golgi complex.","AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin)","GO:0000139; GO:0005765; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0019886; GO:0030131; GO:0030659; GO:0030665; GO:0032438; GO:0032588; GO:0035579; GO:0035646; GO:0043312; GO:0050690; GO:0070062",1e-07,1e-07,1e-07,0.013942944377783,0.00931907652451834,0.0190942631457668,0.014118661349356,0.00705943067467802,5.18871462647748,0.00535553272138859,0.0434912476616383,-6.20276053209052,48587,1.36159813326838,12,3,0,1e-07,0.013942944377783,139429.44377783,17.0891757265097
"720",782,1058,1058,1058,"Q96GM5","SMARCD1","SMRD1_HUMAN","intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8804307, ECO:0000305}.","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (SWI/SNF complex 60 kDa subunit)","GO:0003682; GO:0003713; GO:0005102; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0032947; GO:0043231; GO:0048096; GO:0071398; GO:0071564; GO:0071565",6.15567030215512e-05,0.00019590569041859,0.00011226652216243,0.0190404077544201,0.0380213674884787,0.0379449848589218,0.0315456770620727,0.0158960815029039,5.18365642998379,0.00537543691892679,0.0434912476616383,-6.20722175978341,58233,1.36159813326838,15,0,0,0.00011226652216243,0.0379449848589218,337.990205165722,8.40083762810588
"721",783,1060,1060,1060,"Q8TF61","FBXO41","FBX41_HUMAN","cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]",NA,"F-box only protein 41","GO:0000209; GO:0004842; GO:0005829; GO:0043687",1e-07,1e-07,1e-07,0.0427669731542477,0.0213160757315082,0.0426506992394765,0.0355778160417441,0.0177890080208721,5.17677677475729,0.00540265160376145,0.0435955862684862,-6.21329453667155,94496,1.36055747761838,4,3,0,1e-07,0.0426506992394765,426506.992394765,18.7022098685256
"722",785,1063,1063,1063,"Q6ZRP7","QSOX2","QSOX2_HUMAN","extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:14633699}; Single-pass membrane protein {ECO:0000269|PubMed:14633699}. Secreted {ECO:0000269|PubMed:14633699}. Cell membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Nucleus membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Note=Seems to be predominantly targeted to the nuclear and outer plasma membrane.","Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1)","GO:0003756; GO:0005615; GO:0005654; GO:0005794; GO:0005886; GO:0016971; GO:0030173; GO:0031965; GO:0045454",0.00068221111311064,0.00033644977281241,0.00104410460055479,0.139219445020518,0.217601004655453,0.113516605565935,0.156091429918476,0.0787333034547307,5.17388716194389,0.00541413178837652,0.0435982766778015,-6.21584698282271,77529,1.36053067688079,4,0,0,0.00068221111311064,0.139219445020518,204.070913453354,7.67292675721646
"723",789,1068,1068,1068,"P62993","GRB2","GRB2_HUMAN","cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cellular response to ionizing radiation [GO:0071479]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; fibroblast growth factor receptor signaling pathway [GO:0008543]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; interleukin-15-mediated signaling pathway [GO:0035723]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neurotrophin TRK receptor signaling pathway [GO:0048011]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of cell proliferation [GO:0042127]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]; T cell costimulation [GO:0031295]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21179510}. Cytoplasm {ECO:0000269|PubMed:21179510}. Endosome {ECO:0000269|PubMed:21179510}. Golgi apparatus {ECO:0000250}.","Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2)","GO:0000165; GO:0001784; GO:0003723; GO:0004715; GO:0005070; GO:0005088; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0007173; GO:0007265; GO:0007267; GO:0007411; GO:0007568; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0016032; GO:0016303; GO:0016477; GO:0017124; GO:0019221; GO:0019901; GO:0019903; GO:0030154; GO:0030838; GO:0031234; GO:0031295; GO:0031623; GO:0035635; GO:0035723; GO:0038083; GO:0038095; GO:0038096; GO:0038128; GO:0042059; GO:0042127; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045087; GO:0046875; GO:0046934; GO:0048011; GO:0048646; GO:0050900; GO:0051291; GO:0051897; GO:0060670; GO:0061024; GO:0070062; GO:0070436; GO:0071479; GO:2000379",1e-07,1e-07,1e-07,0.0179372577035178,0.0210570301700665,0.0338854703844411,0.0242931527526751,0.0121466763763376,5.1653118810508,0.005448373748695,0.0436686135663195,-6.22342775029124,25206,1.35983059626403,5,3,0,1e-07,0.0210570301700665,210570.301700665,17.6839424511117
"724",790,1069,1069,1069,"Q9UM73","ALK","ALK_HUMAN","extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; cell proliferation [GO:0008283]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16317043, ECO:0000269|PubMed:9174053}; Single-pass type I membrane protein {ECO:0000269|PubMed:16317043, ECO:0000269|PubMed:9174053}. Note=Membrane attachment was crucial for promotion of neuron-like differentiation and cell proliferation arrest through specific activation of the MAP kinase pathway.","ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)","GO:0000187; GO:0004704; GO:0004713; GO:0004714; GO:0005524; GO:0005622; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0008283; GO:0016310; GO:0021766; GO:0030534; GO:0032991; GO:0036269; GO:0042127; GO:0042802; GO:0042981; GO:0046777; GO:0048666; GO:0051092; GO:0060159; GO:0070062; GO:0090648",3.76422377139974e-05,3.4385219363203e-05,0.00015082426237465,0.0583046018105414,0.0578616573399547,0.0289673606089085,0.0483035893466509,0.0242260785798094,5.16372977475513,0.0054547196792823,0.0436785785356936,-6.22482736575926,176442,1.35973150364008,16,0,0,3.76422377139974e-05,0.0578616573399547,1537.14712126263,10.5860395374971
"725",791,1072,1072,1072,"O15027","SEC16A","SC16A_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; substantia nigra development [GO:0021762]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Golgi apparatus membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. Note=SAR1A activity is required to maintain SEC16A localization at discrete locations on the ER membrane perhaps by preventing its dissociation.","Protein transport protein Sec16A (SEC16 homolog A)","GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0007029; GO:0015031; GO:0021762; GO:0048208",2.05403036979085e-05,1.63802091616274e-05,5.94699710505928e-06,0.0446668597536469,0.0582174563209497,0.0278886064965825,0.0435766850204048,0.0218026316801906,5.15468740012992,0.00549116025195366,0.043834294440709,-6.23283267639821,233517,1.35818597948201,29,0,0,1.63802091616274e-05,0.0446668597536469,2726.87969444764,11.4130353369312
"726",792,1073,1073,1073,"O95861","BPNT1","BPNT1_HUMAN","cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854]",NA,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)","GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046872; GO:0050427",3.29722957326205e-06,1e-07,3.13048614660953e-06,0.0242560186363717,0.0120554270489138,0.0242355472878298,0.0201801550857985,0.0100922534481392,5.15290350867248,0.00549838382232953,0.043834294440709,-6.23441317056238,33392,1.35818597948201,9,1,0,3.13048614660953e-06,0.0242355472878298,7741.78391240545,12.9184503245512
"727",793,1074,1074,1074,"Q92925","SMARCD2","SMRD2_HUMAN","nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)","GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006351; GO:0006357; GO:0016514; GO:0032991; GO:0043044",0.00042730487741304,0.00097743647947195,0.00088735315562849,0.126143682657334,0.253676330950095,0.252308421181186,0.209945446758701,0.105736754883521,5.15173196697637,0.00550313400003465,0.043834294440709,-6.23545134899686,58921,1.35818597948201,4,0,0,0.00088735315562849,0.252308421181186,284.338224956762,8.15146425026944
"728",794,1075,1075,1075,"Q93073","SECISBP2L","SBP2L_HUMAN","mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514]",NA,"Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like)","GO:0001514; GO:0003723; GO:0003730; GO:0035368; GO:0043021",0.00028459924012988,0.0003827345357193,0.00036967150673889,0.066853125925203,0.0682017867647188,0.0337540977093735,0.0559240017055691,0.0283076692803139,5.15129895661576,0.00550489094903763,0.043834294440709,-6.23583511039593,121776,1.35818597948201,5,0,0,0.00036967150673889,0.066853125925203,180.844681579485,7.49860736049871
"729",795,1076,1076,1076,"Q16512","PKN1","PKN1_HUMAN","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:9478917}. Nucleus {ECO:0000269|PubMed:12514133}. Endosome {ECO:0000269|PubMed:9478917}. Cell membrane {ECO:0000250|UniProtKB:Q63433}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q63433}. Cleavage furrow {ECO:0000269|PubMed:17332740}. Midbody {ECO:0000269|PubMed:17332740}. Note=Associates with chromatin in a ligand-dependent manner. Localization to endosomes is mediated via its interaction with RHOB. Association to the cell membrane is dependent on Ser-377 phosphorylation. Accumulates during telophase at the cleavage furrow and finally concentrates around the midbody in cytokinesis. {ECO:0000250|UniProtKB:Q63433, ECO:0000269|PubMed:17332740}.","Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)","GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006351; GO:0006357; GO:0006468; GO:0006469; GO:0006972; GO:0007165; GO:0007257; GO:0010631; GO:0017049; GO:0018105; GO:0030374; GO:0030496; GO:0030889; GO:0032154; GO:0032991; GO:0035402; GO:0035407; GO:0042393; GO:0042826; GO:0048365; GO:0048536; GO:0050681; GO:2000145",0.00518253617581034,0.00291669232800672,0.053381613109123,0.13512499837226,0.151100545216039,0.101852222660554,0.108865641545304,0.0749264346436321,5.14913793393657,0.00551366943333714,0.043863392517998,-6.23775069414237,103932,1.35789778180423,10,0,0,0.00518253617581034,0.13512499837226,26.0731413710068,4.70449250849904
"730",796,1079,1079,1079,"Q92890","UFD1","UFD1_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9ES53}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9ES53}.","Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)","GO:0001501; GO:0004843; GO:0005102; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0030970; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0043161; GO:0044877; GO:0051117; GO:0070987; GO:0071712",4.29289884186023e-06,1e-07,9.89333497724529e-06,0.0121430710729987,0.0239998565154375,0.024835989333824,0.0203215435628137,0.0101655338593466,5.14435021615037,0.00553317806986642,0.0438962041501914,-6.24199670919818,34500,1.35757303301301,9,1,0,4.29289884186023e-06,0.0239998565154375,5590.59446763896,12.4487859827422
"731",797,1081,1081,1081,"Q16401","PSMD5","PSMD5_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]",NA,"26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B)","GO:0000502; GO:0005654; GO:0005829; GO:0016579; GO:0022624; GO:0043687; GO:0070682",1e-07,1e-07,1e-07,0.0120928417675445,0.0120580479513505,0.00598606891318395,0.0100455528773596,0.00502287643867982,5.13460516069927,0.00557314345674699,0.0440909809106121,-6.25064796422446,56196,1.35565023913405,10,3,0,1e-07,0.0120580479513505,120580.479513505,16.8796368461152
"732",798,1082,1082,1082,"P10586","PTPRF","PTPRF_HUMAN","extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:1900121",0.00023190864602139,0.00041545716899777,0.00035716475015672,0.049578587406484,0.102909724703494,0.0770881488594629,0.0761906434680883,0.0384301652557694,5.13416209332685,0.00557496874994594,0.0440909809106121,-6.25104158167851,212879,1.35565023913405,15,0,0,0.00035716475015672,0.0770881488594629,215.833586112956,7.75377557150694
"733",799,1083,1083,1083,"P29083","GTF2E1","T2EA_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcriptional preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus.","General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha)","GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006355; GO:0006366; GO:0006367; GO:0016032; GO:0042795; GO:0043565; GO:0046872; GO:0097550",1e-07,1e-07,1e-07,0.0297911247464962,0.0300311714368583,0.0148206874952245,0.0248808945595263,0.0124405472797632,5.1318089409637,0.00558467502252249,0.0440909809106121,-6.25313251258292,49452,1.35565023913405,4,3,0,1e-07,0.0297911247464962,297911.247464962,18.1845230671602
"734",800,1084,1084,1084,"O60291","MGRN1","MGRN1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G-protein coupled receptor protein signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]","SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:19737927}. Note=The endosomal localization is dependent on the interaction with TSG101.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cytosol. Nucleus. Note=Translocation from the cytosol to the nucleus is seen only in the presence of MC1R and MC4R, but not TBXA2R. Excluded from nucleoli.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytosol. Nucleus. Note=Translocation from the cytosol to the nucleus is seen only in the presence of MC1R and MC4R, but not TBXA2R. Excluded from nucleoli.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol. Cell membrane.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, cytosol. Cell membrane.","E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)","GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006513; GO:0008333; GO:0016020; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0070062",8.70908523822821e-06,1e-07,1e-07,0.0337710191155473,0.0345765265342335,0.0169410552851879,0.0284265639499102,0.0142162516700345,5.1305611911403,0.00558982997626127,0.0440909809106121,-6.25424150017834,60753,1.35565023913405,9,2,0,1e-07,0.0337710191155473,337710.191155473,18.3654261909679
"735",801,1085,1085,1085,"Q6ZMI0","PPP1R21","PPR21_HUMAN","membrane [GO:0016020]",NA,"Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1)","GO:0016020",7.53666483135509e-05,4.56298476063792e-05,2.60163444682917e-05,0.00738197062341329,0.0147051478190569,0.0149922461875444,0.0123107839298755,0.00620439624506714,5.12901204228432,0.00559623809091491,0.0440909809106121,-6.25561863802243,88314,1.35565023913405,19,0,0,4.56298476063792e-05,0.0147051478190569,322.270368858323,8.33212773570753
"736",802,1086,1086,1086,"Q96MZ0","GDAP1L1","GD1L1_HUMAN","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]",NA,"Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1-L1)","GO:0004364; GO:0005737; GO:0006749",1e-07,1e-07,1e-07,0.0166440512623487,0.0324565140295689,0.0344649423772282,0.0278550692230486,0.0139276346115243,5.12864988404251,0.00559773744579413,0.0440909809106121,-6.2559406268381,41973,1.35565023913405,12,3,0,1e-07,0.0324565140295689,324565.140295689,18.3081485309363
"737",803,1089,1089,1089,"Q9C0D7","ZC3H12C","ZC12C_HUMAN","endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]",NA,"Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)","GO:0004519; GO:0046872",0.00016485405799825,0.00019458903383131,0.00020100644823128,0.0884084294314408,0.0900007437474047,0.0442283924850563,0.0740257053746136,0.0371996692006604,5.12094666586389,0.00562974384470898,0.0442521646562983,-6.26279330088483,99340,1.35406548032679,5,0,0,0.00019458903383131,0.0884084294314408,454.334078805707,8.82760971326325
"738",804,1090,1090,1090,"O60477","BRINP1","BRNP1_HUMAN","cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; behavioral fear response [GO:0001662]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; maternal behavior [GO:0042711]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neurogenesis [GO:0050768]; positive regulation of neuron differentiation [GO:0045666]; short-term memory [GO:0007614]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11420708}.","BMP/retinoic acid-inducible neural-specific protein 1 (Deleted in bladder cancer protein 1)","GO:0001662; GO:0005737; GO:0005783; GO:0007050; GO:0007614; GO:0008219; GO:0030425; GO:0035176; GO:0035640; GO:0042711; GO:0043025; GO:0045666; GO:0045786; GO:0045930; GO:0050768; GO:0071300; GO:0071625",4.88285162941674e-05,5.36400875969863e-05,8.198830423832e-05,0.0959042091202782,0.097770054236301,0.0479331040549148,0.0804743035011215,0.0402986373866039,5.11953185492233,0.00563564618155302,0.0442579186367833,-6.26405270119707,88760,1.35400901394727,5,0,0,5.36400875969863e-05,0.0959042091202782,1787.92044190596,10.8040668262049
"739",806,1092,1092,1092,"O43683","BUB1","BUB1_HUMAN","condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere, kinetochore. Note=Nuclear in interphase cells. Accumulates gradually during G1 and S phase of the cell cycle, peaks at G2/M, and drops dramatically after mitosis. Localizes to the outer kinetochore. Kinetochore localization is required for normal mitotic timing and checkpoint response to spindle damage and occurs very early in prophase. AURKB, KNL1 and INCENP are required for kinetochore localization (By similarity). {ECO:0000250}.","Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A)","GO:0000776; GO:0000777; GO:0000942; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007093; GO:0007094; GO:0008283; GO:0016020; GO:0016032; GO:0051301; GO:0051754; GO:0051983",1e-07,1e-07,1e-07,0.0337392512687722,0.0164659729928969,0.0329352590582346,0.0277133944399679,0.013856797219984,5.10883331879159,0.00568052012800657,0.0445013623891365,-6.27358414387482,122375,1.35162669308587,3,3,0,1e-07,0.0329352590582346,329352.590582346,18.3292733723842
"740",807,1093,1093,1093,"Q86UW6","N4BP2","N4BP2_HUMAN","cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)","GO:0004519; GO:0005524; GO:0005829; GO:0046404",0.00044836906444669,0.00045690689359187,0.00037002113973655,0.0736401780548056,0.0359323386814372,0.070928423354265,0.0597418809975776,0.0302960395313805,5.10504589785465,0.00569650892179531,0.0445013623891365,-6.27696182831279,198801,1.35162669308587,9,0,0,0.00044836906444669,0.070928423354265,158.192054221658,7.30553332673525
"741",810,1096,1096,1096,"Q9BV35","SLC25A23","SCMC3_HUMAN","integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial transport [GO:0006839]; regulation of cellular respiration [GO:0043457]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:15716113}; Multi-pass membrane protein {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:15716113}.","Calcium-binding mitochondrial carrier protein SCaMC-3 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Mitochondrial Ca(2+)-dependent solute carrier protein 2) (Small calcium-binding mitochondrial carrier protein 3) (Solute carrier family 25 member 23)","GO:0002082; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0006851; GO:0015217; GO:0016021; GO:0036444; GO:0043457; GO:0051282; GO:0071277; GO:0097274",0.268993155260519,0.256489242545338,0.304984957226808,0.560313597609372,0.417692637584575,0.49768531165257,0.215074730604617,0.384359816979864,5.09996987616484,0.00571802250680525,0.0445013623891365,-6.28149152442066,52378,1.35162669308587,3,0,0,0.268993155260519,0.49768531165257,1.85017834810913,0.887664346163682
"742",811,1097,1097,1097,"P0DPB6","POLR1D","RPAC2_HUMAN","DNA-directed RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) (RNA polymerase I 16 kDa subunit) (RPA16) (RPC16) (hRPA19)","GO:0003677; GO:0003899; GO:0005736; GO:0006351; GO:0046983",0.0253991003130966,0.0355874897744653,0.0379907173252586,0.0553254312683208,0.0522992138409223,0.0511502392744876,0.0199325256569701,0.0429586986327585,5.09973901723834,0.00571900326987926,0.0445013623891365,-6.28169761303906,15237,1.35162669308587,3,0,0,0.0355874897744653,0.0522992138409223,1.46959547223946,0.555419086687282
"743",812,1098,1098,1098,"Q99504","EYA3","EYA3_HUMAN","centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; regulation of transcription, DNA-templated [GO:0006355]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; visual perception [GO:0007601]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P97480}. Nucleus {ECO:0000269|PubMed:19234442}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs) (PubMed:19234442). With decreasing efficiency, translocalized to the nucleus by SIX2 and SIX5, and SIX4, respectively (By similarity). {ECO:0000250|UniProtKB:P97480, ECO:0000269|PubMed:19234442}.","Eyes absent homolog 3 (EC 3.1.3.48)","GO:0004725; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006302; GO:0006351; GO:0006355; GO:0007275; GO:0007601; GO:0009653; GO:0010212; GO:0016576; GO:0030154; GO:0045739; GO:0046872; GO:2001240",0.00015680431455481,0.00032135908527848,0.00042974210533374,0.976512890746072,0.475460149774748,0.951064995215188,0.800710043410281,0.400657656873529,5.09889912170574,0.00572257312252241,0.0445013623891365,-6.28244744724286,62663,1.35162669308587,4,0,0,0.00032135908527848,0.951064995215188,2959.50865802043,11.5311419620444
"744",813,1099,1099,1099,"Q12797","ASPH","ASPH_HUMAN","calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]","SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q28056}.; SUBCELLULAR LOCATION: Isoform 4: Sarcoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000305|PubMed:15485681}.; SUBCELLULAR LOCATION: Isoform 8: Endoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000269|PubMed:22586105}.","Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)","GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779",0.0839937799412359,0.0741895685486715,0.0755883500932516,0.116334301951608,0.10117297086993,0.101893016987915,0.0285428637420982,0.0921953313987687,5.09718296950969,0.00572987570426091,0.0445013623891365,-6.28397985272427,85863,1.35162669308587,7,0,0,0.0755883500932516,0.101893016987915,1.34799895568844,0.430819378846404
"745",814,1100,1100,1100,"Q7LBC6","KDM3B","KDM3B_HUMAN","chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]; response to cisplatin [GO:0072718]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA)","GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0016209; GO:0031490; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051213; GO:0072718",2.1000202355519e-05,1.40073611195255e-05,4.50154881953538e-05,0.0660029123580492,0.0389313804568919,0.0359613055551125,0.0469385251061277,0.0234959369036206,5.09591240852279,0.0057352894181708,0.0445013623891365,-6.28511461389767,191581,1.35162669308587,28,0,0,2.1000202355519e-05,0.0389313804568919,1853.85739612459,10.856314556772
"746",816,1102,1102,1102,"Q9NP90","RAB9B","RAB9B_HUMAN","cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle, phagosome membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Recruited to phagosomes containing S.aureus or M.tuberculosis.","Ras-related protein Rab-9B (Rab-9-like protein) (Rab-9L)","GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030667; GO:0030670; GO:0042147; GO:0042802; GO:0043312; GO:0045335",0.035399014655441,0.017678825974801,0.0849678002991011,0.365178925988155,0.317893398188362,0.206908808568568,0.25064516393858,0.171337795612405,5.09489029053838,0.00573964900651754,0.0445013623891365,-6.28602763304198,22719,1.35162669308587,6,0,0,0.035399014655441,0.317893398188362,8.98028945954009,3.16676194776294
"747",817,1105,1105,1105,"Q9UQF2","MAPK8IP1","JIP1_HUMAN","axonal growth cone [GO:0044295]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860]; JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}. Nucleus {ECO:0000250}. Endoplasmic reticulum membrane. Mitochondrion membrane. Note=Accumulates in cell surface projections. Under certain stress conditions, translocates to the perinuclear region of neurons. In insulin-secreting cells, detected in both the cytoplasm and nucleus (By similarity). {ECO:0000250}.","C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)","GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007258; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043508; GO:0044294; GO:0044295; GO:0044297; GO:0044302; GO:0045202; GO:0046328; GO:0048471; GO:2001243",1e-07,1e-07,1e-07,0.088066995611564,0.180065421004249,0.125332919912015,0.131155012175943,0.0655776060879714,5.09372437176724,0.00574462680373783,0.0445013623891365,-6.28706926396794,77524,1.35162669308587,7,3,0,1e-07,0.125332919912015,1253329.19912015,20.2573339716612
"748",818,1108,1108,1108,"P43681","CHRNA4","ACHA4_HUMAN","acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; exploration behavior [GO:0035640]; inhibitory postsynaptic potential [GO:0060080]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; respiratory gaseous exchange [GO:0007585]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]","SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}.","Neuronal acetylcholine receptor subunit alpha-4","GO:0001508; GO:0001666; GO:0005886; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0007585; GO:0007626; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0016021; GO:0019233; GO:0022848; GO:0030054; GO:0030425; GO:0035094; GO:0035095; GO:0035640; GO:0042113; GO:0042166; GO:0042391; GO:0043025; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500",1e-07,1e-07,1e-07,0.0226662501700448,0.0449849756895902,0.0294719580841115,0.0323742946479155,0.0161872473239578,5.08633413271759,0.00577629976598984,0.0446184882005548,-6.2936756663221,69957,1.35048514891726,5,3,0,1e-07,0.0294719580841115,294719.580841115,18.1689833891367
"749",819,1111,1111,1111,"Q8IUL8","CILP2","CILP2_HUMAN","extracellular exosome [GO:0070062]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:21880736}.","Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]","GO:0070062",4.94911770050285e-05,6.2824187212559e-05,6.42338847790161e-05,0.0651508627227317,0.0632419065000612,0.0315898521163758,0.053268690696724,0.0266931950980275,5.07883027734795,0.00580867458842999,0.0446184882005548,-6.30039065641598,126291,1.35048514891726,4,0,0,6.2824187212559e-05,0.0632419065000612,1006.64902016303,9.97534504334583
"750",820,1112,1112,1112,"Q9UNF0","PACSIN2","PACN2_HUMAN","caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; transporter activity [GO:0005215]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; membrane organization [GO:0061024]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Early endosome. Recycling endosome membrane. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection {ECO:0000250}. Membrane, caveola. Note=Detected at the neck of flask-shaped caveolae. Localization to tubular recycling endosomes probably requires interaction with MICALL1 and EHD1.","Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II)","GO:0005215; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0005925; GO:0008092; GO:0016607; GO:0019898; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045296; GO:0045806; GO:0048858; GO:0055038; GO:0061024; GO:0070062; GO:0070300; GO:0070836; GO:0072584; GO:0097320",1e-07,3.26404428810728e-05,1.04887312649358e-05,0.0110087456064127,0.0232365984296973,0.0210078844158922,0.0184033330926187,0.00921607627102469,5.07848318915639,0.00581017734230588,0.0446184882005548,-6.30070142730558,55739,1.35048514891726,11,1,0,1.04887312649358e-05,0.0210078844158922,2002.90043526259,10.9678749908236
"751",821,1114,1114,1114,"O60245","PCDH7","PCDH7_HUMAN","integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; platelet degranulation [GO:0002576]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.","Protocadherin-7 (Brain-heart protocadherin) (BH-Pcdh)","GO:0002576; GO:0005509; GO:0005886; GO:0005887; GO:0007156; GO:0031092",0.00016795052106715,7.60971200483713e-05,0.00023297872107304,0.0626871883640453,0.129244947709677,0.0913953477067787,0.094283485806104,0.0473007516904482,5.07573368927882,0.00582209810316529,0.0446184882005548,-6.30316377127555,116071,1.35048514891726,12,0,0,0.00016795052106715,0.0913953477067787,544.18019739419,9.08794064794077
"752",822,1116,1116,1116,"A3KN83","SBNO1","SBNO1_HUMAN","regulation of transcription, DNA-templated [GO:0006355]",NA,"Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3)","GO:0006355",3.2194461167017e-06,1.45937122575861e-05,6.44064317312136e-06,0.0164173247096363,0.032595939681483,0.0341187689921096,0.0277025931938938,0.0138593811974627,5.07509007974816,0.00582489278617324,0.0446184882005548,-6.303740300145,154312,1.35048514891726,13,0,0,6.44064317312136e-06,0.032595939681483,5060.9758692292,12.3051998802444
"753",823,1117,1117,1117,"Q9Y5B9","SUPT16H","SP16H_HUMAN","chromosome [GO:0005694]; FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10421373}. Chromosome {ECO:0000269|PubMed:10421373}. Note=Colocalizes with RNA polymerase II on chromatin. Recruited to actively transcribed loci.","FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16)","GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006337; GO:0006366; GO:0006368; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101; GO:0042393; GO:1901796",0.0001685293345522,1.76763408833428e-05,8.30364490051384e-05,0.00977957113976985,0.00573593027372787,0.0121200589924532,0.00912210609383674,0.00465080042173193,5.07405954953319,0.00582937091409285,0.0446184882005548,-6.30466353126028,119914,1.35048514891726,25,0,0,8.30364490051384e-05,0.00977957113976985,117.774438297147,6.87988264113651
"754",825,1119,1119,1119,"O43427","FIBP","FIBP_HUMAN","endomembrane system [GO:0012505]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor signaling pathway [GO:0008543]; platelet aggregation [GO:0070527]","SUBCELLULAR LOCATION: Nucleus. Endomembrane system; Peripheral membrane protein. Note=Also associated with cytoplasmic membranes, particularly of mitochondria.","Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)","GO:0005634; GO:0005739; GO:0008543; GO:0012505; GO:0016020; GO:0016607; GO:0017134; GO:0070527",4.63378723224874e-05,2.59003503627955e-05,8.1159999571327e-05,0.0113876607148625,0.0226733867999731,0.0235719536466695,0.0191598676464162,0.00963106656396028,5.07102960838122,0.00584256137981275,0.0446184882005548,-6.30737876908338,41878,1.35048514891726,9,0,0,4.63378723224874e-05,0.0226733867999731,489.305737695036,8.93459238996984
"755",826,1120,1120,1120,"Q96MX3","ZNF48","ZNF48_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Zinc finger protein 48 (Zinc finger protein 553)","GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0046872",0.00029349219015071,0.00026614649042198,0.00011704282118479,0.0892507499994978,0.0445365761749737,0.0917664137563869,0.074959019476367,0.0377050702387693,5.06985023237807,0.00584770533675303,0.0446184882005548,-6.30843596261815,67820,1.35048514891726,4,0,0,0.00026614649042198,0.0892507499994978,335.344455822014,8.38949994025679
"756",828,1124,1124,1124,"Q96TA2","YME1L1","YMEL1_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:10843804, ECO:0000269|PubMed:22262461}. Mitochondrion {ECO:0000269|PubMed:26923599, ECO:0000269|PubMed:27495975}.","ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1)","GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006515; GO:0007005; GO:0008237; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872",6.14574920951054e-05,0.00010385267116258,0.00016716612784463,0.00428559403361662,0.00235921296882525,0.00489457847756631,0.00373563639630195,0.00197864362851842,5.0649516405131,0.00586912931008989,0.0446972837138518,-6.31282894138984,86455,1.34971886845485,10,0,0,0.00010385267116258,0.00428559403361662,41.2660934537503,5.36688496377112
"757",829,1125,1125,1125,"O94880","PHF14","PHF14_HUMAN","nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]",NA,"PHD finger protein 14","GO:0000122; GO:0005634; GO:0046872; GO:0048286; GO:2000584; GO:2000791",1e-07,1e-07,3.66073998685046e-06,0.0159828936590615,0.00771120216359615,0.0154637248022228,0.0130513199616312,0.00652694689414455,5.06238189563064,0.00588040578123046,0.0447433542109625,-6.31513465829022,100053,1.34927146188648,11,2,0,1e-07,0.0154637248022228,154637.248022228,17.2385283426288
"758",830,1126,1126,1126,"O94876","TMCC1","TMCC1_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; endoplasmic reticulum organization [GO:0007029]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:24454821}; Multi-pass membrane protein {ECO:0000269|PubMed:24454821}.","Transmembrane and coiled-coil domains protein 1","GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0016021; GO:0042803; GO:0046982; GO:0051260; GO:0051291",0.00024765803653025,0.00026590076740446,0.0603672216375279,0.156992737731522,0.255896645968352,0.177337546519753,0.176448716592721,0.108517951776848,5.05694615333001,0.0059043445969529,0.0448856036855389,-6.32001465404656,72083,1.3478929294304,7,0,0,0.00026590076740446,0.177337546519753,666.931307685946,9.38139436473137
"759",831,1127,1127,1127,"Q04917","YWHAH","1433F_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; membrane organization [GO:0061024]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; substantia nigra development [GO:0021762]",NA,"14-3-3 protein eta (Protein AS1)","GO:0002028; GO:0003779; GO:0005159; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006713; GO:0006886; GO:0014704; GO:0017080; GO:0019899; GO:0019904; GO:0021762; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045664; GO:0045893; GO:0046982; GO:0048167; GO:0050774; GO:0061024; GO:0070062; GO:0086010; GO:1900740; GO:2000649",1e-07,1e-07,1e-07,0.00298299173025626,0.00153755510137421,0.003242077270058,0.00258744136722949,0.00129382068361474,5.05526063291772,0.00591179133350729,0.0449023370140394,-6.3215286064479,28219,1.34773105485662,11,3,0,1e-07,0.00298299173025626,29829.9173025626,14.8644723576467
"760",832,1128,1128,1128,"O43164","PJA2","PJA2_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; hippo signaling [GO:0035329]; long-term memory [GO:0007616]; protein ubiquitination [GO:0016567]; regulation of protein kinase A signaling [GO:0010738]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21423175}. Cell membrane {ECO:0000269|PubMed:21423175}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:21423175}; Peripheral membrane protein {ECO:0000269|PubMed:21423175}. Golgi apparatus membrane {ECO:0000269|PubMed:21423175}; Peripheral membrane protein {ECO:0000269|PubMed:21423175}. Cell junction, synapse {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}. Note=Localizes at the cytoplasmic side of endoplasmic reticulum and Golgi apparatus. Expressed in the postsynaptic density region of synapses (By similarity). Colocalizes with PRKAR2A and PRKAR2B in the cytoplasm and the cell membrane. {ECO:0000250}.","E3 ubiquitin-protein ligase Praja-2 (Praja2) (EC 2.3.2.27) (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)","GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0030054; GO:0034236; GO:0034237; GO:0035329; GO:0045111; GO:0045211; GO:0046872; GO:0061630",4.30966828397926e-05,0.00010761636397749,0.00013046369182026,0.0531645923787495,0.106373805311946,0.110492707748569,0.0899166429002091,0.0450520470296504,5.05373962742146,0.00591852091779378,0.0449135984541797,-6.32289509814807,78214,1.347622148095,4,0,0,0.00010761636397749,0.106373805311946,988.453812973983,9.94902974515749
"761",833,1129,1129,1129,"P42224","STAT1","STAT1_HUMAN","axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; CCR5 chemokine receptor binding [GO:0031730]; core promoter binding [GO:0001047]; DNA binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nuclear hormone receptor binding [GO:0035257]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; repressing transcription factor binding [GO:0070491]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding [GO:0000983]; transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000982]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-like protein ligase binding [GO:0044389]; blood circulation [GO:0008015]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; JAK-STAT cascade [GO:0007259]; macrophage derived foam cell differentiation [GO:0010742]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; renal tubule development [GO:0061326]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to interferon-beta [GO:0035456]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; transcription, DNA-templated [GO:0006351]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:27796300, ECO:0000269|PubMed:28753426}. Nucleus {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28753426}. Note=Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to IFN-gamma and signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4 (PubMed:15322115). Monomethylation at Lys-525 is required for phosphorylation at Tyr-701 and translocation into the nucleus (PubMed:28753426). Translocates into the nucleus in response to interferon-beta stimulation (PubMed:26479788). {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28753426}.","Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84)","GO:0000122; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0000982; GO:0000983; GO:0001047; GO:0001937; GO:0002053; GO:0002230; GO:0003340; GO:0003690; GO:0003700; GO:0005164; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0007221; GO:0007259; GO:0007584; GO:0008015; GO:0009612; GO:0010742; GO:0016032; GO:0016525; GO:0019221; GO:0019899; GO:0030424; GO:0030425; GO:0031730; GO:0032727; GO:0032869; GO:0032991; GO:0033209; GO:0034097; GO:0035035; GO:0035257; GO:0035456; GO:0035458; GO:0038114; GO:0042393; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0043124; GO:0043434; GO:0044389; GO:0045296; GO:0045648; GO:0045893; GO:0045944; GO:0046725; GO:0048471; GO:0048661; GO:0051591; GO:0051607; GO:0051721; GO:0051770; GO:0060333; GO:0060334; GO:0060337; GO:0061326; GO:0070102; GO:0070106; GO:0070491; GO:0070757; GO:0071346; GO:0071407; GO:0072136; GO:0072162; GO:0072308; GO:1990841",7.59357229944397e-05,1.68484393202887e-05,1e-07,0.0256327160138617,0.0499632122248825,0.054118549452819,0.0432071978430828,0.0216345603089797,5.04631293164768,0.00595151227130281,0.0451239548647937,-6.32957154537253,87335,1.34559284384993,13,1,0,1.68484393202887e-05,0.0499632122248825,2965.4504654753,11.5340355580487
"762",834,1130,1130,1130,"Q7L014","DDX46","DDX46_HUMAN","Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]","SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:12234937}. Nucleus, Cajal body {ECO:0000269|PubMed:12234937}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Present in Cajal bodies (CBs) and nuclear speckles.","Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog)","GO:0000398; GO:0001650; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010468; GO:0010501; GO:0015030; GO:0016020; GO:0016607",7.81752647666994e-05,0.00010147006091009,0.00064844915707226,0.00609199934056399,0.0125875710162752,0.0114289585698607,0.00976014481465029,0.00515610390157483,5.04063252267262,0.00597689530745574,0.0452763042759479,-6.33468283177598,117362,1.34412903009865,24,0,0,0.00010147006091009,0.0114289585698607,112.633800229879,6.81549601991575
"763",835,1131,1131,1131,"Q9Y5R8","TRAPPC1","TPPC1_HUMAN","azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; neutrophil degranulation [GO:0043312]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network {ECO:0000250}. Endoplasmic reticulum {ECO:0000250}.","Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2)","GO:0000139; GO:0005576; GO:0005783; GO:0005829; GO:0006888; GO:0017112; GO:0030008; GO:0035578; GO:0043312; GO:0048208",2.55597803071783,2.18915380942764,2.29371171992328,3.37345100253318,2.92629329808843,3.2395372748211,0.833479338457985,2.76302085591858,5.03862796886678,0.00598588372408102,0.0452998393208518,-6.33648752508261,16832,1.34390333843289,3,0,0,2.29371171992328,3.2395372748211,1.41235589750985,0.49810367704757
"764",836,1132,1132,1132,"Q2Y0W8","SLC4A8","S4A8_HUMAN","integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:17715183}; Multi-pass membrane protein {ECO:0000269|PubMed:17715183}.","Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3)","GO:0005452; GO:0005886; GO:0005887; GO:0008510; GO:0015301; GO:0015701; GO:0032809; GO:0043005; GO:0051453",1e-07,1e-07,1e-07,0.0197286508008321,0.0180812937237159,0.00930617447764594,0.0157052730007313,0.00785273650036565,5.03758067866748,0.00599058622794441,0.0452998393208518,-6.33743059979988,122938,1.34390333843289,12,3,0,1e-07,0.0180812937237159,180812.937237159,17.4641383812837
"765",837,1133,1133,1133,"Q96DZ1","ERLEC1","ERLEC_HUMAN","endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; unfolded protein binding [GO:0051082]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]","SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:16531414, ECO:0000269|PubMed:18502753}.","Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein)","GO:0005788; GO:0030433; GO:0036503; GO:0044322; GO:0051082; GO:0055085; GO:1904153",1.52423907856942e-05,8.68235786170394e-05,3.48680475833286e-05,0.0147976442382651,0.0313808512294358,0.0287050044140981,0.0249155219549377,0.0125034056497975,5.02943322990426,0.00602732151137373,0.0454392644363145,-6.34477205425722,54858,1.34256870753109,7,0,0,3.48680475833286e-05,0.0287050044140981,823.246680087209,9.68518097864044
"766",838,1134,1134,1134,"Q9H6K5","PRR36","PRR36_HUMAN",NA,NA,"Proline-rich protein 36",NA,4.96806427060295e-05,0.00390910994973868,4.97826671642008e-05,0.0244560500684324,0.0156020494864397,0.0308336979986763,0.0222944080979798,0.0124833951355262,5.02892081582533,0.00602964091672905,0.0454392644363145,-6.34523405914285,132748,1.34256870753109,12,0,0,4.97826671642008e-05,0.0244560500684324,491.256323968495,8.94033216915465
"767",839,1135,1135,1135,"Q13126","MTAP","MTAP_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; interleukin-12-mediated signaling pathway [GO:0035722]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000255|HAMAP-Rule:MF_03155}.","S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)","GO:0004645; GO:0005634; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0032259; GO:0033574; GO:0035722; GO:0070062",5.65688104603275e-05,9.63573547258551e-05,8.96845853776596e-05,0.01106925716934,0.0236579260313429,0.0188315693493164,0.0177720472664785,0.00896689388342718,5.02880319421985,0.00603017347367809,0.0454392644363145,-6.3453401143277,31236,1.34256870753109,8,0,0,8.96845853776596e-05,0.0188315693493164,209.975541170393,7.71407747629818
"768",841,1138,1138,1138,"Q6P6B7","ANKRD16","ANR16_HUMAN",NA,NA,"Ankyrin repeat domain-containing protein 16",NA,1e-07,1e-07,1e-07,0.0238133434120162,0.0113818022835179,0.0228961790572671,0.0193636749176004,0.0096819374588002,5.02315680259926,0.00605580528445355,0.045546054001357,-6.35043333263884,39284,1.34154924327212,4,3,0,1e-07,0.0228961790572671,228961.790572671,17.8047473341097
"769",842,1139,1139,1139,"Q9BT40","INPP5K","INP5K_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G-protein coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:12536145, ECO:0000269|PubMed:26940976, ECO:0000269|PubMed:28190456}. Note=Following stimulation with EGF, translocates to membrane ruffles. {ECO:0000269|PubMed:12536145, ECO:0000269|PubMed:26940976}.","Inositol polyphosphate 5-phosphatase K (EC 3.1.3.56) (Skeletal muscle and kidney-enriched inositol phosphatase)","GO:0001701; GO:0001726; GO:0001933; GO:0004439; GO:0004445; GO:0005000; GO:0005634; GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0005886; GO:0005979; GO:0006469; GO:0006661; GO:0007186; GO:0010801; GO:0010829; GO:0016020; GO:0016311; GO:0016312; GO:0030036; GO:0032587; GO:0032869; GO:0032870; GO:0033137; GO:0034485; GO:0034594; GO:0034595; GO:0035305; GO:0035810; GO:0042577; GO:0042593; GO:0043005; GO:0043407; GO:0043922; GO:0045719; GO:0045869; GO:0045892; GO:0045893; GO:0046030; GO:0046627; GO:0046855; GO:0046856; GO:0048471; GO:0051497; GO:0051898; GO:0051926; GO:0052658; GO:0052659; GO:0071320; GO:0071356; GO:0071364; GO:0072659; GO:0090315; GO:0097178; GO:2000466; GO:2001153",4.05806142260537e-07,3.09591076120411e-05,3.79349336149877e-05,0.0267645189644086,0.0133357832969939,0.02791331649078,0.0226481063016044,0.0113471530999253,5.02179575700478,0.00606200331018716,0.045546054001357,-6.35166164420489,51090,1.34154924327212,5,0,0,3.09591076120411e-05,0.0267645189644086,864.511965260876,9.75574212137284
"770",843,1140,1140,1140,"Q6R2W3","ZBED9","SCND3_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; DNA integration [GO:0015074]",NA,"SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)","GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0015074",0.00026281907013337,0.00019619574411121,0.00039727593917155,0.0919913459728914,0.113086982016959,0.179765529500097,0.127995855578844,0.0642833580405606,5.02064597234313,0.00606724521702296,0.045546054001357,-6.35269948150926,151666,1.34154924327212,6,0,0,0.00026281907013337,0.113086982016959,430.284537417973,8.74914718671624
"771",844,1142,1142,1142,"Q13191","CBLB","CBLB_HUMAN","cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; NLS-bearing protein import into nucleus [GO:0006607]; proteolysis [GO:0006508]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12177062}. Note=Upon EGF stimulation, associates with endocytic vesicles.","E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)","GO:0001784; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006508; GO:0006607; GO:0007165; GO:0007173; GO:0007175; GO:0008270; GO:0017124; GO:0030971; GO:0045121; GO:0061630",0.0001002818057649,0.00010309135867746,0.00010864478251602,0.0255380711396895,0.0535712639190465,0.0509800621346563,0.043259126415478,0.0217335691900584,5.01861995326736,0.00607649515695414,0.0455471090573796,-6.35452864941018,109450,1.34153918313163,10,0,0,0.00010309135867746,0.0509800621346563,494.513437291642,8.94986591328819
"772",845,1143,1143,1143,"Q5SYC1","CLVS2","CLVS2_HUMAN","clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cytoplasmic vesicle, clathrin-coated vesicle {ECO:0000250}. Early endosome membrane {ECO:0000269|PubMed:19651769}; Peripheral membrane protein {ECO:0000269|PubMed:19651769}.","Clavesin-2 (Retinaldehyde-binding protein 1-like 2) (clathrin vesicle-associated Sec14 protein 2)","GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0032588; GO:0080025",1e-07,0.0073264349344776,1e-07,0.0367645724049465,0.031426372040251,0.0568557579210631,0.039240022477261,0.0220622228834564,5.01563495133094,0.00609015427529204,0.0456095543276464,-6.3572245766413,38000,1.34094417143347,3,2,0,1e-07,0.0367645724049465,367645.724049465,18.4879566800114
"773",846,1144,1144,1144,"Q9Y3Z3","SAMHD1","SAMH1_HUMAN","intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; immune response [GO:0006955]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; type I interferon signaling pathway [GO:0060337]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19525956, ECO:0000269|PubMed:23092512, ECO:0000269|PubMed:28229507}.","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1)","GO:0003676; GO:0003723; GO:0004540; GO:0005622; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0008270; GO:0008832; GO:0009264; GO:0016793; GO:0032567; GO:0042802; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060337",8.81130802964413e-06,4.71183147915499e-06,6.10450983650685e-06,0.00019211285960253,0.00015187712989651,0.00014547866285,0.00015661366766791,8.48493836157265e-05,5.01415399498131,0.00609694468836622,0.0456204952206423,-6.35856253509919,72201,1.3408400046704,16,0,0,6.10450983650685e-06,0.00015187712989651,24.8794963009541,4.6368853724993
"774",847,1145,1145,1145,"Q6P1M0","SLC27A4","S27A4_HUMAN","brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000250}.","Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4)","GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005789; GO:0005886; GO:0005902; GO:0006629; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043588; GO:0044539",1e-07,1e-07,1e-07,0.0121689125087003,0.0256903853571593,0.0242268712301935,0.0206952896986844,0.0103477448493422,5.01226471281732,0.00610562053849001,0.0456455124973576,-6.36026979824086,72064,1.34060191239982,12,3,0,1e-07,0.0242268712301935,242268.712301935,17.8862485749693
"775",848,1146,1146,1146,"Q9Y3A6","TMED5","TMED5_HUMAN","cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; Golgi ribbon formation [GO:0090161]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19948005}; Single-pass type I membrane protein {ECO:0000269|PubMed:19948005}. Golgi apparatus, cis-Golgi network membrane {ECO:0000269|PubMed:19948005}; Single-pass type I membrane protein {ECO:0000269|PubMed:19948005}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:19948005}; Single-pass type I membrane protein {ECO:0000269|PubMed:19948005}. Note=Probably cycles between compartments of the early secretatory pathway.","Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28)","GO:0005789; GO:0005793; GO:0005801; GO:0015031; GO:0016021; GO:0033116; GO:0070971; GO:0090161",0.00010611534614083,8.98654196185915e-05,0.00010198579484715,0.0265426493455453,0.0531124250808121,0.0557801564524312,0.0450457547727274,0.0226221995732325,5.00798113265686,0.00612534630646538,0.0457385080860181,-6.36414237215559,26005,1.33971800546117,4,0,0,0.00010198579484715,0.0531124250808121,520.782577224737,9.02453737373925
"776",849,1147,1147,1147,"O95502","NPTXR","NPTXR_HUMAN","integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.","Neuronal pentraxin receptor","GO:0016021; GO:0046872",0.0106185567913077,0.0138258395931256,0.00785635922565683,0.0277107888624536,0.0203906453287246,0.0279544901788486,0.0145850562533122,0.0180594466633528,5.00724446378143,0.00612874635218023,0.0457385080860181,-6.36480859420515,52846,1.33971800546117,3,0,0,0.0106185567913077,0.0277107888624536,2.60965679301518,1.38386008435349
"777",850,1148,1148,1148,"Q96JN8","NEURL4","NEUL4_HUMAN","centriole [GO:0005814]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:22261722, ECO:0000269|PubMed:22441691}. Note=Localizes to procentriole and daughter centriole in growing and quiescent cells (PubMed:22441691). May loose association with centrosomes during mitosis (PubMed:22261722). {ECO:0000269|PubMed:22261722, ECO:0000269|PubMed:22441691}.","Neuralized-like protein 4","GO:0005814",4.54495008412956e-05,3.5175726313159e-05,4.46070613527967e-05,0.0838808930671411,0.0886360960369914,0.041994219587818,0.0714619921344811,0.0357727401634096,5.00385660606485,0.00614441198309944,0.0457854415735503,-6.36787336700481,166907,1.33927259294315,11,0,0,4.46070613527967e-05,0.0838808930671411,1880.43978964963,10.8768543977063
"778",851,1149,1149,1149,"P11274","BCR","BCR_HUMAN","cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250|UniProtKB:Q6PAJ1}.","Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26)","GO:0002692; GO:0003014; GO:0004674; GO:0004713; GO:0005089; GO:0005096; GO:0005524; GO:0005829; GO:0006468; GO:0007165; GO:0007420; GO:0014069; GO:0016020; GO:0016301; GO:0030036; GO:0030054; GO:0032991; GO:0035023; GO:0035556; GO:0042472; GO:0043114; GO:0043314; GO:0043547; GO:0045211; GO:0046777; GO:0048008; GO:0048872; GO:0050728; GO:0050766; GO:0050885; GO:0051056; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0070062; GO:0071222; GO:2000378",5.86791336916647e-05,1e-07,4.08819426369158e-06,0.0137068788860321,0.0273046013738773,0.0289609688373251,0.023303193923093,0.0116725527375316,5.00357144968134,0.00614573275327211,0.0457854415735503,-6.36813139618448,142819,1.33927259294315,26,1,0,4.08819426369158e-06,0.0273046013738773,6678.89038844784,12.7053927220837
"779",852,1151,1151,1151,"Q92560","BAP1","BAP1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cellular protein modification process [GO:0006464]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cell proliferation [GO:0008285]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18757409, ECO:0000269|PubMed:19188440, ECO:0000269|PubMed:19815555, ECO:0000269|PubMed:24703950}. Nucleus {ECO:0000269|PubMed:18757409, ECO:0000269|PubMed:19188440, ECO:0000269|PubMed:19815555, ECO:0000269|PubMed:24703950, ECO:0000269|PubMed:9528852}. Note=Mainly nuclear. Binds to chromatin. Localizes to the cytoplasm when monoubiquitinated by the E2/E3 hybrid ubiquitin-protein ligase UBE2O (PubMed:24703950). {ECO:0000269|PubMed:24703950}.","Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6)","GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0008233; GO:0008285; GO:0010035; GO:0016579; GO:0035517; GO:0035520; GO:0035522; GO:0036459; GO:0051726; GO:0061519; GO:0071108; GO:1900015; GO:1903955",0.00103609376918765,0.00087230213855138,0.0006328583421248,0.1602521718671,0.104106248112597,0.0803767177291995,0.114064627819677,0.0578793986597933,4.99747768211879,0.00617403913502729,0.0459163987800466,-6.37364794189022,80362,1.33803218096035,6,0,0,0.00087230213855138,0.104106248112597,119.346546926372,6.89901301506105
"780",853,1152,1152,1152,"Q9ULK0","GRID1","GRID1_HUMAN","cell junction [GO:0030054]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; social behavior [GO:0035176]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit)","GO:0004970; GO:0005234; GO:0016021; GO:0030054; GO:0035176; GO:0045211; GO:0070062",0.137776385431188,0.0785866654045956,0.115336562295671,0.323525558224326,0.297155782467431,0.220828721781536,0.16993681644728,0.195534945934125,4.99560494255029,0.00618276968856494,0.0459414136580867,-6.37534424332447,112131,1.33779564530859,5,0,0,0.115336562295671,0.297155782467431,2.57642309214711,1.36536952777758
"781",854,1153,1153,1153,"O60488","ACSL4","ACSL4_HUMAN","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; ER-mitochondrion membrane contact site [GO:0044233]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of cell growth [GO:0030307]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]","SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Peroxisome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}.","Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4)","GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005789; GO:0005811; GO:0006629; GO:0007584; GO:0008610; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0030307; GO:0031957; GO:0032307; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070062; GO:0070672; GO:0102391",1e-07,1e-07,1e-07,0.00018180909603546,0.00016183251310284,0.00012916052400034,0.00015750071104621,7.88503555231096e-05,4.99292441656137,0.0061952918761797,0.0459945346575006,-6.37777300742809,79188,1.33729377069026,22,3,0,1e-07,0.00016183251310284,1618.3251310284,10.660285767461
"782",855,1154,1154,1154,"Q96JK2","DCAF5","DCAF5_HUMAN","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]",NA,"DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)","GO:0005654; GO:0016567; GO:0043687; GO:0080008",0.000120859020983,0.00028551174324339,0.00012551163333827,0.0558113782773984,0.0282741334487186,0.0599811639905435,0.0478449311063653,0.0240997596857042,4.99072104972688,0.00620560779799132,0.0460311982242683,-6.37977011726613,103963,1.33694771996992,8,0,0,0.00012551163333827,0.0558113782773984,444.670958324473,8.79659437442945
"783",856,1155,1155,1155,"Q96AX9","MIB2","MIB2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein polyubiquitination [GO:0000209]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14507647}. Endosome {ECO:0000269|PubMed:14507647}. Note=Colocalizes with endosomal compartments.","E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)","GO:0000151; GO:0000209; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0043123; GO:0061630",0.00045139607238103,0.00067015970160558,0.00024131253051145,0.151018894069157,0.0715860679645892,0.143165754265322,0.121469282664857,0.061188930767261,4.98745264701159,0.00622094810555527,0.0461050353104356,-6.38273371053555,109939,1.33625164102862,6,0,0,0.00045139607238103,0.143165754265322,317.162162067892,8.30907685535277
"784",857,1156,1156,1156,"Q86VP1","TAX1BP1","TAXB1_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]",NA,"Tax1-binding protein 1 (TRAF6-binding protein)","GO:0005829; GO:0006915; GO:0010803; GO:0019900; GO:0032088; GO:0032480; GO:0043066; GO:0046872; GO:0070062",5.6066359365276e-05,5.6885732324395e-05,6.45572454758465e-05,0.0538308898679125,0.107632903789385,0.114132808609711,0.0918063643099479,0.0459623519340291,4.98486425592652,0.00623312907234213,0.0461553502242635,-6.38508168118998,90877,1.33577794928167,4,0,0,5.6885732324395e-05,0.107632903789385,1892.08962232569,10.8857647108778
"785",858,1157,1157,1157,"Q9NUS5","AP5S1","AP5S1_HUMAN","AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22022230}. Late endosome membrane {ECO:0000305|PubMed:22022230}; Peripheral membrane protein {ECO:0000305|PubMed:22022230}; Cytoplasmic side {ECO:0000305|PubMed:22022230}. Lysosome membrane {ECO:0000305|PubMed:22022230}; Peripheral membrane protein {ECO:0000305|PubMed:22022230}; Cytoplasmic side {ECO:0000305|PubMed:22022230}.","AP-5 complex subunit sigma-1 (Adaptor-related protein complex 5 sigma subunit) (Sigma5)","GO:0000724; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016197; GO:0030119; GO:0031902",1e-07,1e-07,1e-07,0.0502815829486497,0.0259805249771467,0.0558410051369439,0.0440342710209134,0.0220172355104567,4.98339882379905,0.0062400380872062,0.0461665739209032,-6.38641137882891,22522,1.33567235378881,3,3,0,1e-07,0.0502815829486497,502815.829486497,18.9396705433722
"786",859,1158,1158,1158,"Q64LD2","WDR25","WDR25_HUMAN",NA,NA,"WD repeat-containing protein 25",NA,1.43799989263052e-05,1.97490662378097e-05,2.57488528302553e-05,0.0303432921818115,0.0321245069797967,0.0151487127433898,0.0258522113290012,0.0129460649704987,4.98003801744423,0.00625591789234288,0.0462124069824706,-6.38946193363262,60161,1.33524141057714,5,0,0,1.97490662378097e-05,0.0303432921818115,1536.44186598145,10.5853774656854
"787",860,1159,1159,1159,"Q5TCY1","TTBK1","TTBK1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tubulin complex [GO:0045298]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; substantia nigra development [GO:0021762]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16923168}.","Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase)","GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007611; GO:0008360; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032091; GO:0032273; GO:0045298; GO:0048471; GO:0061890; GO:1903980; GO:1904031; GO:2001056",6.56088392630563e-05,0.00016001522729218,0.00451971890589835,0.0732705640797845,0.0744306602473538,0.0366925080714155,0.0598827964753667,0.0315231792285012,4.97980296301031,0.00625703033793031,0.0462124069824706,-6.38967534334342,142737,1.33524141057714,14,0,0,0.00016001522729218,0.0732705640797845,457.897447134803,8.83888071150987
"788",861,1160,1160,1160,"Q9BQ95","ECSIT","ECSIT_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17344420}. Nucleus {ECO:0000269|PubMed:17344420}. Mitochondrion {ECO:0000269|PubMed:17344420}.","Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)","GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005829; GO:0016651; GO:0032981; GO:0045087; GO:0051341",1e-07,1e-07,2.56982205995396e-06,0.0304063347138466,0.0322321538542731,0.0151763594319156,0.0259373593926584,0.0129696029703492,4.97760360372109,0.00626745079064709,0.0462494644551199,-6.39167252080748,49148,1.33489329180133,6,2,0,1e-07,0.0304063347138466,304063.347138466,18.2140123937699
"789",862,1163,1163,1163,"Q13523","PRPF4B","PRP4B_HUMAN","catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus.","Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog)","GO:0000398; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005694; GO:0006468; GO:0008380; GO:0016607; GO:0071013",0.00019618212780608,9.6991662975538e-05,0.00011144036956514,0.0188081614111467,0.0399956632705108,0.0372417374973462,0.031880316006219,0.0160750293898918,4.97334118280875,0.00628770528654711,0.0462792409740699,-6.39554487643583,116987,1.3346137725266,14,0,0,0.00011144036956514,0.0372417374973462,334.185337348306,8.38450462515184
"790",863,1164,1164,1164,"Q9NZ56","FMN2","FMN2_HUMAN","cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Cytoplasm, cytosol. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasm, cell cortex {ECO:0000250}. Nucleus, nucleolus. Note=Recruited to the membranes via its interaction with SPIRE1. Colocalizes with the actin cytoskeleton. Detected at the cleavage furrow during asymmetric oocyte division and polar body extrusion (By similarity). {ECO:0000250}.","Formin-2","GO:0003779; GO:0005730; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0007275; GO:0015031; GO:0016192; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456",0.00056582770790746,0.00603955695312405,0.00045646198818479,0.0301486297733816,0.0416411030877823,0.0590952364078981,0.0412743742066152,0.0229911359863797,4.97143605906128,0.00629678359687834,0.0463062436334009,-6.39727641234596,180106,1.33436044758422,17,0,0,0.00056582770790746,0.0416411030877823,73.5932555190327,6.20150165091019
"791",865,1166,1166,1166,"Q09161","NCBP1","NCBP1_HUMAN","cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; snRNA transcription by RNA polymerase II [GO:0042795]; spliceosomal complex assembly [GO:0000245]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19648179}. Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000269|PubMed:17289661}.","Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)","GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006366; GO:0006368; GO:0006369; GO:0006370; GO:0006405; GO:0006406; GO:0006446; GO:0008334; GO:0008380; GO:0008543; GO:0016070; GO:0030307; GO:0031053; GO:0031124; GO:0031442; GO:0034518; GO:0042795; GO:0045292; GO:0048026; GO:0051168; GO:0098789; GO:1905216; GO:1990904",1.49129279993978e-05,2.52599903778746e-05,3.03550022689298e-05,0.00045712619551168,0.00024347335401565,0.00034887058488745,0.00032631407125619,0.00018666634251016,4.95957904170922,0.00635363970393822,0.0465805765961315,-6.40806355993208,91839,1.33179513986814,16,0,0,2.52599903778746e-05,0.00034887058488745,13.8111923111827,3.78776596677724
"792",866,1167,1167,1167,"Q96E22","NUS1","NGBR_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; prenyltransferase activity [GO:0004659]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19723497, ECO:0000269|PubMed:21572394}; Multi-pass membrane protein {ECO:0000303|PubMed:21572394}. Note=Colocalizes with Nogo-B during VEGF and wound healing angiogenesis. {ECO:0000269|PubMed:19723497}.","Dehydrodolichyl diphosphate synthase complex subunit NUS1 (EC 2.5.1.87) (Di-trans,poly-cis-decaprenylcistransferase) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)","GO:0001525; GO:0004659; GO:0005789; GO:0016021; GO:0019408; GO:0030154; GO:0032383; GO:0035268; GO:0038084; GO:0042632; GO:0043536; GO:0051000",7.43713627103287e-05,8.70799982870314e-05,9.91080538875518e-05,0.157274589345934,0.167844243468285,0.0786373630232608,0.134498545474198,0.0673361258753942,4.95939261551453,0.00635453855229071,0.0465805765961315,-6.40823330929273,33224,1.33179513986814,3,0,0,8.70799982870314e-05,0.157274589345934,1806.09316076843,10.8186565955939
"793",867,1168,1168,1168,"Q9Y6X4","FAM169A","F169A_HUMAN","nuclear inner membrane [GO:0005637]","SUBCELLULAR LOCATION: Nucleus envelope {ECO:0000269|PubMed:22412018}. Nucleus inner membrane {ECO:0000269|PubMed:22412018}; Peripheral membrane protein {ECO:0000269|PubMed:22412018}; Nucleoplasmic side {ECO:0000269|PubMed:22412018}. Note=Enriched at the nuclear lamina.","Soluble lamin-associated protein of 75 kDa (SLAP75) (Protein FAM169A)","GO:0005637",0.0004544932768876,0.00055885685137801,0.0003371276674713,0.00782576309612178,0.00400929166742423,0.00785591307185998,0.00611349667988969,0.00350690760519048,4.95911976321148,0.0063558543766684,0.0465805765961315,-6.40848176155364,74955,1.33179513986814,17,0,0,0.0004544932768876,0.00782576309612178,17.2186553555052,4.10590057863905
"794",868,1169,1169,1169,"Q96RN5","MED15","MED15_HUMAN","cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription initiation from RNA polymerase II promoter [GO:0006367]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus.","Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein)","GO:0001104; GO:0005634; GO:0005654; GO:0005737; GO:0006367; GO:0016020; GO:0016592",3.868807565476e-06,6.87299671983045e-05,8.55085442231188e-06,0.0787387851134114,0.0840356552101205,0.0393162755425134,0.067336522078953,0.0336953109158719,4.95285955355393,0.00638613410281234,0.0467091699704694,-6.41418478366875,86753,1.33059785012707,5,0,0,8.55085442231188e-06,0.0787387851134114,9208.2944258713,13.1687182475798
"795",869,1170,1170,1170,"Q9Y5H9","PCDHA2","PCDA2_HUMAN","integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Protocadherin alpha-2 (PCDH-alpha-2)","GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399",1e-07,1e-07,4.03648331838384e-05,0.0928442767373514,0.068319119323562,0.0433682420311845,0.0681636910863047,0.0340953671542136,4.95195288321344,0.00639053387237861,0.0467091699704694,-6.4150111753208,102063,1.33059785012707,7,2,0,1e-07,0.068319119323562,683191.19323562,19.3819298522682
"796",870,1171,1171,1171,"Q9Y3A2","UTP11","UTP11_HUMAN","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.","Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein)","GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0042274; GO:0043065",1e-07,7.74328746166189e-05,1e-07,0.0062088013096081,0.00297116394664287,0.00609664732584426,0.00506632656915954,0.00255904090945197,4.95127306203278,0.00639383520456887,0.0467091699704694,-6.41563087316896,30447,1.33059785012707,3,2,0,1e-07,0.00609664732584426,60966.4732584426,15.8957284720468
"797",871,1172,1172,1172,"Q9UQ16","DNM3","DYN3_HUMAN","apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synapse assembly [GO:0007416]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cytoplasm, cytoskeleton {ECO:0000305}. Note=Microtubule-associated. {ECO:0000305}.","Dynamin-3 (EC 3.6.5.5) (Dynamin, testicular) (T-dynamin)","GO:0000266; GO:0001917; GO:0003374; GO:0003924; GO:0005525; GO:0005794; GO:0005874; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0016185; GO:0030424; GO:0031798; GO:0031802; GO:0031966; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0046847; GO:0048471; GO:0050998; GO:0051491; GO:0061002; GO:0061025; GO:0061828; GO:0061829; GO:0070062; GO:0098844; GO:0098884; GO:1903423",0.00038573637415836,6.67089910284551e-05,4.99310094048745e-05,0.00577574834568251,0.00588831899111026,0.00290513937238505,0.00468894344486204,0.00251193051396159,4.95098648691558,0.00639522747726521,0.0467091699704694,-6.41589212148085,97746,1.33059785012707,20,0,0,6.67089910284551e-05,0.00577574834568251,86.5812577380886,6.43598285315677
"798",872,1173,1173,1173,"Q9H2E6","SEMA6A","SEM6A_HUMAN","axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of sprouting angiogenesis [GO:1903671]; nervous system development [GO:0007399]; positive regulation of neuron migration [GO:2001224]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.","Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1)","GO:0005887; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016021; GO:0016525; GO:0030424; GO:0106089; GO:1903671; GO:2001224",6.06277721764132e-06,1.09937544808539e-06,9.11250046519097e-06,0.0524275029772871,0.112289837024936,0.104921297093749,0.0898741208142804,0.0449424852915172,4.94810384210204,0.00640925253141031,0.0467716979274273,-6.41852059505154,114395,1.33001686384973,3,0,0,6.06277721764132e-06,0.104921297093749,17305.8143697663,14.0789692123894
"799",873,1174,1174,1174,"Q96AJ9","VTI1A","VTI1A_HUMAN","autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]","SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000269|PubMed:19138172}. Golgi apparatus membrane {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}.","Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2)","GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006623; GO:0006888; GO:0006891; GO:0006896; GO:0006914; GO:0008021; GO:0012507; GO:0016021; GO:0030136; GO:0031201; GO:0031902; GO:0032588; GO:0042147; GO:0043025; GO:0043231; GO:0044306; GO:0048280; GO:0048471; GO:0050882; GO:0090161",0.00997455795725921,1e-07,1e-07,0.0239422061149289,0.0325366455516085,0.0420379268052433,0.0295140068381738,0.0180819227381733,4.94411835983161,0.00642870410143535,0.0468736857821862,-6.42215643376341,25218,1.32907089559587,4,2,0,1e-07,0.0325366455516085,325366.455516085,18.3117059947921
"800",875,1177,1177,1177,"Q9UH73","EBF1","COE1_HUMAN","nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor)","GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0007275; GO:0046872; GO:0046983; GO:0070742",0.041989338878476,0.136039027562297,0.0525952820048003,0.209993084646589,0.283129935092582,0.26963419286045,0.177377854718016,0.165563476840866,4.93767462153403,0.0064603035058256,0.0469700604736886,-6.42803921208778,64464,1.32817888066469,3,0,0,0.0525952820048003,0.26963419286045,5.12658517233239,2.35799816396665
"801",876,1178,1178,1178,"Q9BT73","PSMG3","PSMG3_HUMAN",NA,NA,"Proteasome assembly chaperone 3 (PAC-3) (hPAC3)",NA,1e-07,1e-07,1e-07,0.012409912713006,0.0131332099792485,0.00614231663885029,0.0105617131103683,0.00528095655518413,4.9369496229759,0.00646387047172958,0.0469700604736886,-6.42870143210948,13104,1.32817888066469,3,3,0,1e-07,0.012409912713006,124099.12713006,16.9211334425275
"802",877,1179,1179,1179,"Q9BY43","CHMP4A","CHM4A_HUMAN","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; cell separation after cytokinesis [GO:0000920]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of neuron death [GO:1901215]; nucleus organization [GO:0006997]; plasma membrane tubulation [GO:0097320]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; vacuolar transport [GO:0007034]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane. Late endosome membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. Note=Membrane-associated. Localizes to large vesicle-like structures. Localizes to the midbody of dividing cells. Localized in two distinct rings on either side of the Fleming body.","Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1)","GO:0000815; GO:0000920; GO:0005634; GO:0005737; GO:0005829; GO:0006620; GO:0006900; GO:0006997; GO:0007034; GO:0007080; GO:0008289; GO:0009898; GO:0010324; GO:0016197; GO:0016236; GO:0019058; GO:0030117; GO:0030496; GO:0030659; GO:0031902; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0051117; GO:0051258; GO:0051260; GO:0097320; GO:1901215; GO:1902902",0.00054571691340506,5.23473192116233e-05,9.94143873345089e-05,0.00752062049946829,0.0161467554112111,0.0134849868477486,0.0121516280461589,0.00630830689639653,4.93438218563956,0.00647652118143095,0.0470220706641637,-6.4310470990597,25098,1.32769825019578,4,0,0,9.94143873345089e-05,0.0134849868477486,135.644218199267,7.08368374419129
"803",878,1180,1180,1180,"P05026","ATP1B1","AT1B1_HUMAN","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; membrane [GO:0016020]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; MHC class II protein complex binding [GO:0023026]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; sodium:potassium-exchanging ATPase activity [GO:0005391]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; leukocyte migration [GO:0050900]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of ATPase activity [GO:0032781]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of potassium ion import [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import [GO:0010107]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport into plasma membrane raft [GO:0044861]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; response to hypoxia [GO:0001666]; sodium ion export across plasma membrane [GO:0036376]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000255}; Single-pass type II membrane protein {ECO:0000255}. Cell membrane, sarcolemma {ECO:0000250|UniProtKB:P14094}. Note=Colocalizes with OBSCN at the intercalated disk and sarcolemma in cardiomyocytes. Localizes in long striations at the level of Z and M lines. {ECO:0000250|UniProtKB:P14094}.","Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1)","GO:0001666; GO:0001671; GO:0005391; GO:0005622; GO:0005886; GO:0005890; GO:0005901; GO:0006874; GO:0006883; GO:0007155; GO:0008022; GO:0010107; GO:0010468; GO:0010882; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0019901; GO:0023026; GO:0030007; GO:0032781; GO:0036376; GO:0042383; GO:0043209; GO:0044861; GO:0046034; GO:0050821; GO:0050900; GO:0051117; GO:0055119; GO:0060048; GO:0070062; GO:0072659; GO:0086009; GO:0086013; GO:0086064; GO:1901018; GO:1903278; GO:1903281; GO:1903288; GO:1903561; GO:1990573",4.42417298058483e-05,6.67434618750962e-06,1.88176166961689e-05,0.00067018601888584,0.0010868824697917,0.00141424590876524,0.00103386023491775,0.00054017468168871,4.93167366608816,0.00648989926573209,0.0470792692497176,-6.43352258728431,35061,1.32717028676485,9,0,0,1.88176166961689e-05,0.0010868824697917,57.7587739903842,5.85196821424602
"804",879,1181,1181,1181,"P51674","GPM6A","GPM6A_HUMAN","axonal growth cone [GO:0044295]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; neural retina development [GO:0003407]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of filopodium assembly [GO:0051491]; stem cell differentiation [GO:0048863]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell projection, axon {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Note=Localizes to cholesterol-rich lipid rafts of the plasma membrane of hippocampal neurons. Localized to plasma membrane of cell bodies and neurites of hippocampal neurons. Localized in membrane protrusions (filopodia and spines) of primary hippocampal neurons. Localized to the growth cone edge membrane of elongating axons (By similarity). {ECO:0000250}.","Neuronal membrane glycoprotein M6-a (M6a)","GO:0001764; GO:0003407; GO:0005262; GO:0005886; GO:0007416; GO:0016021; GO:0030175; GO:0043005; GO:0043025; GO:0043197; GO:0044295; GO:0048812; GO:0048863; GO:0051491; GO:0070062; GO:1903561",0.00025677465440236,0.00013530598824281,0.00029881638544397,0.00370419947590417,0.00210107930646216,0.00430969584570236,0.00314135919999318,0.00180097860935964,4.92856287958585,0.00650530517634008,0.0471510084442873,-6.43636690588645,31210,1.3265090143348,7,0,0,0.00025677465440236,0.00370419947590417,14.4258765902174,3.85058708196855
"805",880,1182,1182,1182,"Q96P47","AGAP3","AGAP3_HUMAN","cell periphery [GO:0071944]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to reactive oxygen species [GO:0034614]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus, translocation [GO:0000060]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16461359}. Note=In cells upon oxidative stress or in brains of Machado-Joseph disease patients, translocates to PML nuclear bodies.","Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP-3) (CRAM-associated GTPase) (CRAG) (Centaurin-gamma-3) (Cnt-g3) (MR1-interacting protein) (MRIP-1)","GO:0000060; GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0005737; GO:0007165; GO:0016020; GO:0031593; GO:0034614; GO:0043161; GO:0046872; GO:0071944",1e-07,1e-07,1.36809849943237e-05,0.0234563437926546,0.0117001313651957,0.0251717622163671,0.0201047854630744,0.0100570197265353,4.92723183277856,0.00651191047430696,0.0471510084442873,-6.43758431940134,95044,1.3265090143348,11,2,0,1e-07,0.0234563437926546,234563.437926546,17.8396186283283
"806",881,1183,1183,1183,"Q8N608","DPP10","DPP10_HUMAN","membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q6NXK7, ECO:0000269|PubMed:14566338}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:P42658}.","Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2)","GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078",1.78235768988502e-05,1e-07,1e-07,0.0207126682339943,0.0223029989731491,0.0103554297545859,0.0177843577949435,0.00889818675643802,4.9263454829893,0.00651631343336354,0.0471510084442873,-6.43839512775243,90888,1.3265090143348,8,2,0,1e-07,0.0207126682339943,207126.682339943,17.6601538898975
"807",882,1184,1184,1184,"P27544","CERS1","CERS1_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; sphingosine N-acyltransferase activity [GO:0050291]; cellular response to dithiothreitol [GO:0072721]; cellular response to drug [GO:0035690]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; sphingolipid biosynthetic process [GO:0030148]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Isoform 1 may recycle from the Golgi to the endoplasmic reticulum.","Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1)","GO:0000139; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030148; GO:0035690; GO:0036146; GO:0043231; GO:0046513; GO:0050291; GO:0051974; GO:0071492; GO:0072721",0.916795242032809,0.237662930338888,0.119317446700998,1.5010119094007,1.95073884174407,1.93482874187489,1.37093462464899,1.11005918534873,4.92454774275638,0.00652525471356438,0.0471758279967154,-6.4400399639676,39536,1.32628046866703,4,0,0,0.237662930338888,1.93482874187489,8.14106238240849,3.02521707383085
"808",883,1186,1186,1186,"Q8TAQ2","SMARCC2","SMRC2_HUMAN","nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus.","SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)","GO:0000790; GO:0000981; GO:0003677; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006351; GO:0006357; GO:0007399; GO:0016514; GO:0032991; GO:0043044; GO:0045892; GO:0045893; GO:0071564; GO:0071565",0.00011258449777919,0.00011052555963287,7.28948978008485e-05,0.0343337461775608,0.0376190801084895,0.0174127458570274,0.0296898557292883,0.0149435961830485,4.92098686775887,0.00654300864385715,0.0472244131462202,-6.44329921254002,132879,1.32583343031331,19,0,0,0.00011052555963287,0.0343337461775608,310.640781115304,8.27910342983707
"809",884,1187,1187,1187,"P40692","MLH1","MLH1_HUMAN","chiasma [GO:0005712]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11429708, ECO:0000269|PubMed:14676842, ECO:0000269|PubMed:21120944, ECO:0000269|PubMed:22753075}.","DNA mismatch repair protein Mlh1 (MutL protein homolog 1)","GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257",0.00022058438570809,6.29633767454161e-05,0.00017095841606147,0.0331652724599792,0.0356343290219274,0.0166058487909036,0.0283169813647651,0.0143099927418875,4.91811163179633,0.006557386386262,0.0472723936346858,-6.44593210117518,84601,1.32539240666648,11,0,0,0.00017095841606147,0.0331652724599792,193.996137914932,7.59988412122611
"810",885,1188,1188,1188,"Q14166","TTLL12","TTL12_HUMAN","ATP binding [GO:0005524]; cellular protein modification process [GO:0006464]",NA,"Tubulin--tyrosine ligase-like protein 12","GO:0005524; GO:0006464",9.59537243224765e-05,6.91234552164994e-05,0.00023898838686588,0.00306983320646923,0.00275244680722673,0.00510769977500823,0.00350863807409978,0.00188900755918484,4.91744978183958,0.00656070135958023,0.0472723936346858,-6.44653831732596,74404,1.32539240666648,21,0,0,9.59537243224765e-05,0.00306983320646923,31.9928510138104,4.99967765752572
"811",886,1189,1189,1189,"O60506","SYNCRIP","HNRPQ_HUMAN","catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11574476, ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:19029303}. Microsome {ECO:0000250|UniProtKB:Q7TMK9}. Endoplasmic reticulum {ECO:0000250}. Nucleus {ECO:0000250|UniProtKB:Q7TMK9}. Note=The tyrosine phosphorylated form bound to RNA is found in microsomes (By similarity). Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). {ECO:0000250|UniProtKB:O43390, ECO:0000250|UniProtKB:Q7TMK9}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q7TMK9}. Note=Expressed predominantly in the nucleoplasm. {ECO:0000250|UniProtKB:Q7TMK9}.; SUBCELLULAR LOCATION: Isoform 2: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q7TMK9}. Note=Expressed predominantly in the nucleoplasm. {ECO:0000250|UniProtKB:Q7TMK9}.; SUBCELLULAR LOCATION: Isoform 3: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q7TMK9}. Note=Expressed predominantly in the nucleoplasm. {ECO:0000250|UniProtKB:Q7TMK9}.","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)","GO:0000398; GO:0001649; GO:0003723; GO:0005634; GO:0005654; GO:0005783; GO:0006396; GO:0008143; GO:0008380; GO:0016020; GO:0016032; GO:0017148; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:1990904",1e-07,1e-07,1e-07,0.00492514704904505,0.00811156241756672,0.0107074780455797,0.0079146291707305,0.00395741458536525,4.9105924851016,0.00659516571640866,0.0474716938820769,-6.45282255488641,69603,1.32356527153603,16,3,0,1e-07,0.00811156241756672,81115.6241756672,16.3076922070591
"812",887,1190,1190,1190,"O43172","PRPF4","PRP4_HUMAN","Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:25383878}. Note=Colocalizes with spliceosomal snRNPs. {ECO:0000250}.","U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)","GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525",1e-07,4.27007129663451e-05,1e-07,0.00883122328108805,0.0040788439007265,0.0080895063179191,0.0069855575955891,0.00350707903545,4.90919834612089,0.00660219911201489,0.0474716938820769,-6.45410093493584,58449,1.32356527153603,8,2,0,1e-07,0.0080895063179191,80895.063179191,16.303764040867
"813",889,1193,1193,1193,"Q7Z5N4","SDK1","SDK1_HUMAN","cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; behavioral response to cocaine [GO:0048148]; cell-cell junction organization [GO:0045216]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8AV58}; Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q8AV58}. Cell junction, synapse {ECO:0000250|UniProtKB:Q8AV58}.","Protein sidekick-1","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0030054; GO:0042802; GO:0045202; GO:0045216; GO:0048148; GO:0060998",3.97410550588227e-05,4.35656505712818e-05,4.38132721089633e-05,0.0426931585687046,0.0371486383430112,0.0715594434255786,0.0504247067865184,0.0252547267191722,4.90496324007126,0.00662362035445626,0.0475053231780825,-6.45798594117972,242112,1.32325772306277,8,0,0,4.35656505712818e-05,0.0426931585687046,979.972937597945,9.93659809886754
"814",890,1194,1194,1194,"Q9UJA5","TRMT6","TRM6_HUMAN","nucleoplasm [GO:0005654]; tRNA (m1A) methyltransferase complex [GO:0031515]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P41814}.","tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)","GO:0003723; GO:0005654; GO:0030488; GO:0031515; GO:0080009",0.00011399872898175,2.06388075729546e-05,1.98784963232246e-05,0.0136672522110033,0.0296183871630187,0.0271320189842517,0.0234210474417986,0.0117620290651919,4.90442936411925,0.00662632662086805,0.0475053231780825,-6.45847584947744,55799,1.32325772306277,9,0,0,2.06388075729546e-05,0.0271320189842517,1314.61175207651,10.3604210719689
"815",891,1195,1195,1195,"O75874","IDH1","IDHC_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADPH regeneration [GO:0006740]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10521434}. Peroxisome {ECO:0000269|PubMed:10521434}.","Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","GO:0000287; GO:0004450; GO:0005102; GO:0005576; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006625; GO:0006740; GO:0006749; GO:0006979; GO:0008585; GO:0034774; GO:0042802; GO:0042803; GO:0043312; GO:0045296; GO:0048545; GO:0050661; GO:0051287; GO:0051990; GO:0060696; GO:0070062; GO:0071071; GO:1904724; GO:1904813",1e-07,4.4640986022938e-05,1e-07,0.00042852037168662,0.00043386281678681,0.00023168446745857,0.00034974222330302,0.00018981810699249,4.90165467738588,0.00664041313827257,0.0475616680511089,-6.46102262344607,46659,1.32274292249976,24,2,0,1e-07,0.00042852037168662,4285.2037168662,12.0651480757738
"816",892,1197,1197,1197,"Q96KQ7","EHMT2","EHMT2_HUMAN","nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11316813}. Chromosome {ECO:0000269|PubMed:11316813}. Note=Associates with euchromatic regions. Does not associate with heterochromatin.","Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)","GO:0000122; GO:0000790; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0008270; GO:0009267; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0046974; GO:0046976; GO:0070317; GO:0070742; GO:1990841",0.00010142354105055,9.41124538548769e-05,9.07504801591312e-05,0.0231845349715092,0.0460419094397003,0.0286361875194238,0.0325254484851896,0.0163581530676163,4.89633777590491,0.00666750643602642,0.0476109036489725,-6.46590559925339,132370,1.32229357559253,12,0,0,9.41124538548769e-05,0.0286361875194238,304.276281687239,8.24923807004255
"817",893,1198,1198,1198,"O94898","LRIG2","LRIG2_HUMAN","cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15145052}; Single-pass type I membrane protein {ECO:0000269|PubMed:15145052}. Cytoplasm {ECO:0000269|PubMed:15145052}.","Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2)","GO:0005102; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222",1e-07,1e-07,1e-07,0.124053111364623,0.0660456208453252,0.0715217656968898,0.0872067326356127,0.0436034663178063,4.89358352802649,0.00668159335382093,0.0476109036489725,-6.46843651623658,118965,1.32229357559253,12,3,0,1e-07,0.0715217656968898,715217.656968898,19.4480228279981
"818",894,1199,1199,1199,"Q9ULB1","NRXN1","NRX1A_HUMAN","cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell junction, synapse {ECO:0000305}. Note=Localized on the pre-synaptic membrane. {ECO:0000250}.","Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)","GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030054; GO:0030534; GO:0031965; GO:0031982; GO:0032991; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0060134; GO:0061178; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0099560; GO:2000463; GO:2000821",0.00010943611202254,0.0168103164690214,0.00012097277275194,0.0568110415450649,0.0837814041849682,0.0479708746498772,0.0571741983420381,0.0342673409556177,4.89354740056617,0.00668177836889135,0.0476109036489725,-6.46846972084611,161883,1.32229357559253,14,0,0,0.00012097277275194,0.0568110415450649,469.618412909808,8.87534516486003
"819",897,1204,1204,1204,"Q15648","MED1","MED1_HUMAN","chromatin [GO:0000785]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; ligand-dependent nuclear receptor binding [GO:0016922]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; mediator complex binding [GO:0036033]; nuclear hormone receptor binding [GO:0035257]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription cofactor activity [GO:0001104]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; signaling receptor activity [GO:0038023]; thyroid hormone receptor binding [GO:0046966]; thyroid hormone receptor coactivator activity [GO:0030375]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; androgen biosynthetic process [GO:0006702]; androgen receptor signaling pathway [GO:0030521]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERK1 and ERK2 cascade [GO:0070371]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein import into nucleus, translocation [GO:0033160]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of lipid metabolic process [GO:0019216]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase I [GO:0006356]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular trabecula myocardium morphogenesis [GO:0003222]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15471764, ECO:0000269|PubMed:16314496, ECO:0000269|PubMed:16574658}. Note=A subset of the protein may enter the nucleolus subsequent to phosphorylation by MAPK1 or MAPK3.","Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)","GO:0000122; GO:0000151; GO:0000785; GO:0000902; GO:0000978; GO:0000979; GO:0000981; GO:0001047; GO:0001104; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006356; GO:0006367; GO:0006590; GO:0006702; GO:0007420; GO:0007595; GO:0008134; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0019216; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030375; GO:0030518; GO:0030521; GO:0031100; GO:0031490; GO:0032993; GO:0033148; GO:0033160; GO:0033601; GO:0035050; GO:0035116; GO:0035162; GO:0035257; GO:0035357; GO:0035729; GO:0035855; GO:0036033; GO:0038023; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051726; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0061630; GO:0070318; GO:0070371; GO:0070562; GO:0071364; GO:0071383; GO:0097067; GO:2000273; GO:2000347; GO:2001141",0.00017947605340536,0.00016165569644245,8.35600935163448e-05,0.00566840325903054,0.0111518474512992,0.0121839278029657,0.00952649555664376,0.00490481172610993,4.88784255911463,0.00671107109872802,0.0477132629610564,-6.47371515749145,168478,1.32136088238207,17,0,0,0.00016165569644245,0.0111518474512992,68.9851808301064,6.10821457505219
"820",898,1205,1205,1205,"Q6PJG6","BRAT1","BRAT1_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; glucose metabolic process [GO:0006006]; mitochondrion localization [GO:0051646]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; response to ionizing radiation [GO:0010212]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16452482, ECO:0000269|PubMed:25631046}. Cytoplasm {ECO:0000269|PubMed:25631046}. Note=Present at double strand breaks (DSBs)following ionizing radiation treatment. The ubiquitinated form localizes in the nucleus in a NDFIP1-dependent manner. {ECO:0000269|PubMed:16452482, ECO:0000269|PubMed:25631046}.","BRCA1-associated ATM activator 1 (BRCA1-associated protein required for ATM activation protein 1)","GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0006006; GO:0006915; GO:0006974; GO:0008283; GO:0010212; GO:0016020; GO:0016477; GO:0030307; GO:0051646",1e-07,1e-07,1e-07,0.0314016976847141,0.0684630671501921,0.0627006318065067,0.0541883655471376,0.0270942827735688,4.88321430461829,0.00673494905690651,0.0478222741557161,-6.47797382888715,88119,1.32036977515051,10,3,0,1e-07,0.0627006318065067,627006.318065067,19.2581204549366
"821",899,1206,1206,1206,"Q9ULN7","PNMA8B","PNM8B_HUMAN",NA,NA,"Paraneoplastic antigen-like protein 8B (PNMA-like protein 2)",NA,9.32199287298695e-05,0.00010286967031548,9.88492920762021e-05,0.103059714808233,0.0515230409056768,0.112156986177506,0.0888149343334312,0.0445057801304228,4.88144683788132,0.00674409459140104,0.0478222741557161,-6.47960089622929,68615,1.32036977515051,5,0,0,9.88492920762021e-05,0.103059714808233,1042.59436404244,10.0259622509459
"822",901,1208,1208,1208,"Q9H3F6","KCTD10","BACD3_HUMAN","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19125419}.","BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)","GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:0051260",9.9133728548188e-05,0.00011919545471736,0.0608778837955956,0.214898251735066,0.126128662148822,0.193883478730971,0.157938059878666,0.0993344342656199,4.8801124390055,0.00675100913654145,0.0478222741557161,-6.48082956745965,35432,1.32036977515051,3,0,0,0.00011919545471736,0.193883478730971,1626.60127595229,10.667644935363
"823",902,1209,1209,1209,"Q8WU90","ZC3H15","ZC3HF_HUMAN","cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; cytokine-mediated signaling pathway [GO:0019221]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15676025, ECO:0000269|PubMed:19819225}. Nucleus {ECO:0000250}. Note=The DRG1-DFRP2/ZC3H15 complex associates with polysomes.","Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4)","GO:0000981; GO:0003723; GO:0005730; GO:0005829; GO:0019221; GO:0045296; GO:0046872",2.01568371737981e-05,5.68111010138107e-05,0.00015141369027039,0.0231002326006999,0.0504200666713532,0.0457750733248014,0.0396889969894655,0.0199206257042188,4.87947069089365,0.00675433755306785,0.0478222741557161,-6.48142055132122,48602,1.32036977515051,9,0,0,5.68111010138107e-05,0.0457750733248014,805.74170378556,9.65417361861456
"824",903,1210,1210,1210,"Q9C0B1","FTO","FTO_HUMAN","nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; RNA N6-methyladenosine dioxygenase activity [GO:1990931]; adipose tissue development [GO:0060612]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative single-stranded DNA demethylation [GO:0035552]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of brown fat cell differentiation [GO:0090335]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; regulation of respiratory system process [GO:0044065]; regulation of white fat cell proliferation [GO:0070350]; RNA repair [GO:0042245]; temperature homeostasis [GO:0001659]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22002720, ECO:0000269|PubMed:26458103}. Nucleus speckle {ECO:0000269|PubMed:22002720}.","Alpha-ketoglutarate-dependent dioxygenase FTO (EC 1.14.11.-) (Fat mass and obesity-associated protein)","GO:0001659; GO:0005634; GO:0005654; GO:0006307; GO:0008198; GO:0010883; GO:0016607; GO:0035515; GO:0035516; GO:0035552; GO:0035553; GO:0040014; GO:0042245; GO:0043734; GO:0044065; GO:0060612; GO:0070350; GO:0070989; GO:0080111; GO:0090335; GO:1990931",1e-07,1e-07,1e-07,0.00280802824433418,0.00266001101988864,0.00130203589622429,0.00225659172014904,0.00112839586007452,4.87694975621688,0.00676743140078513,0.0478297787123994,-6.48374259428392,58282,1.32030162841522,18,3,0,1e-07,0.00266001101988864,26600.1101988864,14.6991446020826
"825",904,1212,1212,1212,"Q9BWH6","RPAP1","RPAP1_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","RNA polymerase II-associated protein 1","GO:0003677; GO:0003899; GO:0005634; GO:0006366",1e-07,1e-07,1e-07,0.0268970151425712,0.0587818569667487,0.0536157246507195,0.0464314322533465,0.0232158161266732,4.8760407551759,0.00677216025694254,0.0478297787123994,-6.48458008293275,152755,1.32030162841522,15,3,0,1e-07,0.0536157246507195,536157.246507195,19.0322966569964
"826",906,1214,1214,1214,"Q9P2Q2","FRMD4A","FRM4A_HUMAN","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding, bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q8BIE6}. Cell junction, tight junction {ECO:0000250|UniProtKB:Q8BIE6}. Note=Colocalized with CYTH1 at adherens junction and tight junction. Colocalized with PARD3 during the process of epithelial polarization. {ECO:0000250|UniProtKB:Q8BIE6}.","FERM domain-containing protein 4A","GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0090162",1e-07,1e-07,6.74407398331917e-05,0.0497506517734886,0.0248221883760532,0.0541588713602376,0.0428880235899821,0.0214665587082688,4.87236705099336,0.00679131221230335,0.0478486923327834,-6.48796587462554,115458,1.32012992665237,12,2,0,1e-07,0.0497506517734886,497506.517734886,18.9243559006804
"827",907,1215,1215,1215,"O76062","TM7SF2","ERG24_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; receptor complex [GO:0043235]; delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol biosynthetic process [GO:0006695]; regulation of cholesterol biosynthetic process [GO:0045540]; sterol biosynthetic process [GO:0016126]","SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:9878250}; Multi-pass membrane protein {ECO:0000269|PubMed:9878250}.","Delta(14)-sterol reductase (Delta-14-SR) (EC 1.3.1.70) (Another new gene 1 protein) (C-14 sterol reductase) (Putative sterol reductase SR-1) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2)","GO:0005783; GO:0005789; GO:0005887; GO:0006695; GO:0016126; GO:0016627; GO:0030176; GO:0031090; GO:0043231; GO:0043235; GO:0045540; GO:0050613; GO:0050661",0.223282220791498,0.00011411045270353,0.00014308164047436,0.403839996447164,0.468102303603295,0.431738934472546,0.360047273879443,0.254536774567947,4.87231048451982,0.00679160761499204,0.0478486923327834,-6.48801802174698,46406,1.32012992665237,6,0,0,0.00014308164047436,0.431738934472546,3017.43069929306,11.5591049219442
"828",908,1216,1216,1216,"Q6PD74","AAGAB","AAGAB_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:23000146, ECO:0000269|PubMed:23064416}.","Alpha- and gamma-adaptin-binding protein p34","GO:0005737; GO:0005829; GO:0015031; GO:0016607",0.00339425572367364,2.06110093966529e-05,2.89621346966417e-05,0.00901775018193536,0.0063664314698096,0.00729421694243852,0.00641152324213885,0.00435370457699173,4.87050701740573,0.00680103380081665,0.0478496011670665,-6.4896808098383,34594,1.32012167777562,6,0,0,2.89621346966417e-05,0.00729421694243852,251.853567385153,7.9764413559998
"829",909,1217,1217,1217,"P59923","ZNF445","ZN445_HUMAN","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00187}.","Zinc finger protein 445 (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15)","GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0046872",0.00048042419682865,0.00048664597435172,0.00039535231899666,0.00075861535013692,0.00106077781729944,0.00104748166688893,0.00050148411471608,0.00070488288741705,4.86898546019726,0.00680899872820895,0.0478496011670665,-6.49108401008772,118963,1.32012167777562,10,0,0,0.00048042419682865,0.00104748166688893,2.18032662343718,1.12454427386272
"830",910,1219,1219,1219,"Q8N5D0","WDTC1","WDTC1_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]",NA,"WD and tetratricopeptide repeats protein 1","GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0043687; GO:0045717; GO:0055082",1e-07,1e-07,1e-07,0.100113168512393,0.219116846976842,0.199885471784698,0.173038395757977,0.0865192978789887,4.86801279074111,0.00681409624096426,0.0478496011670665,-6.49198117789629,75920,1.32012167777562,6,3,0,1e-07,0.199885471784698,1998854.71784698,20.9307421862498
"831",912,1221,1221,1221,"Q8N0U8","VKORC1L1","VKORL_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:21367861, ECO:0000269|PubMed:24532791}; Multi-pass membrane protein {ECO:0000269|PubMed:21367861, ECO:0000269|PubMed:24532791}.","Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)","GO:0005783; GO:0005789; GO:0016021; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038",1e-07,1e-07,1e-07,0.00099763981849371,0.00049324808395411,0.0010565752319553,0.00084905437813437,0.00042462718906718,4.86498445595578,0.00682999629357928,0.0478826930983117,-6.49477523886914,19836,1.31982143126387,3,3,0,1e-07,0.00099763981849371,9976.3981849371,13.2843033328258
"832",914,1223,1223,1223,"Q8NBI6","XXYLT1","XXLT1_HUMAN","integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22117070}; Single-pass type II membrane protein {ECO:0000269|PubMed:22117070}.","Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)","GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252",0.00018127674933842,1e-07,1e-07,0.0797851047449282,0.0871449738853825,0.039823013024337,0.0688572049684365,0.0344890947339977,4.85973165273748,0.00685768137153421,0.0479527162632602,-6.49962453793506,43807,1.31918678735184,4,2,0,1e-07,0.0797851047449282,797851.047449282,19.605759906142
"833",915,1225,1225,1225,"Q96PK6","RBM14","RBM14_HUMAN","cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor complex [GO:0005667]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; protein binding, bridging [GO:0030674]; RNA binding [GO:0003723]; RNA polymerase II transcription cofactor activity [GO:0001104]; activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; glucocorticoid receptor signaling pathway [GO:0042921]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:25385835}. Nucleus, nucleolus {ECO:0000269|PubMed:11790299}. Cytoplasm {ECO:0000269|PubMed:25385835}. Note=In punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles (PubMed:11790299). Cytoplasmic localization is crucial for its function in suppressing the formation of aberrant centriolar protein complexes (PubMed:25385835). {ECO:0000269|PubMed:11790299, ECO:0000269|PubMed:25385835}.","RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein)","GO:0001104; GO:0002218; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006351; GO:0009725; GO:0016575; GO:0016592; GO:0016607; GO:0030374; GO:0030520; GO:0030674; GO:0042921; GO:0045087; GO:0045944; GO:0046600; GO:0060395; GO:0098534; GO:1990904",1.0039314632683e-05,2.28298186440216e-05,4.04032278649185e-05,0.0162903933739345,0.007440506311919,0.0148514242555226,0.0128363505267448,0.00644259938375295,4.85753619853597,0.00686929243848863,0.0479527162632602,-6.50165241842594,69492,1.31918678735184,13,0,0,2.28298186440216e-05,0.0148514242555226,650.527474050334,9.34546617806162
"834",916,1226,1226,1226,"Q96KG9","SCYL1","SCYL1_HUMAN","cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; regulation of transcription, DNA-templated [GO:0006355]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:18556652}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000269|PubMed:18556652}. Golgi apparatus, cis-Golgi network {ECO:0000269|PubMed:18556652}. Note=Localized to the Endoplasmic reticulum-Golgi intermediate and cis-Golgi in an ARF1-independent manner.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Cytoplasmic during interphase and centrosomal during mitosis, it localizes to the centrosomes in a microtubule-independent manner.; SUBCELLULAR LOCATION: Isoform 6: Nucleus {ECO:0000269|PubMed:15504359}.","N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)","GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0006890; GO:0016020; GO:0030126; GO:0045296",0.00023446873824051,0.00023232337022533,0.00010438115971477,0.0203745558538536,0.0102365165827984,0.0221868136176024,0.0174089042620246,0.00889484322040584,4.85746973856973,0.00686964429168163,0.0479527162632602,-6.50171381554461,89631,1.31918678735184,13,0,0,0.00023232337022533,0.0203745558538536,87.6991231406998,6.45449051284941
"835",917,1227,1227,1227,"Q9UBF2","COPG2","COPG2_HUMAN","COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasmic vesicle, COPI-coated vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=The coatomer is cytoplasmic or polymerized on the cytoplasmic side of the Golgi, as well as on the vesicles/buds originating from it. Tends to be more abundant in the trans-Golgi network compared to the cis-Golgi. {ECO:0000250}.","Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP)","GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133",0.00228666849694695,0.00017461026364156,0.00010461641983553,0.0136042535760592,0.0178774446662238,0.00889073680027258,0.0126021799540439,0.00715638837049662,4.85672357416549,0.00687359612792292,0.0479527162632602,-6.50240317782313,97622,1.31918678735184,21,0,0,0.00017461026364156,0.0136042535760592,77.9121071828058,6.28377562876326
"836",918,1228,1228,1228,"P49918","CDKN1C","CDN1C_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mitotic cell cycle [GO:0007346]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2)","GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007050; GO:0007346; GO:0030511; GO:0033673; GO:0042326; GO:0044877; GO:0045892; GO:0045893; GO:0050680; GO:1904030",3.84127699176152e-05,0.00372039718029218,6.04525091108705e-05,0.110415634119917,0.0551707741537347,0.118796634183961,0.0935212599994309,0.0480337174861557,4.85278750613954,0.00689448749077534,0.0480076428204435,-6.50604082274484,32177,1.31868961740526,3,0,0,6.04525091108705e-05,0.110415634119917,1826.4855461568,10.8348546216796
"837",919,1229,1229,1229,"Q9NS86","LANCL2","LANC2_HUMAN","cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12566319}. Cytoplasm {ECO:0000269|PubMed:12566319}. Cell membrane {ECO:0000269|PubMed:12566319, ECO:0000269|PubMed:16979580}. Note=Localizes to the juxta-nuclear vesicles (PubMed:16979580). Associates with the cortical actin cytoskeleton (PubMed:16979580). Cholesterol depletion by methyl-beta-cyclodextrin causes partial dissociation from the cell membrane in vitro and an enhanced cell detachment from the matrix in vivo (PubMed:16979580). Membrane-association is important for the increased cellular sensitivity to an anticancer drug (adriamycin) (PubMed:16979580). {ECO:0000269|PubMed:16979580}.","LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)","GO:0003824; GO:0005524; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273",7.79709993965729e-05,0.00012261785241419,0.00012205563702402,0.00678841595724496,0.00722645084739947,0.00337842052317601,0.00569021427966189,0.00295265530277587,4.85267070983881,0.0068951085692173,0.0480076428204435,-6.50614879497302,50854,1.31868961740526,14,0,0,0.00012205563702402,0.00678841595724496,55.617389927751,5.79746413682753
"838",920,1230,1230,1230,"Q14980","NUMA1","NUMA1_HUMAN","cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:27462074}. Nucleus, nucleoplasm {ECO:0000269|PubMed:10811826}. Nucleus matrix {ECO:0000269|PubMed:10075938, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:7962183}. Chromosome {ECO:0000269|PubMed:1541630}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006, ECO:0000269|PubMed:7962183}. Cytoplasm, cell cortex {ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901}. Cell membrane {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901}; Lipid-anchor {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901}; Cytoplasmic side {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901}. Lateral cell membrane {ECO:0000250|UniProtKB:E9Q7G0}. Note=Mitotic cell cycle-dependent shuttling protein that relocalizes from the interphase nucleus to the spindle poles and cell cortex (PubMed:1541636, PubMed:10811826). In interphase, resides in the nuclear matrix (PubMed:1541630, PubMed:1541636, PubMed:23921553). In prophase, restricted to the interchromatin or condensed chromosome space (PubMed:10811826). In prometaphase, after nuclear envelope disassembly, forms aggregates both in the spindle midzone and at duplicated centrosomes and astral microtubules (MTs) of the bipolar spindle apparatus (PubMed:10811826). Translocates from the spindle midzone towards the spindle poles along spindle fibers in a MT- and dynein-dynactin-dependent manner until the anaphase onset (PubMed:1541636, PubMed:10811826). In metaphase, recruited to the polar cortical region in a GPSM2- and GNAI1-dependent manner (PubMed:23870127, PubMed:24109598, PubMed:24996901). Excluded from the metaphase equatorial cortical region in a RanGTP-dependent manner (PubMed:22327364, PubMed:23870127). Phosphorylation on Thr-2055 by CDK1 results in its localization at spindle poles in metaphase, but not at the cell cortex (PubMed:23921553). In anaphase, recruited and anchored at the cell membrane of the polar cortical region in a EPB41-, EPB41L2-, phosphatidylinositol-dependent and GPSM2- and G(i) alpha proteins-independent manner (PubMed:23870127, PubMed:24996901, PubMed:24109598, PubMed:24371089). Excluded from the anaphase equatorial region of the cell cortex in a RACGAP1- and KIF23-dependent and RanGTP-independent manner (PubMed:24996901). Associated with astral MTs emanating from the spindle poles during anaphase (PubMed:12445386, PubMed:24996901). Nonphosphorylated Thr-2055 localizes at the cell cortex, weakly during metaphase and more prominently during anaphase in a phosphatase PPP2CA-dependent manner (PubMed:23921553). As mitosis progresses it reassociates with telophase chromosomes very early during nuclear reformation, before substantial accumulation of lamins on chromosomal surfaces is evident (PubMed:1541636). Localizes to the tips of cortical MTs in prometaphase (PubMed:26765568). Localizes along MTs and specifically to both MT plus and minus ends (PubMed:26765568). Accumulates also at MT tips near the cell periphery (PubMed:26765568). Colocalizes with GPSM2 at mitotic spindle poles during mitosis (PubMed:11781568, PubMed:21816348). Colocalizes with SPAG5 at mitotic spindle at prometaphase and at mitotic spindle poles at metaphase and anaphase (PubMed:27462074). Colocalizes with ABRO1 at mitotic spindle poles (PubMed:26195665). Colocalized with TNKS from prophase through to anaphase in mitosis (PubMed:16076287). Colocalizes with tubulin alpha (PubMed:12445386). CCSAP is essential for its centrosomal localization (PubMed:26562023). In horizontally retinal progenitor dividing cells, localized to the lateral cortical region (By similarity). {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:27462074}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:7962183}. Note=During interphase, mainly clustered at the centrosomal region in the cytosol. After entry into mitosis, detected at mitotic spindle poles. {ECO:0000269|PubMed:7962183}.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, cytosol {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:7962183}. Note=During interphase, mainly clustered at the centrosomal region in the cytosol. After entry into mitosis, detected at mitotic spindle poles. {ECO:0000269|PubMed:7962183}.","Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22) (NMP-22) (Nuclear mitotic apparatus protein) (NuMA protein) (SP-H antigen)","GO:0000132; GO:0000139; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005938; GO:0006997; GO:0007059; GO:0008017; GO:0008022; GO:0015631; GO:0016328; GO:0016363; GO:0019897; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023",2.5718591246343e-05,1.04353726047009e-05,6.58230426033427e-05,0.0154177132744256,0.0340444292327465,0.0300492739948233,0.0264698131651803,0.013268898918075,4.85094586669784,0.0069042884437719,0.0480076428204435,-6.50774353359929,238260,1.31868961740526,55,0,0,2.5718591246343e-05,0.0300492739948233,1168.38724590314,10.1903027995913
"839",921,1231,1231,1231,"P19404","NDUFV2","NDUV2_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Mitochondrion inner membrane.","NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (NADH-ubiquinone oxidoreductase 24 kDa subunit)","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009055; GO:0032981; GO:0043209; GO:0046872; GO:0048738; GO:0051537",1e-07,1e-07,1e-07,0.00450953869015692,0.00915993622758151,0.009847356555723,0.00783884382448715,0.00391952191224357,4.85088505615626,0.00690461235386874,0.0480076428204435,-6.50779976436259,27392,1.31868961740526,6,3,0,1e-07,0.00915993622758151,91599.3622758151,16.4830499337153
"840",922,1232,1232,1232,"Q96A33","CCDC47","CCD47_HUMAN","endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.","Coiled-coil domain-containing protein 47","GO:0001649; GO:0003723; GO:0005509; GO:0005783; GO:0005791; GO:0006983; GO:0007029; GO:0009791; GO:0016020; GO:0016021; GO:0030433; GO:0055074",0.0006717322677301,0.00065132922242248,0.00133528397205589,0.103939267838759,0.0682663118194956,0.146163275430849,0.105236836542298,0.0535045334252186,4.84996576682344,0.00690951120967131,0.0480076428204435,-6.50864987926326,55874,1.31868961740526,8,0,0,0.0006717322677301,0.103939267838759,154.733176939658,7.27363875355957
"841",923,1233,1233,1233,"P63104","YWHAZ","1433Z_HUMAN","blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; cytokine-mediated signaling pathway [GO:0019221]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; platelet activation [GO:0030168]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Located to stage I to stage IV melanosomes.","14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)","GO:0003723; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0007165; GO:0008134; GO:0019221; GO:0019901; GO:0019904; GO:0030168; GO:0031625; GO:0031982; GO:0042470; GO:0042802; GO:0043066; GO:0043488; GO:0044325; GO:0045296; GO:0051683; GO:0061024; GO:0070062; GO:0072562; GO:0090168; GO:1900740",7.17430300867606e-05,9.29389529126317e-05,7.42479512108787e-05,0.00028766430120121,0.00025194545441187,0.00038123928381237,0.00022730636840506,0.00019329649560595,4.84819384843138,0.00691896545053532,0.0480088376394158,-6.51028877878117,27745,1.31867880877565,10,0,0,7.42479512108787e-05,0.00028766430120121,3.87437358889792,1.95396307342078
"842",924,1234,1234,1234,"Q9NPF5","DMAP1","DMAP1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Targeted to replication foci throughout S phase by DNMT1.","DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1)","GO:0000122; GO:0000981; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0006338; GO:0006351; GO:0035267; GO:0040008; GO:0042307; GO:0043967; GO:0043968; GO:0045471; GO:0045892",0.00026923313487672,0.00352999375681019,0.00029746644047723,0.0902220667914224,0.0933142185182469,0.16548344487205,0.114974345616518,0.0588527372523139,4.84720851045552,0.00692422952435455,0.0480088376394158,-6.51120032581444,52993,1.31867880877565,11,0,0,0.00029746644047723,0.0933142185182469,313.696625301804,8.29322619875688
"843",925,1235,1235,1235,"Q03001","DST","DYST_HUMAN","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11751855, ECO:0000269|PubMed:19932097}. Cell projection, axon {ECO:0000250|UniProtKB:Q91ZU6}. Note=Associates with intermediate filaments, actin and microtubule cytoskeletons. Localizes to actin stress fibers and to actin-rich ruffling at the cortex of cells (By similarity). Associated at the growing distal tip of microtubules. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril, sarcomere, Z line. Cytoplasm, myofibril, sarcomere, H zone {ECO:0000250}. Note=Localizes to microtubules and actin microfilaments throughout the cytoplasm and at focal contact attachments at the plasma membrane. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes both cortical and cytoplasmic actin filaments. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytoskeleton. Cell junction, hemidesmosome. Note=Localizes to actin and intermediate filaments cytoskeletons (By similarity). Colocalizes with the epidermal KRT5-KRT14 intermediate filaments network of keratins. Colocalizes with ITGB4 at the leading edge of migrating keratinocytes. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 6: Nucleus {ECO:0000250}. Nucleus envelope {ECO:0000269|PubMed:10428034}. Membrane {ECO:0000269|PubMed:10428034}; Single-pass membrane protein {ECO:0000269|PubMed:10428034}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10428034}. Note=Localizes to actin and intermediate filaments cytoskeletons. Localizes to central actin stress fibers around the nucleus and is excluded form focal contact sites in myoblast cells. Translocates to the nucleus (By similarity). Associates with actin cytoskeleton in sensory neurons. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 7: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10428034}. Cell projection, axon {ECO:0000269|PubMed:10428034}. Membrane {ECO:0000269|PubMed:10428034}. Note=Associates with axonal microtubules and intermediate filaments, but not with actin cytoskeleton, in sensory neurons.; SUBCELLULAR LOCATION: Isoform 8: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, cell cortex {ECO:0000250}. Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}.","Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)","GO:0000226; GO:0003779; GO:0005178; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115",0.00018109149792979,0.00031663605000629,0.0001946295574991,0.00048328075965138,0.00046025609644272,0.00052853258124806,0.00025990411063566,0.00036073775712956,4.84678216882648,0.00692650870148114,0.0480088376394158,-6.51159477880219,860662,1.31867880877565,125,0,0,0.0001946295574991,0.00048328075965138,2.48307998980892,1.31213073716593
"844",926,1236,1236,1236,"Q13485","SMAD4","SMAD4_HUMAN","activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein deubiquitination [GO:0016579]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}. Nucleus {ECO:0000269|PubMed:15799969}. Note=Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD (PubMed:15799969). PDPK1 prevents its nuclear translocation in response to TGF-beta (PubMed:17327236). {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}.","Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)","GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001077; GO:0001085; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0016579; GO:0017015; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035019; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0046982; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:1901522; GO:1905305; GO:2000617",0.00272856723611486,0.00511533841694915,0.0013484836459544,0.030146082944044,0.0604721966768181,0.0600474406186038,0.0471577769801492,0.026643018256414,4.84525765650632,0.00693466594225613,0.0480264890499292,-6.51300545965706,60439,1.31851916105987,6,0,0,0.00272856723611486,0.0600474406186038,22.00694922369,4.4598872562498
"845",927,1238,1238,1238,"Q76NI1","KNDC1","KNDC1_HUMAN","dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cell projection, dendrite {ECO:0000250|UniProtKB:Q0KK55}. Perikaryon {ECO:0000250|UniProtKB:Q0KK55}.","Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2)","GO:0001934; GO:0005088; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773",1e-07,1e-07,6.79007644184257e-06,0.0806715325418146,0.0731604913900748,0.0365782509081056,0.063467761587851,0.0317362108194061,4.83527602364297,0.00698836029482406,0.0483201648818206,-6.52224936138607,191397,1.31587159245102,5,2,0,1e-07,0.0731604913900748,731604.913900748,19.4807052395678
"846",929,1240,1240,1240,"P60891","PRPS1","PRPS1_HUMAN","cytosol [GO:0005829]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; hypoxanthine biosynthetic process [GO:0046101]; nervous system development [GO:0007399]; nucleoside metabolic process [GO:0009116]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide biosynthetic process [GO:0006164]; pyrimidine nucleotide biosynthetic process [GO:0006221]; urate biosynthetic process [GO:0034418]",NA,"Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase I) (PRS-I)","GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005829; GO:0006015; GO:0006144; GO:0006164; GO:0006167; GO:0006221; GO:0007399; GO:0009116; GO:0016208; GO:0016301; GO:0019003; GO:0030246; GO:0031100; GO:0034418; GO:0042802; GO:0042803; GO:0043531; GO:0046101",1e-07,1e-07,1e-07,0.00723371058013665,0.00352737170299694,0.00772222104316845,0.00616100110876735,0.00308060055438367,4.82574898706247,0.00704007458973918,0.0485992245872318,-6.53108453572634,34834,1.31337065995937,3,3,0,1e-07,0.00723371058013665,72337.1058013665,16.1424482566481
"847",930,1242,1242,1242,"Q9UNF1","MAGED2","MAGD2_HUMAN","cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; female pregnancy [GO:0007565]; platelet degranulation [GO:0002576]; renal sodium ion absorption [GO:0070294]",NA,"Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen)","GO:0002576; GO:0005576; GO:0005634; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294",1e-07,1e-07,1e-07,0.0231251519343595,0.0460896195899178,0.0512837402858914,0.0401660706033896,0.0200831353016948,4.81729122404934,0.00708636937046062,0.0488111841726697,-6.53893814822748,64954,1.31148065611283,6,3,0,1e-07,0.0460896195899178,460896.195899178,18.8140823345825
"848",931,1243,1243,1243,"Q96EV2","RBM33","RBM33_HUMAN","RNA binding [GO:0003723]",NA,"RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33)","GO:0003723",1e-07,1e-07,1e-07,0.0120876454132934,0.0240273569875388,0.0268260849863192,0.0209802624623838,0.0104902312311919,4.81701531371066,0.0070878857390921,0.0488111841726697,-6.53919450943786,129986,1.31148065611283,13,3,0,1e-07,0.0240273569875388,240273.569875388,17.8743184349861
"849",934,1246,1246,1246,"P53999","SUB1","TCP4_HUMAN","extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0001205]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]","SUBCELLULAR LOCATION: Nucleus.","Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14)","GO:0001205; GO:0003697; GO:0003713; GO:0003723; GO:0005634; GO:0005667; GO:0005730; GO:0006357; GO:0042802; GO:0060261; GO:0060395; GO:0070062",2.39284167583369e-05,0.00026708862409328,9.21207274354181e-05,0.00274836744509574,0.0013339532171948,0.00255456913617059,0.00208458401005803,0.00117000459445803,4.81160924007987,0.00711767542652699,0.0488692999081827,-6.54421958121154,14395,1.31096388254316,14,0,0,9.21207274354181e-05,0.00255456913617059,27.7306661300682,4.7934103672692
"850",936,1248,1248,1248,"Q86U70","LDB1","LDB1_HUMAN","beta-catenin-TCF complex [GO:1990907]; cell leading edge [GO:0031252]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enhancer sequence-specific DNA binding [GO:0001158]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription corepressor activity [GO:0003714]; transcription factor activity, transcription factor binding [GO:0000989]; anterior/posterior axis specification [GO:0009948]; cellular component assembly [GO:0022607]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial structure maintenance [GO:0010669]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; histone H3-K4 acetylation [GO:0043973]; multicellular organism development [GO:0007275]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of cell adhesion [GO:0045785]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of focal adhesion assembly [GO:0051893]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of kinase activity [GO:0043549]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (hLdb1) (Nuclear LIM interactor)","GO:0000790; GO:0000972; GO:0000989; GO:0001102; GO:0001158; GO:0001702; GO:0001942; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006351; GO:0006355; GO:0006366; GO:0007275; GO:0009948; GO:0010669; GO:0016055; GO:0019899; GO:0021702; GO:0022607; GO:0030182; GO:0030274; GO:0030334; GO:0031252; GO:0032784; GO:0032991; GO:0035019; GO:0042803; GO:0043549; GO:0043621; GO:0043973; GO:0045647; GO:0045785; GO:0045892; GO:0045944; GO:0046985; GO:0051893; GO:1902036; GO:1990907",0.00821134929723639,1e-07,6.79658929028217e-06,0.0575328217361542,0.0464077428608045,0.0899735816392504,0.0618986334498942,0.033688732020456,4.81030768999168,0.00712486989315561,0.0488692999081827,-6.54542998127313,46533,1.31096388254316,6,1,0,6.79658929028217e-06,0.0575328217361542,8464.95488824302,13.0472866643386
"851",937,1249,1249,1249,"Q9BV68","RNF126","RN126_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; epidermal growth factor receptor binding [GO:0005154]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23026136}. Nucleus {ECO:0000269|PubMed:23026136}.","E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126)","GO:0000209; GO:0005154; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0042059; GO:0042127; GO:0042147; GO:0043161; GO:0043162; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:0071629",1e-07,1e-07,1e-07,0.134122511294638,0.120901541819381,0.0604103896322435,0.105144714248754,0.0525724571243771,4.80814235073383,0.00713685836742492,0.0488747977948715,-6.54744417571747,35585,1.31091502635829,3,3,0,1e-07,0.120901541819381,1209015.41819381,20.2054012122652
"852",938,1253,1253,1253,"P09661","SNRPA1","RU2A_HUMAN","catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166}.","U2 small nuclear ribonucleoprotein A' (U2 snRNP A')","GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0035722; GO:0071005; GO:0071007; GO:0071013",0.00457350465340558,0.011829479270997,0.00858378049783036,0.0201150479451543,0.0298535236803232,0.0309480151483529,0.0186432741171991,0.0176505585326772,4.79737179613237,0.0071968502086296,0.0491660317524895,-6.55747217626297,28416,1.30833484270726,8,0,0,0.00858378049783036,0.0298535236803232,3.47789924123398,1.79821613670496
"853",940,1255,1255,1255,"P09525","ANXA4","ANXA4_HUMAN","cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phospholipase inhibitor activity [GO:0004859]; epithelial cell differentiation [GO:0030855]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; Notch signaling pathway [GO:0007219]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]",NA,"Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)","GO:0004859; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006357; GO:0007165; GO:0007219; GO:0009986; GO:0012506; GO:0030855; GO:0031965; GO:0032088; GO:0042802; GO:0043066; GO:0048306; GO:0048471; GO:0051059; GO:0070062; GO:2000483",1e-07,1e-07,1e-07,0.0003618126046219,0.00028556817091263,0.00018119340900942,0.00027609139484798,0.00013814569742399,4.79027837383982,0.00723669052301903,0.0492753681449829,-6.56408498151576,35883,1.30737012234558,3,3,0,1e-07,0.00028556817091263,2855.6817091263,11.4796194719231
"854",941,1256,1256,1256,"Q92618","ZNF516","ZN516_HUMAN","nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; response to cold [GO:0009409]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7TSH3}.","Zinc finger protein 516","GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006366; GO:0007165; GO:0007275; GO:0009409; GO:0033613; GO:0043565; GO:0044212; GO:0045893; GO:0046872; GO:0050873; GO:0060612",0.00012167072972903,0.00012399423284498,0.00026687158618428,0.0676854991607118,0.0339760333608729,0.075601978588947,0.0589169915205911,0.0296293412765483,4.79011161973089,0.00723763027375307,0.0492753681449829,-6.56424051772902,124289,1.30737012234558,3,0,0,0.00012399423284498,0.0676854991607118,545.876188010563,9.09242995557432
"855",942,1258,1258,1258,"Q15637","SF1","SF01_HUMAN","nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus.","Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162)","GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0006351; GO:0006355; GO:0008270; GO:0016604; GO:0030238; GO:0030575; GO:0033327; GO:0042802; GO:0045131; GO:0048662; GO:0050810",0.00013693294118456,0.00013952763904018,0.00015501292546738,0.00717390219259481,0.0159368193971642,0.0136434226425027,0.0121075569088565,0.00619760295632564,4.7880475389893,0.00724927461056925,0.0492753681449829,-6.56616605012762,68330,1.30737012234558,13,0,0,0.00013952763904018,0.0136434226425027,97.7829391822059,6.61151086574644
"856",943,1259,1259,1259,"Q9Y2K7","KDM2A","KDM2A_HUMAN","nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:19001877, ECO:0000269|PubMed:20417597}. Note=Punctate expression throughout the nucleoplasm and enriched in the perinucleolar region. Specifically nucleates at CpG islands where it's presence results in chromatin depleted in H3K36me2.","Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)","GO:0000981; GO:0003677; GO:0005654; GO:0006303; GO:0006351; GO:0008270; GO:0032452; GO:0051864; GO:0070544",0.00641521965667311,0.00030492537006607,0.00060912711813395,0.0858572424595586,0.0542144307035942,0.116097969657585,0.0829467902252881,0.0439164858276018,4.78783578483734,0.0072504704723749,0.0492753681449829,-6.56636362269768,132793,1.30737012234558,10,0,0,0.00060912711813395,0.0858572424595586,140.951272572761,7.13905269305463
"857",944,1261,1261,1261,"Q14249","ENDOG","NUCG_HUMAN","cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; deoxyribonuclease activity [GO:0004536]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; aging [GO:0007568]; apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; DNA recombination [GO:0006310]; in utero embryonic development [GO:0001701]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]","SUBCELLULAR LOCATION: Mitochondrion.","Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-)","GO:0001701; GO:0003676; GO:0004519; GO:0004536; GO:0005634; GO:0005739; GO:0005829; GO:0006309; GO:0006310; GO:0007568; GO:0009612; GO:0032355; GO:0034612; GO:0036475; GO:0043204; GO:0046677; GO:0046872; GO:0071277; GO:0071333; GO:0071456; GO:1901300; GO:1902512",7.26192579735389e-05,7.46531890288638e-05,4.31543967412378e-05,0.046790378251941,0.104403447614549,0.093593012594101,0.0815321372056157,0.0408295442173891,4.78492157514974,0.00726695222612511,0.0493041947240156,-6.56908326915498,32620,1.3071161300535,4,0,0,7.26192579735389e-05,0.093593012594101,1288.81807947149,10.3318329220105
"858",945,1262,1262,1262,"P22626","HNRNPA2B1","ROA2_HUMAN","Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047]; G-quadruplex DNA unwinding [GO:0044806]; interleukin-12-mediated signaling pathway [GO:0035722]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:17289661}. Cytoplasmic granule {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:24356509}. Secreted, exosome {ECO:0000269|PubMed:24356509}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs (PubMed:17289661). Component of ribonucleosomes (PubMed:17289661). Not found in the nucleolus (PubMed:17289661). Found in exosomes follwong sumoylation (PubMed:24356509). {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:24356509}.; SUBCELLULAR LOCATION: Isoform A2: Nucleus {ECO:0000269|PubMed:10772824, ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:24098712}. Cytoplasm {ECO:0000269|PubMed:10772824, ECO:0000269|PubMed:17289661}. Note=Predominantly nucleoplasmic, however is also found in the cytoplasm of cells in some tissues (PubMed:17289661). {ECO:0000269|PubMed:17289661}.","Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)","GO:0000122; GO:0000398; GO:0000781; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0006406; GO:0015030; GO:0016020; GO:0016070; GO:0016363; GO:0031053; GO:0035198; GO:0035722; GO:0042802; GO:0043047; GO:0044806; GO:0048025; GO:0050658; GO:0070062; GO:0071013; GO:0097157; GO:0098505; GO:1904358; GO:1905663; GO:1990247; GO:1990428; GO:1990904",0.00011291809995686,6.9429693954622e-05,7.51616815477043e-05,0.00717430915877848,0.0152706600316012,0.0103799033003965,0.0108557876717723,0.00551373032770589,4.78457544100262,0.00726891282029295,0.0493041947240156,-6.56940636933846,37430,1.3071161300535,18,0,0,7.51616815477043e-05,0.0103799033003965,138.100998895408,7.10957994453535
"859",946,1264,1264,1264,"Q8IZ07","ANKRD13A","AN13A_HUMAN","cytoplasm [GO:0005737]; late endosome [GO:0005770]; plasma membrane [GO:0005886]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22298428}. Late endosome {ECO:0000269|PubMed:22298428}. Note=Interaction with EGFR may enhance association with the cell membrane.","Ankyrin repeat domain-containing protein 13A (Protein KE03)","GO:0005737; GO:0005770; GO:0005886",0.00358748956978973,0.00033380840946756,0.00021398260620081,0.0174933265818683,0.0342864013631809,0.0363929551136595,0.0280124674910835,0.0153846606073611,4.77972495250673,0.00729645401067213,0.0494101529496561,-6.57393575625895,67619,1.3061838017453,13,0,0,0.00033380840946756,0.0342864013631809,102.712814868473,6.68247237916045
"860",947,1265,1265,1265,"Q13283","G3BP1","G3BP1_HUMAN","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20180778}. Perikaryon {ECO:0000250|UniProtKB:P97855}. Cytoplasm, Stress granule {ECO:0000269|PubMed:12642610, ECO:0000269|PubMed:20180778, ECO:0000269|PubMed:23953116}. Nucleus {ECO:0000269|PubMed:11604510}. Note=Cytoplasmic in proliferating cells (PubMed:11604510). Cytosolic and partially nuclear in resting cells (PubMed:11604510). Recruited to stress granules in response to arsenite treatment (PubMed:12642610, PubMed:20180778). The unphosphorylated form is recruited to stress granules (PubMed:12642610). HRAS signaling contributes to this process by regulating G3BP dephosphorylation (PubMed:12642610). {ECO:0000269|PubMed:11604510, ECO:0000269|PubMed:12642610, ECO:0000269|PubMed:20180778}.","Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1)","GO:0003677; GO:0003723; GO:0003729; GO:0004003; GO:0004004; GO:0004519; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005925; GO:0007265; GO:0010494; GO:0034063; GO:0090090",1.13761765491971e-06,0.00013416096570114,1.5441134695152e-06,0.0044192720118042,0.00889858851992406,0.00978996769781926,0.00765699517757398,0.00387411182106218,4.77877703925166,0.00730185087398539,0.0494101529496561,-6.57482128444092,52164,1.3061838017453,11,0,0,1.5441134695152e-06,0.00889858851992406,5762.91101373393,12.4925820276149
"861",948,1266,1266,1266,"P09651","HNRNPA1","ROA1_HUMAN","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]; cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; fibroblast growth factor receptor signaling pathway [GO:0008543]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA metabolic process [GO:0016070]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:27694260}. Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles continuously between the nucleus and the cytoplasm along with mRNA. Component of ribonucleosomes (PubMed:17289661). {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:27694260}.; SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17229681}. Note=(Microbial infection) In the course of viral infection, colocalizes with HCV NS5B at speckles in the cytoplasm in a HCV-replication dependent manner. {ECO:0000269|PubMed:17229681}.","Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]","GO:0000381; GO:0000398; GO:0003697; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0008543; GO:0016020; GO:0016032; GO:0016070; GO:0019904; GO:0032211; GO:0032212; GO:0035198; GO:0036002; GO:0042149; GO:0042802; GO:0051028; GO:0051168; GO:0051170; GO:0061752; GO:0070062; GO:0071013; GO:0098505; GO:1903936; GO:1990904",1e-07,1e-07,1e-07,0.0049538078863071,0.0110476806226632,0.0100320644747665,0.00867775099457893,0.00433897549728946,4.77625695062456,0.00731622205083182,0.049445121438747,-6.57717610160412,38747,1.30587655213054,5,3,0,1e-07,0.0100320644747665,100320.644747665,16.6142589997316
"862",950,1269,1269,1269,"Q15276","RABEP1","RABE1_HUMAN","early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cytoplasm. Early endosome. Recycling endosome. Cytoplasmic vesicle.","Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17)","GO:0005096; GO:0005768; GO:0005769; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025",0.00021876740145841,0.00015227780253578,0.00039147646593632,0.00262119195793568,0.0029872170861971,0.00148415474252881,0.00211001403891036,0.00130918090943202,4.76969809597189,0.00735378398789368,0.0496047209900472,-6.58330879270663,99290,1.30447698878485,24,0,0,0.00021876740145841,0.00262119195793568,11.9816386740508,3.58275332732585
"863",951,1270,1270,1270,"O00534","VWA5A","VMA5A_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]",NA,"von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)","GO:0005634; GO:0005654",1e-07,1e-07,1e-07,0.00023195010399988,0.00022608511564556,0.00013392833187259,0.00019722118383934,9.87105919196734e-05,4.76626995676714,0.00737350850273239,0.0496873552671541,-6.58651647572416,86489,1.30375411904132,15,3,0,1e-07,0.00022608511564556,2260.8511564556,11.1426502997892
"864",952,1271,1271,1271,"Q9H425","C1orf198","CA198_HUMAN","cytosol [GO:0005829]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22361696}.","Uncharacterized protein C1orf198","GO:0005829",0.00015963121012476,1e-07,1e-07,0.0395124984899814,0.0200954061607576,0.0451675909487687,0.0348718881297943,0.0174892211349387,4.76555267893833,0.00737764352155992,0.0496873552671541,-6.58718782583244,36346,1.30375411904132,5,2,0,1e-07,0.0395124984899814,395124.984899814,18.5919495494322
"865",953,1272,1272,1272,"Q9Y2Q0","ATP8A1","AT8A1_HUMAN","azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; magnesium ion binding [GO:0000287]; phospholipid-translocating ATPase activity [GO:0004012]; Golgi vesicle budding [GO:0048194]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; neutrophil degranulation [GO:0043312]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane {ECO:0000250|UniProtKB:P70704}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P70704}. Cytoplasmic granule {ECO:0000269|PubMed:20947505}. Cell membrane {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:21914794}. Endoplasmic reticulum {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:21914794}. Golgi apparatus {ECO:0000269|PubMed:20947505, ECO:0000269|PubMed:21914794}. Note=Exit from the endoplasmic reticulum requires the presence of TMEM30A, but not TMEM30B (PubMed:20947505). In the presence of TMEM30A, predominantly located in cytoplasmic punctate structures and localizes to the plasma membrane (PubMed:20947505). Localizes to plasma membranes of red blood cells (By similarity). {ECO:0000250|UniProtKB:P70704, ECO:0000269|PubMed:20947505}.","Phospholipid-transporting ATPase IA (EC 3.6.3.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)","GO:0000139; GO:0000287; GO:0004012; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0019829; GO:0030335; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0043312; GO:0045332; GO:0048194; GO:0061092; GO:0070062",0.00014363803311716,0.0001346548848389,0.00024795428559421,0.0122894060410911,0.0160616100043438,0.0252674792769473,0.0176974160396106,0.00902412375432208,4.76388788811383,0.00738725154343069,0.0497099368519324,-6.58874628443763,131369,1.30355678855834,21,0,0,0.00014363803311716,0.0160616100043438,111.82003579263,6.80503490164886
"866",954,1273,1273,1273,"Q9P286","PAK5","PAK5_HUMAN","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth [GO:0016049]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; regulation of mitotic cell cycle [GO:0007346]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]","SUBCELLULAR LOCATION: Mitochondrion. Cytoplasm. Nucleus. Note=Shuttles between the nucleus and the mitochondria, and mitochondrial localization is essential for the role in cell survival.","Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7)","GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0006915; GO:0007010; GO:0007165; GO:0007266; GO:0007346; GO:0007612; GO:0007613; GO:0007626; GO:0008283; GO:0016049; GO:0016477; GO:0023014; GO:0030036; GO:0031098; GO:0032147; GO:0042981; GO:0043408; GO:0048365; GO:2001237",1e-07,3.40871394724703e-06,1e-07,0.0403847687023501,0.0454811993966709,0.0202433338083203,0.035368564397798,0.0176854851035481,4.76296038731802,0.00739261093604089,0.0497099368519324,-6.58961470551933,80745,1.30355678855834,13,2,0,1e-07,0.0403847687023501,403847.687023501,18.6234517510554
"867",955,1274,1274,1274,"P36894","BMPR1A","BMR1A_HUMAN","dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular trabecula myocardium morphogenesis [GO:0003222]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292)","GO:0000981; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003148; GO:0003151; GO:0003161; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0004675; GO:0005524; GO:0005886; GO:0006468; GO:0006955; GO:0007179; GO:0007398; GO:0009897; GO:0009950; GO:0010862; GO:0014032; GO:0014912; GO:0016021; GO:0019827; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0035137; GO:0035912; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0050679; GO:0050768; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060914; GO:0061312; GO:0061626; GO:0071773; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:1990712; GO:2000772",1e-07,1e-07,1e-07,0.0514528731173516,0.0228875967195646,0.0458085053408438,0.0400495583925867,0.0200248791962933,4.75771590555229,0.00742300295100872,0.04987512186863,-6.59452729268618,60198,1.30211603011605,4,3,0,1e-07,0.0458085053408438,458085.053408438,18.8052559652008
"868",958,1280,1280,1280,"Q8N4S0","CCDC82","CCD82_HUMAN",NA,NA,"Coiled-coil domain-containing protein 82",NA,0.0505721664190286,0.0541874568647919,0.0420937466545672,0.0776150775703973,0.109717138647111,0.0966792421154349,0.0457193627981853,0.0718108047118885,4.75022653997788,0.00746666396294592,0.0499074445385387,-6.6015490875849,64002,1.30183466718506,5,0,0,0.0505721664190286,0.0966792421154349,1.91170853378861,0.934862581419401
"869",959,1282,1282,1282,"Q05BQ5","MBTD1","MBTD1_HUMAN","nucleus [GO:0005634]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; embryonic skeletal system development [GO:0048706]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","MBT domain-containing protein 1","GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0008270; GO:0035064; GO:0048706",1e-07,2.6773207613814e-05,1e-07,0.0088999493305349,0.0200419420048105,0.0178594669463634,0.015591461691365,0.00780472191488711,4.74547683232229,0.00749451285353071,0.0499989026125066,-6.60600616441501,70547,1.30103952755524,5,2,0,1e-07,0.0178594669463634,178594.669463634,17.4463294952479
